1 00:00:05,633 --> 00:00:07,101 GOOD MORNING. 2 00:00:07,101 --> 00:00:09,504 WELCOME TO OUR WORKSHOP. 3 00:00:09,504 --> 00:00:11,038 TRANSFORMING HYPERTENSION 4 00:00:11,038 --> 00:00:13,541 DIAGNOSIS AND MANAGEMENT, IN THE 5 00:00:13,541 --> 00:00:16,177 ERA OF ARTIFICIAL INTELLIGENCE. 6 00:00:16,177 --> 00:00:19,347 TODAY WE HAVE THREE SESSIONS 7 00:00:19,347 --> 00:00:19,947 WITH EXCELLENT SPEAKERS UNTIL 8 00:00:19,947 --> 00:00:23,050 4:00 P.M. EASTERN TIME. 9 00:00:23,050 --> 00:00:25,052 TOMORROW WE BEGIN AT 11:00 A.M. 10 00:00:25,052 --> 00:00:27,655 EASTERN TIME AND CONCLUDE WITH 11 00:00:27,655 --> 00:00:28,422 SESSIONS 4 AND 5. 12 00:00:28,422 --> 00:00:30,391 WE'LL HAVE A BREAK TODAY AFTER 13 00:00:30,391 --> 00:00:31,259 SESSIONS 1 AND 2. 14 00:00:31,259 --> 00:00:33,461 WE ASK THAT YOU TYPE YOUR 15 00:00:33,461 --> 00:00:34,996 QUESTIONS IN THE CHAT BOX 16 00:00:34,996 --> 00:00:38,399 ACADEMIC KEEP -- AND KEEP YOUR 17 00:00:38,399 --> 00:00:39,467 VOLUME ON MUTE UNLESS SPEAKING. 18 00:00:39,467 --> 00:00:41,536 WE ASK THAT YOU KEEP YOUR VIDEO 19 00:00:41,536 --> 00:00:44,071 OFF UNLESS YOU ARE SPEAKING AS 20 00:00:44,071 --> 00:00:44,605 WELL. 21 00:00:44,605 --> 00:00:46,807 I'D LIKE TO BEGIN BY INTRODUCING 22 00:00:46,807 --> 00:00:49,110 OUR FIRST SPEAKER TODAY, DR. 23 00:00:49,110 --> 00:00:56,984 GOFF, DIRECTOR OF THE DIVISION 24 00:00:56,984 --> 00:00:58,519 OF CARDIOVASCULAR SCIENCE NHLBI, 25 00:00:58,519 --> 00:01:02,256 BEFORE THAT WAS DEAN AND 26 00:01:02,256 --> 00:01:06,093 PROFESSOR OF EPIDEMIOLOGY, 27 00:01:06,093 --> 00:01:07,061 COLORADO SCHOOL OF PUBLIC HEALTH 28 00:01:07,061 --> 00:01:09,463 AND AT THE WAKE FOREST SCHOOL OF 29 00:01:09,463 --> 00:01:09,730 MEDICINE. 30 00:01:09,730 --> 00:01:12,400 HE RECEIVED AN M.D. FROM 31 00:01:12,400 --> 00:01:15,603 UNIVERSITY OF NORTH CAROLINA, 32 00:01:15,603 --> 00:01:16,470 Ph.D. IN EPIDEMIOLOGY FROM 33 00:01:16,470 --> 00:01:17,371 UNIVERSITY OF TEXAS HOUSTON 34 00:01:17,371 --> 00:01:18,873 SCHOOL OF PUBLIC HEALTH. 35 00:01:18,873 --> 00:01:23,911 HE IS AN ELECTED MEMBER OF THE 36 00:01:23,911 --> 00:01:25,313 AMERICAN EPIDEMIOLOGICAL 37 00:01:25,313 --> 00:01:26,013 SOCIETY, FELLOW OF AMERICAN 38 00:01:26,013 --> 00:01:27,515 COLLEGE OF PHYSICIANS, AMERICAN 39 00:01:27,515 --> 00:01:29,584 HEART ASSOCIATION. 40 00:01:29,584 --> 00:01:32,220 HE HAS PUBLISHED OVER 300 41 00:01:32,220 --> 00:01:33,855 MANUSCRIPTS, BOOK CHAPTERS AND 42 00:01:33,855 --> 00:01:40,228 SCIENTIFIC REPORTS. 43 00:01:40,228 --> 00:01:44,699 PLEASE WELCOME DR. GOFF. 44 00:01:44,699 --> 00:01:46,567 >> THANKS, I APPRECIATE THE KIND 45 00:01:46,567 --> 00:01:47,168 INTRODUCTION. 46 00:01:47,168 --> 00:01:50,204 I WANT TO WELCOME EVERYONE TO 47 00:01:50,204 --> 00:01:51,305 THIS REALLY IMPORTANT WORKSHOP. 48 00:01:51,305 --> 00:01:56,110 IT'S IMPORTANT FOR US AS AN 49 00:01:56,110 --> 00:01:58,846 INSTITUTE AND CLOSE TO MY HEART. 50 00:01:58,846 --> 00:02:00,915 I SEE LONGTIME FRIENDS AND 51 00:02:00,915 --> 00:02:01,449 COLLEAGUES HERE. 52 00:02:01,449 --> 00:02:05,553 WHEN HE WAS AT THE UNIVERSITY OF 53 00:02:05,553 --> 00:02:07,188 TEXAS HOUSTON SCHOOL OF PUBLIC 54 00:02:07,188 --> 00:02:16,931 HEALTH IN THE LAST MILL ENYUM, I 55 00:02:16,931 --> 00:02:21,002 CUT MY TEETH THERE WITH THE 56 00:02:21,002 --> 00:02:21,235 TRIAL. 57 00:02:21,235 --> 00:02:22,837 IT'S BEEN A LONG JOURNEY TO TRY 58 00:02:22,837 --> 00:02:28,442 TO GET TO THE POINT WHERE WE CAN 59 00:02:28,442 --> 00:02:30,177 ELIMINATE HYPERTENSION OR 60 00:02:30,177 --> 00:02:30,878 RELATED CARDIOVASCULAR DISEASES. 61 00:02:30,878 --> 00:02:34,015 WHICH IS ONE OF THE PILLARS AND 62 00:02:34,015 --> 00:02:34,782 STRATEGIC VISION AND 63 00:02:34,782 --> 00:02:37,518 IMPLEMENTATION PLAN FOR THE 64 00:02:37,518 --> 00:02:40,288 DIVISION OF CARDIOVASCULAR 65 00:02:40,288 --> 00:02:41,889 SCIENCES AT NHLBI. 66 00:02:41,889 --> 00:02:47,695 SO, ELIMINATION OF HYPERTENSION 67 00:02:47,695 --> 00:02:48,896 OR HYPERTENSION-RELATED 68 00:02:48,896 --> 00:02:50,097 CARDIOVASCULAR DISEASE IS A GOAL 69 00:02:50,097 --> 00:02:51,299 FOR US. 70 00:02:51,299 --> 00:02:51,632 WHY? 71 00:02:51,632 --> 00:02:55,703 WELL, THE GLOBAL BURDEN OF 72 00:02:55,703 --> 00:02:56,570 DISEASE PROJECT TELLS US THAT 73 00:02:56,570 --> 00:02:58,105 HIGH BLOOD PRESSURE IS LEADING 74 00:02:58,105 --> 00:03:02,476 CAUSE OF DEATH ON THIS PLANET. 75 00:03:02,476 --> 00:03:04,545 I OFTEN SAY, WELL, THAT'S JUST 76 00:03:04,545 --> 00:03:07,181 THIS PLANET BUT IT SHOULD COUNT 77 00:03:07,181 --> 00:03:09,684 FOR SOMETHING. 78 00:03:09,684 --> 00:03:12,520 SO FOCUSING ON PREVENTION, 79 00:03:12,520 --> 00:03:13,688 DETECTION, TREATMENT, AND 80 00:03:13,688 --> 00:03:14,322 CONTROL OF HIGH BLOOD PRESSURE 81 00:03:14,322 --> 00:03:16,524 MUST BE ONE OF OUR HIGHEST 82 00:03:16,524 --> 00:03:17,491 PRIORITIES, GIVEN THAT HIGH 83 00:03:17,491 --> 00:03:19,327 BLOOD PRESSURE IS LEADING CAUSE 84 00:03:19,327 --> 00:03:22,163 OF DEATH AND DISABILITY ON THE 85 00:03:22,163 --> 00:03:22,630 PLANET. 86 00:03:22,630 --> 00:03:23,798 SO, WHAT YOU'RE GOING TO BE 87 00:03:23,798 --> 00:03:27,001 DOING OVER THE NEXT COUPLE DAYS 88 00:03:27,001 --> 00:03:29,704 GIVING US INPUT AND IDENTIFYING 89 00:03:29,704 --> 00:03:30,604 OPPORTUNITIES TO ADVANCE THIS 90 00:03:30,604 --> 00:03:32,239 PART OF OUR STRATEGIC VISION IS 91 00:03:32,239 --> 00:03:32,974 JUST CRITICALLY IMPORTANT. 92 00:03:32,974 --> 00:03:33,774 WE THANK YOU VERY MUCH. 93 00:03:33,774 --> 00:03:35,109 WE KNOW THERE ARE MANY THINGS 94 00:03:35,109 --> 00:03:37,712 YOU COULD BE DOING, ESPECIALLY 95 00:03:37,712 --> 00:03:38,179 THESE DAYS. 96 00:03:38,179 --> 00:03:39,580 THE FACT THAT YOU CHOSE TO SPEND 97 00:03:39,580 --> 00:03:42,216 TIME WITH US IS SOMETHING FOR 98 00:03:42,216 --> 00:03:43,084 WHICH WE'RE GRATEFUL. 99 00:03:43,084 --> 00:03:44,785 SO WE WANT TO MAKE GOOD USE OF 100 00:03:44,785 --> 00:03:46,053 YOUR TIME AND INPUT. 101 00:03:46,053 --> 00:03:49,023 HOW WILL WE DO THAT? 102 00:03:49,023 --> 00:03:50,992 WELL, THERE'S SOME THINGS THAT 103 00:03:50,992 --> 00:03:51,659 ARE STRAIGHTFORWARD. 104 00:03:51,659 --> 00:03:52,960 WE'LL GET A REPORT ON OUR 105 00:03:52,960 --> 00:03:53,394 WEBSITE. 106 00:03:53,394 --> 00:03:57,565 WE HOPE TO GET THAT REPORT OUT 107 00:03:57,565 --> 00:03:59,433 WITHIN THE NEXT MONTH OR SO, SO 108 00:03:59,433 --> 00:04:01,068 THE INFORMATION IS TIMELY WHEN 109 00:04:01,068 --> 00:04:03,037 WE SHARE IT WITH THE BIOMEDICAL 110 00:04:03,037 --> 00:04:03,571 RESEARCH COMMUNITY. 111 00:04:03,571 --> 00:04:08,843 FOR THAT WE'LL BE LEANING ON YOU 112 00:04:08,843 --> 00:04:09,643 AND ESPECIALLY YOUR CO-CHAIRS, 113 00:04:09,643 --> 00:04:12,246 WHO WILL BE WORKING WITH US AND 114 00:04:12,246 --> 00:04:16,317 YOU TO GET THAT REPORT OUT 115 00:04:16,317 --> 00:04:16,584 PROMPTLY. 116 00:04:16,584 --> 00:04:18,386 WE ALSO ANTICIPATE THAT YOU MAY 117 00:04:18,386 --> 00:04:21,555 WANT TO PUT TOGETHER A PAPER FOR 118 00:04:21,555 --> 00:04:23,958 SUBMISSION FOR PUBLICATION TO A 119 00:04:23,958 --> 00:04:25,059 PEER-REVIEWED JOURNAL, WE'LL 120 00:04:25,059 --> 00:04:25,960 SUPPORT THAT IF THAT'S SOMETHING 121 00:04:25,960 --> 00:04:27,061 YOU WOULD LIKE TO DO. 122 00:04:27,061 --> 00:04:30,131 IT'S NOT A REQUIREMENT BUT IT'S 123 00:04:30,131 --> 00:04:31,532 OFTEN A USEFUL WORK PRODUCT OUT 124 00:04:31,532 --> 00:04:34,168 OF A WORKSHOP LIKE THIS. 125 00:04:34,168 --> 00:04:36,036 IF YOU DO THAT WE HOPE YOU'LL DO 126 00:04:36,036 --> 00:04:37,538 IT PROMPTLY AND GET THE 127 00:04:37,538 --> 00:04:39,507 INFORMATION OUT WITHIN SIX 128 00:04:39,507 --> 00:04:42,143 MONTHS OR SO AT THE LATEST SO 129 00:04:42,143 --> 00:04:44,445 THAT AGAIN IT'S TIMELY FOR THE 130 00:04:44,445 --> 00:04:46,881 BIOMEDICAL RESEARCH COMMUNITY TO 131 00:04:46,881 --> 00:04:49,617 GET YOUR IMPORTANT INSIGHTS AND 132 00:04:49,617 --> 00:04:50,151 INPUT. 133 00:04:50,151 --> 00:04:51,385 WE ALSO HOPE THAT AT THE END OF 134 00:04:51,385 --> 00:04:54,855 THIS YOU AND THE OTHERS WHO ARE 135 00:04:54,855 --> 00:04:57,658 LISTENING WILL BE STIMULATED TO 136 00:04:57,658 --> 00:04:58,826 SUBMIT INVESTIGATOR-INITIATED 137 00:04:58,826 --> 00:05:00,094 APPLICATIONS TO THE INSTITUTE. 138 00:05:00,094 --> 00:05:02,396 THE VAST MAJORITY OF THE 139 00:05:02,396 --> 00:05:04,832 RESOURCES THAT WE HAVE ARE GIVEN 140 00:05:04,832 --> 00:05:11,839 OUT EACH YEAR IN 141 00:05:11,839 --> 00:05:16,010 INVESTIGATOR-INITIATED -- TO 142 00:05:16,010 --> 00:05:16,844 INVESTIGATOR-INITIATED 143 00:05:16,844 --> 00:05:17,178 APPLICATIONS. 144 00:05:17,178 --> 00:05:18,913 WE HOPE THIS WILL STIMULATE 145 00:05:18,913 --> 00:05:20,714 IDEAS THROUGH THAT PROCESS. 146 00:05:20,714 --> 00:05:22,016 WE USE YOUR INPUT TO GUIDE 147 00:05:22,016 --> 00:05:23,451 SELECT PAY. 148 00:05:23,451 --> 00:05:27,288 WE HAVE A POT OF FUNDS THAT WE 149 00:05:27,288 --> 00:05:29,557 RESERVE EACH YEAR TO BE ABLE TO 150 00:05:29,557 --> 00:05:31,859 PICK UP APPLICATIONS THAT COME 151 00:05:31,859 --> 00:05:32,760 IN THROUGH THE PEER-REVIEWED 152 00:05:32,760 --> 00:05:33,894 PROCESS THAT ARE NOT QUITE ON 153 00:05:33,894 --> 00:05:37,031 THE RIGHT SIDE OF THE PAYLINE 154 00:05:37,031 --> 00:05:39,733 BUT ARE STRATEGICALLY ALIGNED. 155 00:05:39,733 --> 00:05:40,935 GIVEN THE IMPORTANCE OF THIS 156 00:05:40,935 --> 00:05:43,571 AREA TO OUR MISSION AND 157 00:05:43,571 --> 00:05:45,339 STRATEGIC VISION, WE USE YOUR 158 00:05:45,339 --> 00:05:49,043 INPUT TO HELP GUIDE OUR SELECT 159 00:05:49,043 --> 00:05:50,044 PAY PROCESS. 160 00:05:50,044 --> 00:05:52,246 NOW, THERE ARE SOMETIMES FUNDING 161 00:05:52,246 --> 00:05:54,215 OPPORTUNITIES THAT ARE ANNOUNCED 162 00:05:54,215 --> 00:05:56,050 IN ASSOCIATION WITH WORKSHOPS. 163 00:05:56,050 --> 00:05:57,485 I WANT TO SET REASONABLE 164 00:05:57,485 --> 00:05:58,886 EXPECTATIONS BECAUSE WE DO MORE 165 00:05:58,886 --> 00:06:02,189 WORKSHOPS EACH YEAR THAN WE CAN 166 00:06:02,189 --> 00:06:04,358 POSSIBLY PUT OUT WELL-FUNDED 167 00:06:04,358 --> 00:06:05,226 FUNDING OPPORTUNITIES. 168 00:06:05,226 --> 00:06:06,327 SO WHETHER A FUNDING OPPORTUNITY 169 00:06:06,327 --> 00:06:08,496 GROWS OUT OF THIS WORKSHOP OR 170 00:06:08,496 --> 00:06:12,233 NOT IS I THINK YET TO BE 171 00:06:12,233 --> 00:06:12,566 DETERMINED. 172 00:06:12,566 --> 00:06:18,706 IT'S A POSSIBILITY, BUT IT'S NOT 173 00:06:18,706 --> 00:06:19,240 A DEFINITE. 174 00:06:19,240 --> 00:06:21,709 DEPENDS HOW STRONG THE IDEAS ARE 175 00:06:21,709 --> 00:06:23,410 AND HOW PRACTICAL THEY ARE AND 176 00:06:23,410 --> 00:06:24,712 THE RESOURCES THAT WE HAVE TO BE 177 00:06:24,712 --> 00:06:26,947 ABLE TO PUT BEHIND IDEAS. 178 00:06:26,947 --> 00:06:30,417 BUT WE WILL TAKE YOUR INPUT VERY 179 00:06:30,417 --> 00:06:30,918 SERIOUSLY. 180 00:06:30,918 --> 00:06:33,954 THIS IS AN ISSUE THAT'S JUST 181 00:06:33,954 --> 00:06:37,124 CRITICAL TO OUR MISSION. 182 00:06:37,124 --> 00:06:39,093 AND IT'S, YOU KNOW, IF YOU LOOK 183 00:06:39,093 --> 00:06:40,294 AT OUR STRATEGIC VISION 184 00:06:40,294 --> 00:06:42,029 IMPLEMENTATION PLAN AND YOU LOOK 185 00:06:42,029 --> 00:06:43,197 ACROSS OUR PILLARS, I MENTIONED 186 00:06:43,197 --> 00:06:45,666 THIS IS ONE OF THE SIX PILLARS, 187 00:06:45,666 --> 00:06:47,868 IT'S RELATED TO SEVERAL OTHERS. 188 00:06:47,868 --> 00:06:52,806 ONE OF OUR PRIORITIES IS TO 189 00:06:52,806 --> 00:06:54,275 ADDRESS SOCIAL DETERMINANTS OF 190 00:06:54,275 --> 00:06:57,077 CARDIOVASCULAR HEALTH AND HIGH 191 00:06:57,077 --> 00:07:00,014 BLOOD PRESSURE IS A MAJOR PART 192 00:07:00,014 --> 00:07:01,982 OF THE HEALTH INEQUITY CHALLENGE 193 00:07:01,982 --> 00:07:04,418 IN OUR COUNTRY. 194 00:07:04,418 --> 00:07:05,252 SO ADDRESSING SOCIAL 195 00:07:05,252 --> 00:07:07,555 DETERMINANTS OF HEALTH 196 00:07:07,555 --> 00:07:11,292 INEQUITIES WILL HELP US ADDRESS 197 00:07:11,292 --> 00:07:11,859 HYPERTENSION. 198 00:07:11,859 --> 00:07:13,394 ANOTHER PILLAR IS PROMOTING 199 00:07:13,394 --> 00:07:16,230 CARDIOVASCULAR ACROSS THE 200 00:07:16,230 --> 00:07:16,497 LIFESPAN. 201 00:07:16,497 --> 00:07:17,331 WE KNOW THAT BLOOD PRESSURE 202 00:07:17,331 --> 00:07:21,302 TENDS TO GO UP WITH AGE IN 203 00:07:21,302 --> 00:07:23,337 COUNTRIES IN WHICH A LOT OF 204 00:07:23,337 --> 00:07:25,372 SODIUM IS CONSUMED. 205 00:07:25,372 --> 00:07:30,110 IF WE'RE ABLE TO WORK OUT A WAY 206 00:07:30,110 --> 00:07:32,413 TO PREVENT THE AGE-RELATED 207 00:07:32,413 --> 00:07:34,148 INCREASE OR AGE-ASSOCIATED 208 00:07:34,148 --> 00:07:35,583 INCREASE IN BLOOD PRESSURE, THAT 209 00:07:35,583 --> 00:07:38,786 WILL ALSO GO A LONG WAY TOWARDS 210 00:07:38,786 --> 00:07:40,854 ADDRESSING HEALTH DISPARITIES 211 00:07:40,854 --> 00:07:41,622 AND PREVENTING 212 00:07:41,622 --> 00:07:42,056 HYPERTENSION-RELATED 213 00:07:42,056 --> 00:07:43,791 CARDIOVASCULAR DISEASES. 214 00:07:43,791 --> 00:07:45,893 SO I'M LOOKING FORWARD TO YOUR 215 00:07:45,893 --> 00:07:47,294 INPUT ON THE TOPICS YOU'RE GOING 216 00:07:47,294 --> 00:07:49,263 TO BE DISCUSSING OVER THE NEXT 217 00:07:49,263 --> 00:07:52,099 COUPLE DAYS TO REALLY HELP US 218 00:07:52,099 --> 00:07:54,868 RETHINK HOW WE APPROACH THESE 219 00:07:54,868 --> 00:07:56,370 PARTS OF OUR MISSION. 220 00:07:56,370 --> 00:07:59,707 AND WITH THAT, I'M GOING TO PASS 221 00:07:59,707 --> 00:08:02,276 THE BATON BACK TO DR. ITURRIAGA 222 00:08:02,276 --> 00:08:05,379 AND THE CO-CHAIRS SO WE CAN GET 223 00:08:05,379 --> 00:08:10,117 ON WITH THE WORK OF THE DAY. 224 00:08:10,117 --> 00:08:12,720 THANK YOU VERY MUCH. 225 00:08:12,720 --> 00:08:14,588 >> THANK YOU, DR. GOFF. 226 00:08:14,588 --> 00:08:18,759 I'D LIKE TO INTRODUCE THE TWO 227 00:08:18,759 --> 00:08:21,729 CO-CHAIRS, DOCTORS SHAH AND 228 00:08:21,729 --> 00:08:22,663 SHIMBO. 229 00:08:22,663 --> 00:08:24,064 DR. SHAH IS ASSOCIATE PROFESSOR 230 00:08:24,064 --> 00:08:28,302 UNIVERSITY OF UTAH SCHOOL OF 231 00:08:28,302 --> 00:08:29,169 MEDICINE, CLINICAL RESEARCH 232 00:08:29,169 --> 00:08:32,239 SCIENTIST, OVERALL GOAL IS TO 233 00:08:32,239 --> 00:08:33,741 IMPROVE GLOBAL CARDIOVASCULAR 234 00:08:33,741 --> 00:08:35,109 HEALTH BY EMPHASIZING QUALITY 235 00:08:35,109 --> 00:08:37,044 AND VALUE INSIDE AND OUTSIDE OF 236 00:08:37,044 --> 00:08:39,546 TRADITIONAL HEALTH CARE DELIVERY 237 00:08:39,546 --> 00:08:40,381 SYSTEM. 238 00:08:40,381 --> 00:08:42,316 DR. SHAH'S WORK FOCUSES ON 239 00:08:42,316 --> 00:08:43,417 EMPOWERING PEOPLE TO ACHIEVE 240 00:08:43,417 --> 00:08:45,152 HEALTH BY BUILDING AND 241 00:08:45,152 --> 00:08:46,787 DELIVERING NEW TOOLS AND 242 00:08:46,787 --> 00:08:47,755 RESOURCES THAT WORK. 243 00:08:47,755 --> 00:08:52,393 SHE HAS EXPERIENCE AS A HEALTH 244 00:08:52,393 --> 00:08:54,461 SERVICES RESEARCHER WITH 245 00:08:54,461 --> 00:08:57,331 EXPERTISE IN CLINICAL 246 00:08:57,331 --> 00:08:58,532 INFORMATICS, COMPARATIVE 247 00:08:58,532 --> 00:08:59,099 EFFECTIVENESS, OBSERVATIONAL 248 00:08:59,099 --> 00:09:00,968 STUDY DESIGN. 249 00:09:00,968 --> 00:09:04,004 ACADEMIC WORK INCLUDES CREATING 250 00:09:04,004 --> 00:09:05,739 PHENOTYPES AND ANALYSIS-READY 251 00:09:05,739 --> 00:09:06,940 DATASETS. 252 00:09:06,940 --> 00:09:10,244 PREVIOUS ACHIEVEMENTS INCLUDE 253 00:09:10,244 --> 00:09:12,546 NIH GRANTS, DORIS DUKE AWARD, 254 00:09:12,546 --> 00:09:16,583 INAUGURAL WOMAN AS AN ESCALATOR 255 00:09:16,583 --> 00:09:17,451 AWARD. 256 00:09:17,451 --> 00:09:19,653 DR. SHIMBO IS A 257 00:09:19,653 --> 00:09:21,622 PHYSICIAN-SCIENTIST, PROFESSOR 258 00:09:21,622 --> 00:09:22,656 OF MEDICINE AT COLUMBIA 259 00:09:22,656 --> 00:09:24,692 UNIVERSITY IRVING MEDICAL 260 00:09:24,692 --> 00:09:24,925 CENTER. 261 00:09:24,925 --> 00:09:27,294 HE RECEIVED A BACHELOR OF 262 00:09:27,294 --> 00:09:29,730 SCIENCE FROM JOHNS HOPKINS 263 00:09:29,730 --> 00:09:30,364 UNIVERSITY IN BIOMEDICAL 264 00:09:30,364 --> 00:09:33,000 ENGINEERING, M.D. FROM ALBANY 265 00:09:33,000 --> 00:09:35,069 MEDICAL COLLEGE. 266 00:09:35,069 --> 00:09:37,171 AFTER COMPLETING AN INTERNAL 267 00:09:37,171 --> 00:09:40,340 MEDICINE RESIDENCY HE WENT ON TO 268 00:09:40,340 --> 00:09:43,177 COMPLETE CHIEF MEDICAL RESIDENCY 269 00:09:43,177 --> 00:09:46,980 IN INTERNAL MEDICINE IN 270 00:09:46,980 --> 00:09:47,748 CARDIOVASCULAR MEDICINE, MOUNT 271 00:09:47,748 --> 00:09:50,184 SINAI HOSPITAL BEFORE JOINING 272 00:09:50,184 --> 00:09:52,252 FACULTY AT COLUMBIA UNIVERSITY 273 00:09:52,252 --> 00:09:53,454 IN 2003. 274 00:09:53,454 --> 00:09:55,422 DR. SHIMBO IS DIRECTOR OF 275 00:09:55,422 --> 00:09:58,025 COLUMBIA HYPERTENSION CENTER AND 276 00:09:58,025 --> 00:09:59,693 LABORATORY, CONDUCTS RESEARCH 277 00:09:59,693 --> 00:10:03,163 INTO THE BEHAVIORAL AND 278 00:10:03,163 --> 00:10:04,398 BIOLOGICAL MECHANISMS THAT 279 00:10:04,398 --> 00:10:05,599 UNDERLIE HYPERTENSION AND 280 00:10:05,599 --> 00:10:06,667 CARDIOVASCULAR DISEASE. 281 00:10:06,667 --> 00:10:09,870 HE IS AN EXPERT IN THE DIAGNOSIS 282 00:10:09,870 --> 00:10:11,939 AND TREATMENT OF HYPERTENSION 283 00:10:11,939 --> 00:10:14,808 AND HOW HYPERTENSION AND ITS 284 00:10:14,808 --> 00:10:16,310 PHENOTYPES ARE RELATED TO 285 00:10:16,310 --> 00:10:17,511 CARDIOVASCULAR DISEASE ONSET. 286 00:10:17,511 --> 00:10:19,379 I'M NOW TURNING OVER THE 287 00:10:19,379 --> 00:10:24,752 WORKSHOP TO OUR WONDERFUL 288 00:10:24,752 --> 00:10:25,018 CO-CHAIRS. 289 00:10:25,018 --> 00:10:26,053 >> OKAY. 290 00:10:26,053 --> 00:10:28,889 GOOD MORNING HERE IN NEW YORK. 291 00:10:28,889 --> 00:10:31,091 I AM FIRST GOING TO SAY A FEW 292 00:10:31,091 --> 00:10:32,926 WORDS, AND THEN I'M GOING TO 293 00:10:32,926 --> 00:10:34,595 HAVE DR. SHAH TAKE US THROUGH 294 00:10:34,595 --> 00:10:36,897 THE AGENDA FOR DAY 1. 295 00:10:36,897 --> 00:10:39,399 I'M GOING TO END BY GOING 296 00:10:39,399 --> 00:10:40,934 THROUGH DAY 2. 297 00:10:40,934 --> 00:10:44,671 YOU HEARD FROM DR. GOFF. 298 00:10:44,671 --> 00:10:47,708 I'M A CARDIOLOGIST, AS WELL AS 299 00:10:47,708 --> 00:10:49,042 DR. SHAH. 300 00:10:49,042 --> 00:10:51,578 I'M FOCUSED ON HYPERTENSION, I 301 00:10:51,578 --> 00:10:54,181 AM BIASED, IT'S BECOMING MORE 302 00:10:54,181 --> 00:10:56,416 RELEVANT GIVEN IT'S THE NUMBER 303 00:10:56,416 --> 00:10:57,551 ONE KILLER WORLDWIDE. 304 00:10:57,551 --> 00:11:02,055 AND IN THE UNITED STATES, 305 00:11:02,055 --> 00:11:03,290 UNFORTUNATELY, BP CONTROL RATES 306 00:11:03,290 --> 00:11:07,094 HAVE WORSENED EVEN BEFORE THE 307 00:11:07,094 --> 00:11:09,062 PANDEMIC, HAVE GOTTEN WORSE 308 00:11:09,062 --> 00:11:11,365 DURING THE PANDEMIC. 309 00:11:11,365 --> 00:11:14,568 GIVEN HOW IMPORTANT HYPERTENSION 310 00:11:14,568 --> 00:11:18,472 IS, TO ME IT'S TIME TO HIT THE 311 00:11:18,472 --> 00:11:21,508 RESET BUTTON AND IDENTIFY 312 00:11:21,508 --> 00:11:22,843 PRIORITIES FOR BLOOD PRESSURE 313 00:11:22,843 --> 00:11:23,343 CONTROL. 314 00:11:23,343 --> 00:11:25,379 THIS SESSION IS FOCUSED ON 315 00:11:25,379 --> 00:11:26,680 ARTIFICIAL INTELLIGENCE. 316 00:11:26,680 --> 00:11:28,315 YOU HAVE SEEN EVERYWHERE 317 00:11:28,315 --> 00:11:29,516 ALGORITHMS ARE EVERYWHERE, I 318 00:11:29,516 --> 00:11:31,251 JUST PICKED UP THE JAMA LAST 319 00:11:31,251 --> 00:11:33,887 NIGHT AND SAW TWO MORE 320 00:11:33,887 --> 00:11:36,089 PUBLICATIONS ON A.I. AND MEDICAL 321 00:11:36,089 --> 00:11:37,324 HEALTH. 322 00:11:37,324 --> 00:11:39,927 AND WHAT'S CLEAR IS IT'S ALL 323 00:11:39,927 --> 00:11:41,562 OVER SOCIAL MEDIA, AND AS WELL 324 00:11:41,562 --> 00:11:44,631 AS NOT JUST JAMA BUT OTHER 325 00:11:44,631 --> 00:11:46,033 PUBLISHED JOURNALS. 326 00:11:46,033 --> 00:11:50,304 AND IT'S PRETTY CLEAR THAT 327 00:11:50,304 --> 00:11:53,173 INDUSTRY PARTNERS ARE INCREASING 328 00:11:53,173 --> 00:11:55,042 INVESTMENTS, FACEBOOK, GOOGLE, 329 00:11:55,042 --> 00:11:59,379 MICROSOFT, REALLY DOUBLING DOWN 330 00:11:59,379 --> 00:12:03,450 ON A.I. I PERSONALLY HAVE CHUTE 331 00:12:03,450 --> 00:12:06,086 CHAT USED CHATGPT AND OTHERS AND 332 00:12:06,086 --> 00:12:06,887 HAVE BEEN IMPRESSED. 333 00:12:06,887 --> 00:12:09,590 I THINK THE CHALLENGES THAT A.I. 334 00:12:09,590 --> 00:12:12,659 IS NOW BEING USED SOMEWHAT IN 335 00:12:12,659 --> 00:12:15,062 SOME MEDICAL DISCIPLINES AND AS 336 00:12:15,062 --> 00:12:17,598 WELL AS, FOR EXAMPLE, 337 00:12:17,598 --> 00:12:18,465 HYPERTENSION, THERE'S BEEN SOME 338 00:12:18,465 --> 00:12:19,700 CONCERNS THAT HAVE ARISEN. 339 00:12:19,700 --> 00:12:20,667 SOME QUESTIONS THAT HAVE COME 340 00:12:20,667 --> 00:12:23,737 ABOUT IS HOW GOOD ARE THE 341 00:12:23,737 --> 00:12:26,340 ALGORITHMS, DO THEY REALLY HELP 342 00:12:26,340 --> 00:12:28,675 HUMAN HEALTH, AND WHAT ARE THE 343 00:12:28,675 --> 00:12:31,078 POTENTIAL RISKS AND DOWN SIDES. 344 00:12:31,078 --> 00:12:33,614 SO, DR. SHAH, MYSELF, AND THE 345 00:12:33,614 --> 00:12:35,449 ENTIRE NIH STAFF WHO PUT THIS 346 00:12:35,449 --> 00:12:37,251 SESSION TOGETHER REALLY DESIGNED 347 00:12:37,251 --> 00:12:40,187 THIS SESSION AROUND A.I. AND ITS 348 00:12:40,187 --> 00:12:42,155 USE IN HYPERTENSION DIAGNOSIS, 349 00:12:42,155 --> 00:12:43,357 IN MANAGEMENT. 350 00:12:43,357 --> 00:12:45,525 THE WAY THE SESSION'S BEEN 351 00:12:45,525 --> 00:12:48,061 DESIGNED, THE WORKSHOP, IS IT'S 352 00:12:48,061 --> 00:12:50,797 CLEAR WITH SO MANY PEOPLE 353 00:12:50,797 --> 00:12:52,099 INVOLVED, CLINICIANS, INDUSTRY 354 00:12:52,099 --> 00:12:54,268 LEADERS, LEGAL AND REGULATORY 355 00:12:54,268 --> 00:12:57,137 EXPERTS, PUBLIC HEALTH EXPERTS, 356 00:12:57,137 --> 00:12:57,704 CLINICAL RESEARCHERS, DATA 357 00:12:57,704 --> 00:12:58,906 SCIENTISTS, ET CETERA WE'RE 358 00:12:58,906 --> 00:13:01,608 DEEPLY CONCERNED THAT WE'RE 359 00:13:01,608 --> 00:13:04,278 SPEAKING DIFFERENT LANGUAGES. 360 00:13:04,278 --> 00:13:06,780 AND I ALWAYS THINK OF THE 361 00:13:06,780 --> 00:13:07,981 PICTURE OF THE BLIND MONKS 362 00:13:07,981 --> 00:13:10,284 HOLDING DIFFERENT PARTS OF THE 363 00:13:10,284 --> 00:13:11,485 ELEPHANT, DESCRIBING THE 364 00:13:11,485 --> 00:13:14,421 ELEPHANT BUT OF COURSE 365 00:13:14,421 --> 00:13:16,957 DESCRIBING DIFFERENT PIECES. 366 00:13:16,957 --> 00:13:17,658 THE DESCRIPTIONS SOUND DIFFERENT 367 00:13:17,658 --> 00:13:19,459 BUT THEY ARE THE SAME ELEPHANT 368 00:13:19,459 --> 00:13:24,498 WHAT YOU'LL SEE FROM THE 369 00:13:24,498 --> 00:13:27,000 DIFFERENT SESSIONS IS THAT WE 370 00:13:27,000 --> 00:13:29,536 WANT TO EDUCATE EACH OTHER ON 371 00:13:29,536 --> 00:13:32,906 THE DIFFERENT CONTENT IN THIS 372 00:13:32,906 --> 00:13:33,140 AREA. 373 00:13:33,140 --> 00:13:35,642 IF YOU'RE A HYPERTENSION EXPERT 374 00:13:35,642 --> 00:13:36,743 AND LISTEN, YOU MIGHT SAY 375 00:13:36,743 --> 00:13:37,911 THERE'S NOTHING NEW HERE BUT 376 00:13:37,911 --> 00:13:40,047 REALLY THE TARGET IS THE OTHER 377 00:13:40,047 --> 00:13:41,114 PEOPLE WHO DON'T KNOW. 378 00:13:41,114 --> 00:13:43,116 AND SO WE HOPE THAT YOU LEARN 379 00:13:43,116 --> 00:13:45,619 FROM THE AREAS THAT YOU'RE NOT 380 00:13:45,619 --> 00:13:45,953 FAMILIAR WITH. 381 00:13:45,953 --> 00:13:48,155 AND AT THE END OF THE DAY, THERE 382 00:13:48,155 --> 00:13:51,191 WILL BE LOTS OF DISCUSSION ABOUT 383 00:13:51,191 --> 00:13:52,960 THE BENEFITS AND DOWN SIDES TO 384 00:13:52,960 --> 00:13:57,331 A.I. AND HYPERTENSION. 385 00:13:57,331 --> 00:13:58,198 WITH THAT INTRODUCTION, I'LL 386 00:13:58,198 --> 00:14:01,468 HAVE YOU TAKE US THROUGH DAY 1. 387 00:14:01,468 --> 00:14:04,137 >> THAT SOUNDS GREAT. 388 00:14:04,137 --> 00:14:06,440 THANK YOU FOR PARTICIPATING, AND 389 00:14:06,440 --> 00:14:08,976 NIH STAFF FOR HELPING ORGANIZE. 390 00:14:08,976 --> 00:14:12,145 THIS HAS GOT ME EXCITED BECAUSE 391 00:14:12,145 --> 00:14:14,881 I LOVE HOW THIS GROUP OF 392 00:14:14,881 --> 00:14:15,849 SESSIONS AND SPEAKERS SPANS THE 393 00:14:15,849 --> 00:14:18,685 WHOLE RANGE OF WHAT WE NEED TO 394 00:14:18,685 --> 00:14:19,886 REALLY ADVANCE THE FIELD, NOT 395 00:14:19,886 --> 00:14:22,222 JUST FROM A SCIENCE STANDPOINT, 396 00:14:22,222 --> 00:14:24,691 ACTUALLY GET SOMETHING DONE 397 00:14:24,691 --> 00:14:24,992 STANDPOINT. 398 00:14:24,992 --> 00:14:27,227 I'M EXCITED ABOUT THE AGENDA. 399 00:14:27,227 --> 00:14:29,830 I'LL BRIEFLY GO OVER WHAT WE 400 00:14:29,830 --> 00:14:31,498 HAVE FOR DAY 1 TODAY. 401 00:14:31,498 --> 00:14:33,266 TODAY WE'LL HAVE THREE SESSIONS. 402 00:14:33,266 --> 00:14:36,770 THE FIRST SESSION IS BRIDGING 403 00:14:36,770 --> 00:14:38,505 THE COMMUNICATIONS GAP BETWEEN 404 00:14:38,505 --> 00:14:39,806 POPULATION HEALTH, CLINICAL 405 00:14:39,806 --> 00:14:40,907 MEDICINE, ENGINEERING. 406 00:14:40,907 --> 00:14:43,977 AND AS DR. SHIMBO ALLUDED TO, 407 00:14:43,977 --> 00:14:45,412 THIS CONCEPT THAT IN SOME WAYS 408 00:14:45,412 --> 00:14:49,583 NOW I WORK A LOT WITH ENGINEERS 409 00:14:49,583 --> 00:14:50,550 BUT WE SPEAK DIFFERENT LANGUAGES 410 00:14:50,550 --> 00:14:52,085 AND HOW DO WE GET ON THE SAME 411 00:14:52,085 --> 00:14:53,086 PAGE TO DO SOMETHING THAT 412 00:14:53,086 --> 00:14:56,657 MATTERS AND DO IT FAST. 413 00:14:56,657 --> 00:14:58,992 SECOND SESSION IS BLOOD PRESSURE 414 00:14:58,992 --> 00:15:00,527 MEASUREMENT, HYPERTENSION RISK, 415 00:15:00,527 --> 00:15:01,828 AND BLOOD PRESSURE CONTROL. 416 00:15:01,828 --> 00:15:03,330 WE'LL LEARN ABOUT SORT OF THE 417 00:15:03,330 --> 00:15:05,065 CURRENT STATE OF BLOOD PRESSURE 418 00:15:05,065 --> 00:15:07,200 CONTROL AND TREATMENT AND 419 00:15:07,200 --> 00:15:07,968 PREVALENCE AND AWARENESS, AGAIN 420 00:15:07,968 --> 00:15:10,470 MAYBE WE HAVE ENGINEERS IN THE 421 00:15:10,470 --> 00:15:11,805 AUDIENCE, GET EVERYBODY ON THE 422 00:15:11,805 --> 00:15:12,439 SAME PAGE. 423 00:15:12,439 --> 00:15:14,541 FINALLY TODAY WE HAVE MAKING A 424 00:15:14,541 --> 00:15:18,011 DENT IN THE PROBLEM. 425 00:15:18,011 --> 00:15:23,483 WE HAVE SCIENCE, TOOLS, 426 00:15:23,483 --> 00:15:24,184 ENGINEERS, PHYSICIANS, HOW ARE 427 00:15:24,184 --> 00:15:26,887 WE GOING TO MAKE A DIFFERENCE? 428 00:15:26,887 --> 00:15:29,022 THEY BEGINNING WE'LL HAVE OUR 429 00:15:29,022 --> 00:15:29,956 KEYNOTE SPEAKER WHO I WILL 430 00:15:29,956 --> 00:15:32,259 INTRODUCE IN A MINUTE HERE. 431 00:15:32,259 --> 00:15:32,559 THANK YOU. 432 00:15:32,559 --> 00:15:34,995 >> THANK YOU, DR. SHAH. 433 00:15:34,995 --> 00:15:37,531 DAY 2 WE START AT THE SAME TIME, 434 00:15:37,531 --> 00:15:39,266 11 A.M. 435 00:15:39,266 --> 00:15:44,304 AND WE WILL END AT 4:00 P.M. 436 00:15:44,304 --> 00:15:44,571 TOMORROW. 437 00:15:44,571 --> 00:15:46,840 AND DAY 2 WILL START OFF WITH 438 00:15:46,840 --> 00:15:49,342 SESSION NUMBER 4, WHICH IS ON 439 00:15:49,342 --> 00:15:50,811 REAL WORLD IMPLEMENTATION 440 00:15:50,811 --> 00:15:52,079 CHALLENGES AND ISSUES. 441 00:15:52,079 --> 00:15:56,349 THIS SESSION WILL FOCUS ON THE 442 00:15:56,349 --> 00:15:58,518 REAL WORLD PRACTICALITY ISSUES 443 00:15:58,518 --> 00:15:59,953 THAT ARE OCCURRING OR AFFECT 444 00:15:59,953 --> 00:16:04,558 USING A.I. IN THE CLINICAL CARE 445 00:16:04,558 --> 00:16:08,295 OF PATIENTS WITH HYPERTENSION. 446 00:16:08,295 --> 00:16:10,931 SESSION 5 IS A DISCUSSION. 447 00:16:10,931 --> 00:16:15,068 IT'S A GROUP DISCUSSION FROM 2 448 00:16:15,068 --> 00:16:17,370 TO 3, INVITED SPEAKERS AND 449 00:16:17,370 --> 00:16:18,572 MODERATORS WILL ACTUALLY GO INTO 450 00:16:18,572 --> 00:16:19,206 A ROOM. 451 00:16:19,206 --> 00:16:22,309 THIS WON'T BE AVAILABLE TO THE 452 00:16:22,309 --> 00:16:22,542 PUBLIC. 453 00:16:22,542 --> 00:16:23,710 WE'LL BE DISCUSSING BEHIND THE 454 00:16:23,710 --> 00:16:25,245 SCENES EVERYTHING THAT WE 455 00:16:25,245 --> 00:16:26,346 LEARNED FROM EACH OTHER AND 456 00:16:26,346 --> 00:16:28,782 WE'RE GOING TO COME OUT WITH 457 00:16:28,782 --> 00:16:30,750 ANSWERS TO THREE QUESTIONS. 458 00:16:30,750 --> 00:16:34,254 RESEARCH GAPS AND HIGH PRIORITY 459 00:16:34,254 --> 00:16:35,655 QUESTIONS, WHAT ARE BARRIERS TO 460 00:16:35,655 --> 00:16:37,524 ADDRESSING GAPS AND QUESTIONS, 461 00:16:37,524 --> 00:16:39,059 AND RECOMMENDATIONS HOW TO MOVE 462 00:16:39,059 --> 00:16:41,194 THIS FIELD FORWARD. 463 00:16:41,194 --> 00:16:42,996 AND THEN FROM -- AT 3:00 WE'LL 464 00:16:42,996 --> 00:16:44,397 RETURN TO THE ROOM, AND THAT 465 00:16:44,397 --> 00:16:47,567 WILL THEN BE OPEN TO THE PUBLIC. 466 00:16:47,567 --> 00:16:51,071 AND WE'LL PRESENT EACH OF OUR 467 00:16:51,071 --> 00:16:52,839 FINDINGS AND RECOMMENDATIONS AND 468 00:16:52,839 --> 00:16:55,675 THOUGHTS TO THE GENERAL PUBLIC 469 00:16:55,675 --> 00:16:58,111 REGARDING THE THREE QUESTIONS 470 00:16:58,111 --> 00:16:59,513 THAT I JUST NAMED. 471 00:16:59,513 --> 00:17:03,350 FINALLY AT THE END, WE'LL HAVE A 472 00:17:03,350 --> 00:17:05,085 CLOSE-UP, 3:45 TO 4:00, AND AT 473 00:17:05,085 --> 00:17:07,721 THAT POINT WE'LL END THE 474 00:17:07,721 --> 00:17:08,355 SESSION. 475 00:17:08,355 --> 00:17:11,324 BEFORE WE START WITH OUR KEYNOTE 476 00:17:11,324 --> 00:17:14,161 SPEAKER, I WILL SAY I WANT TO 477 00:17:14,161 --> 00:17:16,997 REITERATE TO THE AUDIENCE, 478 00:17:16,997 --> 00:17:18,431 VIRTUAL AUDIENCE, PLEASE, 479 00:17:18,431 --> 00:17:19,332 PLEASE, PLEASE TYPE YOUR 480 00:17:19,332 --> 00:17:20,967 QUESTIONS IN THE CHAT BOX. 481 00:17:20,967 --> 00:17:24,437 WE WILL BE MONITORING THOSE 482 00:17:24,437 --> 00:17:24,771 QUESTIONS. 483 00:17:24,771 --> 00:17:26,072 THE MODERATORS THAT HAVE BEEN 484 00:17:26,072 --> 00:17:28,074 ASSIGNED TO EACH SESSION AS WELL 485 00:17:28,074 --> 00:17:31,578 AS DR. SHAH AND MYSELF WILL USE 486 00:17:31,578 --> 00:17:32,479 THESE QUESTIONS. 487 00:17:32,479 --> 00:17:33,547 WE WILL CRAFT THESE QUESTIONS 488 00:17:33,547 --> 00:17:36,183 THAT WE CAN ASK OUR SPEAKERS 489 00:17:36,183 --> 00:17:38,251 BECAUSE THERE'S A LOT OF 490 00:17:38,251 --> 00:17:40,987 BUILT-IN DISCUSSION TIME WITHIN 491 00:17:40,987 --> 00:17:41,755 EACH SESSION. 492 00:17:41,755 --> 00:17:43,056 SO, WITHOUT FURTHER ADO I'M 493 00:17:43,056 --> 00:17:44,824 GOING TO JUST HAND IT BACK OVER 494 00:17:44,824 --> 00:17:48,528 TO DR. SHAH WHO IS GOING TO 495 00:17:48,528 --> 00:17:49,462 INTRODUCE OUR KEYNOTE SPEAKER. 496 00:17:49,462 --> 00:17:50,597 >> EXCELLENT. 497 00:17:50,597 --> 00:17:51,698 THANK YOU. 498 00:17:51,698 --> 00:17:54,100 IT IS REALLY MY HONOR TO 499 00:17:54,100 --> 00:17:57,704 INTRODUCE DR. ERICA SPATZ, 500 00:17:57,704 --> 00:17:58,305 KEYNOTE SPEAKER, FOR TODAY. 501 00:17:58,305 --> 00:18:01,241 SHE WILL BE TALKING ABOUT THE 502 00:18:01,241 --> 00:18:02,542 BLOOD PRESSURE NEXUS. 503 00:18:02,542 --> 00:18:05,278 DR. SPATZ IS AN ASSOCIATE 504 00:18:05,278 --> 00:18:05,946 PROFESSOR OF CARDIOVASCULAR 505 00:18:05,946 --> 00:18:07,280 MEDICINE EPIDEMIOLOGY AT THE 506 00:18:07,280 --> 00:18:09,115 YALE SCHOOL OF MEDICINE. 507 00:18:09,115 --> 00:18:11,384 AND SHE'S ALSO FOUNDER OF THE 508 00:18:11,384 --> 00:18:12,953 YALE HEART AND VASCULAR CENTER 509 00:18:12,953 --> 00:18:15,222 FOR THE DIGITAL HYPERTENSION 510 00:18:15,222 --> 00:18:15,655 PROGRAM. 511 00:18:15,655 --> 00:18:19,159 AS YOU CAN SEE HER EXPERTISE IS 512 00:18:19,159 --> 00:18:20,293 PERFECT FOR TODAY. 513 00:18:20,293 --> 00:18:22,295 ACCOLADES ARE NUMEROUS. 514 00:18:22,295 --> 00:18:24,864 I COULD LIST A LOT BUT I WANT TO 515 00:18:24,864 --> 00:18:26,633 TALK ABOUT WHY SHE'S THE PERFECT 516 00:18:26,633 --> 00:18:27,701 PERSON FOR THIS KEYNOTE. 517 00:18:27,701 --> 00:18:30,871 LOTS OF US DO REALLY EXCELLENT 518 00:18:30,871 --> 00:18:32,739 SCIENCE, BUILD TOOLS, WRITE 519 00:18:32,739 --> 00:18:33,106 CODE. 520 00:18:33,106 --> 00:18:35,475 BUT PEOPLE WHO GET OUT INTO THE 521 00:18:35,475 --> 00:18:37,010 COMMUNITY AND UNDERSTAND THE 522 00:18:37,010 --> 00:18:38,578 PEOPLE AND THE CHALLENGES PEOPLE 523 00:18:38,578 --> 00:18:42,082 IN COMMUNITIES FACE RELATED TO 524 00:18:42,082 --> 00:18:43,283 HYPERTENSION, THOSE PEOPLE 525 00:18:43,283 --> 00:18:44,484 REALLY UNDERSTAND THE PROBLEM 526 00:18:44,484 --> 00:18:46,920 THAT NEEDS TO BE SOLVE AND THAT 527 00:18:46,920 --> 00:18:48,989 IS DR. SPATZ. 528 00:18:48,989 --> 00:18:50,690 WITHOUT FURTHER ADO, I HAND IT 529 00:18:50,690 --> 00:18:55,228 OVER TO HER. 530 00:18:55,228 --> 00:18:59,466 >> THANK YOU SO MUCH. 531 00:18:59,466 --> 00:19:03,904 I'D LIKE TO THANK NHLBI AND 532 00:19:03,904 --> 00:19:05,305 CO-CHAIRS WHO ARE COLLEAGUES AND 533 00:19:05,305 --> 00:19:08,909 FRIENDS AND THOUGHT LEADERS IN 534 00:19:08,909 --> 00:19:09,242 HYPERTENSION. 535 00:19:09,242 --> 00:19:11,578 I'M PRIVILEGED TO TALK ABOUT THE 536 00:19:11,578 --> 00:19:13,179 BLOOD PRESSURE NEXUS, REAL WORLD 537 00:19:13,179 --> 00:19:13,947 CHALLENGES IN COMMUNITIES WITH 538 00:19:13,947 --> 00:19:22,389 OR AT RISK FOR HYPERTENSION. 539 00:19:22,389 --> 00:19:22,923 NEXT SLIDE. 540 00:19:22,923 --> 00:19:27,861 THANK U YOU. 541 00:19:27,861 --> 00:19:35,602 THESE ARE MY DISCLOSURES. 542 00:19:35,602 --> 00:19:36,303 NEXT SLIDE. 543 00:19:36,303 --> 00:19:42,208 I'M GOING TO TELL YOU ABOUT A 544 00:19:42,208 --> 00:19:43,843 PATIENT JOURNEY. 545 00:19:43,843 --> 00:19:45,078 YOU CAN ADVANCE. 546 00:19:45,078 --> 00:19:45,545 SORRY. 547 00:19:45,545 --> 00:19:51,651 YOU CAN ADVANCE ONE. 548 00:19:51,651 --> 00:19:52,285 AND AGAIN. 549 00:19:52,285 --> 00:19:58,959 SO THIS IS A STORY OF THE 550 00:19:58,959 --> 00:20:00,493 42-YEAR-OLD BLACK MAN, WHO I MET 551 00:20:00,493 --> 00:20:02,362 IN THE HOSPITAL IN 2017, 552 00:20:02,362 --> 00:20:04,531 HOSPITALIZED WITH NEW ONSET 553 00:20:04,531 --> 00:20:06,833 HEART FAILURE, EJECTION FRACTION 554 00:20:06,833 --> 00:20:10,003 OF 15%, VERY LOW. 555 00:20:10,003 --> 00:20:13,273 DIAGNOSED WITH A NON-ISCHEMIC 556 00:20:13,273 --> 00:20:13,840 CARDIOMYOPATHY, CAUSE BEING 557 00:20:13,840 --> 00:20:15,775 UNCONTROLLED BLOOD PRESSURE AT 558 00:20:15,775 --> 00:20:18,445 THE AGE OF 42. 559 00:20:18,445 --> 00:20:20,213 YOU CAN ADVANCE. 560 00:20:20,213 --> 00:20:21,648 YOU CAN ADVANCE AGAIN. 561 00:20:21,648 --> 00:20:23,249 I LOOKED BACK AND WONDERED HOW 562 00:20:23,249 --> 00:20:26,319 COULD THIS BE THAT THIS OCCURRED 563 00:20:26,319 --> 00:20:29,389 IN A 42-YEAR-OLD MAN AND FOUND 564 00:20:29,389 --> 00:20:30,690 HE FIRST ENTERED OUR HEALTH 565 00:20:30,690 --> 00:20:31,992 SYSTEM ONE YEAR PRIOR WITH 566 00:20:31,992 --> 00:20:33,960 EMERGENCY ROOM VISIT FOR KNEE 567 00:20:33,960 --> 00:20:34,160 PAIN. 568 00:20:34,160 --> 00:20:36,930 HIS BLOOD PRESSURE WAS DETECTED 569 00:20:36,930 --> 00:20:39,666 TO BE 200/120, STARTED ON 570 00:20:39,666 --> 00:20:41,334 MEDICATION, GIVEN APPOINTMENT 571 00:20:41,334 --> 00:20:42,402 WITH PRIMARY CARE PROVIDER. 572 00:20:42,402 --> 00:20:43,937 HE SHOWED UP FOR THAT 573 00:20:43,937 --> 00:20:46,673 APPOINTMENT AND WE LEARNED HE IS 574 00:20:46,673 --> 00:20:49,409 A SINGLE DATA CARING FOR TWO 575 00:20:49,409 --> 00:20:52,379 YOUNG CHILDREN, WIFE PASSED AWAY 576 00:20:52,379 --> 00:20:54,014 OF BREAST CANCER, WORKING TWO 577 00:20:54,014 --> 00:21:00,620 JOBS, OBESE, DIDN'T EAT WELL, NO 578 00:21:00,620 --> 00:21:00,954 SYMPTOMS. 579 00:21:00,954 --> 00:21:04,524 CAN YOU HEAR ME OKAY? 580 00:21:04,524 --> 00:21:05,825 >> WE CAN HEAR YOU. 581 00:21:05,825 --> 00:21:08,028 >> OKAY, GREAT. 582 00:21:08,028 --> 00:21:09,262 SORRY. 583 00:21:09,262 --> 00:21:10,697 HIS BLOOD PRESSURE WAS 172/90. 584 00:21:10,697 --> 00:21:13,700 HE WAS TOLD TO COME BACK IN A 585 00:21:13,700 --> 00:21:16,236 MONTH, YET NEVER SHOWED UNTIL 586 00:21:16,236 --> 00:21:18,438 PRESENTATION FOR HEART FAILURE. 587 00:21:18,438 --> 00:21:18,838 NEXT SLIDE. 588 00:21:18,838 --> 00:21:21,074 WHEN I MET HIM IN THE HOSPITAL 589 00:21:21,074 --> 00:21:23,810 AND YOU CAN ADVANCE ANOTHER TIME 590 00:21:23,810 --> 00:21:26,546 ON THE SLIDE. 591 00:21:26,546 --> 00:21:27,313 THANK YOU. 592 00:21:27,313 --> 00:21:30,283 I WAS DETERMINED TO CHANGE THE 593 00:21:30,283 --> 00:21:31,451 COURSE FOR THIS GENTLEMAN. 594 00:21:31,451 --> 00:21:33,553 I MET HIM IN THE CARDIOLOGY 595 00:21:33,553 --> 00:21:35,321 CLINIC, TRIED TO BUILD THAT 596 00:21:35,321 --> 00:21:38,057 CONNECTION, AND BUILD A PLAN 597 00:21:38,057 --> 00:21:39,459 TOGETHER TO ADVANCE GDMT. 598 00:21:39,459 --> 00:21:40,360 I FAILED. 599 00:21:40,360 --> 00:21:43,296 TWO YEARS LATER HE PRESENTS WITH 600 00:21:43,296 --> 00:21:47,033 DISABLING STROKE FROM LEFT 601 00:21:47,033 --> 00:21:47,834 VENTRICULAR THROMBUS, A TRAGIC 602 00:21:47,834 --> 00:21:50,970 CASE THAT CONTINUES TO MAKE ME 603 00:21:50,970 --> 00:21:52,071 EMOTIONAL BECAUSE I CONTINUE TO 604 00:21:52,071 --> 00:21:53,940 CARE FOR HIM AND STRUGGLE WITH 605 00:21:53,940 --> 00:21:56,209 LOU TO HAVE PREVENTED THIS 606 00:21:56,209 --> 00:21:56,443 OUTCOME. 607 00:21:56,443 --> 00:21:57,977 SOME MAY SAY THIS IS ON HIM. 608 00:21:57,977 --> 00:22:00,613 HE DIDN'T FOLLOW UP. 609 00:22:00,613 --> 00:22:01,648 BUT IS IT? 610 00:22:01,648 --> 00:22:04,017 HOW ARE WE AS A LEARNING HEALTH 611 00:22:04,017 --> 00:22:05,952 SYSTEM REFLECTING ON THESE CASES 612 00:22:05,952 --> 00:22:07,487 AND USING THESE CASES TO 613 00:22:07,487 --> 00:22:10,990 INNOVATE AND TO BE BETTER? 614 00:22:10,990 --> 00:22:14,294 BLOOD PRESSURE NEXUS IS REALLY 615 00:22:14,294 --> 00:22:16,463 ABOUT COMBINING THE MEDICAL, 616 00:22:16,463 --> 00:22:20,733 SOCIAL, TECHNOLOGY, IN ORDER TO 617 00:22:20,733 --> 00:22:23,903 CREATE BETTER OUTCOMES FOR 618 00:22:23,903 --> 00:22:24,237 PATIENTS. 619 00:22:24,237 --> 00:22:25,338 NEXT SLIDE. 620 00:22:25,338 --> 00:22:26,639 ROOT CAUSE ANALYSIS WE NEED DO 621 00:22:26,639 --> 00:22:27,273 THAT, RIGHT? 622 00:22:27,273 --> 00:22:30,009 IT'S NOT JUST THAT WE UNDERSTAND 623 00:22:30,009 --> 00:22:31,878 MR. GREEN, OUR PATIENT, AT THE 624 00:22:31,878 --> 00:22:32,779 INDIVIDUAL LEVEL. 625 00:22:32,779 --> 00:22:34,848 WE UNDERSTAND HIS STRUGGLES. 626 00:22:34,848 --> 00:22:36,716 BUT IT GOES DEEPER, RIGHT? 627 00:22:36,716 --> 00:22:39,886 MR. GREEN LIVED IN NEW HAVEN. 628 00:22:39,886 --> 00:22:41,754 HE LIVES IN A NEIGHBORHOOD, I 629 00:22:41,754 --> 00:22:44,724 SEE THE ARROWS ARE OFF, BUT AT 630 00:22:44,724 --> 00:22:48,628 THE TOP OF THAT NEW HAVEN, NEW 631 00:22:48,628 --> 00:22:50,196 HALLVILLE WITH SOME OF THE 632 00:22:50,196 --> 00:22:54,334 HIGHEST RATES OF POVERTY, YET 633 00:22:54,334 --> 00:22:55,969 LOWEST LIFE EXPECTANCY, UNDER 74 634 00:22:55,969 --> 00:22:58,938 YEARS IN THE HIGHLY POPULATED 635 00:22:58,938 --> 00:22:59,139 AREA. 636 00:22:59,139 --> 00:23:04,544 THERE'S HIGHER E.D. VISITS FOR 637 00:23:04,544 --> 00:23:06,579 HYPERTENSION, STROKE, A LOT OF 638 00:23:06,579 --> 00:23:09,449 CRIME AND VIOLENCE. 639 00:23:09,449 --> 00:23:10,650 THIS BOOK IS ABOUT THIS 640 00:23:10,650 --> 00:23:17,323 NEIGHBORHOOD CALLED "THE OTHER 641 00:23:17,323 --> 00:23:18,525 SIDE OF PROSPECT." 642 00:23:18,525 --> 00:23:22,462 I PICTURE IS TAKEN FROM ACROSS 643 00:23:22,462 --> 00:23:23,997 THE STRAIGHT FROM BARBER SHOPS 644 00:23:23,997 --> 00:23:24,664 WE'RE SCREENING FOR 645 00:23:24,664 --> 00:23:25,098 HYPERTENSION. 646 00:23:25,098 --> 00:23:27,400 IT'S ABOUT A YOUNG BOY FALSELY 647 00:23:27,400 --> 00:23:28,268 ACCUSED OF MURDER. 648 00:23:28,268 --> 00:23:32,438 THE STRESSES OF GROWING UP IN 649 00:23:32,438 --> 00:23:33,206 THIS ENVIRONMENT THAT HAS A LOT 650 00:23:33,206 --> 00:23:35,808 OF CRIME AND LACK OF 651 00:23:35,808 --> 00:23:36,109 OPPORTUNITY. 652 00:23:36,109 --> 00:23:38,011 I THINK ABOUT THIS BEING THE 653 00:23:38,011 --> 00:23:38,678 NEIGHBORHOOD WHERE MY PATIENT 654 00:23:38,678 --> 00:23:41,414 AND SO MANY OTHER PATIENTS ARE 655 00:23:41,414 --> 00:23:41,948 GROWING UP. 656 00:23:41,948 --> 00:23:44,150 YET HERE WE ARE TRYING TO MAKE A 657 00:23:44,150 --> 00:23:46,119 CONNECTION WITH A PATIENT, AND 658 00:23:46,119 --> 00:23:48,621 MAYBE POTENTIALLY IGNORING OR 659 00:23:48,621 --> 00:23:50,056 NOT EVEN VALIDATING WHAT THE 660 00:23:50,056 --> 00:23:51,691 FACTORS ARE CONTRIBUTING TO 661 00:23:51,691 --> 00:23:54,460 THEIR HIGH BLOOD PRESSURE. 662 00:23:54,460 --> 00:23:54,961 NEXT SLIDE. 663 00:23:54,961 --> 00:23:58,131 THIS IS NOT JUST A STORY ABOUT 664 00:23:58,131 --> 00:23:58,798 POVERTY. 665 00:23:58,798 --> 00:24:00,867 MANY HIGH PROFILE HIGHLY 666 00:24:00,867 --> 00:24:03,069 EDUCATED SUCCESSFUL PEOPLE HAVE 667 00:24:03,069 --> 00:24:07,340 ALSO SUFFERED FROM POOR 668 00:24:07,340 --> 00:24:09,742 HYPERTENSION OUTCOMES, TRAGIC 669 00:24:09,742 --> 00:24:10,610 OUTCOMES. 670 00:24:10,610 --> 00:24:12,478 SHALON IRVING WAS A CDC 671 00:24:12,478 --> 00:24:13,780 RESEARCHER, WHEN PREGNANT AND 672 00:24:13,780 --> 00:24:18,484 HAD A TOUGH PREGNANCY, AFTER SHE 673 00:24:18,484 --> 00:24:19,819 DELIVERED BABY SHE REPORTED NOT 674 00:24:19,819 --> 00:24:21,754 FEELING WELL, HAVING A HEADACHE, 675 00:24:21,754 --> 00:24:22,555 HIGH BLOOD PRESSURE. 676 00:24:22,555 --> 00:24:25,191 TOLD TO GO HOME AND REST. 677 00:24:25,191 --> 00:24:29,462 SHE DIED OF A STROKE. 678 00:24:29,462 --> 00:24:33,166 JOHN SINGLETON, SAME DIRECTOR OF 679 00:24:33,166 --> 00:24:37,437 BOYS IN THE HOOD, DIED AT 51 OF 680 00:24:37,437 --> 00:24:38,671 A STROKE, BOTH FAMILIES WERE 681 00:24:38,671 --> 00:24:39,639 ACTIVE WITH MULTIPLE SOCIETIES 682 00:24:39,639 --> 00:24:44,344 TO GET THE WORD OUT AROUND 683 00:24:44,344 --> 00:24:46,412 HYPERTENSION, AS YOU'VE HEARD 684 00:24:46,412 --> 00:24:49,382 THE MOST COMMON AND DEADLY 685 00:24:49,382 --> 00:24:52,986 KILLER ACROSS THE GLOBE FOR 686 00:24:52,986 --> 00:24:54,087 PEOPLE THROUGHOUT. 687 00:24:54,087 --> 00:24:57,390 WE KNOW THERE ARE SIGNIFICANT 688 00:24:57,390 --> 00:25:01,661 DISPARITIES BY RACE, INCOME, AND 689 00:25:01,661 --> 00:25:01,928 GEOGRAPHY. 690 00:25:01,928 --> 00:25:02,428 NEXT SLIDE. 691 00:25:02,428 --> 00:25:04,931 YOU CAN ADVANCE. 692 00:25:04,931 --> 00:25:06,032 THANKS. 693 00:25:06,032 --> 00:25:08,568 SO, BETWEEN 2000 AND 2018, 694 00:25:08,568 --> 00:25:12,739 HYPERTENSION-RELATED DEATHS HAVE 695 00:25:12,739 --> 00:25:15,241 INCREASED, STAGNATED, OR 696 00:25:15,241 --> 00:25:15,541 DECELERATED. 697 00:25:15,541 --> 00:25:17,777 IF YOU LOOK AT THE TOP TWO LINES 698 00:25:17,777 --> 00:25:19,412 THEY REPRESENT BLACK MEN AND 699 00:25:19,412 --> 00:25:20,179 BLACK WOMEN. 700 00:25:20,179 --> 00:25:23,016 YOU CAN SEE THAT THEY HAVE A 701 00:25:23,016 --> 00:25:26,285 TWO-FOLD HIGHER RATE THAN OTHER 702 00:25:26,285 --> 00:25:30,256 RACE/ETHNICITY GROUPS ACROSS ALL 703 00:25:30,256 --> 00:25:30,757 HYPERTENSION-RELATED 704 00:25:30,757 --> 00:25:31,557 CARDIOVASCULAR DISEASE OUTCOMES. 705 00:25:31,557 --> 00:25:36,462 THE PROBLEMS ARE ONLY GETTING 706 00:25:36,462 --> 00:25:36,696 WORSE. 707 00:25:36,696 --> 00:25:39,999 NEXT SLIDE. 708 00:25:39,999 --> 00:25:40,867 NEXT SLIDE. 709 00:25:40,867 --> 00:25:42,535 THESE ARE DATA FROM NHANES, 710 00:25:42,535 --> 00:25:44,404 COMMUNITY STUDY. 711 00:25:44,404 --> 00:25:46,806 HERE WE'RE LOOKING AT 712 00:25:46,806 --> 00:25:47,507 HYPERTENSION AWARENESS, 713 00:25:47,507 --> 00:25:49,308 TREATMENT, CONTROL BY RACE AND 714 00:25:49,308 --> 00:25:49,742 ETHNICITY. 715 00:25:49,742 --> 00:25:52,912 WHAT I WANT TO BRING OUT HERE IS 716 00:25:52,912 --> 00:25:54,247 THAT THERE ARE DIFFERENCES BY 717 00:25:54,247 --> 00:25:55,348 RACE AND ETHNICITY, BUT ALL 718 00:25:55,348 --> 00:25:59,852 GROUPS ARE NOT DOING WELL. 719 00:25:59,852 --> 00:26:01,621 SO ONLY -- 1 IN 4 PEOPLE ARE 720 00:26:01,621 --> 00:26:03,356 UNAWARE THEY HAVE HIGH BLOOD 721 00:26:03,356 --> 00:26:03,756 PRESSURE. 722 00:26:03,756 --> 00:26:06,159 1 IN 4 ARE NOT TREATED. 723 00:26:06,159 --> 00:26:08,394 ONLY 1 IN 4 HAVE BLOOD PRESSURE 724 00:26:08,394 --> 00:26:11,464 UNDER CONTROL. 725 00:26:11,464 --> 00:26:12,899 YOU CAN ADVANCE. 726 00:26:12,899 --> 00:26:17,403 THESE ARE ALSO DATA FROM NHANES. 727 00:26:17,403 --> 00:26:18,805 HYPERTENSION CONTROL RATES 728 00:26:18,805 --> 00:26:20,006 ACROSS THE LAST DECADE AND A 729 00:26:20,006 --> 00:26:23,276 HALF ARE ACTUALLY GETTING WORSE. 730 00:26:23,276 --> 00:26:26,145 STARTING IN 2013, WHICH 731 00:26:26,145 --> 00:26:31,918 COINCIDES WITH WHEN THE JNC 8 732 00:26:31,918 --> 00:26:33,920 GUIDELINES CAME OUT, FOR PEOPLE 733 00:26:33,920 --> 00:26:37,657 ON TREATMENT WORSE CONTROL. 734 00:26:37,657 --> 00:26:39,392 THIS SUGGESTS BIG GUIDELINES, 735 00:26:39,392 --> 00:26:40,393 POLICY CHANGES CAN AFFECT BLOOD 736 00:26:40,393 --> 00:26:44,530 PRESSURE OUTCOMES AND WE KNOW 737 00:26:44,530 --> 00:26:48,167 THEY ARE DECLINING FURTHER WITH 738 00:26:48,167 --> 00:26:48,534 COVID-19. 739 00:26:48,534 --> 00:26:50,336 THE PROBLEM IS EVEN WORSE THAN 740 00:26:50,336 --> 00:26:51,270 WE MIGHT IMAGINE. 741 00:26:51,270 --> 00:26:55,808 I SHOWED A LOT OF DATA AROUND 742 00:26:55,808 --> 00:26:57,877 HYPERTENSION THAT, 140/90 CUT 743 00:26:57,877 --> 00:26:58,745 POINT. 744 00:26:58,745 --> 00:27:01,948 NOW WE USE 130/80 BASED ON MOST 745 00:27:01,948 --> 00:27:06,452 RECENT GUIDELINES. 746 00:27:06,452 --> 00:27:08,087 THERE'S OTHER PHENOTYPES 747 00:27:08,087 --> 00:27:10,056 INCLUDING MASKED WHEN NORMAL IN 748 00:27:10,056 --> 00:27:11,824 OFFICE, ELEVATED IN OUTPATIENT 749 00:27:11,824 --> 00:27:12,258 SETTINGS. 750 00:27:12,258 --> 00:27:14,327 MASKED HYPERTENSION IS 751 00:27:14,327 --> 00:27:16,996 ASSOCIATED WITH CARDIOVASCULAR 752 00:27:16,996 --> 00:27:21,100 OUTCOMES, SORELY UNDERDETECTED. 753 00:27:21,100 --> 00:27:22,835 IN THIS STUDY YOU CAN SEE AMONG 754 00:27:22,835 --> 00:27:25,171 PEOPLE WITH NORMAL BLOOD 755 00:27:25,171 --> 00:27:27,774 PRESSURE IN THE OFFICE, 13% HAD 756 00:27:27,774 --> 00:27:30,309 MASKED HYPERTENSION, AMONG 757 00:27:30,309 --> 00:27:31,244 PEOPLE WITH PRE-HYPERTENSION, 758 00:27:31,244 --> 00:27:34,914 ELEVATED BLOOD PRESSURE IN THE 759 00:27:34,914 --> 00:27:38,651 OFFICE, 36% HAD MASKED 760 00:27:38,651 --> 00:27:38,985 HYPERTENSION. 761 00:27:38,985 --> 00:27:39,786 YOU CAN ADVANCE. 762 00:27:39,786 --> 00:27:41,921 THIS IS INTERESTING BECAUSE WHY 763 00:27:41,921 --> 00:27:43,523 WOULD A PERSON HAVE HIGH BLOOD 764 00:27:43,523 --> 00:27:45,758 PRESSURE ONLY OUTSIDE OF THE 765 00:27:45,758 --> 00:27:46,025 OFFICE? 766 00:27:46,025 --> 00:27:47,627 WE'VE GOT TO THINK ABOUT THE 767 00:27:47,627 --> 00:27:49,262 STRESSORS THAT MIGHT OCCUR. 768 00:27:49,262 --> 00:27:53,766 THIS GROUP FROM UNIVERSITY OF 769 00:27:53,766 --> 00:27:55,168 ALABAMA STUDIED WHY SOME PEOPLE 770 00:27:55,168 --> 00:27:56,402 HAVE HIGHER BLOOD PRESSURES 771 00:27:56,402 --> 00:28:05,545 OUTSIDE OF THE OFFICE. 772 00:28:05,545 --> 00:28:08,748 THEY LOOKED AT ALDOSTERONE 773 00:28:08,748 --> 00:28:10,049 LEVELS AND COMPARED. 774 00:28:10,049 --> 00:28:12,218 INTERESTINGLY ENOUGH, THEY FOUND 775 00:28:12,218 --> 00:28:16,856 THAT THE LEVEL IN THE MASKED 776 00:28:16,856 --> 00:28:19,258 GROUP WAS HIGHER IN OUTPATIENT 777 00:28:19,258 --> 00:28:20,927 AS COMPARED TO GROUP WITH 778 00:28:20,927 --> 00:28:22,895 CONTROLLED HYPERTENSION. 779 00:28:22,895 --> 00:28:24,931 HOWEVER, IN THE CLINIC THE 780 00:28:24,931 --> 00:28:26,833 ALDOSTERONE LEVELS WERE THE 781 00:28:26,833 --> 00:28:27,567 SAME. 782 00:28:27,567 --> 00:28:28,234 THEY HAVE POSTULATED OUTPATIENT, 783 00:28:28,234 --> 00:28:30,770 WHEN PATIENTS WERE IN THEIR REAL 784 00:28:30,770 --> 00:28:34,273 WORLD THOSE WITH MASKED 785 00:28:34,273 --> 00:28:34,941 HYPERTENSION HAVE INCREASED 786 00:28:34,941 --> 00:28:35,775 SYMPATHETIC RESPONSE. 787 00:28:35,775 --> 00:28:41,647 THE WHOLE CASCADE OF STRESS 788 00:28:41,647 --> 00:28:43,249 HORMONES AND ALDOSTERONE SYSTEM 789 00:28:43,249 --> 00:28:47,787 IS ELEVATED IN PEOPLE WITH 790 00:28:47,787 --> 00:28:48,221 MASKED HYPERTENSION. 791 00:28:48,221 --> 00:28:56,762 IF WE'RE NOT DETECTING AND 792 00:28:56,762 --> 00:28:58,831 CAPTURING, WE'RE MISSING AN 793 00:28:58,831 --> 00:29:00,366 OPPORTUNITY TO IMPROVE OUTCOMES, 794 00:29:00,366 --> 00:29:05,738 IN A SIGNIFICANT PROPORTION OF 795 00:29:05,738 --> 00:29:06,172 PEOPLE. 796 00:29:06,172 --> 00:29:07,273 NEXT SLIDE. 797 00:29:07,273 --> 00:29:09,242 OUR PATIENT, MR. GREEN, AND MANY 798 00:29:09,242 --> 00:29:12,211 OTHERS ARE IN THAT RED CIRCLE, 799 00:29:12,211 --> 00:29:15,281 AND WE'RE WORKING WITH THEM IN A 800 00:29:15,281 --> 00:29:16,249 20-MINUTE VISIT. 801 00:29:16,249 --> 00:29:17,650 THAT'S OUR INTERACTION WITH 802 00:29:17,650 --> 00:29:17,984 THEM. 803 00:29:17,984 --> 00:29:19,852 BUT THEIR LIFE, THEIR WORLD IS 804 00:29:19,852 --> 00:29:22,255 ALL OF THESE DIFFERENT LEVELS. 805 00:29:22,255 --> 00:29:23,256 IT'S THEIR LIFESTYLE. 806 00:29:23,256 --> 00:29:24,991 IT'S SOCIAL AND COMMUNITY 807 00:29:24,991 --> 00:29:25,491 NETWORKS. 808 00:29:25,491 --> 00:29:26,425 IT'S WHERE THEY WORK. 809 00:29:26,425 --> 00:29:29,395 IT'S WHETHER THEY HAVE ACCESS TO 810 00:29:29,395 --> 00:29:31,464 FOOD, OR SAFE WATER, OR GREEN 811 00:29:31,464 --> 00:29:34,000 SPACES TO EXERCISE. 812 00:29:34,000 --> 00:29:35,067 AND IT'S SOCIOECONOMIC CULTURAL 813 00:29:35,067 --> 00:29:36,369 AND ENVIRONMENTAL CONDITIONS 814 00:29:36,369 --> 00:29:37,937 THAT THEY ARE LIVING IN DAY IN 815 00:29:37,937 --> 00:29:39,038 AND DAY OUT. 816 00:29:39,038 --> 00:29:40,673 AND THAT WE NEED TO KIND OF 817 00:29:40,673 --> 00:29:41,974 CAPTURE AND BE ABLE TO BRING 818 00:29:41,974 --> 00:29:45,478 INTO OUR CARE PLANS IN ORDER TO 819 00:29:45,478 --> 00:29:47,013 IMPROVE OUTCOMES. 820 00:29:47,013 --> 00:29:47,647 NEXT SLIDE. 821 00:29:47,647 --> 00:29:50,516 HOW DO WE DO THIS? 822 00:29:50,516 --> 00:29:52,818 DIGITAL HEALTH REPRESENTS A PATH 823 00:29:52,818 --> 00:29:54,020 FORWARD. 824 00:29:54,020 --> 00:29:57,189 WE CAN BETTER CAPTURE OUR 825 00:29:57,189 --> 00:30:01,527 PATIENTS' CONTEXT AND BUILD 826 00:30:01,527 --> 00:30:02,762 CONNECTIONS WITH OUR PATIENTS. 827 00:30:02,762 --> 00:30:04,830 DIGITAL HEALTH TECHNOLOGY IS 828 00:30:04,830 --> 00:30:06,465 HELPING US WITH CAPTURING BLOOD 829 00:30:06,465 --> 00:30:07,800 PRESSURE AND HEART RATE AND 830 00:30:07,800 --> 00:30:08,668 SLEEP AND ACTIVITY. 831 00:30:08,668 --> 00:30:10,903 WE'RE DOING GREAT AND EVEN ABLE 832 00:30:10,903 --> 00:30:13,806 TO CAPTURE A LOT OF DAILY 833 00:30:13,806 --> 00:30:15,474 LIFESTYLE BEHAVIORS LIKE 834 00:30:15,474 --> 00:30:16,208 EXERCISE, NUTRITION, STRESS 835 00:30:16,208 --> 00:30:16,642 LEVELS. 836 00:30:16,642 --> 00:30:19,045 BUT HOW DO WE IMPLEMENT AT THE 837 00:30:19,045 --> 00:30:19,612 BEDSIDE? 838 00:30:19,612 --> 00:30:22,348 EVEN THE BEST DOCTORS AND NURSES 839 00:30:22,348 --> 00:30:24,216 HAVING THESE CONVERSATIONS WITH 840 00:30:24,216 --> 00:30:26,953 PATIENTS IN THE CLINIC ARE STILL 841 00:30:26,953 --> 00:30:29,588 LIMITED AND PATIENTS ARE STILL 842 00:30:29,588 --> 00:30:31,557 LEFT TO JUGGLE ALL 843 00:30:31,557 --> 00:30:32,325 RECOMMENDATIONS ONCE THEY LEAVE 844 00:30:32,325 --> 00:30:38,230 OUR OFFICE. 845 00:30:38,230 --> 00:30:39,131 NEXT SLIDE. 846 00:30:39,131 --> 00:30:43,169 SO I SUBMIT TO YOU THAT LAYING 847 00:30:43,169 --> 00:30:45,471 EVEN THE BEST TECHNOLOGY ONTO 848 00:30:45,471 --> 00:30:47,006 THIS INFRASTRUCTURE DOESN'T 849 00:30:47,006 --> 00:30:47,239 WORK. 850 00:30:47,239 --> 00:30:49,642 WE'RE STILL MOSTLY IN PERSON, 851 00:30:49,642 --> 00:30:51,610 STILL PHYSICIAN BASED, STILL 852 00:30:51,610 --> 00:30:53,279 RELYING ON SCHEDULED FOLLOW-UPS 853 00:30:53,279 --> 00:30:56,115 AND AT BEST THOSE ARE AT 3, 6, 854 00:30:56,115 --> 00:30:57,216 12 MONTHS. 855 00:30:57,216 --> 00:30:58,217 WE DON'T PRESCRIBE HOME BLOOD 856 00:30:58,217 --> 00:30:59,952 PRESSURE CUFFS. 857 00:30:59,952 --> 00:31:06,192 WHEN DO WE DON'T TEACH HOW TO 858 00:31:06,192 --> 00:31:09,562 USE IT, SYNC WITH RECORDS, SO 859 00:31:09,562 --> 00:31:11,864 OFTEN BLAME THE THE PATIENT FOR 860 00:31:11,864 --> 00:31:14,767 NOT CONFORMING WITH WHAT WE'VE 861 00:31:14,767 --> 00:31:15,935 PRESCRIBED, WHICH IS UNTENABLE. 862 00:31:15,935 --> 00:31:19,138 IT'S NOT PRACTICAL. 863 00:31:19,138 --> 00:31:20,006 NEXT SLIDE. 864 00:31:20,006 --> 00:31:23,275 SOCIETY BLOOD PRESSURE NEXUS IS 865 00:31:23,275 --> 00:31:24,076 COMPLEX. 866 00:31:24,076 --> 00:31:24,777 YOU CAN ADVANCE. 867 00:31:24,777 --> 00:31:26,379 WE NEED TO THINK ABOUT 868 00:31:26,379 --> 00:31:26,779 ENGAGEMENT. 869 00:31:26,779 --> 00:31:29,081 WE NEED TO THINK ABOUT 870 00:31:29,081 --> 00:31:30,449 MEASUREMENT, IMPLEMENTATION, 871 00:31:30,449 --> 00:31:31,951 BLOOD PRESSURE OUTCOMES, BIG 872 00:31:31,951 --> 00:31:35,855 HEALTH OUTCOMES AND HEALTH 873 00:31:35,855 --> 00:31:36,889 EQUITY. 874 00:31:36,889 --> 00:31:37,390 ADVANCE. 875 00:31:37,390 --> 00:31:38,524 REGARDING ENGAGEMENT WE KNOW 876 00:31:38,524 --> 00:31:41,627 HYPERTENSION IS A SILENT 877 00:31:41,627 --> 00:31:41,894 CONDITION. 878 00:31:41,894 --> 00:31:50,903 IT'S CREATING CHALLENGES WITH 879 00:31:50,903 --> 00:31:52,438 INFLECTION POINTS WHERE BLOOD 880 00:31:52,438 --> 00:31:54,273 PRESSURE IS HIGHER. 881 00:31:54,273 --> 00:31:57,710 PEOPLE NEED TO BELIEVE THEY ARE 882 00:31:57,710 --> 00:31:58,711 AT RISK. 883 00:31:58,711 --> 00:31:59,645 IT CAN'T BE NORMALIZED. 884 00:31:59,645 --> 00:32:02,181 PEOPLE NEED TO FEEL THEY HAVE 885 00:32:02,181 --> 00:32:04,583 THE CAPACITY TO MAKE CHANGES TO 886 00:32:04,583 --> 00:32:05,051 IMPROVE OUTCOMES. 887 00:32:05,051 --> 00:32:07,119 WE NEED TO TAKE INTO 888 00:32:07,119 --> 00:32:08,888 CONSIDERATION THE SOCIAL 889 00:32:08,888 --> 00:32:10,389 STRESSORS, LIFESTYLE BEHAVIORS, 890 00:32:10,389 --> 00:32:11,490 ENGAGE PEOPLE IN SHARED DECISION 891 00:32:11,490 --> 00:32:13,993 MAKING SO THEY CAN HELP 892 00:32:13,993 --> 00:32:14,493 CO-DESIGN PLANS. 893 00:32:14,493 --> 00:32:15,761 WE NEED TO THINK ABOUT 894 00:32:15,761 --> 00:32:17,730 MEASUREMENTS IN THE OFFICE AND 895 00:32:17,730 --> 00:32:22,701 AT HOME, THINK ABOUT PHENOTYPES 896 00:32:22,701 --> 00:32:24,403 OF MASKED HYPERTENSION, WHAT IS 897 00:32:24,403 --> 00:32:28,908 THE LIFETIME OF EXPOSURE, 898 00:32:28,908 --> 00:32:30,076 ESPECIALLY STRESSORS AT HOME AND 899 00:32:30,076 --> 00:32:30,843 ACROSS THE LIFETIME. 900 00:32:30,843 --> 00:32:35,448 HOW DO WE UNDERSTAND AND 901 00:32:35,448 --> 00:32:36,315 INTERPRET BLOOD PRESSURE 902 00:32:36,315 --> 00:32:39,718 LABILITY IN THE CONTEXT OF OTHER 903 00:32:39,718 --> 00:32:40,119 COMORBIDITIES? 904 00:32:40,119 --> 00:32:42,988 WE NEED TO THINK ABOUT ACCESS TO 905 00:32:42,988 --> 00:32:45,391 BLOOD PRESSURE CUFFS, SYNCING 906 00:32:45,391 --> 00:32:47,026 WITH EHR, CARE TEAM, WHAT DOES 907 00:32:47,026 --> 00:32:53,032 THAT LOOK LIKE? 908 00:32:53,032 --> 00:32:57,103 DECISION SUPPORT, COMBINATION 909 00:32:57,103 --> 00:33:00,072 AND POLY PILLS, ARE THEY 910 00:33:00,072 --> 00:33:02,241 FEASIBLE AND ACCESSIBLE AND HOW 911 00:33:02,241 --> 00:33:04,009 WE PUT OUT POPULATION HEALTH 912 00:33:04,009 --> 00:33:06,979 MEASURES, CAN WE INTEGRATE HOME 913 00:33:06,979 --> 00:33:08,380 BLOOD PRESSURE MONITORING 914 00:33:08,380 --> 00:33:10,082 MEASUREMENTS, CAN WE INTERPRET 915 00:33:10,082 --> 00:33:12,785 CUFFLESS DATA WHICH WE KNOW IS 916 00:33:12,785 --> 00:33:16,589 SOON TO COME. 917 00:33:16,589 --> 00:33:18,457 ARE WE IMPACTING ORGAN DAMAGE, 918 00:33:18,457 --> 00:33:19,992 CARDIOVASCULAR EVENTS, AFFECTING 919 00:33:19,992 --> 00:33:22,294 BRAIN HEALTH, AFFECTING 920 00:33:22,294 --> 00:33:23,295 FUNCTIONAL STATUS? 921 00:33:23,295 --> 00:33:24,930 AND ARE WE DOING THIS THROUGH A 922 00:33:24,930 --> 00:33:26,999 LENS OF HEALTH EQUITY? 923 00:33:26,999 --> 00:33:29,835 WE HAVE INEQUITIES IN BLOOD 924 00:33:29,835 --> 00:33:30,903 PRESSURE CONTROL. 925 00:33:30,903 --> 00:33:32,605 ARE WE MOVING THE NEEDLE ON 926 00:33:32,605 --> 00:33:34,540 EARLY AGE OF ONSET AFFLICTING 927 00:33:34,540 --> 00:33:36,208 MORE BLACK MEN AND WOMEN IN OUR 928 00:33:36,208 --> 00:33:36,675 COUNTRY. 929 00:33:36,675 --> 00:33:40,379 ARE WE MOVING THE NEEDLE ON 930 00:33:40,379 --> 00:33:41,347 PREMATURE MORTALITY? 931 00:33:41,347 --> 00:33:46,418 ARE WE LOOKING AT OUR HEALTH 932 00:33:46,418 --> 00:33:47,653 SYSTEMS AND IMPACT OF 933 00:33:47,653 --> 00:33:50,122 HYPERTENSION ON GENERATIONAL 934 00:33:50,122 --> 00:33:51,790 HEALTH AND WEALTH WHICH AFFECTS 935 00:33:51,790 --> 00:33:55,728 COMMUNITIES WRIT LARGE. 936 00:33:55,728 --> 00:33:57,062 NEXT SLIDE. 937 00:33:57,062 --> 00:33:58,063 THE NATIONAL INSTITUTE ON 938 00:33:58,063 --> 00:33:59,999 MINORITY HEALTH AND HEALTH 939 00:33:59,999 --> 00:34:01,433 DISPARITIES PROVIDES A HELPFUL 940 00:34:01,433 --> 00:34:03,502 FRAMEWORK WHEN YOU'RE DESIGNING 941 00:34:03,502 --> 00:34:04,003 STUDIES. 942 00:34:04,003 --> 00:34:06,672 I ENCOURAGE US TO USE THIS, IT 943 00:34:06,672 --> 00:34:08,674 FORCES YOU TO THINK ABOUT LEVELS 944 00:34:08,674 --> 00:34:11,510 OF INFLUENCE AND DOMAINS OF 945 00:34:11,510 --> 00:34:13,379 INFLUENCE AND HOW THOSE INTERACT 946 00:34:13,379 --> 00:34:15,581 SO WE CAN DESIGN INTERVENTIONS 947 00:34:15,581 --> 00:34:16,982 AND CAPTURE OUTCOMES THAT REALLY 948 00:34:16,982 --> 00:34:22,254 GET TO THE COMPLEXITIES OF THIS 949 00:34:22,254 --> 00:34:22,454 WORK. 950 00:34:22,454 --> 00:34:24,557 NEXT SLIDE. 951 00:34:24,557 --> 00:34:26,292 THE DESIGNING PROGRAMS THAT 952 00:34:26,292 --> 00:34:27,159 LEVERAGE TECHNOLOGY, I PUSH YOU 953 00:34:27,159 --> 00:34:29,461 TO USE WHAT'S OUT THERE. 954 00:34:29,461 --> 00:34:31,130 WE HAVE SO MUCH GOOD BASIS FOR 955 00:34:31,130 --> 00:34:33,199 ALL OF THE WORK THAT YOU'RE 956 00:34:33,199 --> 00:34:36,268 GOING TO BE DOING. 957 00:34:36,268 --> 00:34:39,371 ONE ARE PRINCIPLES FROM AMERICAN 958 00:34:39,371 --> 00:34:42,808 HEART ASSOCIATION TARGET BM MAP, 959 00:34:42,808 --> 00:34:44,343 MEASURE ACCURATELY, ACT RAPIDLY, 960 00:34:44,343 --> 00:34:46,645 PARTNER WITH PATIENTS, THREE 961 00:34:46,645 --> 00:34:49,248 PRINCIPLES TO GET US FAR IF WE 962 00:34:49,248 --> 00:34:49,849 DO THAT WELL. 963 00:34:49,849 --> 00:34:51,250 IT NEEDS TO BE DATA DRIVEN. 964 00:34:51,250 --> 00:34:54,854 I DON'T HAVE TO TELL YOU THAT, 965 00:34:54,854 --> 00:34:58,157 AND WE NEED TO USE 966 00:34:58,157 --> 00:35:01,227 PATIENT-CENTERED APPROACHES, 967 00:35:01,227 --> 00:35:05,664 THINK ABOUT MULTI-DISCIPLINARY 968 00:35:05,664 --> 00:35:06,799 TEAMS AND 969 00:35:06,799 --> 00:35:07,299 [AUDIO DISTORTION] 970 00:35:07,299 --> 00:35:09,101 ABOUT REMOTE BLOOD PRESSURE 971 00:35:09,101 --> 00:35:10,202 MANAGEMENT, COMBINATION PILLS, 972 00:35:10,202 --> 00:35:11,971 MAKING IT EASY AND ADDRESS 973 00:35:11,971 --> 00:35:16,108 SOCIAL DETERMINANTS OF HEALTH. 974 00:35:16,108 --> 00:35:16,775 NEXT SLIDE. 975 00:35:16,775 --> 00:35:19,178 WE DID PILOT WORK AT YALE WHERE 976 00:35:19,178 --> 00:35:22,681 WE WERE LOOKING TO UNDERSTAND 977 00:35:22,681 --> 00:35:25,751 FACILITATORS AND BARRIERS TO 978 00:35:25,751 --> 00:35:26,385 DIGITAL HEALTH UPTAKE, STUDIES 979 00:35:26,385 --> 00:35:29,889 200 LOW INCOME PATIENTS, HALF 980 00:35:29,889 --> 00:35:32,091 SPANISH-SPEAKING ONLY. 981 00:35:32,091 --> 00:35:35,694 WE HAD THEM REGISTER AND SYNC 982 00:35:35,694 --> 00:35:38,430 RECORDS, TRACKERS, CUFFS, INTO A 983 00:35:38,430 --> 00:35:39,531 SINGLE PLATFORM AND SURVEYED 984 00:35:39,531 --> 00:35:42,368 OVER THE COURSE OF 12 WEEKS. 985 00:35:42,368 --> 00:35:44,136 WE PROVIDED MOTIVATION AND 986 00:35:44,136 --> 00:35:44,637 SUSTAINED ENGAGEMENT AND 987 00:35:44,637 --> 00:35:46,839 ADDRESSED SOCIAL DETERMINANTS OF 988 00:35:46,839 --> 00:35:47,306 HEALTH. 989 00:35:47,306 --> 00:35:48,941 THESE RESULTS ARE REPORTED IN 990 00:35:48,941 --> 00:35:50,809 THE STUDY BUT WHAT I WANT TO 991 00:35:50,809 --> 00:35:52,778 HIGHLIGHT, YOU CAN ADVANCE ONE, 992 00:35:52,778 --> 00:35:54,980 IT'S GOING TO HIGHLIGHT THE 993 00:35:54,980 --> 00:35:57,149 PERSON IN THIS PICTURE, OUR 994 00:35:57,149 --> 00:35:58,384 COMMUNITY HEALTH WORKER. 995 00:35:58,384 --> 00:36:01,553 SHE WAS REALLY AT THE EPICENTER 996 00:36:01,553 --> 00:36:02,755 OF PATIENTS AND THEIR 997 00:36:02,755 --> 00:36:03,088 COMMUNITIES. 998 00:36:03,088 --> 00:36:05,824 SHE WORKED WITH US AS CLINICIANS 999 00:36:05,824 --> 00:36:07,993 AND INVESTIGATORS AND WORKED 1000 00:36:07,993 --> 00:36:08,994 WITH INDUSTRY, OUR TECH 1001 00:36:08,994 --> 00:36:10,863 COLLABORATORS, IN ORDER TO BRING 1002 00:36:10,863 --> 00:36:11,697 THIS TOGETHER. 1003 00:36:11,697 --> 00:36:13,799 ONE PERSON WAS ABLE TO WORK WITH 1004 00:36:13,799 --> 00:36:16,769 200 PEOPLE TO KEEP THEM ENGAGED, 1005 00:36:16,769 --> 00:36:18,070 AND REALLY SHOWED THEM HOW TO 1006 00:36:18,070 --> 00:36:19,171 USE THIS TECHNOLOGY TO IMPROVE 1007 00:36:19,171 --> 00:36:19,605 THEIR HEALTH. 1008 00:36:19,605 --> 00:36:23,642 I CAN'T TELL YOU THE VALUE OF 1009 00:36:23,642 --> 00:36:26,045 THIS COMMUNITY HEALTH WORKER IN 1010 00:36:26,045 --> 00:36:26,812 REALLY LEVERAGING THE TECHNOLOGY 1011 00:36:26,812 --> 00:36:29,014 THAT WE WERE TRYING TO INTRODUCE 1012 00:36:29,014 --> 00:36:33,852 IN THIS POPULATION. 1013 00:36:33,852 --> 00:36:34,620 NEXT SLIDE. 1014 00:36:34,620 --> 00:36:37,122 YALE, DR. SHAH MENTIONED, WE 1015 00:36:37,122 --> 00:36:39,091 HAVE A YALE DIGITAL HEALTH 1016 00:36:39,091 --> 00:36:40,526 PROGRAM. 1017 00:36:40,526 --> 00:36:42,394 WE RECEIVE REFERRALS FROM 1018 00:36:42,394 --> 00:36:44,463 PROVIDERS FOR PATIENTS WITH 1019 00:36:44,463 --> 00:36:45,097 POORLY CONTROLLED HYPERTENSION, 1020 00:36:45,097 --> 00:36:47,199 ALSO ON THE LABOR AND DELIVERY 1021 00:36:47,199 --> 00:36:49,735 FLOORS, USING OUR PROGRAM IN THE 1022 00:36:49,735 --> 00:36:57,910 POSTPARTUM POPULATION FOR WOMEN 1023 00:36:57,910 --> 00:36:59,778 WITH PRE-ECLAMPSIA, STAND OF 1024 00:36:59,778 --> 00:37:00,012 CARE. 1025 00:37:00,012 --> 00:37:03,048 WE'RE IN THE COMMUNITY IN 1026 00:37:03,048 --> 00:37:03,916 BARBERSHOPS, CHURCHES, TRYING TO 1027 00:37:03,916 --> 00:37:05,017 DETECT HYPERTENSION AND GET 1028 00:37:05,017 --> 00:37:07,019 PEOPLE INVOLVED IN REMOTE BLOOD 1029 00:37:07,019 --> 00:37:07,986 PRESSURE MONITORING PROGRAMS. 1030 00:37:07,986 --> 00:37:10,189 WE GIVE THEM A BLOOD PRESSURE 1031 00:37:10,189 --> 00:37:11,390 CUFF THAT'S BLUETOOTH ENABLED, 1032 00:37:11,390 --> 00:37:13,592 SYNC THEM WITH MEDICAL RECORDS, 1033 00:37:13,592 --> 00:37:16,428 AND WE HAVE DIVERSE TEAM OF 1034 00:37:16,428 --> 00:37:18,063 PHARMACISTS ABLE TO DO 1035 00:37:18,063 --> 00:37:19,365 TELEHEALTH VISITS, SEE PEOPLE ON 1036 00:37:19,365 --> 00:37:24,069 A WEEKLY OR BIWEEKLY BASIS, 1037 00:37:24,069 --> 00:37:25,270 TITRATE MEDICATIONS, USING AN 1038 00:37:25,270 --> 00:37:26,505 AGREEMENT BETWEEN PHYSICIANS AND 1039 00:37:26,505 --> 00:37:28,040 PHARMACISTS THAT ALLOWS THEM TO 1040 00:37:28,040 --> 00:37:29,875 PRESCRIBE AND ADDRESS BARRIERS 1041 00:37:29,875 --> 00:37:32,077 TO HEALTH. 1042 00:37:32,077 --> 00:37:33,178 YOU CAN ADVANCE. 1043 00:37:33,178 --> 00:37:34,713 WE'RE WORKING WITH PROJECT 1044 00:37:34,713 --> 00:37:36,682 ACCESS NEW HAVEN WHICH IS WHERE 1045 00:37:36,682 --> 00:37:37,783 THE COMMUNITY HEALTH WORKER 1046 00:37:37,783 --> 00:37:41,086 COMES FROM IN ORDER TO ADDRESS 1047 00:37:41,086 --> 00:37:41,820 SOCIAL DETERMINANTS OF HEALTH, 1048 00:37:41,820 --> 00:37:44,923 MANY TIMES THE BARRIERS ARE 1049 00:37:44,923 --> 00:37:45,758 IMPLEMENTATION BARRIERS THAT 1050 00:37:45,758 --> 00:37:50,929 COMMUNITY HEALTH WORKERS CAN 1051 00:37:50,929 --> 00:37:51,296 ADDRESS. 1052 00:37:51,296 --> 00:37:53,599 NEXT SLIDE. 1053 00:37:53,599 --> 00:37:54,033 NEXT SLIDE. 1054 00:37:54,033 --> 00:37:55,968 SO WHAT ARE SOME LESSONS LEARNED 1055 00:37:55,968 --> 00:37:56,769 THAT MAYBE YOU COULD TAKE WITH 1056 00:37:56,769 --> 00:38:00,406 YOU AS YOU HEAR THE DIFFERENT 1057 00:38:00,406 --> 00:38:01,340 TALKS TODAY? 1058 00:38:01,340 --> 00:38:04,410 THERE IS HIGH SATISFACTION IN 1059 00:38:04,410 --> 00:38:05,944 OUR PROGRAM AMONGST CLINICIANS, 1060 00:38:05,944 --> 00:38:06,912 PHYSICIANS NEED TO WARM UP TO 1061 00:38:06,912 --> 00:38:09,515 THE IDEA OF LETTING GO OF THE 1062 00:38:09,515 --> 00:38:11,517 REINS AND NOW THEY ARE WELCOMING 1063 00:38:11,517 --> 00:38:13,819 THE HELP THEY ARE GETTING BUT IT 1064 00:38:13,819 --> 00:38:14,353 TOOK TIME. 1065 00:38:14,353 --> 00:38:17,423 A CULTURE SHIFT NEEDS TO HAPPEN. 1066 00:38:17,423 --> 00:38:18,624 PHARMACISTS AND COMMUNITY HEALTH 1067 00:38:18,624 --> 00:38:19,625 WORKERS PRACTICE TO THEIR 1068 00:38:19,625 --> 00:38:21,593 LICENSE HAVING THE IMPACT THEY 1069 00:38:21,593 --> 00:38:24,329 WERE TRAINED TO DO. 1070 00:38:24,329 --> 00:38:25,197 REMOTE PATIENT MONITORING NEEDS 1071 00:38:25,197 --> 00:38:26,832 A LOT OF WORK, LIKE IF WE'RE 1072 00:38:26,832 --> 00:38:29,034 GOING TO USE CUFFS WE NEED TO 1073 00:38:29,034 --> 00:38:30,569 MAKE SURE FIT IS GOOD AND 1074 00:38:30,569 --> 00:38:32,070 GETTING A GOOD FIT IS REALLY 1075 00:38:32,070 --> 00:38:32,504 HARD. 1076 00:38:32,504 --> 00:38:35,040 WE NEED TO GET VALID DEVICES, 1077 00:38:35,040 --> 00:38:36,508 FIGURE HOW TO ENCOURAGE 1078 00:38:36,508 --> 00:38:37,976 ADHERENCE TO OUTPATIENT BLOOD 1079 00:38:37,976 --> 00:38:38,544 PRESSURE MONITORING. 1080 00:38:38,544 --> 00:38:40,813 WE NEED TO THINK ABOUT THE DATA 1081 00:38:40,813 --> 00:38:41,580 ASCERTAINMENT AND AGGREGATION, 1082 00:38:41,580 --> 00:38:46,852 HOW DO WE MAKE IT SIMPLE? 1083 00:38:46,852 --> 00:38:53,292 WE NEED TO RELEARN DATA WE'RE 1084 00:38:53,292 --> 00:38:55,160 ACQUIRING, HOW DO WE USE DATA TO 1085 00:38:55,160 --> 00:38:56,995 INDIVIDUALIZE CARE AND KEEP 1086 00:38:56,995 --> 00:38:58,664 PEOPLE ENGAGED IN THE 1087 00:38:58,664 --> 00:39:01,200 LONGITUDINAL WAY ACROSS 12-WEEK 1088 00:39:01,200 --> 00:39:01,433 PROGRAM? 1089 00:39:01,433 --> 00:39:02,835 SHOULD IT BE ONE YEAR? 1090 00:39:02,835 --> 00:39:04,470 HOW DO WE INCORPORATE AND PIVOT 1091 00:39:04,470 --> 00:39:06,872 WHEN PEOPLE ARE HAVING STRESSFUL 1092 00:39:06,872 --> 00:39:09,408 EVENTS, COMPETING HEALTH OR 1093 00:39:09,408 --> 00:39:09,875 NON-HEALTH PRIORITIES? 1094 00:39:09,875 --> 00:39:12,444 WE NEED TO THINK ABOUT WHO WE'RE 1095 00:39:12,444 --> 00:39:14,980 NOT REACHING. 1096 00:39:14,980 --> 00:39:17,082 WHO ARE NO-SHOWS, WHO DON'T HAVE 1097 00:39:17,082 --> 00:39:20,085 A PRIMARY CARE PROVIDER, WHO ARE 1098 00:39:20,085 --> 00:39:21,753 WE ONLY SEEING IN THE EMERGENCY 1099 00:39:21,753 --> 00:39:23,622 DEPARTMENT OR HOSPITAL? WHO IN 1100 00:39:23,622 --> 00:39:25,491 THE FAMILY AND PEER GROUP, IN 1101 00:39:25,491 --> 00:39:26,692 THE COMMUNITY MIGHT ALSO BENEFIT 1102 00:39:26,692 --> 00:39:28,227 FROM THE INFORMATION THAT WE'RE 1103 00:39:28,227 --> 00:39:30,095 SHARING WHEN WE'RE INTERACTING 1104 00:39:30,095 --> 00:39:30,796 WITH PATIENTS? 1105 00:39:30,796 --> 00:39:34,666 THEN WE NEED TO THINK ABOUT 1106 00:39:34,666 --> 00:39:35,334 SUSTAINABILITY. 1107 00:39:35,334 --> 00:39:37,870 HOW DO WE COMPENSATE, HOW DO WE 1108 00:39:37,870 --> 00:39:38,637 PROVIDE INCENTIVES FOR 1109 00:39:38,637 --> 00:39:39,338 PHARMACISTS, COMMUNITY HEALTH 1110 00:39:39,338 --> 00:39:43,108 WORKERS TO BUILD OUT THAT 1111 00:39:43,108 --> 00:39:43,942 MULTI-DISCIPLINARY TEAM AND 1112 00:39:43,942 --> 00:39:44,843 ENCOURAGE HEALTH SYSTEMS TO DO 1113 00:39:44,843 --> 00:39:46,745 THE RIGHT THING. 1114 00:39:46,745 --> 00:39:48,480 NEXT SLIDE. 1115 00:39:48,480 --> 00:39:50,415 MR. GREEN, OUR PATIENT, IS ONE 1116 00:39:50,415 --> 00:39:51,316 OF MANY. 1117 00:39:51,316 --> 00:39:54,386 THAT'S OUR CHARGE. 1118 00:39:54,386 --> 00:39:55,154 NEXT SLIDE. 1119 00:39:55,154 --> 00:39:58,023 WE KNOW DIGITAL HEALTH IS 1120 00:39:58,023 --> 00:39:58,257 NEEDED. 1121 00:39:58,257 --> 00:40:02,928 WE KNOW IT CAN MAKE CARE 1122 00:40:02,928 --> 00:40:04,463 CONVENIENT AND EFFICIENT, IT CAN 1123 00:40:04,463 --> 00:40:07,199 REVEAL BLOOD PRESSURE PHENOTYPES 1124 00:40:07,199 --> 00:40:10,035 THAT MATTER, WE KNOW IT CAN 1125 00:40:10,035 --> 00:40:12,771 CAPTURE CONTEXTUAL FACTORS AND 1126 00:40:12,771 --> 00:40:14,973 HAVE THIS GREAT, GREAT GOAL THAT 1127 00:40:14,973 --> 00:40:16,608 WE CAN INDIVIDUALIZE CARE PLANS 1128 00:40:16,608 --> 00:40:17,943 IF WE UNDERSTAND MORE ABOUT 1129 00:40:17,943 --> 00:40:19,678 PEOPLE'S BLOOD PRESSURE AND MORE 1130 00:40:19,678 --> 00:40:21,880 ABOUT THE SOCIAL AND BIOLOGICAL 1131 00:40:21,880 --> 00:40:23,048 FACTORS THAT ARE CONTRIBUTING. 1132 00:40:23,048 --> 00:40:28,820 I KNOW WE CAN IMPROVE OUTCOMES. 1133 00:40:28,820 --> 00:40:29,288 NEXT SLIDE. 1134 00:40:29,288 --> 00:40:32,257 BLOOD PRESSURE IS A NEXUS, IT'S 1135 00:40:32,257 --> 00:40:34,660 GOING TO REQUIRE BOLD CHANGE. 1136 00:40:34,660 --> 00:40:36,194 WE NEED FUNDAMENTALLY CHANGE THE 1137 00:40:36,194 --> 00:40:38,597 DELIVERY SYSTEM TO DO THIS WELL. 1138 00:40:38,597 --> 00:40:41,767 WE NEED TO MOVE FROM OUR HEALTH 1139 00:40:41,767 --> 00:40:42,768 SYSTEMS SILOS TO COMMUNITY 1140 00:40:42,768 --> 00:40:44,169 PARTNERSHIP. 1141 00:40:44,169 --> 00:40:50,108 WE NEED TO MOVE FROM ONEROUS 1142 00:40:50,108 --> 00:40:52,044 MEASUREMENTS IN THE OFFICE. 1143 00:40:52,044 --> 00:40:55,881 WE NEED TO MOVE FROM BEING 1144 00:40:55,881 --> 00:41:04,289 REACTIVE TO PRO-ACTIVE, FROM 1145 00:41:04,289 --> 00:41:09,561 BEING PHYSICIAN CENTRIC TO TEAM 1146 00:41:09,561 --> 00:41:13,332 CENTRIC, FROM FEE FOR SERVICE TO 1147 00:41:13,332 --> 00:41:14,700 VALUE-BASED CARE. 1148 00:41:14,700 --> 00:41:19,204 BLOOD PRESSURE IS INDEED A VERY 1149 00:41:19,204 --> 00:41:21,473 COMPLEX NEXUS. 1150 00:41:21,473 --> 00:41:22,574 YOU CAN ADVANCE. 1151 00:41:22,574 --> 00:41:24,876 THE SURGEON GENERAL HAS THE CALL 1152 00:41:24,876 --> 00:41:26,912 TO ACTION TO CONTROL 1153 00:41:26,912 --> 00:41:29,348 HYPERTENSION, I ENCOURAGE YOU TO 1154 00:41:29,348 --> 00:41:37,556 READ THIS AMAZING RESPONSE THAT 1155 00:41:37,556 --> 00:41:38,557 DR. MENSAH LED. 1156 00:41:38,557 --> 00:41:40,325 IT'S WONDERFUL TO HAVE THE 1157 00:41:40,325 --> 00:41:41,493 SURGEONS GENERAL BEHIND THIS. 1158 00:41:41,493 --> 00:41:43,262 THE NHLBI AS YOU HEARD FROM DR. 1159 00:41:43,262 --> 00:41:45,330 GOFF IS DEDICATED TO FUNDING 1160 00:41:45,330 --> 00:41:46,732 STUDIES THAT ADVANCE 1161 00:41:46,732 --> 00:41:47,633 HYPERTENSION AND HEALTH EQUITY, 1162 00:41:47,633 --> 00:41:49,801 AND THIS IS AN ENORMOUS 1163 00:41:49,801 --> 00:41:50,202 OPPORTUNITY. 1164 00:41:50,202 --> 00:41:52,104 I WOULD LIKE TO IMAGINE, YOU CAN 1165 00:41:52,104 --> 00:41:55,507 ADVANCE, THAT OTHER KEY FUNDERS 1166 00:41:55,507 --> 00:41:57,709 LIKE PCORI AND AMERICAN HEART 1167 00:41:57,709 --> 00:41:58,810 ASSOCIATION WITH DOUBLING DOWN 1168 00:41:58,810 --> 00:42:00,545 ON STUDIES AND RESEARCH TO 1169 00:42:00,545 --> 00:42:02,314 ADVANCE HYPERTENSION IN OUR 1170 00:42:02,314 --> 00:42:04,716 PATIENT POPULATIONS AND IN OUR 1171 00:42:04,716 --> 00:42:05,717 COMMUNITIES AND GLOBALLY 1172 00:42:05,717 --> 00:42:05,984 WORLDWIDE. 1173 00:42:05,984 --> 00:42:07,586 WITH THAT I'D LIKE TO THANK YOU 1174 00:42:07,586 --> 00:42:09,988 SO MUCH FOR YOUR ATTENTION TODAY 1175 00:42:09,988 --> 00:42:12,190 AND AM THRILLED TO HEAR YOUR 1176 00:42:12,190 --> 00:42:15,227 TALKS AND BE CHARGED BY THE WORK 1177 00:42:15,227 --> 00:42:17,296 THAT IS GOING TO COME OUT OF 1178 00:42:17,296 --> 00:42:17,763 THESE TWO DAYS. 1179 00:42:17,763 --> 00:42:27,973 THANK YOU SO MUCH FOR HAVING ME. 1180 00:42:27,973 --> 00:42:29,408 >> WHAT AN INCREDIBLY 1181 00:42:29,408 --> 00:42:30,776 INFORMATIVE KEYNOTE, PERFECT TO 1182 00:42:30,776 --> 00:42:33,612 KICK OFF THE SESSIONS. 1183 00:42:33,612 --> 00:42:34,246 THANK YOU. 1184 00:42:34,246 --> 00:42:37,449 SO, DR. SHAH IS GOING TO 1185 00:42:37,449 --> 00:42:39,184 MODERATE THE NEXT SESSION. 1186 00:42:39,184 --> 00:42:42,821 BRIDGING THE COMMUNICATION GAP 1187 00:42:42,821 --> 00:42:44,222 BETWEEN POPULATION-HEALTH, 1188 00:42:44,222 --> 00:42:45,957 CLINICAL MEDICINE, ENGINEERING. 1189 00:42:45,957 --> 00:42:48,794 >> THANK YOU. 1190 00:42:48,794 --> 00:42:50,896 THAT WAS AMAZING, DR. SPATZ. 1191 00:42:50,896 --> 00:42:52,130 YOU COVERED STARTING FROM THE 1192 00:42:52,130 --> 00:42:54,733 PEOPLE TO THE END, THE WHOLE 1193 00:42:54,733 --> 00:42:55,400 SYSTEM. 1194 00:42:55,400 --> 00:42:56,468 THAT WAS AN AMAZING 1195 00:42:56,468 --> 00:42:58,870 PRESENTATION. 1196 00:42:58,870 --> 00:43:00,472 THANK YOU FOR PARTICIPATING. 1197 00:43:00,472 --> 00:43:03,942 SO, LET'S MOVE ON NOW TO OUR 1198 00:43:03,942 --> 00:43:06,344 FIRST SESSION. 1199 00:43:06,344 --> 00:43:07,779 BRIDGING THE COMMUNICATION GAP, 1200 00:43:07,779 --> 00:43:09,348 NEAR AND DEAR TO MY HEART, I 1201 00:43:09,348 --> 00:43:11,516 WORK WITH A LOT OF ENGINEERS. 1202 00:43:11,516 --> 00:43:13,352 WE'RE FROM DIFFERENT PLANETS. 1203 00:43:13,352 --> 00:43:15,654 A FEW PEOPLE HERE HAVE 1204 00:43:15,654 --> 00:43:18,156 SUCCESSFULLY DONE THIS. 1205 00:43:18,156 --> 00:43:19,424 SOME PHYSICIAN, SOME COMPUTER 1206 00:43:19,424 --> 00:43:21,093 SCIENTISTS AND ENGINEERS WHO 1207 00:43:21,093 --> 00:43:21,860 MADE THIS WORK. 1208 00:43:21,860 --> 00:43:25,163 I'M THRILLED TO PRESENT THE 1209 00:43:25,163 --> 00:43:29,000 GROUP LEER. 1210 00:43:29,000 --> 00:43:31,837 DR. BOBAK MORTAZAVI, TEXAS A & M 1211 00:43:31,837 --> 00:43:32,170 UNIVERSITY. 1212 00:43:32,170 --> 00:43:34,439 HE'S DONE WONDERFUL WORK 1213 00:43:34,439 --> 00:43:35,440 COLLABORATING WITH CARDIOLOGISTS 1214 00:43:35,440 --> 00:43:37,743 AND DEVELOPING NEW TECHNOLOGY IN 1215 00:43:37,743 --> 00:43:42,447 THE FIELD. 1216 00:43:42,447 --> 00:43:44,082 NEXT DR. ATTIA 1217 00:43:44,082 --> 00:43:45,384 CO-DIRECTOR OF ARTIFICIAL 1218 00:43:45,384 --> 00:43:46,818 INTELLIGENCE AT THE MAYO CLINIC. 1219 00:43:46,818 --> 00:43:48,987 HE ALSO HAS TRAINING IN 1220 00:43:48,987 --> 00:43:50,422 ELECTRICAL ENGINEERING, HAS DONE 1221 00:43:50,422 --> 00:43:52,557 AMAZING WORK LEVERAGING THE 1222 00:43:52,557 --> 00:43:53,592 MAYO'S HEALTH SYSTEM DATA TO 1223 00:43:53,592 --> 00:43:55,927 ADVANCE THE FIELD. 1224 00:43:55,927 --> 00:43:58,563 AND FINALLY DR. AHMAD, 1225 00:43:58,563 --> 00:44:00,499 PRACTICING PHYSICIAN, ADVANCED 1226 00:44:00,499 --> 00:44:03,001 HEART FAILURE PHYSICIAN, THE 1227 00:44:03,001 --> 00:44:06,838 ASSOCIATE DIRECTOR CENTER FOR 1228 00:44:06,838 --> 00:44:12,210 ARTIFICIAL INTELLIGENCE AT THE 1229 00:44:12,210 --> 00:44:12,944 BLOOM INSTITUTE. 1230 00:44:12,944 --> 00:44:13,445 I'LL MODERATE. 1231 00:44:13,445 --> 00:44:14,713 IF THINGS ARE GETTING CLOSE TO 1232 00:44:14,713 --> 00:44:18,750 TIME LIMIT I MIGHT STEP IN TO 1233 00:44:18,750 --> 00:44:19,985 ASK THE PRESENTERS TO MOVE 1234 00:44:19,985 --> 00:44:20,218 FORWARD. 1235 00:44:20,218 --> 00:44:21,920 AT THE END WE'LL HAVE A PANEL 1236 00:44:21,920 --> 00:44:22,387 DISCUSSION. 1237 00:44:22,387 --> 00:44:23,488 IF YOU PUT YOUR QUESTIONS IN THE 1238 00:44:23,488 --> 00:44:25,123 CHAT I'LL KEEP UP WITH THOSE. 1239 00:44:25,123 --> 00:44:26,425 AND I THINK IT'S GOING TO BE A 1240 00:44:26,425 --> 00:44:27,392 WONDERFUL SESSION. 1241 00:44:27,392 --> 00:44:37,269 WITH THAT, I WILL HAND IT OVER 1242 00:44:37,269 --> 00:44:38,470 TO DR. MORTAZAVI. 1243 00:44:38,470 --> 00:44:39,771 >> THANK YOU FOR THE 1244 00:44:39,771 --> 00:44:41,006 INTRODUCTION, I'M EXCITED TO 1245 00:44:41,006 --> 00:44:41,873 SPEAK WITH YOU TODAY. 1246 00:44:41,873 --> 00:44:43,508 I HAVE THE PLEASURE OF BEING 1247 00:44:43,508 --> 00:44:47,012 ABLE TO TALK ABOUT SOME OF THE 1248 00:44:47,012 --> 00:44:48,213 ENGINEERING TERMS THAT MAYBE 1249 00:44:48,213 --> 00:44:51,516 SHOULD BE HELPFUL FOR MERGING 1250 00:44:51,516 --> 00:44:53,819 WITH CLINICIANS, MYSELF, I 1251 00:44:53,819 --> 00:44:55,086 TRAINED WITH CARDIOLOGISTS AT 1252 00:44:55,086 --> 00:44:56,588 THE YALE SCHOOL OF MEDICINE, 1253 00:44:56,588 --> 00:45:00,692 HAVE HAD THE FORTUNE OF WORKING 1254 00:45:00,692 --> 00:45:02,661 WITH THEM CLOSELY, HAVE THESE 1255 00:45:02,661 --> 00:45:04,996 DISCLOSURES THAT ARE FUNDING 1256 00:45:04,996 --> 00:45:06,932 WORK IN THIS AREA. 1257 00:45:06,932 --> 00:45:08,133 SO, JUST TO GO THROUGH HERE, 1258 00:45:08,133 --> 00:45:10,402 IT'S GOING TO BE DIFFICULT TO 1259 00:45:10,402 --> 00:45:13,939 TALK ABOUT ALL OF THE TERMS IN 1260 00:45:13,939 --> 00:45:14,973 ENGINEERING THAT ARE NECESSARY 1261 00:45:14,973 --> 00:45:15,907 FOR HYPERTENSION MANAGEMENT BUT 1262 00:45:15,907 --> 00:45:18,109 I'M HOPING GOING THROUGH THIS 1263 00:45:18,109 --> 00:45:20,312 OUTLINE WE CAN TALK ABOUT 1264 00:45:20,312 --> 00:45:23,815 GENERALLY KEY MODELS AND TERMS 1265 00:45:23,815 --> 00:45:25,684 TO USE, LANGUAGE THAT NEEDS TO 1266 00:45:25,684 --> 00:45:27,519 BE CONSISTENT ACROSS ENGINEERS 1267 00:45:27,519 --> 00:45:30,255 AND CLINICIANS. 1268 00:45:30,255 --> 00:45:31,990 I WHEN I STARTED SPENT AN 1269 00:45:31,990 --> 00:45:33,625 EMBARRASSING AMOUNT OF TIME 1270 00:45:33,625 --> 00:45:35,393 FIGURING OUT DIFFERENCE BETWEEN 1271 00:45:35,393 --> 00:45:37,462 SOME MEASUREMENTS WE USE, LIKE 1272 00:45:37,462 --> 00:45:40,332 AREA UNDER THE ROC CURVE AND 1273 00:45:40,332 --> 00:45:42,767 STATISTICS AND LEARNING THESE 1274 00:45:42,767 --> 00:45:45,470 ARE THE SAME THINGS. 1275 00:45:45,470 --> 00:45:47,539 IT'S THINGS LIKE THIS THAT 1276 00:45:47,539 --> 00:45:48,206 CHALLENGE INTEGRATING BETWEEN 1277 00:45:48,206 --> 00:45:49,341 FIELDS BUT WE CAN UNDERSTAND 1278 00:45:49,341 --> 00:45:51,142 SORT OF WHAT ARE THE KEY KINDS 1279 00:45:51,142 --> 00:45:54,212 OF MODELS AND TECHNIQUES USED, 1280 00:45:54,212 --> 00:45:58,850 AND TALK ABOUT JUST SORT OF 1281 00:45:58,850 --> 00:46:00,485 ADVANCED SURVEY OF MODELS AND 1282 00:46:00,485 --> 00:46:01,786 SENSING AND THINGS AVAILABLE TO 1283 00:46:01,786 --> 00:46:04,689 US TO TRY TO PROMOTE NEW 1284 00:46:04,689 --> 00:46:07,926 SOLUTIONS HERE. 1285 00:46:07,926 --> 00:46:10,228 MOST OF THIS IS JUST A QUICK 1286 00:46:10,228 --> 00:46:11,530 SURVEY OF THINGS YOU MIGHT HEAR 1287 00:46:11,530 --> 00:46:15,267 IN DIFFERENT TALKS AS WE GO 1288 00:46:15,267 --> 00:46:16,601 THROUGH THE DAY AND HOPEFULLY 1289 00:46:16,601 --> 00:46:18,470 LOOK FAMILIAR TO SOME THINGS AND 1290 00:46:18,470 --> 00:46:19,337 EXCITES YOUR INTEREST IN 1291 00:46:19,337 --> 00:46:21,072 LEARNING ABOUT SOME THINGS THAT 1292 00:46:21,072 --> 00:46:21,606 DON'T. 1293 00:46:21,606 --> 00:46:22,741 TYPICALLY WHEN WE LOOK AT A 1294 00:46:22,741 --> 00:46:25,010 BUNCH OF THESE STUDIES AND 1295 00:46:25,010 --> 00:46:30,682 GATHER DATA WE LOOK AT 1296 00:46:30,682 --> 00:46:33,451 SUPERVISED MACHINE LEARNING 1297 00:46:33,451 --> 00:46:34,753 TECHNIQUES. 1298 00:46:34,753 --> 00:46:36,821 SUPERVISED MODELS HAVE DATA 1299 00:46:36,821 --> 00:46:37,822 POINTS AND DIAGNOSING SOMETHING 1300 00:46:37,822 --> 00:46:40,458 WITH HYPERTENSION OR NOT 1301 00:46:40,458 --> 00:46:41,226 DIAGNOSING CARDIOVASCULAR 1302 00:46:41,226 --> 00:46:43,728 DISORDER OR NOT BASED ON THESE 1303 00:46:43,728 --> 00:46:45,096 TECHNIQUES THAT INVOLVE GRABBING 1304 00:46:45,096 --> 00:46:46,131 DATA AND UNDERSTANDING WHETHER 1305 00:46:46,131 --> 00:46:48,867 YOU HAVE THESE THINGS OR WHAT 1306 00:46:48,867 --> 00:46:54,139 ARE THE TIMES FOR THESE EVENTS. 1307 00:46:54,139 --> 00:46:55,674 IT'S IMPORTANT AS WE'VE COVERED 1308 00:46:55,674 --> 00:46:56,875 UNDERSTANDING A SUITE OF 1309 00:46:56,875 --> 00:47:00,045 MEASUREMENTS TO UNDERSTAND 1310 00:47:00,045 --> 00:47:03,748 THINGS THAT ARE NOT -- WE WANT 1311 00:47:03,748 --> 00:47:05,183 TO DIAGNOSE HYPERTENSIVE STATUS 1312 00:47:05,183 --> 00:47:07,352 AND PREDICT THE RISKS OF 1313 00:47:07,352 --> 00:47:07,619 OUTCOMES. 1314 00:47:07,619 --> 00:47:09,888 IT ISN'T JUST BEING ABLE TO 1315 00:47:09,888 --> 00:47:10,956 DISCRIMINATE BETWEEN ONE CLASS 1316 00:47:10,956 --> 00:47:12,223 OR ANOTHER BUT UNDERSTAND THE 1317 00:47:12,223 --> 00:47:17,329 RANGE OF PROBABILITY, CHANGES 1318 00:47:17,329 --> 00:47:20,732 AND RISKS, AND 1319 00:47:20,732 --> 00:47:21,800 THRESHOLD-SPECIFIC THINGS. 1320 00:47:21,800 --> 00:47:25,437 AS WE MOVE FORWARD AND DISCUSS 1321 00:47:25,437 --> 00:47:27,939 THESE TECHNIQUES AND SOLUTIONS, 1322 00:47:27,939 --> 00:47:29,808 WE NEED A SUITE OF MEASUREMENTS. 1323 00:47:29,808 --> 00:47:33,078 ANY ONE NUMBER IS NOT GOING TO 1324 00:47:33,078 --> 00:47:36,681 BE DEFINITIVE UNTIL IT TELLS US 1325 00:47:36,681 --> 00:47:38,783 THOUSAND ADDRESS PROBLEMS AND 1326 00:47:38,783 --> 00:47:41,853 INTERVENE EARLY. 1327 00:47:41,853 --> 00:47:42,754 THIS INCLUDES CLASSIFICATION 1328 00:47:42,754 --> 00:47:47,859 TECHNIQUES, AND REGRESSION 1329 00:47:47,859 --> 00:47:48,393 MEASUREMENTS. 1330 00:47:48,393 --> 00:47:49,294 REGRESSION MEASUREMENTS ARIC 1331 00:47:49,294 --> 00:47:50,161 THATTING NOVEL SENSING 1332 00:47:50,161 --> 00:47:52,230 TECHNIQUES AND BEING ABLE TO 1333 00:47:52,230 --> 00:47:53,131 PREDICT BLOOD PRESSURE 1334 00:47:53,131 --> 00:47:54,933 MEASUREMENTS AS WE GO ALONG, SO 1335 00:47:54,933 --> 00:48:02,407 CORRELATION ROOT MEAN SQUARE 1336 00:48:02,407 --> 00:48:03,241 ERROR, MEAN ABSOLUTE DIFFERENCE, 1337 00:48:03,241 --> 00:48:05,443 AND WHAT THEY ARE TELLING YOU IS 1338 00:48:05,443 --> 00:48:06,478 THAT WHAT PERCENTAGE OF THE 1339 00:48:06,478 --> 00:48:11,416 TIME, HOW FAR OFF ARE THESE SORT 1340 00:48:11,416 --> 00:48:12,884 OF MAYBE COMMERCIALLY AVAILABLE 1341 00:48:12,884 --> 00:48:13,818 DEVICES PRESENTING DATA VERSUS 1342 00:48:13,818 --> 00:48:15,453 WHAT YOU MIGHT MEASURE IN THE 1343 00:48:15,453 --> 00:48:16,321 CLINIC. 1344 00:48:16,321 --> 00:48:18,657 IF WE HAVE A SUITE, WE CAN THINK 1345 00:48:18,657 --> 00:48:19,824 ABOUT THE ADVANCEMENTS IN 1346 00:48:19,824 --> 00:48:23,895 ENGINEERING THAT ALLOW US TO 1347 00:48:23,895 --> 00:48:26,197 POTENTIALLY HELP DEVELOP AND 1348 00:48:26,197 --> 00:48:29,834 TECHNOLOGY AND INTERVENTION TO 1349 00:48:29,834 --> 00:48:31,670 AID IN ADDRESSING BURDENS. 1350 00:48:31,670 --> 00:48:34,205 WHAT I'M EXCITING ABOUT IN 1351 00:48:34,205 --> 00:48:36,041 COMING TALKS, OTHER TERMS YOU 1352 00:48:36,041 --> 00:48:38,009 MIGHT HEAR FROM SENSORS, WE LIKE 1353 00:48:38,009 --> 00:48:42,947 TO TALK ABOUT SPECIFICALLY 1354 00:48:42,947 --> 00:48:43,581 WEARABLES, NEARABLES, 1355 00:48:43,581 --> 00:48:44,049 IMPLANTABLES, SENSING 1356 00:48:44,049 --> 00:48:45,350 TECHNOLOGIES ON THE PATIENT OR 1357 00:48:45,350 --> 00:48:48,086 NEAR THE PATIENT WITH THE 1358 00:48:48,086 --> 00:48:49,954 PATIENT, AND HAVE IT 1359 00:48:49,954 --> 00:48:52,891 CONTINUOUSLY MEASURE THINGS. 1360 00:48:52,891 --> 00:48:56,494 THEY CAN COME FROM MORE 1361 00:48:56,494 --> 00:48:58,263 CLINICALLY ORIENTED LIKE 1362 00:48:58,263 --> 00:48:59,364 AMBULATORY CUFF OR COMMERCIALLY 1363 00:48:59,364 --> 00:49:00,865 AVAILABLE TECHNIQUES THAT MAY 1364 00:49:00,865 --> 00:49:04,169 HAVE MORE LONGITUDINAL USE AND 1365 00:49:04,169 --> 00:49:05,470 MORE UPTAKE IN COMMUNITIES THAT 1366 00:49:05,470 --> 00:49:08,673 DON'T HAVE MAYBE BURDENS OF 1367 00:49:08,673 --> 00:49:10,742 USING SIGNIFICANT BULKY CLINICAL 1368 00:49:10,742 --> 00:49:15,880 DEVICES LIKE FITNESS TRACKERS, 1369 00:49:15,880 --> 00:49:18,183 CONTINUOUS GLUCOSE MONITORS 1370 00:49:18,183 --> 00:49:23,555 BROADENING ACCEPTABILITY ACROSS 1371 00:49:23,555 --> 00:49:25,857 PATIENT POPULATIONS, NOT JUST 1372 00:49:25,857 --> 00:49:28,927 TYPE 1 DIABETICS. 1373 00:49:28,927 --> 00:49:32,964 A TREND IS TAKE THESE 1374 00:49:32,964 --> 00:49:33,965 TECHNOLOGIES THAT USE SENSING 1375 00:49:33,965 --> 00:49:36,234 SOLUTIONS AND SEE IF WE IS 1376 00:49:36,234 --> 00:49:37,335 DEVELOP NEW TECHNIQUES WHILE 1377 00:49:37,335 --> 00:49:38,336 MEASURING BLOOD PRESSURE. 1378 00:49:38,336 --> 00:49:40,738 FOR EXAMPLE, ONE THAT I'M 1379 00:49:40,738 --> 00:49:42,841 INVOLVED WITH USES ELECTRICAL 1380 00:49:42,841 --> 00:49:47,112 IMPULSES TO IDENTIFY RADIAL 1381 00:49:47,112 --> 00:49:48,079 ARTERY AND TRACK PRESSURE FLOW. 1382 00:49:48,079 --> 00:49:52,784 IF YOU CAN DO THIS DATA CAPTURE, 1383 00:49:52,784 --> 00:49:55,687 THE BIGGEST CONCERN AS 1384 00:49:55,687 --> 00:49:58,156 ENGINEERS, WHAT DO YOU WITH SUCH 1385 00:49:58,156 --> 00:50:02,761 OVERWHELMING AMOUNTS OF DATA, 1386 00:50:02,761 --> 00:50:03,862 THESE THINGS ARE ALMOST -- 1387 00:50:03,862 --> 00:50:04,929 DIFFICULT TO DEAL WITH. 1388 00:50:04,929 --> 00:50:06,865 WHAT WE'RE TALKING ABOUT MAY BE 1389 00:50:06,865 --> 00:50:08,766 A SINGLE MEASUREMENT AT A VISIT 1390 00:50:08,766 --> 00:50:10,401 OR PERIODIC, NOW I'M TALKING 1391 00:50:10,401 --> 00:50:11,703 ABOUT GIVING YOU A CONTINUOUS 1392 00:50:11,703 --> 00:50:12,504 SIGNAL SIMILAR TO SOMETHING YOU 1393 00:50:12,504 --> 00:50:21,146 WOULD SEE IN ELECTROCARDIOGRAM. 1394 00:50:21,146 --> 00:50:23,114 NOW LOOK AT ADVANCEMENTS IN 1395 00:50:23,114 --> 00:50:25,216 TECHNIQUES AVAILABLE TO LOOK AT 1396 00:50:25,216 --> 00:50:28,586 WAVE FORMS OF DATA, CONTINUOUS 1397 00:50:28,586 --> 00:50:31,556 CAPTURES OF BIOMETRIC SIGNALS 1398 00:50:31,556 --> 00:50:33,625 RATHER THAN MAYBE STANDARD 1399 00:50:33,625 --> 00:50:36,161 METRIC OR THRESHOLD DATES, 1400 00:50:36,161 --> 00:50:40,832 VALUES CAPTURED PERIODICALLY. 1401 00:50:40,832 --> 00:50:44,135 WE'LL DIVE INTO ANOTHER SET OF 1402 00:50:44,135 --> 00:50:45,870 TERMS, WE'LL DESCRIBE THEM AS A 1403 00:50:45,870 --> 00:50:51,142 HIGH LEVEL TUTORIAL HERE, ONE 1404 00:50:51,142 --> 00:50:52,911 THING PARTICULARLY POPULAR ARE 1405 00:50:52,911 --> 00:50:55,313 DEEP LEARNING TECHNIQUES. 1406 00:50:55,313 --> 00:50:57,382 WHAT THESE ARE, UNIVERSAL 1407 00:50:57,382 --> 00:50:58,817 ESTIMATORS THAT CAN LEARN AND 1408 00:50:58,817 --> 00:51:01,653 INFER PATTERNS FROM RAW DATA. 1409 00:51:01,653 --> 00:51:04,989 WHEREAS PREVIOUSLY I MIGHT NEED 1410 00:51:04,989 --> 00:51:07,358 AN ECG SIGNAL AND DETECT PEAKS 1411 00:51:07,358 --> 00:51:13,064 AND QRS COMPLEXES AND UNDERSTAND 1412 00:51:13,064 --> 00:51:14,833 AN AREA UNDER ELEVATION, I CAN 1413 00:51:14,833 --> 00:51:16,234 PROVIDE DEEP LEARNING TECHNIQUE 1414 00:51:16,234 --> 00:51:17,669 WITH RAW SIGNALS WITHOUT SUCH 1415 00:51:17,669 --> 00:51:20,071 ANNOTATIONS AND SEE IF IT CAN 1416 00:51:20,071 --> 00:51:24,442 LEARN SETS OF FEATURES AND 1417 00:51:24,442 --> 00:51:25,877 PARAMETERS AND RELATIONSHIPS 1418 00:51:25,877 --> 00:51:28,279 THAT IDENTIFY NEW THINGS, 1419 00:51:28,279 --> 00:51:29,480 PRESENT NEW KNOWLEDGE, AND 1420 00:51:29,480 --> 00:51:31,349 IMPORTANTLY THESE KIND OF 1421 00:51:31,349 --> 00:51:34,519 TECHNIQUES CAN BE CONTINUALLY 1422 00:51:34,519 --> 00:51:35,620 ADAPTED, CONTINUALLY UPDATED AND 1423 00:51:35,620 --> 00:51:37,689 LEARN MULTIPLE THINGS AT ONCE, 1424 00:51:37,689 --> 00:51:38,423 SO THINGS RELATED TO BLOOD 1425 00:51:38,423 --> 00:51:42,961 PRESSURE IF WE'RE CAPTURING 1426 00:51:42,961 --> 00:51:43,828 CHARACTERISTICS OVER STUDIES, WE 1427 00:51:43,828 --> 00:51:45,463 DON'T HAVE TO THINK ABOUT EACH 1428 00:51:45,463 --> 00:51:47,098 AS INDIVIDUAL THINGS, JUST 1429 00:51:47,098 --> 00:51:49,534 LOOKING AT THE SYSTOLIC OR JUST 1430 00:51:49,534 --> 00:51:51,069 LOOKING AT DIASTOLIC OR CHANGES 1431 00:51:51,069 --> 00:51:53,104 IN HEART RATE, BUT ACTUALLY CAN 1432 00:51:53,104 --> 00:51:57,609 CAPTURE A SET OF SENSING DATA ON 1433 00:51:57,609 --> 00:51:58,710 THE PARTICIPANT AND LEARN, 1434 00:51:58,710 --> 00:52:06,484 INTERNAL REPRESENTATIVE 1435 00:52:06,484 --> 00:52:07,185 REPRESENTATIONS AND 1436 00:52:07,185 --> 00:52:12,390 PREDICTING SYSTOLIC AND 1437 00:52:12,390 --> 00:52:16,995 DIASTOLIC, PERHAPS NOT RELATING 1438 00:52:16,995 --> 00:52:20,865 IN THE SAME FUNCTION, WE USE 1439 00:52:20,865 --> 00:52:23,768 MULTI-TASK LEARNING LENDING TO 1440 00:52:23,768 --> 00:52:26,938 THE THING THAT'S ALL OVER THAT 1441 00:52:26,938 --> 00:52:28,373 WE'VE BEEN HEARING ABOUT, 1442 00:52:28,373 --> 00:52:29,474 GENERATEIVE MODELS. 1443 00:52:29,474 --> 00:52:31,209 IF WE CAN TAKE THESE DEEP 1444 00:52:31,209 --> 00:52:33,077 LEARNING TECHNIQUES AND PROVIDE 1445 00:52:33,077 --> 00:52:36,247 ENOUGH DATA TO THEM, THEY BECOME 1446 00:52:36,247 --> 00:52:38,116 CAPABLE OF REPRESENTING WHAT A 1447 00:52:38,116 --> 00:52:40,718 PATIENT AND CURRENT PATIENT 1448 00:52:40,718 --> 00:52:42,487 STATE LOOKS LIKE, INDEPENDENT OF 1449 00:52:42,487 --> 00:52:42,687 TASK. 1450 00:52:42,687 --> 00:52:44,355 WHETHER IT'S TRYING TO MEASURE 1451 00:52:44,355 --> 00:52:47,725 SYSTOLIC BLOOD PRESSURE OR 1452 00:52:47,725 --> 00:52:50,928 CLASSIFY HYPERTENSION OR NOW YOU 1453 00:52:50,928 --> 00:52:53,965 WANT TO MODEL RISKS OF ACUTE 1454 00:52:53,965 --> 00:52:57,969 EVENT IN THE NEXT SIX MONTHS, 12 1455 00:52:57,969 --> 00:52:59,570 OR 18 MONTHS, RATHER THAN 1456 00:52:59,570 --> 00:53:00,538 BUILDING DATASETS AND 1457 00:53:00,538 --> 00:53:01,739 INDEPENDENT STUDIES, WHAT WE CAN 1458 00:53:01,739 --> 00:53:03,274 DO IS LOOK AT OBSERVATIONAL 1459 00:53:03,274 --> 00:53:04,275 DATA, COLLECT IT OVER LARGE 1460 00:53:04,275 --> 00:53:06,444 PERIODS OF TIME OVER LARGE 1461 00:53:06,444 --> 00:53:07,278 POPULATION SOURCES, AND SORT OF 1462 00:53:07,278 --> 00:53:08,813 START TO LEARN WHAT DATA 1463 00:53:08,813 --> 00:53:13,451 REPRESENTS DIFFERENT TASKS AND 1464 00:53:13,451 --> 00:53:14,752 THINGS ABOUT PATIENTS, AND WE 1465 00:53:14,752 --> 00:53:17,288 CAN GENERATE FROM THIS AND LEARN 1466 00:53:17,288 --> 00:53:19,123 ALL KINDS OF DIFFERENT TASKS 1467 00:53:19,123 --> 00:53:19,457 FROM THIS. 1468 00:53:19,457 --> 00:53:20,925 AND THIS IS, YOU KNOW, YOU HAVE 1469 00:53:20,925 --> 00:53:24,595 HEARD A LOT OF THESE THINGS 1470 00:53:24,595 --> 00:53:26,264 LATELY, GENERATIVE MODELS, 1471 00:53:26,264 --> 00:53:27,231 SPECIFICALLY LARGE LANGUAGE 1472 00:53:27,231 --> 00:53:29,734 MODELS THAT ENABLE THINGS LIKE 1473 00:53:29,734 --> 00:53:30,835 CHAT GPT AND SUCH, TO BE ABLE TO 1474 00:53:30,835 --> 00:53:39,610 CREATE EXPLANATIONS ANSWERS AND 1475 00:53:39,610 --> 00:53:40,378 DESCRIPTIVES BEHIND DATA TOO 1476 00:53:40,378 --> 00:53:45,216 COMPLEX TO UNDERSTAND ON ITS 1477 00:53:45,216 --> 00:53:45,650 OWN. 1478 00:53:45,650 --> 00:53:47,085 THESE ARE FEASIBLE IN RECENT 1479 00:53:47,085 --> 00:53:49,721 YEARS SPECIFICALLY BECAUSE OF 1480 00:53:49,721 --> 00:53:50,588 THE COMPUTATIONAL AND 1481 00:53:50,588 --> 00:53:51,456 ENGINEERING ADVANCEMENTS THAT 1482 00:53:51,456 --> 00:53:52,991 WE'VE HAD. 1483 00:53:52,991 --> 00:53:54,392 WHILE DEEP LEARNING HAS EXISTED 1484 00:53:54,392 --> 00:53:56,928 FOR A LONG TIME, IT'S COMING TO 1485 00:53:56,928 --> 00:53:59,230 THE FOREFRONT NOW BEING ABLE TO 1486 00:53:59,230 --> 00:54:01,032 USE THESE THINGS, UNDERSTAND AND 1487 00:54:01,032 --> 00:54:05,036 REPRESENT WHAT DATA LOOKS LIKES 1488 00:54:05,036 --> 00:54:06,137 AND TRANSFER ACROSS POPULATIONS. 1489 00:54:06,137 --> 00:54:08,840 WE MIGHT HAVE A STUDY LIKE THE 1490 00:54:08,840 --> 00:54:09,974 ONE DR. SPATZ MENTIONED AT YALE 1491 00:54:09,974 --> 00:54:12,810 LOOKING AT PATIENTS AND 1492 00:54:12,810 --> 00:54:14,445 COLLECTING DATA AROUND THE 1493 00:54:14,445 --> 00:54:15,880 CONNECTICUT AREA, AND SAY, OKAY, 1494 00:54:15,880 --> 00:54:17,482 WHAT ABOUT MY PATIENT POPULATION 1495 00:54:17,482 --> 00:54:19,450 IN TEXAS, DO THEY LOOK THE SAME, 1496 00:54:19,450 --> 00:54:19,884 DIFFERENT? 1497 00:54:19,884 --> 00:54:25,056 HOW MUCH DO I NEED REPLICATE TO 1498 00:54:25,056 --> 00:54:26,891 GENERATE DATA TO IMPLEMENT THESE 1499 00:54:26,891 --> 00:54:28,226 SOLUTIONS HERE AND TREAT 1500 00:54:28,226 --> 00:54:30,094 PATIENTS IN TEXAS SIMILAR TO HOW 1501 00:54:30,094 --> 00:54:32,263 SHE MIGHT BE DOING IN 1502 00:54:32,263 --> 00:54:32,563 CONNECTICUT. 1503 00:54:32,563 --> 00:54:34,465 THE BEAUTY IS ONCE I CAN GET 1504 00:54:34,465 --> 00:54:36,100 ENOUGH DATA TO SORT OF LEARNING 1505 00:54:36,100 --> 00:54:38,603 AND GENERATE WHAT I THINK 1506 00:54:38,603 --> 00:54:42,039 DIFFERENT PATIENTS AT DIFFERENT 1507 00:54:42,039 --> 00:54:43,141 STAGES OF THEIR CARDIOVASCULAR 1508 00:54:43,141 --> 00:54:44,375 HEALTH AND HYPERTENSION LOOK 1509 00:54:44,375 --> 00:54:46,511 LIKE, I CAN TAKE THESE MODELS 1510 00:54:46,511 --> 00:54:49,280 AND ONLY JUST SORT OF FINE TUNE 1511 00:54:49,280 --> 00:54:53,651 THEM AND SAY, LOOK, WE KNOW 1512 00:54:53,651 --> 00:54:54,252 CLINICALLY, PHYSIOLOGICALLY 1513 00:54:54,252 --> 00:54:55,853 THERE ARE THINGS GOING ON THAT 1514 00:54:55,853 --> 00:54:57,622 ARE GOING TO BE COMMON, AND I 1515 00:54:57,622 --> 00:55:00,358 NEED TO LEARN THE ACUTE 1516 00:55:00,358 --> 00:55:01,759 DIFFERENCES THAT COME IN 1517 00:55:01,759 --> 00:55:04,162 CAPTURING DATA AND THEN SEEING 1518 00:55:04,162 --> 00:55:06,130 WHAT OUTCOMES COME AND MIGHT 1519 00:55:06,130 --> 00:55:09,867 PATIENT POPULATIONS, PERHAPS MY 1520 00:55:09,867 --> 00:55:11,836 SORT OF RURAL UNDERREPRESENTED 1521 00:55:11,836 --> 00:55:13,104 AREAS IN SOUTHEAST TEXAS. 1522 00:55:13,104 --> 00:55:18,409 THAT RAISES A CHALLENGE, 1523 00:55:18,409 --> 00:55:19,944 HOPEFULLY YOU CAN LOOK AT LINKS 1524 00:55:19,944 --> 00:55:21,913 AND FOLLOW UP WITH ME, ONE KEY 1525 00:55:21,913 --> 00:55:23,414 IS GOING TO BE PRIVACY CONCERNS 1526 00:55:23,414 --> 00:55:25,516 THAT COME UP IN THESE KIND OF 1527 00:55:25,516 --> 00:55:25,817 THINGS. 1528 00:55:25,817 --> 00:55:27,151 FEDERATED LEARNING IS A TERM WE 1529 00:55:27,151 --> 00:55:28,519 ALL NEED TO BECOME FAMILIAR 1530 00:55:28,519 --> 00:55:29,887 WITH, WHICH SUGGESTS THAT 1531 00:55:29,887 --> 00:55:31,756 THERE'S A METHOD BY WHICH THESE 1532 00:55:31,756 --> 00:55:32,757 DEEP LEARNING TECHNIQUES, ONCE 1533 00:55:32,757 --> 00:55:35,393 WE CAN TRAIN THEM AND UNDERSTAND 1534 00:55:35,393 --> 00:55:37,995 WHAT GENERATES DIFFERENT PATIENT 1535 00:55:37,995 --> 00:55:39,330 STATES AND REPRESENTS PATIENTS 1536 00:55:39,330 --> 00:55:41,499 PROPERLY, I CAN SHARE THAT 1537 00:55:41,499 --> 00:55:42,100 INFORMATION WITHOUT SHARING 1538 00:55:42,100 --> 00:55:47,305 PATIENT DATA. 1539 00:55:47,305 --> 00:55:49,407 I CAN LOOK AT WHAT WE LEARNED 1540 00:55:49,407 --> 00:55:51,242 FROM DIFFERENT HOSPITALS AND 1541 00:55:51,242 --> 00:55:53,878 COMMUNITIES, DIFFERENT CENTERS 1542 00:55:53,878 --> 00:55:57,248 AROUND THE COUNTRY, AND THEN 1543 00:55:57,248 --> 00:55:59,650 LEARN HOW TO ADAPT WITHOUT 1544 00:55:59,650 --> 00:56:04,489 NEEDING MAYBE THE PHI THAT GOES 1545 00:56:04,489 --> 00:56:06,224 WITH COLLECTING AND TRAINING IN 1546 00:56:06,224 --> 00:56:06,891 CONNECTICUT. 1547 00:56:06,891 --> 00:56:09,627 SO I THINK WHILE REGULATORY 1548 00:56:09,627 --> 00:56:11,162 THINGS ARE A CONCERN, THIS IS 1549 00:56:11,162 --> 00:56:12,230 PERHAPS AN APPROACH WE CAN 1550 00:56:12,230 --> 00:56:14,298 FIGURE OUT HOW TO WORK TOGETHER 1551 00:56:14,298 --> 00:56:17,635 WITHOUT HAVING THE BURDEN OF THE 1552 00:56:17,635 --> 00:56:19,103 CHALLENGE OF DAILY USE WITH EACH 1553 00:56:19,103 --> 00:56:19,303 OTHER. 1554 00:56:19,303 --> 00:56:21,639 AND IF WE CAN DO ALL THESE 1555 00:56:21,639 --> 00:56:24,475 THINGS, THE LAST THING THAT 1556 00:56:24,475 --> 00:56:28,513 NEEDS TO BE IMPORTANT IS 1557 00:56:28,513 --> 00:56:28,913 EXPLAINABILITY AND 1558 00:56:28,913 --> 00:56:29,313 INTERPRETABILITY. 1559 00:56:29,313 --> 00:56:31,048 HOW DO YOU TRUST THAT IT'S 1560 00:56:31,048 --> 00:56:32,717 DEVELOPING SOMETHING CORRECTLY? 1561 00:56:32,717 --> 00:56:36,254 HOW DO YOU UNDERSTAND RISK WORKS 1562 00:56:36,254 --> 00:56:38,823 WELL, HOW DO YOU KNOW YOU'RE 1563 00:56:38,823 --> 00:56:40,458 MODELING CORRECTLY NOT DEALING 1564 00:56:40,458 --> 00:56:41,325 WITH BIAS? 1565 00:56:41,325 --> 00:56:43,861 THERE'S A SERIES OF 1566 00:56:43,861 --> 00:56:44,529 EXPLAINABILITY AND INTERPRETABLE 1567 00:56:44,529 --> 00:56:51,169 A I THAT NEEDS TO GO WITH 1568 00:56:51,169 --> 00:56:54,705 TECHNIQUES. 1569 00:56:54,705 --> 00:56:56,340 YOU NEED TO TRUST IDENTIFYING 1570 00:56:56,340 --> 00:56:58,109 THIS IS A HUSKY IN THE PICTURE 1571 00:56:58,109 --> 00:56:59,544 BECAUSE IT'S TAKING FEATURES OF 1572 00:56:59,544 --> 00:57:01,312 THE DOG AND NOT, SAY, 1573 00:57:01,312 --> 00:57:05,116 IDENTIFYING IN TRAINING SET ALL 1574 00:57:05,116 --> 00:57:06,784 THE FEATURES HAD SNOW IN THE 1575 00:57:06,784 --> 00:57:07,084 BACKGROUND. 1576 00:57:07,084 --> 00:57:10,521 IF WE DO THAT WE GET TO SOME 1577 00:57:10,521 --> 00:57:11,455 FURTHER ADVANCEMENTS THAT WE'LL 1578 00:57:11,455 --> 00:57:13,124 HEAR ABOUT LATER TODAY FROM 1579 00:57:13,124 --> 00:57:15,860 SPEAKERS ABOUT HOW WE CAN THEN 1580 00:57:15,860 --> 00:57:16,827 PHENOTYPE AND TREAT AND 1581 00:57:16,827 --> 00:57:17,361 INTERVENE. 1582 00:57:17,361 --> 00:57:18,596 IF WE CAN UNDERSTAND 1583 00:57:18,596 --> 00:57:19,196 REPRESENTATION, WE NO LONGER 1584 00:57:19,196 --> 00:57:23,968 HAVE TO LOOK AT TREATMENT AFFECT 1585 00:57:23,968 --> 00:57:27,538 ACROSS LARGE SCALES BUT WE CAN 1586 00:57:27,538 --> 00:57:27,972 IDENTIFY PHENOTYPIC 1587 00:57:27,972 --> 00:57:29,540 NEIGHBORHOODS AND REGIONS AND DO 1588 00:57:29,540 --> 00:57:31,075 UNSUPERVISED CLUSTERING. 1589 00:57:31,075 --> 00:57:31,842 WE TAKE THESE REPRESENTATIONS, 1590 00:57:31,842 --> 00:57:34,145 WITHOUT WORRYING ABOUT THE 1591 00:57:34,145 --> 00:57:37,949 DOWNSTREAM TASKS, SEEING WHO 1592 00:57:37,949 --> 00:57:39,150 LOOKS SIMILAR, WHO DOESN'T, AND 1593 00:57:39,150 --> 00:57:40,151 UNDERSTAND WHAT KIND OF 1594 00:57:40,151 --> 00:57:41,786 TREATMENTS SEEM TO BE SUCCESSFUL 1595 00:57:41,786 --> 00:57:42,553 OR NOT. 1596 00:57:42,553 --> 00:57:46,924 FROM THOSE, WE CAN THEN DO THE 1597 00:57:46,924 --> 00:57:48,259 LAST TERM THAT HAS NOT SEEN AS 1598 00:57:48,259 --> 00:57:50,094 MUCH IN THE CLINICAL FIELD AND 1599 00:57:50,094 --> 00:57:52,063 DOMAIN, NEED COME IN MORE AND 1600 00:57:52,063 --> 00:57:53,397 MORE, REINFORCEMENT LEARNING. 1601 00:57:53,397 --> 00:57:55,466 SO THIS IDEA THAT ENGINEERING 1602 00:57:55,466 --> 00:57:56,334 TECHNIQUES CAN BE TAUGHT WHEN 1603 00:57:56,334 --> 00:57:57,768 THEY ARE DOING WELL AND WHEN 1604 00:57:57,768 --> 00:57:59,403 THEY ARE DOING POORLY AND ADAPT 1605 00:57:59,403 --> 00:58:00,204 PROPERLY. 1606 00:58:00,204 --> 00:58:02,573 SO YOU TAKE THESE PHENOTYPIC 1607 00:58:02,573 --> 00:58:06,244 REGIONS, THE MODEL CAN LEARN THE 1608 00:58:06,244 --> 00:58:07,111 RIGHT SPHERE AROUND THE PERSON 1609 00:58:07,111 --> 00:58:10,481 TO LOOK AT TO UNDERSTAND 1610 00:58:10,481 --> 00:58:12,116 LOCALIZED TREATMENT EFFECT TO 1611 00:58:12,116 --> 00:58:16,754 THEN PROVIDE POTENTIAL CLINICAL 1612 00:58:16,754 --> 00:58:17,555 DECISION SUPPORT. 1613 00:58:17,555 --> 00:58:20,825 THAT'S A SIGNIFICANT NUMBER OF 1614 00:58:20,825 --> 00:58:21,192 TERMS. 1615 00:58:21,192 --> 00:58:22,693 I HOPE MOST ARE MORE FAMILIAR 1616 00:58:22,693 --> 00:58:24,228 THAN NOT GIVEN ADVANCES BUT IF 1617 00:58:24,228 --> 00:58:25,863 WE CAN LEARN FROM THESE 1618 00:58:25,863 --> 00:58:26,964 TECHNIQUES WE HAVE THE ABILITY 1619 00:58:26,964 --> 00:58:30,601 AND TOOL SETS NOW TO TRY TO 1620 00:58:30,601 --> 00:58:32,103 REALLY DEVELOP TECHNIQUES THAT 1621 00:58:32,103 --> 00:58:34,005 YOU ALL HAVE DONE OVER DECADES 1622 00:58:34,005 --> 00:58:35,272 BUT MAYBE HAVE NOT USED THE 1623 00:58:35,272 --> 00:58:40,211 TERMS WE HAVE WITH RESPECT TO 1624 00:58:40,211 --> 00:58:40,811 GENERATIVE MODELS AND 1625 00:58:40,811 --> 00:58:42,980 REPRESENTING STATES BEING THE 1626 00:58:42,980 --> 00:58:44,282 SAME AS PHENOTYPING AND 1627 00:58:44,282 --> 00:58:46,017 CLUSTERING, AND IF WE CAN LOOK 1628 00:58:46,017 --> 00:58:47,885 AT THAT WE ENABLE CONTINUOUS 1629 00:58:47,885 --> 00:58:50,421 MEASUREMENT ALSO, WE CAN RUN 1630 00:58:50,421 --> 00:58:51,622 INTO ADDITIONAL CHALLENGES OF, 1631 00:58:51,622 --> 00:58:54,258 YOU KNOW, CAUSAL INFERENCE 1632 00:58:54,258 --> 00:58:55,660 ISSUES, MISSING DATA, AND AT THE 1633 00:58:55,660 --> 00:58:57,094 END REALLY CHALLENGE OURSELVES 1634 00:58:57,094 --> 00:58:59,363 TO LOOK AT THE REGULATORY 1635 00:58:59,363 --> 00:59:00,064 HURDLES THAT COME ACROSS. 1636 00:59:00,064 --> 00:59:01,365 IF YOU CAN GET PATIENTS TO 1637 00:59:01,365 --> 00:59:05,903 GENERATE THIS DATA, WHO OWNS 1638 00:59:05,903 --> 00:59:10,875 DATA, HOW DO YOU SHARE, HOW DO 1639 00:59:10,875 --> 00:59:12,076 WE ENABLE SHARED DECISION MAKING 1640 00:59:12,076 --> 00:59:13,277 AND COMMUNITY LEARNING WITHOUT 1641 00:59:13,277 --> 00:59:16,013 HAVING PRIVACY AND ACCESS 1642 00:59:16,013 --> 00:59:17,348 ISSUES, WITHOUT POTENTIALLY 1643 00:59:17,348 --> 00:59:18,616 HAVING INSURANCE REGULATORY 1644 00:59:18,616 --> 00:59:18,849 ISSUES. 1645 00:59:18,849 --> 00:59:23,888 IN PARTICULAR I'M VERY EXCITED 1646 00:59:23,888 --> 00:59:24,889 TO HEAR LUCIA SAVAGE SPEAK 1647 00:59:24,889 --> 00:59:30,227 TOMORROW FROM THE LEGAL SIDE. 1648 00:59:30,227 --> 00:59:35,633 I LOOK FORWARD TO YOUR 1649 00:59:35,633 --> 00:59:35,900 QUESTIONS. 1650 00:59:35,900 --> 00:59:38,035 I'M EXCITED TO TALK ABOUT 1651 00:59:38,035 --> 00:59:38,703 SENSING AND MODELING TECHNIQUES 1652 00:59:38,703 --> 00:59:40,871 THROUGH THE COURSE OF THE NEXT 1653 00:59:40,871 --> 00:59:41,138 FEW DAYS. 1654 00:59:41,138 --> 00:59:42,740 >> THANK YOU SO MUCH. 1655 00:59:42,740 --> 00:59:47,311 THAT WAS AMAZING. 1656 00:59:47,311 --> 00:59:51,148 AS YOU CAN SEE, HE HAS A WIDE 1657 00:59:51,148 --> 00:59:52,116 RANGE OF EXPERTISE. 1658 00:59:52,116 --> 00:59:53,351 PLEASE PUT YOUR QUESTIONS IN THE 1659 00:59:53,351 --> 00:59:56,053 CHAT AND I'LL TRY TO KEEP TRACK 1660 00:59:56,053 --> 00:59:58,489 FOR OUR DISCUSSION AT THE END OF 1661 00:59:58,489 --> 01:00:02,760 THE THREE TALKS. 1662 01:00:02,760 --> 01:00:06,030 NEXT DR. ATTIA WILL TALK ABOUT 1663 01:00:06,030 --> 01:00:07,231 ENGINEERS ARE FROM EARTH, 1664 01:00:07,231 --> 01:00:09,900 CLINICIANS ARE FROM VENUS. 1665 01:00:09,900 --> 01:00:13,504 >> THANK YOU AGAIN FOR THIS 1666 01:00:13,504 --> 01:00:14,472 OPPORTUNITY TO TALK AND 1667 01:00:14,472 --> 01:00:20,044 PARTICIPATE IN THIS REALLY 1668 01:00:20,044 --> 01:00:20,811 EXCITING SESSION. 1669 01:00:20,811 --> 01:00:22,480 I DIDN'T CHANGE THE TOPIC BUT 1670 01:00:22,480 --> 01:00:25,416 I'M GOING TO ADDRESS AS AN 1671 01:00:25,416 --> 01:00:29,053 ENGINEER AS AN EXTENT, LOOKING 1672 01:00:29,053 --> 01:00:32,223 AT THE IDEA, AND WHAT WE NEEDED 1673 01:00:32,223 --> 01:00:35,493 TO DO TO OPEN DIVERSITY, TO 1674 01:00:35,493 --> 01:00:37,061 ACTUALLY IMPLEMENT THIS INTO 1675 01:00:37,061 --> 01:00:40,464 PRACTICE. 1676 01:00:40,464 --> 01:00:48,205 THESE ARE MY DISCLOSURES. 1677 01:00:48,205 --> 01:00:50,174 AGAIN, I'LL DISCUSS HOW THIS 1678 01:00:50,174 --> 01:00:53,677 ENGINEERS WORK TOGETHER WITH 1679 01:00:53,677 --> 01:00:53,978 PHYSICIANS. 1680 01:00:53,978 --> 01:00:56,413 BUT THE USE CASE I'M GOING TO 1681 01:00:56,413 --> 01:01:00,017 DISCUSS IS DETECTION OF LOW 1682 01:01:00,017 --> 01:01:04,188 EJECTION FRACTION USING APPLE 1683 01:01:04,188 --> 01:01:04,588 WATCH. 1684 01:01:04,588 --> 01:01:06,490 AND MAYO APPLE WATCH STUDY. 1685 01:01:06,490 --> 01:01:08,125 APPLE DID NOT SUPPORT THIS STUDY 1686 01:01:08,125 --> 01:01:09,226 IN ANY WAY. 1687 01:01:09,226 --> 01:01:12,396 WE USED THE APPLE WATCH BECAUSE 1688 01:01:12,396 --> 01:01:19,970 WE HAD ACCESS. 1689 01:01:19,970 --> 01:01:24,875 LEFT VENTRICULAR FUNCTION 1690 01:01:24,875 --> 01:01:28,179 AFFECTS 2% OF THE GLOBAL 1691 01:01:28,179 --> 01:01:30,247 POPULATIONS, HIGH RATE OF 1692 01:01:30,247 --> 01:01:31,448 CLINICAL HEART FAILURE, 1693 01:01:31,448 --> 01:01:38,789 HOSPITALIZATION AND DEATH. 1694 01:01:38,789 --> 01:01:41,759 AS WE'VE HEARD IN KEYNOTE, THE 1695 01:01:41,759 --> 01:01:46,931 MAIN ISSUE IS IDENTIFYING THESE 1696 01:01:46,931 --> 01:01:47,598 PATIENTS. 1697 01:01:47,598 --> 01:01:50,534 AND IDENTIFICATION IS EXTENSIVE, 1698 01:01:50,534 --> 01:01:52,636 NOT READILY AVAILABLE TESTS LIKE 1699 01:01:52,636 --> 01:01:54,271 ECHO CARDIOGRAM. 1700 01:01:54,271 --> 01:01:57,107 CAN WE USE SOMETHING THAT'S MORE 1701 01:01:57,107 --> 01:02:03,347 UBIQUITOUS AND CHEAPER TO USE? 1702 01:02:03,347 --> 01:02:06,283 WE TALKED ABOUT ECG, THE 1703 01:02:06,283 --> 01:02:08,619 REPORTING OF THE ELECTRICAL 1704 01:02:08,619 --> 01:02:10,454 ACTIVITY OF THE HEART. 1705 01:02:10,454 --> 01:02:18,896 IF YOU PUT A SENSOR ON EACH, 1706 01:02:18,896 --> 01:02:21,098 YOU'LL GET MORPHOLOGY AND ECG. 1707 01:02:21,098 --> 01:02:22,566 THE PROBLEM IS HUMANS CANNOT 1708 01:02:22,566 --> 01:02:26,570 DETECT LOW EJECTION FRACTURE 1709 01:02:26,570 --> 01:02:28,205 FROM ECG BUT MAY A.I. WOULD BE 1710 01:02:28,205 --> 01:02:31,141 ABLE TO DO IT AFTER SEEING 1711 01:02:31,141 --> 01:02:35,412 ENOUGH EXAMPLES. 1712 01:02:35,412 --> 01:02:37,815 WE STARTED WITH 600,000 1713 01:02:37,815 --> 01:02:40,985 PATIENTS, ECHO AND ECG PAIR, 1714 01:02:40,985 --> 01:02:43,621 AFTER DATA CLEANING, MAJORITY OF 1715 01:02:43,621 --> 01:02:47,892 WORK FOR MOST SCIENTISTS, 1716 01:02:47,892 --> 01:02:50,528 CREATING GOOD DATASETS, WE HAD 1717 01:02:50,528 --> 01:02:52,930 100,000 PATIENTS, USING A THIRD 1718 01:02:52,930 --> 01:02:57,635 FOR TRAINING, THE REST FOR 1719 01:02:57,635 --> 01:03:02,673 VALIDATION. 1720 01:03:02,673 --> 01:03:06,844 WE FEED IN INPUT, ALL ECG, WE 1721 01:03:06,844 --> 01:03:10,681 DID NOT FEET QT PR, WE FIT IN 1722 01:03:10,681 --> 01:03:11,849 ECG AS A WHOLE. 1723 01:03:11,849 --> 01:03:14,685 AND DOING TRAINING FOR TRAINING 1724 01:03:14,685 --> 01:03:16,220 SAID WE SHOWED EJECTION FRACTION 1725 01:03:16,220 --> 01:03:17,988 FROM THE ECHO. 1726 01:03:17,988 --> 01:03:20,724 WE ASKED IT TO FIND PATTERNS IF 1727 01:03:20,724 --> 01:03:23,560 THE EF IS BELOW 35% OR ABOVE IT. 1728 01:03:23,560 --> 01:03:25,963 WE WOULD LATER CHANGE IT TO 40 1729 01:03:25,963 --> 01:03:27,831 TO MATCH THE GUIDELINES, BUT 1730 01:03:27,831 --> 01:03:30,234 IT'S THE SAME CONCEPT. 1731 01:03:30,234 --> 01:03:32,636 SHOW ECG, ASK BINARY QUESTION 1732 01:03:32,636 --> 01:03:34,838 ABOUT EJECTION FRACTION, AGAIN 1733 01:03:34,838 --> 01:03:38,976 HUMAN CONSIST NOT DO, BUT 1734 01:03:38,976 --> 01:03:40,311 BECAUSE WE HAD MATCHED PATIENTS 1735 01:03:40,311 --> 01:03:42,179 WE COULD TRAIN THE NETWORK. 1736 01:03:42,179 --> 01:03:44,882 WE USED THE AREA UNDER THE CURVE 1737 01:03:44,882 --> 01:03:51,121 TO SELECT OUR BEST MODEL. 1738 01:03:51,121 --> 01:03:57,161 YOU SEE 0.5 IS RANDOM TEST, 1 IS 1739 01:03:57,161 --> 01:03:58,696 PERFECT. 1740 01:03:58,696 --> 01:04:02,533 WE HAD AUC OF 0.93, SPECIFICITY 1741 01:04:02,533 --> 01:04:04,902 86% COMPARING FAVORABLY TO OTHER 1742 01:04:04,902 --> 01:04:12,042 MEDICAL TESTS. 1743 01:04:12,042 --> 01:04:15,412 WE THEN KNEW WHY IT IS BETTER 1744 01:04:15,412 --> 01:04:17,715 THAN ECHO FOR SCALABILITY, 1745 01:04:17,715 --> 01:04:23,520 TAKING IT TO MOBILE PHONE 1746 01:04:23,520 --> 01:04:25,155 WEARABLES MAKE IT MORE SCALABLE 1747 01:04:25,155 --> 01:04:27,358 BUT WE DON'T HAVE SIGNALS IN OUR 1748 01:04:27,358 --> 01:04:29,093 HEALTH SYSTEM AND DIDN'T WANT TO 1749 01:04:29,093 --> 01:04:30,194 GIVE AWAY APPLE WATCHES SO 1750 01:04:30,194 --> 01:04:33,497 NEEDED TO FIND A WAY TO RECORD 1751 01:04:33,497 --> 01:04:37,334 PATIENTS AND GET SIGNALS WHILE 1752 01:04:37,334 --> 01:04:39,603 KEEPING THEM ENGAGED. 1753 01:04:39,603 --> 01:04:43,140 IF THE ECG IS GENERATED BY WATCH 1754 01:04:43,140 --> 01:04:44,208 WILL WORK AS WELL BECAUSE THERE 1755 01:04:44,208 --> 01:04:54,652 ARE A LOT OF DIFFERENCES. 1756 01:04:54,985 --> 01:04:56,687 LYING SUPINE, OBVIOUS POSITIONS, 1757 01:04:56,687 --> 01:04:58,455 SKIN IS PREPPED, QUALITY IS MUCH 1758 01:04:58,455 --> 01:04:58,689 BETTER. 1759 01:04:58,689 --> 01:05:01,058 WHEN I DO AN APPLE WATCH ON MY 1760 01:05:01,058 --> 01:05:03,460 WATCH, I MIGHT BE SITTING ON THE 1761 01:05:03,460 --> 01:05:07,765 COUCH, LAYING DOWN, SO ON. 1762 01:05:07,765 --> 01:05:12,002 THE FIRST AIM WAS TO DEVELOP 1763 01:05:12,002 --> 01:05:13,904 INFRASTRUCTURE TO RECORD 1764 01:05:13,904 --> 01:05:19,076 REMOTELY AND SECURELY, SECOND TO 1765 01:05:19,076 --> 01:05:22,513 ADAPT USING A SINGLE WATCH ECG. 1766 01:05:22,513 --> 01:05:25,115 WE DID WEARABLE STUDIES REMOTELY 1767 01:05:25,115 --> 01:05:26,550 AND DIGITALLY, SENT E-MAILS, NO 1768 01:05:26,550 --> 01:05:31,155 ONE WAS IN DIRECT CONTACT WITH 1769 01:05:31,155 --> 01:05:31,422 PATIENTS. 1770 01:05:31,422 --> 01:05:33,757 SINGLE STUDY SENT SURVEY WITH 1771 01:05:33,757 --> 01:05:36,627 THE MAYO APP AND ASKED TWO 1772 01:05:36,627 --> 01:05:36,894 QUESTIONS. 1773 01:05:36,894 --> 01:05:38,028 DO YOU HAVE AN APPLE WATCH AND 1774 01:05:38,028 --> 01:05:39,563 WOULD YOU BE WILLING TO 1775 01:05:39,563 --> 01:05:40,130 PARTICIPATE? 1776 01:05:40,130 --> 01:05:44,701 IF YES TO BOTH WE SEND THEM A 1777 01:05:44,701 --> 01:05:48,005 SHORT CONSENT FORM USING PTRAX 1778 01:05:48,005 --> 01:05:50,207 WHICH THEY SIGN USING DIGITAL 1779 01:05:50,207 --> 01:05:54,011 SIGNATURE. 1780 01:05:54,011 --> 01:05:56,547 THEY CONSENT AND RECEIVE A LINK. 1781 01:05:56,547 --> 01:06:03,020 THIS WAS CREATED INTERNALLY IN 1782 01:06:03,020 --> 01:06:05,355 MAYO CLINIC, SOFTWARE ENGINEERS 1783 01:06:05,355 --> 01:06:06,824 AND A LOT OF TECH. 1784 01:06:06,824 --> 01:06:10,327 THIS APP ALLOWS PATIENTS TO 1785 01:06:10,327 --> 01:06:13,964 UPLOAD ECGs TO UDP AND DIGITAL 1786 01:06:13,964 --> 01:06:16,733 DASHBOARD. 1787 01:06:16,733 --> 01:06:22,005 WE NEED TO SEE IF WE CAN RUN THE 1788 01:06:22,005 --> 01:06:27,678 A.I. MODEL USING SINGLE LEAD, WE 1789 01:06:27,678 --> 01:06:28,712 HAD TO RETRAIN. 1790 01:06:28,712 --> 01:06:31,048 YOU CAN SEE THIS IS A PATIENT 1791 01:06:31,048 --> 01:06:33,350 THAT HAS AN APPLE WATCH, WITHIN 1792 01:06:33,350 --> 01:06:34,651 A FEW MINUTES FROM EACH OTHER, 1793 01:06:34,651 --> 01:06:38,021 YOU CAN SEE EVEN THOUGH THE 1794 01:06:38,021 --> 01:06:39,790 MORPHOLOGIES ARE SIMILAR THERE 1795 01:06:39,790 --> 01:06:41,759 ARE BIG DIFFERENCES IN THE HIGH 1796 01:06:41,759 --> 01:06:47,898 FREQUENCY NOISE, IN THIS CASE, 1797 01:06:47,898 --> 01:06:50,968 SO WE HAD TO WEIGHT TO NOT USE 1798 01:06:50,968 --> 01:06:57,107 FEATURES NOT EXISTING EXISTINGN 1799 01:06:57,107 --> 01:07:00,077 APPLE WATCH. 1800 01:07:00,077 --> 01:07:02,913 WE LOWERED THE NUMBER OF LEADS. 1801 01:07:02,913 --> 01:07:04,915 RETRAINED THE NETWORK. 1802 01:07:04,915 --> 01:07:07,684 NOW WITH THE SYNTHETIC DATA, AUC 1803 01:07:07,684 --> 01:07:11,021 DROPPED TO 0.88 BECAUSE WE HAVE 1804 01:07:11,021 --> 01:07:14,191 SIGNIFICANTLY LESS DATA SO THAT 1805 01:07:14,191 --> 01:07:16,160 MAKES SENSE. 1806 01:07:16,160 --> 01:07:25,469 WE WERE ABLE TO COLLECT 125,000 1807 01:07:25,469 --> 01:07:29,206 ECGs FROM 2454 PATIENTS, 56% 1808 01:07:29,206 --> 01:07:32,342 WOMEN, FROM 21 TO 92, FROM 45 1809 01:07:32,342 --> 01:07:33,911 STATES, 11 COUNTRIES, IN LESS 1810 01:07:33,911 --> 01:07:38,415 THAN FIVE MONTHS. 1811 01:07:38,415 --> 01:07:40,050 WE LOOKED AT USE STATISTICS. 1812 01:07:40,050 --> 01:07:41,952 YOU HEAR A LOT IN THE NEXT TWO 1813 01:07:41,952 --> 01:07:43,720 DAYS, WE LOSE A LOT OF PATIENTS 1814 01:07:43,720 --> 01:07:49,226 BECAUSE NOT ALWAYS KNOW HOW TO 1815 01:07:49,226 --> 01:07:50,861 USE SYSTEM, HARDER AT HOME 1816 01:07:50,861 --> 01:07:52,062 VERSUS SOMEONE HELPING YOU IN 1817 01:07:52,062 --> 01:07:53,597 THE CLINIC. 1818 01:07:53,597 --> 01:07:55,365 WE LOOK HOW OFTEN ANT HOW LONG 1819 01:07:55,365 --> 01:07:59,636 THEY USE IT, THEY USE EIGHT 1820 01:07:59,636 --> 01:08:02,139 TIMES ON AVERAGE, WHICH MATCHES 1821 01:08:02,139 --> 01:08:03,807 UP WITH NOTIFICATIONS. 1822 01:08:03,807 --> 01:08:05,142 ALSO MOST PATIENTS USED UNTIL 1823 01:08:05,142 --> 01:08:07,211 THE LAST DAY OF THE STUDY, 1824 01:08:07,211 --> 01:08:11,448 NORMALIZED TIME FOR USE. 1825 01:08:11,448 --> 01:08:12,549 THEY WERE ENGAGED AND KEPT 1826 01:08:12,549 --> 01:08:13,417 SENDING DATA. 1827 01:08:13,417 --> 01:08:14,418 ANOTHER INTERESTING FINDING THAT 1828 01:08:14,418 --> 01:08:16,587 AS THE PATIENTS WERE OLDER THEY 1829 01:08:16,587 --> 01:08:20,657 USED THE APP MORE OFTEN, AND 1830 01:08:20,657 --> 01:08:21,658 WHICH WAS ACTUALLY SURPRISING. 1831 01:08:21,658 --> 01:08:22,392 WE WERE WORRIED THE ONLY 1832 01:08:22,392 --> 01:08:25,696 PATIENTS THAT WOULD USE IT WERE 1833 01:08:25,696 --> 01:08:26,997 YOUNGER PATIENTS BUT SEEMS LIKE 1834 01:08:26,997 --> 01:08:29,600 PATIENTS THAT ARE OLDER ACTUALLY 1835 01:08:29,600 --> 01:08:30,868 WERE MORE INTERESTED IN 1836 01:08:30,868 --> 01:08:33,837 CONTRIBUTING THEIR DATA TO THE 1837 01:08:33,837 --> 01:08:36,506 STUDY. 1838 01:08:36,506 --> 01:08:39,676 WE TOOK PATIENTS WITH CLINICALLY 1839 01:08:39,676 --> 01:08:41,378 INDICATED ECHO CARDIOGRAM AT THE 1840 01:08:41,378 --> 01:08:45,616 SAME TIME, WITHIN 30 DAYS, 421 1841 01:08:45,616 --> 01:08:47,351 PATIENTS WITH ECHO CAN APPLE 1842 01:08:47,351 --> 01:08:53,890 WATCH ECG AND TOOK ALL THE APPLE 1843 01:08:53,890 --> 01:08:54,891 WATCH ECG. 1844 01:08:54,891 --> 01:08:58,629 16 HAD EF LESS THAN 40. 1845 01:08:58,629 --> 01:09:01,898 DURING MODEL THAT WAS TRAINED ON 1846 01:09:01,898 --> 01:09:02,766 SYNTHETIC DATA, REAL DATA 1847 01:09:02,766 --> 01:09:08,005 COLLECTED BY PATIENTS IN THEIR 1848 01:09:08,005 --> 01:09:12,276 OWN HOME, AUC 0.885, SENSITIVITY 1849 01:09:12,276 --> 01:09:13,577 AND SPECIFICITY 81%, HUMANS 1850 01:09:13,577 --> 01:09:20,751 CANNOT DO LOOKING AT ECG. 1851 01:09:20,751 --> 01:09:23,787 WE COLLECTED DATA FROM 125,000 1852 01:09:23,787 --> 01:09:24,788 ECGs, 46 STATES, 11 COUNTRIES, 1853 01:09:24,788 --> 01:09:28,959 APPLIED MAYO A.I. TO APPLE 1854 01:09:28,959 --> 01:09:29,293 WATCH. 1855 01:09:29,293 --> 01:09:31,595 WE'RE DOING SIMILAR WORK FOR 1856 01:09:31,595 --> 01:09:32,896 ADDITIONAL DISEASES, AND PEOPLE 1857 01:09:32,896 --> 01:09:36,199 WHO ARE INTERESTED IN 1858 01:09:36,199 --> 01:09:38,101 HYPERTENSION WE'RE ACTIVELY 1859 01:09:38,101 --> 01:09:42,406 LOOKING AT, ONE OF THE POSTDOCS 1860 01:09:42,406 --> 01:09:44,508 PUBLISHED IN ACC, AND WORK 1861 01:09:44,508 --> 01:09:47,344 SHOWING WE CAN DETECT HISTORIC 1862 01:09:47,344 --> 01:09:48,712 DYSFUNCTION FROM AN ECG IN 1863 01:09:48,712 --> 01:09:50,080 SIMILAR WAY BUT THE MOST 1864 01:09:50,080 --> 01:09:53,050 IMPORTANT THING FOR TODAY IS 1865 01:09:53,050 --> 01:09:57,754 THAT THIS WORK REQUIRED A LOT OF 1866 01:09:57,754 --> 01:10:00,924 PEOPLE FROM DIFFERENT EXPERTISE, 1867 01:10:00,924 --> 01:10:02,693 ENGINEERS, COORDINATORS, APP 1868 01:10:02,693 --> 01:10:03,460 DEVELOPERS, ENGINEERS, 1869 01:10:03,460 --> 01:10:03,794 STATISTICIANS. 1870 01:10:03,794 --> 01:10:07,197 I WANTED TO SPEND THE LAST FEW 1871 01:10:07,197 --> 01:10:09,499 MINUTES HOW WE ALIGN THE STARS. 1872 01:10:09,499 --> 01:10:11,535 WE FOUND IN THE LAST EIGHT YEARS 1873 01:10:11,535 --> 01:10:14,404 SINCE WE STARTED A.I. GROUP THAT 1874 01:10:14,404 --> 01:10:17,641 LANGUAGE BARRIER IS THE MAIN 1875 01:10:17,641 --> 01:10:18,241 PROBLEM. 1876 01:10:18,241 --> 01:10:19,309 ENGINEERS DON'T UNDERSTAND 1877 01:10:19,309 --> 01:10:21,178 MEDICINE AND CLINICIANS DON'T 1878 01:10:21,178 --> 01:10:23,380 UNDERSTAND TECHNOLOGY AS WELL AS 1879 01:10:23,380 --> 01:10:23,880 ENGINEERS. 1880 01:10:23,880 --> 01:10:25,916 WE TRIED TO FIND WAYS TO 1881 01:10:25,916 --> 01:10:26,883 UNDERSTAND THE PROBLEM AND GET 1882 01:10:26,883 --> 01:10:30,053 THEM TO TALK TO EACH OTHER. 1883 01:10:30,053 --> 01:10:31,688 AND FOR ENGINEERS, FOR EXAMPLE, 1884 01:10:31,688 --> 01:10:32,990 THE BIGGEST PROBLEM IS THAT 1885 01:10:32,990 --> 01:10:34,524 NUMBERS DON'T ALWAYS TELL THE 1886 01:10:34,524 --> 01:10:35,659 WHOLE STORY. 1887 01:10:35,659 --> 01:10:36,593 CLINICAL CONTEXT IS IMPORTANT, 1888 01:10:36,593 --> 01:10:36,827 RIGHT? 1889 01:10:36,827 --> 01:10:41,665 WE DON'T WANT THESE MODELS TO BE 1890 01:10:41,665 --> 01:10:47,671 COMPLETELY AUTONOMOUS, LOOK AT 1891 01:10:47,671 --> 01:10:49,106 CONTEXT, SHOWING AN OUTCOME A 1892 01:10:49,106 --> 01:10:51,408 PHYSICIAN CAN'T DO ANYTHING OUT, 1893 01:10:51,408 --> 01:10:53,577 TO US SHOULD BE A LOW PRIORITY. 1894 01:10:53,577 --> 01:10:58,882 AND WE HAVE TO BUILD IN A WAY 1895 01:10:58,882 --> 01:11:01,151 BECAUSE WE DON'T WANT TO ADD TO 1896 01:11:01,151 --> 01:11:03,186 CLINICAL BURDEN OF CLINICIANS. 1897 01:11:03,186 --> 01:11:06,723 FOR CLINICIANS WE HAD TO TEACH 1898 01:11:06,723 --> 01:11:10,761 A.I. IS NOT A MAGIC BULLET, IF 1899 01:11:10,761 --> 01:11:11,628 NOT SUPPORTED BY BIOLOGY IT 1900 01:11:11,628 --> 01:11:12,529 WON'T WORK. 1901 01:11:12,529 --> 01:11:16,032 IT'S A BLACK BOX, NOT A MAGIC 1902 01:11:16,032 --> 01:11:16,366 BOX. 1903 01:11:16,366 --> 01:11:18,869 CAN ONLY SEE PATTERNS IN 1904 01:11:18,869 --> 01:11:19,202 BIOLOGY. 1905 01:11:19,202 --> 01:11:21,605 WHAT CLEARLY DRIVES THE ACCURACY 1906 01:11:21,605 --> 01:11:29,713 IS THE DATA, ACCURACY OF IT, HOW 1907 01:11:29,713 --> 01:11:32,549 LABOR IS ADJUDICATED, AND WE ASK 1908 01:11:32,549 --> 01:11:34,451 THE QUESTION, IS THERE A GOLD 1909 01:11:34,451 --> 01:11:35,652 STANDARD TO ANSWER. 1910 01:11:35,652 --> 01:11:38,822 SO, TO DO THAT AND ANSWER THESE 1911 01:11:38,822 --> 01:11:41,525 QUESTIONS, WE EMBEDDED 1912 01:11:41,525 --> 01:11:42,959 ENGINEERING IN THE PRACTICE, 1913 01:11:42,959 --> 01:11:44,261 PART OF THE CARDIOVASCULAR 1914 01:11:44,261 --> 01:11:45,929 MEDICINE DEPARTMENT, NOT FROM 1915 01:11:45,929 --> 01:11:46,229 ENGINEERING. 1916 01:11:46,229 --> 01:11:49,533 THEY SIT IN THE SAME PHYSICAL 1917 01:11:49,533 --> 01:11:49,733 SPACE. 1918 01:11:49,733 --> 01:11:51,935 THEY OBSERVE PROCEDURES. 1919 01:11:51,935 --> 01:11:55,439 AND EACH OF THEM HAVE DUAL 1920 01:11:55,439 --> 01:11:55,772 APPOINTMENTS. 1921 01:11:55,772 --> 01:11:57,941 ENGINEERS ARE PART OF THE A.I. 1922 01:11:57,941 --> 01:12:01,678 LAB, ALSO PART OF THE CATH, 1923 01:12:01,678 --> 01:12:05,515 ECHO, ECG LABS, THEY CAN ATTEND 1924 01:12:05,515 --> 01:12:09,453 EVENTS TO IMPROVE THOSE, AND 1925 01:12:09,453 --> 01:12:10,554 COMMUNICATION SKILLS. 1926 01:12:10,554 --> 01:12:14,624 AS YOU CAN SEE WE ACTUALLY ASK 1927 01:12:14,624 --> 01:12:15,826 QUESTIONS, WHY ARE YOU DOING 1928 01:12:15,826 --> 01:12:17,561 THIS AND THAT, WE HAVE A CME 1929 01:12:17,561 --> 01:12:20,397 ONCE A YEAR THAT WE INVITE 1930 01:12:20,397 --> 01:12:22,065 ENGINEERS AND PHYSICIANS TO 1931 01:12:22,065 --> 01:12:25,202 LEARN ABOUT WHAT EACH OTHER IS 1932 01:12:25,202 --> 01:12:26,303 DOING, AND IT'S IMPORTANT TO 1933 01:12:26,303 --> 01:12:28,605 UNDERSTAND THERE ARE MORE STARS 1934 01:12:28,605 --> 01:12:30,907 IN THE SOLAR SYSTEM, AS I 1935 01:12:30,907 --> 01:12:33,844 MENTIONED, BUT WE CAN ONLY DO IT 1936 01:12:33,844 --> 01:12:34,945 TOGETHER, THESE MODELS WILL 1937 01:12:34,945 --> 01:12:38,014 BE -- WILL HAVE TO BE TESTED IN 1938 01:12:38,014 --> 01:12:39,449 THE WILD. 1939 01:12:39,449 --> 01:12:42,052 DIGITAL STUDIES, TO DO THESE WE 1940 01:12:42,052 --> 01:12:43,920 NEED DIVERSE TEAMS. 1941 01:12:43,920 --> 01:12:47,757 TO SQUEEZE THAT SOLAR SYSTEM 1942 01:12:47,757 --> 01:12:48,959 ANALOGY, WE ALL UNDERSTAND IT'S 1943 01:12:48,959 --> 01:12:51,328 NOT THE PHYSICIAN OR NOT THE 1944 01:12:51,328 --> 01:12:53,396 ENGINEERS, THE PATIENT SHOULD BE 1945 01:12:53,396 --> 01:12:54,965 IN THE CENTER, I THINK WE CAN 1946 01:12:54,965 --> 01:13:00,370 ALL BE ALIGNED AND WORK TOGETHER 1947 01:13:00,370 --> 01:13:01,771 TO BENEFIT AND IMPROVE HUMAN 1948 01:13:01,771 --> 01:13:02,205 HEALTH. 1949 01:13:02,205 --> 01:13:03,740 THANK YOU FOR THIS OPPORTUNITY. 1950 01:13:03,740 --> 01:13:11,948 AND IF YOU HAVE ANY QUESTIONS. 1951 01:13:11,948 --> 01:13:12,582 >> WONDERFUL. 1952 01:13:12,582 --> 01:13:13,150 THANK YOU. 1953 01:13:13,150 --> 01:13:17,854 I CAN SEE YOU HAVE SUCCESSFULLY 1954 01:13:17,854 --> 01:13:19,055 TRAVERSED THIS COMMUNICATION 1955 01:13:19,055 --> 01:13:19,289 BARRIER. 1956 01:13:19,289 --> 01:13:20,624 I LIKE YOUR LAST LINE, THERE'S 1957 01:13:20,624 --> 01:13:22,692 MANY STARS IN THE SOLAR SYSTEM. 1958 01:13:22,692 --> 01:13:26,096 WE'LL BE HEARING ABOUT ALL THOSE 1959 01:13:26,096 --> 01:13:27,264 OR PLANETS, REGULATORY PRIVACY, 1960 01:13:27,264 --> 01:13:28,598 ALL THE OTHER PIECES OF THE 1961 01:13:28,598 --> 01:13:28,965 PUZZLE. 1962 01:13:28,965 --> 01:13:32,302 I APPRECIATE THAT GREAT TALK. 1963 01:13:32,302 --> 01:13:36,039 AND NOW LAST BUT NOT LEAST WE 1964 01:13:36,039 --> 01:13:37,774 HAVE DR. AHMAD FROM NORTHWESTERN 1965 01:13:37,774 --> 01:13:39,543 MEDICINE WHO WILL BE TALKING 1966 01:13:39,543 --> 01:13:42,045 ABOUT THE BLOOD PRESSURE DATA 1967 01:13:42,045 --> 01:13:44,147 PUZZLE PIECES, AND I THINK DR. 1968 01:13:44,147 --> 01:13:45,115 ATTIA ALLUDED TO THIS. 1969 01:13:45,115 --> 01:13:47,117 90% OF THE WORK IS FINDING AND 1970 01:13:47,117 --> 01:13:48,518 CLEANING UP THAT DATA. 1971 01:13:48,518 --> 01:13:52,189 LOOKING FORWARD TO IT. 1972 01:13:52,189 --> 01:13:55,892 THANK YOU. 1973 01:13:55,892 --> 01:13:59,896 >> GREAT, THANK YOU. 1974 01:13:59,896 --> 01:14:00,530 ONE SECOND. 1975 01:14:00,530 --> 01:14:00,997 OKAY. 1976 01:14:00,997 --> 01:14:04,634 CAN YOU SEE MY SLIDES? 1977 01:14:04,634 --> 01:14:05,001 >> WE DO. 1978 01:14:05,001 --> 01:14:05,735 >> GREAT. 1979 01:14:05,735 --> 01:14:06,670 THANK YOU. 1980 01:14:06,670 --> 01:14:09,739 THANK YOU TO THE ORGANIZERS FOR 1981 01:14:09,739 --> 01:14:12,275 INVITING ME, I'M EXCITED TO 1982 01:14:12,275 --> 01:14:14,377 COVER THIS TOPIC, DATA PUZZLE 1983 01:14:14,377 --> 01:14:15,579 PIECES. 1984 01:14:15,579 --> 01:14:17,647 THESE ARE MY DISCLOSURES. 1985 01:14:17,647 --> 01:14:21,051 SO WE'RE ASKED BY ORGANIZERS TO 1986 01:14:21,051 --> 01:14:22,719 HIGHLIGHT KEY TAKEAWAYS FROM THE 1987 01:14:22,719 --> 01:14:23,553 TALKS. 1988 01:14:23,553 --> 01:14:25,555 TO COVER THESE THREE QUESTIONS I 1989 01:14:25,555 --> 01:14:27,190 PLAN TO HIGHLIGHT SIX AREAS. 1990 01:14:27,190 --> 01:14:29,059 ONE IS HOW DO WE IMPROVE DIGITAL 1991 01:14:29,059 --> 01:14:31,695 INFRASTRUCTURE IN OUR HEALTH 1992 01:14:31,695 --> 01:14:33,563 CARE ECOSYSTEM, DATA ECOSYSTEM. 1993 01:14:33,563 --> 01:14:35,298 TWO, HOW DO WE INCREASE 1994 01:14:35,298 --> 01:14:36,933 EFFICIENCY OF PROCESSING ANNUAL 1995 01:14:36,933 --> 01:14:38,034 HARMONIZING COMPLEX DIVERSE 1996 01:14:38,034 --> 01:14:38,368 DATA. 1997 01:14:38,368 --> 01:14:44,908 THREE, HOW DO WE IMPROVE DATA 1998 01:14:44,908 --> 01:14:46,876 INTEGRATION, EHR USABILITY. 1999 01:14:46,876 --> 01:14:53,216 FOUR, HOW DO WE TEST DEVICES AND 2000 01:14:53,216 --> 01:14:55,852 DIGITAL HEALTH TOOLS, FIVE CROSS 2001 01:14:55,852 --> 01:14:57,354 TRAINING EXPERTS, AND SIX 2002 01:14:57,354 --> 01:15:02,225 ADVANCING EQUITY WITH AI/mL 2003 01:15:02,225 --> 01:15:03,660 DIGITAL HEALTH TOOLS THAT DR. 2004 01:15:03,660 --> 01:15:07,964 SPATZ SPOKE ABOUT EARLIER. 2005 01:15:07,964 --> 01:15:09,866 THIS IS FOUR MAIN AREAS, FIRST 2006 01:15:09,866 --> 01:15:12,268 AN OVERVIEW OF THE ECOSYSTEM FOR 2007 01:15:12,268 --> 01:15:14,571 HYPERTENSION, THEN THE ROLE OF 2008 01:15:14,571 --> 01:15:17,107 STANDARDS TO DRIVE HYPERTENSION 2009 01:15:17,107 --> 01:15:18,608 DIAGNOSIS IN THIS ERA. 2010 01:15:18,608 --> 01:15:20,477 THEN EXAMPLES OF INTEGRATION OF 2011 01:15:20,477 --> 01:15:23,346 HOME BP INTO HEALTH SYSTEMS AND 2012 01:15:23,346 --> 01:15:24,314 PROMISING AREAS AND CHALLENGES 2013 01:15:24,314 --> 01:15:27,584 IN THE ERA OF A.I. 2014 01:15:27,584 --> 01:15:29,252 AND SO AS WE'VE HEARD, WE'RE 2015 01:15:29,252 --> 01:15:31,321 LIVING IN A WORLD IN WHICH DATA 2016 01:15:31,321 --> 01:15:34,157 CONTINUES TO GROW EACH DAY. 2017 01:15:34,157 --> 01:15:36,693 NORMAL SCIENCE DATA IS GENERATED 2018 01:15:36,693 --> 01:15:39,095 THROUGH DAILY INTERACTIONS CAN 2019 01:15:39,095 --> 01:15:40,497 TECHNOLOGY ACROSS SOCIETY. 2020 01:15:40,497 --> 01:15:41,698 THERE'S BEEN GROWTH OF HEALTH 2021 01:15:41,698 --> 01:15:45,101 CARE DATA, OLDER DATA FROM 2020. 2022 01:15:45,101 --> 01:15:48,171 I CAN SEE THE AMOUNT CONTINUES 2023 01:15:48,171 --> 01:15:49,572 TO GROW. 2024 01:15:49,572 --> 01:15:51,775 AS I'VE MENTIONED THIS IS A 2025 01:15:51,775 --> 01:15:54,411 GROWING ECOSYSTEM OF DEVICES TO 2026 01:15:54,411 --> 01:15:56,379 MEASURE BLOOD PRESSURE, MOVING 2027 01:15:56,379 --> 01:15:57,347 BEYOND TRADITIONAL BLOOD 2028 01:15:57,347 --> 01:15:57,814 PRESSURE CUFF. 2029 01:15:57,814 --> 01:16:04,020 AND THIS IS A FIGURE FROM A NICE 2030 01:16:04,020 --> 01:16:07,757 PAPER HIGHLIGHTING NEED OF 2031 01:16:07,757 --> 01:16:09,526 CONSENSUS STANDARDS FOR ACCURACY 2032 01:16:09,526 --> 01:16:11,995 OF THESE DEVICES, WE'LL TALK 2033 01:16:11,995 --> 01:16:12,796 ABOUT THIS LATER TODAY. 2034 01:16:12,796 --> 01:16:16,399 IT'S IMPORTANT WE HAVE STANDARDS 2035 01:16:16,399 --> 01:16:17,934 WITH ACCURACY BECAUSE FOR THESE 2036 01:16:17,934 --> 01:16:21,004 GARBAGE IN REALLY MEANS GARBAGE 2037 01:16:21,004 --> 01:16:22,105 OUT. 2038 01:16:22,105 --> 01:16:25,508 IDEALLY WE TAKE THESE DATA FROM 2039 01:16:25,508 --> 01:16:26,910 WEARABLES AND MERGE WITH OTHER 2040 01:16:26,910 --> 01:16:28,011 DATA THAT WE KNOW ARE IMPORTANT 2041 01:16:28,011 --> 01:16:31,081 TO HEALTH CARE AND MANAGEMENT OF 2042 01:16:31,081 --> 01:16:34,150 PATIENTS INCLUDING OMICS DATA, 2043 01:16:34,150 --> 01:16:35,485 MICROBIOME DATA, EHR DATA, AND 2044 01:16:35,485 --> 01:16:38,555 IDEALLY WOULD HAVE A WAY TO 2045 01:16:38,555 --> 01:16:39,756 MERGE THESE DATA TOGETHER, FOR A 2046 01:16:39,756 --> 01:16:41,725 NUMBER OF OPPORTUNITIES TO 2047 01:16:41,725 --> 01:16:42,425 IMPROVE CARE, PHYSICIAN 2048 01:16:42,425 --> 01:16:44,661 STRATEGIES BASED ON BLOOD 2049 01:16:44,661 --> 01:16:45,762 PRESSURE PHENOTYPES, DIGITAL 2050 01:16:45,762 --> 01:16:47,664 CLINICAL TRIALS, HOSPITAL AT 2051 01:16:47,664 --> 01:16:50,033 HOME PROGRAM, VIRTUAL HEALTH 2052 01:16:50,033 --> 01:16:53,203 COACHING WHICH IS ESPECIALLY 2053 01:16:53,203 --> 01:16:55,371 EXCITING GIVEN EMERGENCE OF 2054 01:16:55,371 --> 01:16:56,940 LARGE LANGUAGE MODELS. 2055 01:16:56,940 --> 01:16:59,476 THESE WOULD SEND INFORMATION 2056 01:16:59,476 --> 01:17:00,744 COMMONS AND RUN MULTI-MODAL 2057 01:17:00,744 --> 01:17:02,979 MODELS THAT WERE TALKED ABOUT 2058 01:17:02,979 --> 01:17:04,614 EARLIER TODAY, AND DEVELOP 2059 01:17:04,614 --> 01:17:07,450 INFERENCE AND USE IN GROUP CARE. 2060 01:17:07,450 --> 01:17:08,451 THERE IS A DIFFERENCE BETWEEN 2061 01:17:08,451 --> 01:17:12,889 WHAT I THINK WE HOPE TO DO AND 2062 01:17:12,889 --> 01:17:14,357 WHAT IS IN THE CLINIC AND LIVES 2063 01:17:14,357 --> 01:17:14,958 OF OUR PATIENTS. 2064 01:17:14,958 --> 01:17:18,628 THIS IS ME IN THE CLINIC. 2065 01:17:18,628 --> 01:17:20,063 THIS IS MY EXPERIENCE. 2066 01:17:20,063 --> 01:17:26,736 PATIENTS BRING IN DATA, VERY 2067 01:17:26,736 --> 01:17:31,775 WELL DETAILED, HELPFUL TO HAVE 2068 01:17:31,775 --> 01:17:33,076 DATA. 2069 01:17:33,076 --> 01:17:35,278 IT'S A CHALLENGE HOW TO 2070 01:17:35,278 --> 01:17:37,447 INCORPORATE, HOW MUCH IS 2071 01:17:37,447 --> 01:17:38,548 DOCUMENTED INTO EPIC ITSELF, AND 2072 01:17:38,548 --> 01:17:41,951 HOW CAN I USE THIS IN THE BEST 2073 01:17:41,951 --> 01:17:44,821 WAY TO TAKE CARE OF MY PATIENTS? 2074 01:17:44,821 --> 01:17:46,756 IT'S A CHALLENGE THAT THERE ARE 2075 01:17:46,756 --> 01:17:51,127 A LOT OF MODELS, TRADITIONAL 2076 01:17:51,127 --> 01:17:52,228 MODELING TECHNIQUES AND DEEP 2077 01:17:52,228 --> 01:17:52,695 LEARNING. 2078 01:17:52,695 --> 01:17:58,268 THIS IS A FIGURE I LOVE TALKING 2079 01:17:58,268 --> 01:18:00,336 ABOUT HOW THERE ARE DIFFERENT 2080 01:18:00,336 --> 01:18:04,274 WAYS IN WHICH MODELS DO NOT 2081 01:18:04,274 --> 01:18:05,675 ULTIMATELY IMPACT CLINICAL CARE. 2082 01:18:05,675 --> 01:18:10,613 I DO THINK THIS IS A TIME FOR 2083 01:18:10,613 --> 01:18:12,015 HOPE IN THIS SPACE BECAUSE WE 2084 01:18:12,015 --> 01:18:15,185 HAVE AN OPPORTUNITY BECAUSE DATA 2085 01:18:15,185 --> 01:18:19,923 IS BEING -- THERE ARE A LOT MORE 2086 01:18:19,923 --> 01:18:21,458 OPPORTUNITIES TO INTEGRATE. 2087 01:18:21,458 --> 01:18:22,358 TO FIGURE OUT WHAT "STAR WARS" 2088 01:18:22,358 --> 01:18:26,196 MOVIE OF THIS WAS FROM, YODA DID 2089 01:18:26,196 --> 01:18:29,132 NOT ACTUALLY SAY THIS, THAT MAY 2090 01:18:29,132 --> 01:18:33,837 HAVE BEEN CHAT TV HALLUCINATING. 2091 01:18:33,837 --> 01:18:36,372 I'M EXCITED. 2092 01:18:36,372 --> 01:18:40,176 I THINK WE'VE BEEN SEEING MORE 2093 01:18:40,176 --> 01:18:41,744 AND MORE DATA LIBERATION FROM 2094 01:18:41,744 --> 01:18:43,146 ELECTRONIC HEALTH RECORD, AND 2095 01:18:43,146 --> 01:18:46,216 THE 21ST CENTURY CURES ACT 2096 01:18:46,216 --> 01:18:47,417 STARTS PENALIZING EHR VENDORS 2097 01:18:47,417 --> 01:18:48,818 AND HEALTH SYSTEMS FOR BLOCKING 2098 01:18:48,818 --> 01:18:50,486 INFORMATION, BUILDING ON A 2099 01:18:50,486 --> 01:18:52,121 DECADE OF LEGISLATION FROM A 2100 01:18:52,121 --> 01:18:53,223 VARIETY OF STAKEHOLDERS, MANY 2101 01:18:53,223 --> 01:18:56,392 LIKELY ON THIS CALL, TO DRIVE 2102 01:18:56,392 --> 01:18:58,161 INTEROPERABILITY AND DATA 2103 01:18:58,161 --> 01:18:59,729 EXCHANGE. 2104 01:18:59,729 --> 01:19:05,902 IT'S EXCITING NOW DATA -- 2105 01:19:05,902 --> 01:19:10,540 PATIENTS CAN ACCESS VIA FHIR AND 2106 01:19:10,540 --> 01:19:13,142 IT'S STANDARDIZED, THROUGH 2107 01:19:13,142 --> 01:19:13,943 APIs FROM VENDORS. 2108 01:19:13,943 --> 01:19:17,180 NEXT I'LL TALK ABOUT ROLES OF 2109 01:19:17,180 --> 01:19:17,447 STANDARDS. 2110 01:19:17,447 --> 01:19:21,484 THIS IS A BRIEF STANDARDS 101 2111 01:19:21,484 --> 01:19:22,986 SUMMARY SLIDE THAT I TOOK FROM 2112 01:19:22,986 --> 01:19:23,887 THE GOVERNMENT. 2113 01:19:23,887 --> 01:19:26,856 THERE ARE DIFFERENT CATEGORIES 2114 01:19:26,856 --> 01:19:27,824 OF STANDARDS. 2115 01:19:27,824 --> 01:19:31,427 VOCABULARY AND CODE SETS, 2116 01:19:31,427 --> 01:19:34,364 SEMANTICS, THEIR FUNCTION IS 2117 01:19:34,364 --> 01:19:38,868 INFORMATION UNDERSTOOD, AND 2118 01:19:38,868 --> 01:19:43,039 TYPES CAN INCLUDE RxNORM OR 2119 01:19:43,039 --> 01:19:44,474 SNOMED, THERE'S SYNTAX STANDARDS 2120 01:19:44,474 --> 01:19:46,676 THAT ARE USED TO MAKE SURE 2121 01:19:46,676 --> 01:19:50,613 INFORMATION ITSELF IS IN AN 2122 01:19:50,613 --> 01:19:51,481 APPROPRIATE FORMAT. 2123 01:19:51,481 --> 01:19:53,550 CCDA IS TYPE OF STANDARD BUT 2124 01:19:53,550 --> 01:19:56,753 FHIR IS MORE COMMONLY USED. 2125 01:19:56,753 --> 01:19:58,688 THERE ARE STANDARDS FOR 2126 01:19:58,688 --> 01:19:59,789 TRANSPORT SECURITY AND SERVICES, 2127 01:19:59,789 --> 01:20:01,658 THESE ARE REALLY IMPORTANT FOR 2128 01:20:01,658 --> 01:20:08,798 ENABLING THIRD PARTY ACCESS TO 2129 01:20:08,798 --> 01:20:10,099 DATA VIA FHIR APIs. 2130 01:20:10,099 --> 01:20:12,268 I WANT TO HIGHLIGHT OTHER GROUPS 2131 01:20:12,268 --> 01:20:13,036 IN THIS SPACE. 2132 01:20:13,036 --> 01:20:14,837 FHIR IS A REALLY IMPORTANT 2133 01:20:14,837 --> 01:20:15,672 STANDARD THAT LIKELY A LOT OF 2134 01:20:15,672 --> 01:20:17,507 YOU HEARD ABOUT AND ARE USING IN 2135 01:20:17,507 --> 01:20:18,975 YOUR WORK. 2136 01:20:18,975 --> 01:20:22,111 SET OF RULES AND SPECIFICATIONS 2137 01:20:22,111 --> 01:20:23,980 FORE CHANGING HEALTH CARE DATA, 2138 01:20:23,980 --> 01:20:32,188 DESIGNED TO BE FLEXIBLE, 2139 01:20:32,188 --> 01:20:33,790 ADAPTABLE. 2140 01:20:33,790 --> 01:20:35,358 THE USCDI THAT VENDORS ARE 2141 01:20:35,358 --> 01:20:37,794 MANDATED TO MAP TO, THERE'S 2142 01:20:37,794 --> 01:20:40,096 DIFFERENT VERSIONS OVER TIME, 2143 01:20:40,096 --> 01:20:42,599 AND DRAFT VERSION 4 IN JANUARY 2144 01:20:42,599 --> 01:20:45,902 OF 2023. 2145 01:20:45,902 --> 01:20:48,404 OPEN mHEALTH IS USING 2146 01:20:48,404 --> 01:20:49,505 STAKEHOLDER-DRIVEN GROUP USING 2147 01:20:49,505 --> 01:20:52,108 STANDARDS FOR MOBILE HEALTH 2148 01:20:52,108 --> 01:20:53,543 DATA. 2149 01:20:53,543 --> 01:20:55,645 THIS IS AN EXAMPLE OF A FHIR 2150 01:20:55,645 --> 01:20:56,813 REPRESENTATION OF BLOOD 2151 01:20:56,813 --> 01:20:57,080 PRESSURE. 2152 01:20:57,080 --> 01:21:01,751 YOU CAN SEE HERE THERE'S A BLANK 2153 01:21:01,751 --> 01:21:03,319 CODE ASSIGNED, A VALUE, AND THIS 2154 01:21:03,319 --> 01:21:04,954 IS A NARRATIVE VERSION. 2155 01:21:04,954 --> 01:21:08,157 THERE'S ALSO MACHINE READABLE 2156 01:21:08,157 --> 01:21:08,992 VERSIONS OF THIS. 2157 01:21:08,992 --> 01:21:11,594 ONE OF THE REALLY AMAZING THINGS 2158 01:21:11,594 --> 01:21:14,664 ABOUT HAVING DATA MAPPED TO FHIR 2159 01:21:14,664 --> 01:21:17,200 IS THAT IT'S AN ECO-SYSTEM SMART 2160 01:21:17,200 --> 01:21:19,369 TOOLS LED BY PEOPLE OUT OF 2161 01:21:19,369 --> 01:21:22,538 BOSTON CHILDREN'S HOSPITAL AND 2162 01:21:22,538 --> 01:21:24,273 TOMORROW YOU'LL HEAR A TALK FROM 2163 01:21:24,273 --> 01:21:28,011 ONE OF THE LEADERS OF SMART ON 2164 01:21:28,011 --> 01:21:29,312 FHIR INTEGRATING TOOLS INTO 2165 01:21:29,312 --> 01:21:31,748 CLINICAL CARE, AFFORDING THE 2166 01:21:31,748 --> 01:21:33,049 OPPORTUNITY TO DEVELOP WORK 2167 01:21:33,049 --> 01:21:35,685 FLOWS AND APPS THAT CAN LEVERAGE 2168 01:21:35,685 --> 01:21:37,453 HOME BLOOD PRESSURE MONITORING 2169 01:21:37,453 --> 01:21:40,156 INTO CLINICAL CARE IN AN 2170 01:21:40,156 --> 01:21:41,157 EFFICIENT SCALABLE WAY. 2171 01:21:41,157 --> 01:21:45,828 THERE'S ALSO A COMMUNITY OF 2172 01:21:45,828 --> 01:21:48,598 FOLKS, CODEX, TRYING TO WORK ON 2173 01:21:48,598 --> 01:21:51,901 THE ISSUE OF SILOED HEALTH CARE 2174 01:21:51,901 --> 01:21:53,102 DATA. 2175 01:21:53,102 --> 01:21:55,171 THEY STARTED IN ONCOLOGY, ALSO 2176 01:21:55,171 --> 01:21:56,039 IN GENOMICS AND CARDIOVASCULAR, 2177 01:21:56,039 --> 01:21:58,541 TO HELP THINK ABOUT HOW DO WE 2178 01:21:58,541 --> 01:22:02,412 TAKE DATA GENERATED FROM PEOPLE, 2179 01:22:02,412 --> 01:22:04,480 AND USE THAT DATA ACROSS THE 2180 01:22:04,480 --> 01:22:06,916 PATIENT'S JOURNEY AND ENTIRE 2181 01:22:06,916 --> 01:22:09,552 HEALTH CARE ECOSYSTEM. 2182 01:22:09,552 --> 01:22:12,055 AND THESE ARE -- THIS SLIDE 2183 01:22:12,055 --> 01:22:14,791 SUMMARIZES WHAT CODEX DOES FROM 2184 01:22:14,791 --> 01:22:17,093 THEIR WEBSITE BELOW, HOW THEY 2185 01:22:17,093 --> 01:22:23,866 HAVE A SYSTEM TO PRIOR TOPICS, 2186 01:22:23,866 --> 01:22:24,967 EXECUTE PILOTS AT SCALE. 2187 01:22:24,967 --> 01:22:27,804 AS I MENTIONED THERE'S A CARDX, 2188 01:22:27,804 --> 01:22:31,541 THE GROUP WORKING ON 2189 01:22:31,541 --> 01:22:32,508 CARDIOVASCULAR DISEASE, FIRST IS 2190 01:22:32,508 --> 01:22:33,242 HYPERTENSION MANAGEMENT. 2191 01:22:33,242 --> 01:22:36,879 THESE ARE GOALS FROM THEIR SITE. 2192 01:22:36,879 --> 01:22:47,390 TO CREATE INTEGRATED AUTOMATED 2193 01:22:47,790 --> 01:22:53,529 VENDOR AGNOSTIC STANDARD, ENABLE 2194 01:22:53,529 --> 01:22:55,832 LIQUIDITY BETWEEN DEVICES, 2195 01:22:55,832 --> 01:22:56,466 HARMONIZE HYPERTENSION 2196 01:22:56,466 --> 01:22:57,800 VOCABULARY, AND DEVELOP DATAE 2197 01:22:57,800 --> 01:22:59,435 CHANGE STANDARDS FOR HOME BLOOD 2198 01:22:59,435 --> 01:23:02,939 PRESSURE DEVICE AND DATA 2199 01:23:02,939 --> 01:23:06,976 COMMUNICATION BETWEEN PATIENTS 2200 01:23:06,976 --> 01:23:07,543 AND CLINICIANS. 2201 01:23:07,543 --> 01:23:10,713 AND THIS IS A SUMMARY FROM THE 2202 01:23:10,713 --> 01:23:12,782 WEBSITE OF HOW THEY ENVISION 2203 01:23:12,782 --> 01:23:15,251 THIS ECOSYSTEM WORKING. 2204 01:23:15,251 --> 01:23:17,286 THE PATIENT AND PERSON HAS 2205 01:23:17,286 --> 01:23:19,589 DEVICES, THEY CAN SHARE VIA 2206 01:23:19,589 --> 01:23:22,759 FHIR, BLOOD PRESSURE DAD, 2207 01:23:22,759 --> 01:23:23,626 PERSONAL HEALTH, PATIENT 2208 01:23:23,626 --> 01:23:30,099 GUIDANCE ENGINES THAT WORK ON 2209 01:23:30,099 --> 01:23:32,502 TOP OF THE PERSONAL HEALTH AND 2210 01:23:32,502 --> 01:23:38,074 CAN BE SHARED VIA FHIR TO EHR, 2211 01:23:38,074 --> 01:23:39,475 WHICH CLINICIAN FACING PORTALS 2212 01:23:39,475 --> 01:23:42,879 CAN BE BUILT, INFORMED FROM THE 2213 01:23:42,879 --> 01:23:43,646 GUIDELINES. 2214 01:23:43,646 --> 01:23:48,684 EVENTUALLY YOU CAN ALSO THEN 2215 01:23:48,684 --> 01:23:50,419 SHARE INFORMATION, ALSO WITH 2216 01:23:50,419 --> 01:23:51,287 PAYERS TOO. 2217 01:23:51,287 --> 01:23:53,289 A KEY STEP IS TO MAKE SURE 2218 01:23:53,289 --> 01:23:56,325 GUIDELINES AND QUALITY MEASURES 2219 01:23:56,325 --> 01:24:00,296 CAN BE COMPUTABLE IN USING 2220 01:24:00,296 --> 01:24:01,397 DIGITAL HEALTH DATA, A LOT OF 2221 01:24:01,397 --> 01:24:04,133 WORK OPPORTUNITIES IN THAT 2222 01:24:04,133 --> 01:24:04,333 SPACE. 2223 01:24:04,333 --> 01:24:09,172 THERE'S ALSO A LOT OF INTEREST 2224 01:24:09,172 --> 01:24:12,542 IN OMICS, AND HOW OMICS, 2225 01:24:12,542 --> 01:24:15,311 DIFFERENT TYPES OF DATA CAN BE 2226 01:24:15,311 --> 01:24:17,280 USED TO PREDICT ADVERSE EVENTS. 2227 01:24:17,280 --> 01:24:19,015 AND THERE ARE GROUPS WORKING ON 2228 01:24:19,015 --> 01:24:23,486 THINKING ABOUT HOW DO WE 2229 01:24:23,486 --> 01:24:24,353 REPRESENT GENOMICS DATA WITH 2230 01:24:24,353 --> 01:24:27,423 FHIR, AND INTEGRATE THAT INTO 2231 01:24:27,423 --> 01:24:28,824 CLINICAL CARE, EMPOWER PATIENTS 2232 01:24:28,824 --> 01:24:30,927 WITH DATA TO BE USED FOR 2233 01:24:30,927 --> 01:24:31,594 RESEARCH IF THEY CHOOSE, AND 2234 01:24:31,594 --> 01:24:35,198 THIS IS AN IMPORTANT AREA OF 2235 01:24:35,198 --> 01:24:37,633 DEVELOPMENT ENABLED BY STANDARDS 2236 01:24:37,633 --> 01:24:39,368 AND THE CHEAPNESS AND 2237 01:24:39,368 --> 01:24:40,636 ACCESSIBILITY OF CLOUD COMPUTING 2238 01:24:40,636 --> 01:24:40,970 AND STORAGE. 2239 01:24:40,970 --> 01:24:43,206 THERE ARE A NUMBER OF COMMON 2240 01:24:43,206 --> 01:24:45,641 DATA MODELS ALSO FOR RESEARCH 2241 01:24:45,641 --> 01:24:47,276 AND SURVEILLANCE. 2242 01:24:47,276 --> 01:24:51,113 THESE INCLUDE MODELS LIKE 2243 01:24:51,113 --> 01:24:52,615 ODYSSEY, PCORnet AND OTHERS 2244 01:24:52,615 --> 01:24:54,383 SHOWN HERE, VERY IMPORTANT FOR 2245 01:24:54,383 --> 01:24:57,019 BOTH RESEARCH AND QUALITY 2246 01:24:57,019 --> 01:24:57,987 EFFORTS AND SURVEILLANCE 2247 01:24:57,987 --> 01:24:58,521 EFFORTS. 2248 01:24:58,521 --> 01:25:01,490 AND THERE'S A LOT OF ACTIVE WORK 2249 01:25:01,490 --> 01:25:02,792 ON HARMONIZING ACROSS DIFFERENT 2250 01:25:02,792 --> 01:25:06,629 DATA MODELS. 2251 01:25:06,629 --> 01:25:11,133 HERE I SHOW OMOP ON FHIR, REPORT 2252 01:25:11,133 --> 01:25:13,202 ON CROSSWALKS, A LINK FROM NIH 2253 01:25:13,202 --> 01:25:14,837 THAT HIGHLIGHTS IMPORTANT 2254 01:25:14,837 --> 01:25:17,673 RESOURCES FOR MAPPING FHIR TO 2255 01:25:17,673 --> 01:25:19,542 OTHER COMMON DATA MODELS. 2256 01:25:19,542 --> 01:25:29,619 AND THIS IS WORK FROM OUR GROUP, 2257 01:25:29,619 --> 01:25:34,957 AND IN THIS WORK WE USED A 2258 01:25:34,957 --> 01:25:37,260 LANGUAGE CQL, CLINICAL QUALITY 2259 01:25:37,260 --> 01:25:39,662 LANGUAGE TO FIND A PHENOTYPE OF 2260 01:25:39,662 --> 01:25:42,865 HEART FAILURE, RAN ACROSS OMOP 2261 01:25:42,865 --> 01:25:46,135 AND FHIR, DATA REPRESENTED IN OH 2262 01:25:46,135 --> 01:25:48,104 MOPE AND FIRE, USING THIS QUERY. 2263 01:25:48,104 --> 01:25:50,273 WITH THE GROWTH AND USE OF 2264 01:25:50,273 --> 01:25:51,707 STANDARDS, MORE AND MORE 2265 01:25:51,707 --> 01:25:53,576 OPPORTUNITIES WILL BE THERE TO 2266 01:25:53,576 --> 01:25:54,577 EFFICIENTLY DEVELOP PHENOTYPES 2267 01:25:54,577 --> 01:25:57,280 AND RUN THEM ACROSS MULTIPLE 2268 01:25:57,280 --> 01:26:00,216 TYPES OF DATA. 2269 01:26:00,216 --> 01:26:02,318 NEXT I WANT TO HIGHLIGHT HOW 2270 01:26:02,318 --> 01:26:05,554 HOME BP MEASUREMENT IS USED IN 2271 01:26:05,554 --> 01:26:06,155 HEALTH SYSTEMS. 2272 01:26:06,155 --> 01:26:11,294 THERE ARE A LOT THROUGH VENDORS 2273 01:26:11,294 --> 01:26:14,030 AND PLATFORMS. 2274 01:26:14,030 --> 01:26:15,998 HERE AT NORTHWESTERN THIS IS LED 2275 01:26:15,998 --> 01:26:22,505 BY DR. STEVE PERSE WILL,L. 2276 01:26:22,505 --> 01:26:24,473 WE PARTNERED WITH OMRON, 2277 01:26:24,473 --> 01:26:25,107 INTEGRATED INTO EPIC. 2278 01:26:25,107 --> 01:26:27,109 THIS IS WHAT IT LOOKS LIKE TO 2279 01:26:27,109 --> 01:26:28,077 THE CLINICIAN. 2280 01:26:28,077 --> 01:26:30,479 YOU CAN SEE HERE IT GOES IN THE 2281 01:26:30,479 --> 01:26:33,015 PATIENT FLOW SHEET. 2282 01:26:33,015 --> 01:26:34,417 YOU CAN VIEW STRUCTURED DATA 2283 01:26:34,417 --> 01:26:36,285 WITH MEDICATION IN THIS VIEW. 2284 01:26:36,285 --> 01:26:39,355 DIFFERENT VIEWS, CAN YOU SEE 2285 01:26:39,355 --> 01:26:41,657 GRAPHICALLY WITH MEDS. 2286 01:26:41,657 --> 01:26:45,161 HERE'S ANOTHER VIEW AS WELL. 2287 01:26:45,161 --> 01:26:47,096 THIS IS AN IMPROVEMENT TO GET A 2288 01:26:47,096 --> 01:26:48,764 BETTER VIEW OF A PATIENT'S BLOOD 2289 01:26:48,764 --> 01:26:51,067 PRESSURE, IT'S A LOT BETTER THAN 2290 01:26:51,067 --> 01:26:52,268 THE VERSION WE USED PREVIOUSLY, 2291 01:26:52,268 --> 01:26:56,739 STILL A LOT OF ROOM FOR 2292 01:26:56,739 --> 01:26:57,273 IMPROVEMENT. 2293 01:26:57,273 --> 01:27:00,676 INSTITUTE OF CHICAGO, LED BY DR. 2294 01:27:00,676 --> 01:27:03,312 BERNSTEIN, INFORMATICS FELLOW, 2295 01:27:03,312 --> 01:27:05,047 LEVERAGING EXISTING PLATFORMS BY 2296 01:27:05,047 --> 01:27:07,817 APPLE AND GOOGLE, AND USED THAT 2297 01:27:07,817 --> 01:27:09,985 TO WRITE BLOOD PRESSURE INTO 2298 01:27:09,985 --> 01:27:12,421 MYCHART AND EPIC, DEVELOPED A 2299 01:27:12,421 --> 01:27:14,156 WORKFLOW WITH CLINICAL TEAM TO 2300 01:27:14,156 --> 01:27:17,126 MAKE SURE PATIENTS DID NOT HAVE 2301 01:27:17,126 --> 01:27:18,127 OPTIMAL PROFESSIONAL MEASUREMENT 2302 01:27:18,127 --> 01:27:22,398 HAD TITRATION OF DRUGS, AND 2303 01:27:22,398 --> 01:27:23,499 TITRATION OF MEDICATION REGIMEN. 2304 01:27:23,499 --> 01:27:26,235 AND SO LASTLY I WANT TO TALK 2305 01:27:26,235 --> 01:27:27,636 ABOUT PROMISING AREAS AND 2306 01:27:27,636 --> 01:27:31,707 CHALLENGES IN THE ERA OF A.I. 2307 01:27:31,707 --> 01:27:36,278 THESE ARE MY SIX KEY TAKEAWAYS 2308 01:27:36,278 --> 01:27:37,480 TO TACKLE THE THREE QUESTIONS. 2309 01:27:37,480 --> 01:27:41,317 FIRST I WANT TO TALK ABOUT 2310 01:27:41,317 --> 01:27:43,285 PROMISING AREA OF IMPROVING 2311 01:27:43,285 --> 01:27:46,922 DIGITAL INFRASTRUCTURE IN HEALTH 2312 01:27:46,922 --> 01:27:49,125 ECOSYSTEM COURTESY OF 2313 01:27:49,125 --> 01:27:49,892 NORTHWESTERN MEDICINE. 2314 01:27:49,892 --> 01:27:52,728 WE'VE INVESTED TRYING TO DEVELOP 2315 01:27:52,728 --> 01:27:54,230 A DIGITAL PLATFORM, MOVING FROM 2316 01:27:54,230 --> 01:27:56,532 THE DATA WAREHOUSE TO THE CLOUD, 2317 01:27:56,532 --> 01:27:58,534 AND SO THIS IS OVER 2318 01:27:58,534 --> 01:28:00,836 ARCHITECTURE, AS YOU CAN SEE, 2319 01:28:00,836 --> 01:28:03,572 I'LL WALK THROUGH THESE. 2320 01:28:03,572 --> 01:28:05,174 YOU CAN IMAGINE THAT A PATIENT 2321 01:28:05,174 --> 01:28:07,476 HAS A WEARABLE AND THE WEARABLE 2322 01:28:07,476 --> 01:28:08,911 SENDS ELEVATED HEALTH 2323 01:28:08,911 --> 01:28:09,578 MEASUREMENT OF SOME KIND, 2324 01:28:09,578 --> 01:28:11,013 WHETHER BLOOD PRESSURE OR 2325 01:28:11,013 --> 01:28:18,220 SOMETHING ELSE, VIA MESSAGE TO 2326 01:28:18,220 --> 01:28:19,889 THE CLOUD. 2327 01:28:19,889 --> 01:28:21,090 INGESTED AND TRIGGERS EVENT 2328 01:28:21,090 --> 01:28:24,593 ENGAGE THAT PROCESS AND 2329 01:28:24,593 --> 01:28:26,262 PUBLISHED AS ELEVATED TOPIC, 2330 01:28:26,262 --> 01:28:27,863 STORED IN DATA WAREHOUSE. 2331 01:28:27,863 --> 01:28:31,033 I CAN HAVE A.I. MODEL THAT 2332 01:28:31,033 --> 01:28:36,405 SUBSCRIBES TO THAT EVENT ENGINE, 2333 01:28:36,405 --> 01:28:38,607 READ IT AND TRIGGER, IDEALLY 2334 01:28:38,607 --> 01:28:41,777 BASED ON FHIR, MORE SCALABLE. 2335 01:28:41,777 --> 01:28:43,846 AND DEPENDING ON OUTPUT AND YOU 2336 01:28:43,846 --> 01:28:46,482 WHO IT'S SET UP COULD SEND SCORE 2337 01:28:46,482 --> 01:28:48,217 AS A NEW EVENT TRIGGERS 2338 01:28:48,217 --> 01:28:50,085 NOTIFICATION TO THE PROVIDER OR 2339 01:28:50,085 --> 01:28:51,187 WHATEVER IS SET UP TO TAKE CARE 2340 01:28:51,187 --> 01:28:53,956 OF PATIENTS WITH THAT PARTICULAR 2341 01:28:53,956 --> 01:28:54,156 ALERT. 2342 01:28:54,156 --> 01:28:55,691 I THINK WE'RE IN THE PROCESS OF 2343 01:28:55,691 --> 01:29:00,396 A LOT OF HEALTH SYSTEMS AND IN 2344 01:29:00,396 --> 01:29:01,597 GENERAL EVOLVING OUR SYSTEMS TO 2345 01:29:01,597 --> 01:29:02,565 BETTER INCORPORATE THESE TYPES 2346 01:29:02,565 --> 01:29:05,568 OF DATA BUT WE STILL HAVE A WAYS 2347 01:29:05,568 --> 01:29:08,270 TO GO, BOTH HERE AT NORTHWESTERN 2348 01:29:08,270 --> 01:29:08,737 AND NATIONALLY. 2349 01:29:08,737 --> 01:29:09,905 I THINK ANOTHER PROMISING AREA 2350 01:29:09,905 --> 01:29:13,108 IN THIS SPACE IS HOW DO WE 2351 01:29:13,108 --> 01:29:14,743 PROCESS AND HARMONIZE COMPLEX 2352 01:29:14,743 --> 01:29:16,178 DIVERSE DATA. 2353 01:29:16,178 --> 01:29:18,681 LARGELY MODELS HAVE HUGE 2354 01:29:18,681 --> 01:29:21,550 POTENTIAL IN THIS AREA. 2355 01:29:21,550 --> 01:29:25,254 THIS IS A TWEET FROM JOSH MENDEL 2356 01:29:25,254 --> 01:29:27,756 WHO WORKS AT MICROSOFT, ONE OF 2357 01:29:27,756 --> 01:29:32,127 THE LEADING THINKERS IN SMART ON 2358 01:29:32,127 --> 01:29:33,329 FHIR AND TOOK COMPLEX 2359 01:29:33,329 --> 01:29:34,230 DOCUMENTATION FROM EPIC AND 2360 01:29:34,230 --> 01:29:36,398 QUICKLY CLEANED IT UP IN A WAY 2361 01:29:36,398 --> 01:29:38,501 THAT'S MORE USABLE IN JSON 2362 01:29:38,501 --> 01:29:38,868 FORMAT. 2363 01:29:38,868 --> 01:29:41,237 THIS COULD BE USEFUL AS WE LOOK 2364 01:29:41,237 --> 01:29:43,072 THROUGH THE EXPERTS FROM EHRs, 2365 01:29:43,072 --> 01:29:46,942 MY PRIOR WORK WE LOOKED AT THE 2366 01:29:46,942 --> 01:29:49,778 QUALITY OF MAPPING TO CCBA, I 2367 01:29:49,778 --> 01:29:53,182 SUSPECT, I HAVEN'T TAKEN A DEEP 2368 01:29:53,182 --> 01:29:56,886 DIVE YET BUT ISSUES WITH DATA 2369 01:29:56,886 --> 01:29:58,320 QUALITY, OPPORTUNITY TO AUTOMATE 2370 01:29:58,320 --> 01:30:00,189 THE WAY WE ANALYZE THESE 2371 01:30:00,189 --> 01:30:01,090 STANDARDS AND ULTIMATELY CLEAN 2372 01:30:01,090 --> 01:30:05,427 THEM UP AND MAKE THEM USABLE. 2373 01:30:05,427 --> 01:30:06,962 I THINK ANOTHER PROMISING AREA 2374 01:30:06,962 --> 01:30:11,467 IS HOW DO WE IMPROVE DATA 2375 01:30:11,467 --> 01:30:14,303 INTEGRATION AND EHR USABILITY. 2376 01:30:14,303 --> 01:30:15,871 I DESCRIBE USER-CENTERED DESIGN 2377 01:30:15,871 --> 01:30:17,306 PROCESS TO CREATE IDEAL WAY TO 2378 01:30:17,306 --> 01:30:19,141 VISUALIZE BLOOD PRESSURE FOR 2379 01:30:19,141 --> 01:30:19,441 CLINICIANS. 2380 01:30:19,441 --> 01:30:20,676 YOU CAN SEE THIS IS A MUCH 2381 01:30:20,676 --> 01:30:22,545 IMPROVED VERSION OF WHAT I 2382 01:30:22,545 --> 01:30:24,046 SHOWED EARLIER THAT WE'RE USING 2383 01:30:24,046 --> 01:30:27,449 IN EPIC AND OUR WORKFLOW HERE. 2384 01:30:27,449 --> 01:30:28,884 AND I THINK ANOTHER REALLY 2385 01:30:28,884 --> 01:30:30,853 PROMISING AREA IS USE OF LARGE 2386 01:30:30,853 --> 01:30:33,355 LANGUAGE MODELS FOR DATA 2387 01:30:33,355 --> 01:30:36,759 INTEGRATION, FROM THE MOVIE 2388 01:30:36,759 --> 01:30:38,193 "OFFICE SPACE" YEARS AGO, ONE OF 2389 01:30:38,193 --> 01:30:41,230 MY FAVORITE MOVIES FROM A LONG 2390 01:30:41,230 --> 01:30:42,665 TIME AGO. 2391 01:30:42,665 --> 01:30:45,067 THIS IS ABOUT DISGRUNTLED OFFICE 2392 01:30:45,067 --> 01:30:46,268 WORKERS WHO TAKE A FAX MACHINE 2393 01:30:46,268 --> 01:30:48,804 AND SPARK IT IN A FIELD. 2394 01:30:48,804 --> 01:30:51,207 I DO THINK THAT THERE'S 2395 01:30:51,207 --> 01:30:52,074 OPPORTUNITY WHERE WE START 2396 01:30:52,074 --> 01:30:53,275 INTERACTING WITH COMPUTERS IN A 2397 01:30:53,275 --> 01:30:55,611 MORE EFFICIENT WAY INSTEAD OF 2398 01:30:55,611 --> 01:30:56,912 HAVING COMPLICATED GRAPHICAL 2399 01:30:56,912 --> 01:30:58,914 USER INTERFACES, CLICK ALL THE 2400 01:30:58,914 --> 01:31:02,084 TIME, START USING NATURAL 2401 01:31:02,084 --> 01:31:02,952 LANGUAGE INTERFACE. 2402 01:31:02,952 --> 01:31:04,486 BILL GATES PUBLISHED A BLOG POST 2403 01:31:04,486 --> 01:31:06,121 ABOUT THIS TOO. 2404 01:31:06,121 --> 01:31:07,323 THAT CAN TRANSFORM OUR 2405 01:31:07,323 --> 01:31:09,191 INTERACTION AND HELP US BE MORE 2406 01:31:09,191 --> 01:31:11,827 EFFICIENT AND TAKE CARE OF 2407 01:31:11,827 --> 01:31:12,828 PATIENTS BETTER. 2408 01:31:12,828 --> 01:31:14,363 I ALSO THINK THERE'S A LOT OF 2409 01:31:14,363 --> 01:31:16,432 CHALLENGES ALONG THE WHOLE 2410 01:31:16,432 --> 01:31:18,801 PIPELINE OF USING -- INTEGRATING 2411 01:31:18,801 --> 01:31:19,602 PATIENT GENERATED HEALTH DATA. 2412 01:31:19,602 --> 01:31:24,073 THE FIGURE ON THE LEFT IS FROM A 2413 01:31:24,073 --> 01:31:25,174 REVIEW OF PATIENT-GENERATED 2414 01:31:25,174 --> 01:31:27,943 HEALTH DATA INTERVIEWING LEADERS 2415 01:31:27,943 --> 01:31:30,312 IN THE SPACE. 2416 01:31:30,312 --> 01:31:32,715 YOU CAN SEE EACH KEY THEME UNDER 2417 01:31:32,715 --> 01:31:35,451 CORE AREAS OF DATA CAPTURE, 2418 01:31:35,451 --> 01:31:36,018 TRANSFER, REVIEW. 2419 01:31:36,018 --> 01:31:37,653 AND ALSO I THINK THERE'S GOING 2420 01:31:37,653 --> 01:31:38,954 TO BE A LOT OF WORK THAT NEEDS 2421 01:31:38,954 --> 01:31:41,256 TO BE DONE THINKING ABOUT LOU DO 2422 01:31:41,256 --> 01:31:43,792 WE SURFACE MODELS, MACHINE 2423 01:31:43,792 --> 01:31:44,493 LEARNING MODELS TO CLINICIANS, 2424 01:31:44,493 --> 01:31:48,831 THE FIGURE ON THE RIGHT FROM 2425 01:31:48,831 --> 01:31:52,034 DUKE, A NICE EXAMPLE OF A FOOD 2426 01:31:52,034 --> 01:31:53,135 LABEL EQUIVALENT TO MACHINE 2427 01:31:53,135 --> 01:31:58,040 LEARNING MODELS TO HELP 2428 01:31:58,040 --> 01:31:59,575 CLINICIANS UNDERSTAND HOW THE 2429 01:31:59,575 --> 01:32:00,876 MODEL IS TRAINED AND HOW IT 2430 01:32:00,876 --> 01:32:03,078 SHOULD BE USED. 2431 01:32:03,078 --> 01:32:06,148 ANOTHER PROMISING AREA, TESTING 2432 01:32:06,148 --> 01:32:07,549 DEVICES IN PRAGMATIC TRIALS. 2433 01:32:07,549 --> 01:32:09,652 THE FIGURE ON THE LEFT IS FROM A 2434 01:32:09,652 --> 01:32:15,624 REVIEW THAT TALKS ABOUT 2435 01:32:15,624 --> 01:32:16,525 STRATEGIES TO DRIVE IMPROVEMENT 2436 01:32:16,525 --> 01:32:19,295 IN QUALITY OF CARE FOR PATIENTS 2437 01:32:19,295 --> 01:32:19,928 WITH HYPERTENSION. 2438 01:32:19,928 --> 01:32:22,097 THE RIGHT I THINK IS A FIGURE 2439 01:32:22,097 --> 01:32:23,866 THAT SHOWS SOME DIFFERENT 2440 01:32:23,866 --> 01:32:25,934 PHENOTYPES OF PATIENTS WITH 2441 01:32:25,934 --> 01:32:29,772 HYPERTENSION AND EVENTUALLY HAVE 2442 01:32:29,772 --> 01:32:30,506 POTENTIALLY TARGETED 2443 01:32:30,506 --> 01:32:31,173 NON-PHARMACOLOGIC OR 2444 01:32:31,173 --> 01:32:32,474 PHARMACOLOGIC THERAPIES BASED ON 2445 01:32:32,474 --> 01:32:36,745 PHENOTYPE IF WE HAVE A LOW 2446 01:32:36,745 --> 01:32:39,048 PROFILE WIDELY USED 24-HOUR 2447 01:32:39,048 --> 01:32:39,982 BLOOD PRESSURE MONITOR. 2448 01:32:39,982 --> 01:32:42,451 THIS IS TO LEVERAGE LATEST FROM 2449 01:32:42,451 --> 01:32:44,420 IMPLEMENTATION SCIENCE AND 2450 01:32:44,420 --> 01:32:46,155 DESIGN TRIALS THAT MEASURE 2451 01:32:46,155 --> 01:32:47,256 CLINICAL EFFECTIVENESS OF DEVICE 2452 01:32:47,256 --> 01:32:50,759 OR TOOL, ALSO HOW IT'S 2453 01:32:50,759 --> 01:32:51,960 IMPLEMENTED ITSELF AND 2454 01:32:51,960 --> 01:32:54,263 IMPLEMENTATION STRATEGIES. 2455 01:32:54,263 --> 01:32:58,100 AND IT'S IMPORTANT FOR ANY MLA 2456 01:32:58,100 --> 01:32:59,968 TRIAL TO ADHERE TO IMPORTANT 2457 01:32:59,968 --> 01:33:01,537 STANDARDS OUT THERE AND ON THE 2458 01:33:01,537 --> 01:33:06,075 RIGHT YOU CAN SEE CHART THAT 2459 01:33:06,075 --> 01:33:08,043 HIGHLIGHTS CURRENT mL CLINICAL 2460 01:33:08,043 --> 01:33:11,880 TRIALS AND SOME OPPORTUNITIES TO 2461 01:33:11,880 --> 01:33:14,950 IMPROVE REPORTING THEM. 2462 01:33:14,950 --> 01:33:15,684 ANOTHER PROMISING AREA RELATED 2463 01:33:15,684 --> 01:33:18,120 TO CLINICAL TRIALS HOW DO WE 2464 01:33:18,120 --> 01:33:19,888 BUILD UP THE INFRASTRUCTURE TO 2465 01:33:19,888 --> 01:33:22,624 EXECUTE THESE TRIALS AT SCALE. 2466 01:33:22,624 --> 01:33:25,894 AND NIH ALREADY SUPPORTS A 2467 01:33:25,894 --> 01:33:29,965 NUMBER OF INITIATIVES AND 2468 01:33:29,965 --> 01:33:35,971 CARDIOVASCULAR TRIAL AND AI/ ML 2469 01:33:35,971 --> 01:33:38,841 SPACE, BUT HELP IT WILL TO SCALE 2470 01:33:38,841 --> 01:33:45,314 AND TEST INTERVENTIONS EFFICIENT 2471 01:33:45,314 --> 01:33:49,351 LIP ACROSS DIVERSE POPULATIONS. 2472 01:33:49,351 --> 01:33:51,553 ANOTHER GAP TO TRAIN PEOPLE TO 2473 01:33:51,553 --> 01:33:54,056 SPEAK BOTH LANGUAGES. 2474 01:33:54,056 --> 01:33:57,926 WE STARTED A FELLOWSHIP THREE 2475 01:33:57,926 --> 01:33:59,995 YEARS AGO, TAKING FELLOWS, AND 2476 01:33:59,995 --> 01:34:01,930 EVEN FROM INTERNAL MEDICINE 2477 01:34:01,930 --> 01:34:05,033 RESIDENTS, SPEND A YEAR WITH 2478 01:34:05,033 --> 01:34:05,901 ENGINEERS, MASTER IN 2479 01:34:05,901 --> 01:34:06,568 ENGINEERING, RECRUIT THEM 2480 01:34:06,568 --> 01:34:10,072 INTERNALLY OR PUT THEM IN 2481 01:34:10,072 --> 01:34:13,008 DIFFERENT POSITIONS IN ACADEMICS 2482 01:34:13,008 --> 01:34:14,209 OR HEALTH TECH. 2483 01:34:14,209 --> 01:34:18,814 LASTLY I WANT TO BRIEFLY MENTION 2484 01:34:18,814 --> 01:34:20,149 IMPORTANCE OF THINKING OF 2485 01:34:20,149 --> 01:34:22,217 VIEWING TECHNOLOGY WITH EQUITY 2486 01:34:22,217 --> 01:34:22,885 LENS. 2487 01:34:22,885 --> 01:34:24,553 DR. SPATZ DISCUSSED THIS 2488 01:34:24,553 --> 01:34:26,488 EARLIER, AND IT WILL BE COVERED 2489 01:34:26,488 --> 01:34:26,855 TOMORROW. 2490 01:34:26,855 --> 01:34:28,991 IT'S REALLY IMPORTANT TO THINK 2491 01:34:28,991 --> 01:34:32,394 ABOUT HOW DO WE USE TOOLS TO 2492 01:34:32,394 --> 01:34:33,729 IMPACT MULTI-LEVEL AND 2493 01:34:33,729 --> 01:34:35,030 MULTI-FACETED FACTORS TO 2494 01:34:35,030 --> 01:34:39,034 CONTRIBUTE TO HEALTH INEQUITIES 2495 01:34:39,034 --> 01:34:39,835 RELATED TO HYPERTENSION. 2496 01:34:39,835 --> 01:34:42,004 THANK YOU FOR YOUR TIME AND 2497 01:34:42,004 --> 01:34:42,271 ATTENTION. 2498 01:34:42,271 --> 01:34:44,706 I LOOK FORWARD TO THE 2499 01:34:44,706 --> 01:34:45,007 DISCUSSION. 2500 01:34:45,007 --> 01:34:46,308 >> THANK YOU SO MUCH. 2501 01:34:46,308 --> 01:34:53,182 THAT WAS A TOUR DE FORCE IN 2502 01:34:53,182 --> 01:34:54,750 TERMS OF DATA INFRASTRUCTURE. 2503 01:34:54,750 --> 01:34:56,218 SO EVERYBODY, IF YOU HAVE 2504 01:34:56,218 --> 01:34:57,653 QUESTIONS PLEASE PUT THEM IN THE 2505 01:34:57,653 --> 01:34:59,521 CHAT, I'LL TRY TO KEEP AN EYE. 2506 01:34:59,521 --> 01:35:02,791 WE HAVE SOME TIME NOW FOR A 2507 01:35:02,791 --> 01:35:04,560 PANEL DISCUSSION SO WE CAN PICK 2508 01:35:04,560 --> 01:35:06,295 THE BRAINS OF THESE BRILLIANT 2509 01:35:06,295 --> 01:35:07,930 PEOPLE WHO HAVE CROSSED THIS 2510 01:35:07,930 --> 01:35:14,503 CHASM BETWEEN THE CLINICAL WORLD 2511 01:35:14,503 --> 01:35:16,138 AND ENGINEERING WORLD. 2512 01:35:16,138 --> 01:35:17,339 I'M GOING TO HIGHLIGHT A FEW 2513 01:35:17,339 --> 01:35:18,740 THEMES THAT CAUGHT MY ATTENTION 2514 01:35:18,740 --> 01:35:19,875 AND START WITH A FEW QUESTIONS. 2515 01:35:19,875 --> 01:35:22,811 SO SOME OF THE THEMES I HEARD IS 2516 01:35:22,811 --> 01:35:25,214 THAT WE HAVE A LOT OF MODELS AND 2517 01:35:25,214 --> 01:35:25,681 COMPUTATIONAL POWER. 2518 01:35:25,681 --> 01:35:27,749 AS FAR AS I CAN SEE THAT 2519 01:35:27,749 --> 01:35:29,518 INCREASE IN COMPUTE POWER IS NOT 2520 01:35:29,518 --> 01:35:29,952 STOPPING. 2521 01:35:29,952 --> 01:35:33,889 IT'S GOING TO KEEP GROWING. 2522 01:35:33,889 --> 01:35:36,191 AND ADVANCEMENT OF TECH AND 2523 01:35:36,191 --> 01:35:37,726 PARTICULARLY HOW HUMANS INTERACT 2524 01:35:37,726 --> 01:35:40,362 WITH TECH OR SOME COMPUTATIONAL 2525 01:35:40,362 --> 01:35:41,330 PLATFORMS IS ALSO GROWING FAST. 2526 01:35:41,330 --> 01:35:44,299 WE HAVE A TON OF DATA, 2527 01:35:44,299 --> 01:35:45,500 PARTICULARLY HEALTHCARE DATA, 2528 01:35:45,500 --> 01:35:46,468 AND DIGITAL INFRASTRUCTURE IS 2529 01:35:46,468 --> 01:35:49,204 ADVANCING TO BE ABLE TO 2530 01:35:49,204 --> 01:35:50,973 HARMONIZE AND AGGREGATE DATA IN 2531 01:35:50,973 --> 01:35:54,142 WAYS THAT MAKE IT MORE SCALABLE 2532 01:35:54,142 --> 01:35:55,010 FOR USE. 2533 01:35:55,010 --> 01:35:56,979 BUT WHEN CHALLENGED NOW WE 2534 01:35:56,979 --> 01:35:59,414 SEE -- ONE CHALLENGE IS WE NEED 2535 01:35:59,414 --> 01:36:00,949 TRUE INTEGGATION OF DIFFERENT 2536 01:36:00,949 --> 01:36:02,684 TYPES OF EXPERTISE AND HEARD 2537 01:36:02,684 --> 01:36:04,653 BOTH SIDES, WHERE AT MAYO 2538 01:36:04,653 --> 01:36:07,956 ENGINEERS ARE HANGING OUT WITH 2539 01:36:07,956 --> 01:36:09,291 CLINICIANS, AT NORTHWESTERN 2540 01:36:09,291 --> 01:36:10,826 ENGINEERS -- CLINICIANS ARE 2541 01:36:10,826 --> 01:36:14,863 HANGING OUT WITH ENGINEERS, GOOD 2542 01:36:14,863 --> 01:36:17,933 TWO-WAY ROADS, LEADING TO THE 2543 01:36:17,933 --> 01:36:19,668 IMPORTANT CONCEPT WE HEARD THAT 2544 01:36:19,668 --> 01:36:21,870 THE NUMBERS ALONE WILL NEVER 2545 01:36:21,870 --> 01:36:23,639 SOLVE THE PROBLEM. 2546 01:36:23,639 --> 01:36:24,940 IT'S THE CLINICAL CONTEXT THAT 2547 01:36:24,940 --> 01:36:25,274 MATTERS. 2548 01:36:25,274 --> 01:36:27,342 NUMBERS DO NOT TELL THE WHOLE 2549 01:36:27,342 --> 01:36:27,543 STORY. 2550 01:36:27,543 --> 01:36:30,612 THESE ARE SOME OF THE THEMES I 2551 01:36:30,612 --> 01:36:30,812 HEARD. 2552 01:36:30,812 --> 01:36:33,148 OH, AND 90% OF THE WORK IS 2553 01:36:33,148 --> 01:36:34,249 CREATING GOOD DATASETS. 2554 01:36:34,249 --> 01:36:36,551 IT'S HARD WORK. 2555 01:36:36,551 --> 01:36:38,320 IT'S TEDIOUS, IT'S NOT GLAMOROUS 2556 01:36:38,320 --> 01:36:41,189 BUT IT'S THE FOUNDATION AND 2557 01:36:41,189 --> 01:36:42,691 HOPEFULLY SOME STUFF FARAZ WILL 2558 01:36:42,691 --> 01:36:46,328 MAKE THAT WORK FASTER AND 2559 01:36:46,328 --> 01:36:46,562 EASIER. 2560 01:36:46,562 --> 01:36:47,629 THESE ARE SOME THEMES. 2561 01:36:47,629 --> 01:36:50,032 MAYBE I'LL START WITH A 2562 01:36:50,032 --> 01:36:50,332 QUESTION. 2563 01:36:50,332 --> 01:36:53,969 ALL OF YOU HAVE TAKEN SOME FORM 2564 01:36:53,969 --> 01:36:55,837 OF COMPUTE OR TECH AND SOLVED A 2565 01:36:55,837 --> 01:36:56,204 PROBLEM. 2566 01:36:56,204 --> 01:36:59,341 I'LL PUT ON MY SUBMISSION HAT 2567 01:36:59,341 --> 01:37:00,342 FOR A MINUTE. 2568 01:37:00,342 --> 01:37:04,379 WHEN YOU STARTED HOW WAS THAT 2569 01:37:04,379 --> 01:37:05,113 PROBLEM DEFINED? 2570 01:37:05,113 --> 01:37:06,181 A CLINICIAN HAS AN IDEA, 2571 01:37:06,181 --> 01:37:07,449 SOMETHING THEY WANT TO TACKLE 2572 01:37:07,449 --> 01:37:09,718 AND WORK WITH ENGINEERS OR 2573 01:37:09,718 --> 01:37:17,993 COMPUTER SCIENCE PEOPLE, WHERE 2574 01:37:17,993 --> 01:37:27,502 DID THE IDEA START? 2575 01:37:27,502 --> 01:37:30,572 >> IT NEEDS A VILLAGE. 2576 01:37:30,572 --> 01:37:34,710 WE'VE BEEN DOING IT, MANY 2577 01:37:34,710 --> 01:37:35,944 PROCEDURES WE ATTEND, WE ASK 2578 01:37:35,944 --> 01:37:37,012 CLINICIANS WHY ARE YOU DOING 2579 01:37:37,012 --> 01:37:39,982 THAT, RIGHT? 2580 01:37:39,982 --> 01:37:43,118 WHAT'S THE NEXT STEP? 2581 01:37:43,118 --> 01:37:45,654 MOST OF THE TIME THERE ARE 2582 01:37:45,654 --> 01:37:46,488 STRAIGHTFORWARD ANSWERS BUT 2583 01:37:46,488 --> 01:37:47,723 SOMETIMES -- ACTUALLY, I DON'T 2584 01:37:47,723 --> 01:37:50,158 KNOW, WE'VE ALWAYS DONE THAT, 2585 01:37:50,158 --> 01:37:50,359 RIGHT? 2586 01:37:50,359 --> 01:37:55,697 AND SOME OF THE QUESTIONS ARE 2587 01:37:55,697 --> 01:37:56,365 VERY NAIVE. 2588 01:37:56,365 --> 01:38:01,536 WE'VE DEVELOPED A MODEL THAT 2589 01:38:01,536 --> 01:38:04,906 LOOKS AT ATRIAL FIBRILLATION, 2590 01:38:04,906 --> 01:38:06,908 THAT STARTED AS A TECHNICAL 2591 01:38:06,908 --> 01:38:07,342 CHALLENGE. 2592 01:38:07,342 --> 01:38:14,049 WE DIDN'T KNOW WHICH PATIENTS, 2593 01:38:14,049 --> 01:38:16,084 MAYBE TRY TO PREDICT WHO HAS AS 2594 01:38:16,084 --> 01:38:17,185 SECOND MODEL. 2595 01:38:17,185 --> 01:38:19,154 CLINICIAN SAID THAT'S A USEFUL 2596 01:38:19,154 --> 01:38:23,625 WAY FOR US TO KNOW IF A 2597 01:38:23,625 --> 01:38:25,060 CRYPTOGENIC PATIENT HAS AF OR 2598 01:38:25,060 --> 01:38:28,030 NOT. 2599 01:38:28,030 --> 01:38:29,998 A LOT STARTS WITH SPONTANEOUS 2600 01:38:29,998 --> 01:38:30,632 DISCUSSIONS. 2601 01:38:30,632 --> 01:38:31,733 SOMETIMES WE HAVE BRAINSTORMING 2602 01:38:31,733 --> 01:38:35,037 SESSIONS THAT WE CAN SAY WE HAVE 2603 01:38:35,037 --> 01:38:36,805 THIS TEST, AND ESPECIALLY NOW 2604 01:38:36,805 --> 01:38:38,340 WITH FRAMEWORKS IN PLACE, A 2605 01:38:38,340 --> 01:38:39,107 BIGGER TEAM. 2606 01:38:39,107 --> 01:38:41,610 IT'S EASIER TO DO IT IN A 2607 01:38:41,610 --> 01:38:43,478 STRUCTURED WAY BUT ESPECIALLY 2608 01:38:43,478 --> 01:38:46,448 WITH A SMALL TEAM, ONE OR TWO 2609 01:38:46,448 --> 01:38:47,849 ENGINEERS, SPENDING A LOT OF 2610 01:38:47,849 --> 01:38:53,455 TIME WITH THEM WITH 2611 01:38:53,455 --> 01:38:56,191 AUTOMATICALLY CASCADE THE IDEAS, 2612 01:38:56,191 --> 01:38:56,792 RIGHT? 2613 01:38:56,792 --> 01:38:57,726 ASKING THE QUESTIONS, LOOKING AT 2614 01:38:57,726 --> 01:38:59,594 THE DATA, SEEING WHAT'S 2615 01:38:59,594 --> 01:38:59,961 AVAILABLE. 2616 01:38:59,961 --> 01:39:00,796 EVENTUALLY THAT'S THE MOST 2617 01:39:00,796 --> 01:39:02,431 IMPORTANT THING. 2618 01:39:02,431 --> 01:39:05,267 YOU HAVE TO LOOK AT WHAT YOU 2619 01:39:05,267 --> 01:39:08,103 HAVE AVAILABLE AND THEN START 2620 01:39:08,103 --> 01:39:08,770 FISHING EXPEDITION. 2621 01:39:08,770 --> 01:39:11,606 >> YES. 2622 01:39:11,606 --> 01:39:12,340 SOUNDS LIKE THE 2623 01:39:12,340 --> 01:39:12,908 CROSS-POLLINATION APPROVE. 2624 01:39:12,908 --> 01:39:16,211 IF YOU DO IT ENOUGH AND SPEND 2625 01:39:16,211 --> 01:39:18,547 TIME TOGETHER, SMART PEOPLE WILL 2626 01:39:18,547 --> 01:39:22,884 FIND THE RIGHT QUESTIONS. 2627 01:39:22,884 --> 01:39:24,419 I MADE A COUPLE RELATED 2628 01:39:24,419 --> 01:39:25,520 QUESTIONS IN THE CHAT. 2629 01:39:25,520 --> 01:39:27,923 ONE PERSON MADE A COMMENT, A.I. 2630 01:39:27,923 --> 01:39:30,459 CAN DIRECT OUR ATTENTION TO 2631 01:39:30,459 --> 01:39:32,094 VARIOUS SIGNALS BUT WE NEED TO 2632 01:39:32,094 --> 01:39:33,795 SELECT MEANINGFUL SIGNALINGS. 2633 01:39:33,795 --> 01:39:35,897 ANOTHER QUESTION, WHAT ROLE DO 2634 01:39:35,897 --> 01:39:37,999 YOU SEE A.I. PLAYING IN CLEANING 2635 01:39:37,999 --> 01:39:39,901 AND HARMONIZING DATA. 2636 01:39:39,901 --> 01:39:42,604 I THINK THOSE ARE SORT OF 2637 01:39:42,604 --> 01:39:43,605 RELATED BECAUSE MEANINGFUL 2638 01:39:43,605 --> 01:39:46,875 SIGNALS MEANS YOU CLEANED TO 2639 01:39:46,875 --> 01:39:47,876 SOME EXTENT. 2640 01:39:47,876 --> 01:39:49,945 AND THAT'S A TEDIOUS PROCESS. 2641 01:39:49,945 --> 01:39:54,316 SO SIGNAL DATA IS A GREAT 2642 01:39:54,316 --> 01:39:54,816 EXAMPLE. 2643 01:39:54,816 --> 01:39:56,718 MAYBE TONS AND TONS OF SIGNAL 2644 01:39:56,718 --> 01:40:00,589 DATA, HOW DO YOU DO THAT? 2645 01:40:00,589 --> 01:40:02,991 QUOTE/UNQUOTE USING A.I. TO DO 2646 01:40:02,991 --> 01:40:03,959 THAT CLEANING? 2647 01:40:03,959 --> 01:40:05,060 >> FANTASTIC QUESTION. 2648 01:40:05,060 --> 01:40:07,496 IT'S GOING TO BE THE MOST 2649 01:40:07,496 --> 01:40:08,663 IMPORTANT THING TO ADDRESS. 2650 01:40:08,663 --> 01:40:11,166 LUCKILY THERE ARE SOME MODELS 2651 01:40:11,166 --> 01:40:16,238 THAT CAN TEACH US WHAT SORT OF 2652 01:40:16,238 --> 01:40:18,206 CORE DATA SHOULD LOOK LIKE, WHAT 2653 01:40:18,206 --> 01:40:20,509 ENDS UP BEING COMMON, NOT THAT 2654 01:40:20,509 --> 01:40:21,143 IT ELIMINATES OUTLIERS BECAUSE I 2655 01:40:21,143 --> 01:40:22,811 THINK ONE OF THE THINGS WE CAN 2656 01:40:22,811 --> 01:40:25,480 GET AS WE COLLECT MORE DATA IS 2657 01:40:25,480 --> 01:40:26,648 THAT UNIQUE DATA SHOULDN'T BE 2658 01:40:26,648 --> 01:40:29,151 CONSIDERED AS RARE OR MISSING, 2659 01:40:29,151 --> 01:40:30,819 BUT ACTUALLY AS REPRESENTATIVE 2660 01:40:30,819 --> 01:40:31,786 OF SOMETHING DIFFERENT. 2661 01:40:31,786 --> 01:40:35,190 SO WHAT'S NEEDED ARE A SERIES OF 2662 01:40:35,190 --> 01:40:37,058 TECHNIQUES THAT CAN CLEAN AND 2663 01:40:37,058 --> 01:40:40,996 HARMONIZE DATA, AT LEAST BY SOME 2664 01:40:40,996 --> 01:40:42,330 MEANINGFUL METRIC, SOME CLINICAL 2665 01:40:42,330 --> 01:40:44,966 STANDARD, SO IT'S PROVIDING YOU 2666 01:40:44,966 --> 01:40:47,135 WITH EITHER STANDARDIZED SIGNALS 2667 01:40:47,135 --> 01:40:48,770 OR NEW SIGNALS THAT YOU CAN 2668 01:40:48,770 --> 01:40:52,507 UNDERSTAND WHY THEY ARE 2669 01:40:52,507 --> 01:40:53,375 OUTLIERS. 2670 01:40:53,375 --> 01:40:57,846 THERE ARE TECHNIQUES SORT OF 2671 01:40:57,846 --> 01:41:00,582 AUTOINCLUDING WITH A.I. MODELS 2672 01:41:00,582 --> 01:41:02,684 GIVE DATA AT INPUT, TELL IT TO 2673 01:41:02,684 --> 01:41:04,753 DO ITS MAGIC INTERNALLY, HAVE IT 2674 01:41:04,753 --> 01:41:05,854 GENERATE OUTPUT AND MATCH TO SEE 2675 01:41:05,854 --> 01:41:08,490 HOW FAR THAT OUTPUT IS FROM 2676 01:41:08,490 --> 01:41:11,560 RECONSTRUCTING THE INPUT. 2677 01:41:11,560 --> 01:41:12,994 AUTOENCODING TECHNIQUES ARE 2678 01:41:12,994 --> 01:41:14,629 REMARKABLY GOOD AT DE-NOISING 2679 01:41:14,629 --> 01:41:14,863 SIGNALS. 2680 01:41:14,863 --> 01:41:18,366 WHAT YOU CAN THEN DO IS USE 2681 01:41:18,366 --> 01:41:21,403 THESE TECHNIQUES TO SORT OF 2682 01:41:21,403 --> 01:41:22,370 BOUND REASONABLE SPACE AND 2683 01:41:22,370 --> 01:41:23,738 PROVIDE CLINICIAN A TOOL. 2684 01:41:23,738 --> 01:41:27,142 YOU'RE NOT THROWING OUT SIGNALS 2685 01:41:27,142 --> 01:41:29,444 BECAUSE I DON'T ACTUALLY KNOW IF 2686 01:41:29,444 --> 01:41:31,513 AN OUTLIER VALUE IS FEASIBLE OR 2687 01:41:31,513 --> 01:41:32,714 NOT, FOR EXAMPLE. 2688 01:41:32,714 --> 01:41:35,417 BUT YOU PROVIDE A THRESHOLD, 2689 01:41:35,417 --> 01:41:36,885 TUNEABLE KNOB THAT CAN BE USED 2690 01:41:36,885 --> 01:41:42,324 IN THE LOOP TO DECIDE I DON'T 2691 01:41:42,324 --> 01:41:43,758 WANT TO CONSIDER EXTREME 2692 01:41:43,758 --> 01:41:47,362 OUTLIERS, OR I DO, YOU CAN USE 2693 01:41:47,362 --> 01:41:48,063 TECHNIQUES TO SUMMARIZE 2694 01:41:48,063 --> 01:41:49,464 PLAUSIBLE AND UNCERTAIN RANGES. 2695 01:41:49,464 --> 01:42:00,008 FROM THERE I THINK IT BECOMES A 2696 01:42:01,009 --> 01:42:03,211 FUNCTION OF HOW MUCH MIGHT 2697 01:42:03,211 --> 01:42:04,679 PROVIDE VALUE. 2698 01:42:04,679 --> 01:42:05,914 A.I. IS PLAYING A KEY ROLE BUT 2699 01:42:05,914 --> 01:42:09,951 AS SORT OF A BOX YOU CAN PLAY 2700 01:42:09,951 --> 01:42:18,393 AROUND WITH, PROBABLY TIERS, 2701 01:42:18,393 --> 01:42:20,629 HERE IS DATA THAT'S OBVIOUSLY 2702 01:42:20,629 --> 01:42:22,764 GARBAGE, HERE IS DATA THAT SEEMS 2703 01:42:22,764 --> 01:42:26,701 CLEAN, AND HERE IS DATA IN THE 2704 01:42:26,701 --> 01:42:28,703 MIDDLE THAT YOU HAVE TO DECIDE 2705 01:42:28,703 --> 01:42:31,640 WHAT YOU'RE GOING TO DO, THAT 2706 01:42:31,640 --> 01:42:33,642 HAS VALUE TOO, I THINK. 2707 01:42:33,642 --> 01:42:35,677 >> WHAT YOU'RE SAYING IS THAT 2708 01:42:35,677 --> 01:42:36,611 HUMANS ARE STILL IN THE LOOP AND 2709 01:42:36,611 --> 01:42:39,481 THAT'S GOING TO BE THE CASE FOR 2710 01:42:39,481 --> 01:42:41,516 A LONG TIME? 2711 01:42:41,516 --> 01:42:42,484 >> I THINK SO. 2712 01:42:42,484 --> 01:42:45,120 AS THEY ARE ABLE TO GENERATE 2713 01:42:45,120 --> 01:42:45,854 THESE THINGS, THE HUMAN STILL 2714 01:42:45,854 --> 01:42:48,089 NEEDS TO BE IN THE LOOP BECAUSE 2715 01:42:48,089 --> 01:42:49,057 YOU HAVE TWO FACTORS. 2716 01:42:49,057 --> 01:42:50,592 YOU HAVE THE MODEL TO DECIDE 2717 01:42:50,592 --> 01:42:51,893 THINGS THAT YOU'RE ALREADY 2718 01:42:51,893 --> 01:42:52,761 FAMILIAR WITH AND HAVE 2719 01:42:52,761 --> 01:42:54,095 CONFIDENCE IN. 2720 01:42:54,095 --> 01:42:57,132 IF IT GENERATES SOMETHING NEW, 2721 01:42:57,132 --> 01:43:00,235 THERE'S A SERIES OF POTENTIALS 2722 01:43:00,235 --> 01:43:01,436 OF BIAS AND CONFOUNDING THINGS 2723 01:43:01,436 --> 01:43:02,637 WITH RESPECT TO WHAT DATA TRAINS 2724 01:43:02,637 --> 01:43:06,908 THE MODEL THAT YOU NEED SOME 2725 01:43:06,908 --> 01:43:08,109 GAME TO TRUST. 2726 01:43:08,109 --> 01:43:11,179 IT MAY BE GENERATING NEW 2727 01:43:11,179 --> 01:43:12,947 INFORMATION BUT THE MORE YOU'RE 2728 01:43:12,947 --> 01:43:14,582 INVOLVED YOU'LL UNDERSTAND WHY 2729 01:43:14,582 --> 01:43:16,151 IT'S BEING GENERATE AND TRUST IT 2730 01:43:16,151 --> 01:43:17,352 AND GO FROM THERE. 2731 01:43:17,352 --> 01:43:18,987 >> THAT TO ME MEANS THAT 2732 01:43:18,987 --> 01:43:21,823 BUILDING ON THIS IDEA OF 2733 01:43:21,823 --> 01:43:22,924 CROSS-POLLINATION AND PEOPLE 2734 01:43:22,924 --> 01:43:24,559 MOVING TO DIFFERENT FIELDS THEY 2735 01:43:24,559 --> 01:43:26,428 HAD NOT BEEN IN PREVIOUSLY, 2736 01:43:26,428 --> 01:43:28,496 PHYSICIANS HAVE TO GET OUT OF 2737 01:43:28,496 --> 01:43:32,767 THEIR COMFORT ZONE AND BE MORE 2738 01:43:32,767 --> 01:43:33,868 COMPUTATIONAL AND MAP SAVVY THAN 2739 01:43:33,868 --> 01:43:35,770 IN THE PAST TO PARTICIPATE IN 2740 01:43:35,770 --> 01:43:40,342 THESE HUMAN IN THE LOOP THINGS. 2741 01:43:40,342 --> 01:43:42,777 WHAT ARE THE STEPS TO CONSIDER 2742 01:43:42,777 --> 01:43:44,512 WHEN PROPOSING OR DEVELOPING 2743 01:43:44,512 --> 01:43:46,147 A.I. MODELS FOR DIAGNOSTIC 2744 01:43:46,147 --> 01:43:46,614 SUPPORT? 2745 01:43:46,614 --> 01:43:49,651 I'LL BUILD ON THAT ONE. 2746 01:43:49,651 --> 01:43:51,086 ONE PIECE OF THAT IS LET'S SAY 2747 01:43:51,086 --> 01:43:54,122 YOU DO BUILD SOMETHING FOR 2748 01:43:54,122 --> 01:43:58,393 DIAGNOSTIC OR ADDRESSING SOME 2749 01:43:58,393 --> 01:44:00,028 PROBLEM YOU'VE IDENTIFIED IN 2750 01:44:00,028 --> 01:44:00,829 YOUR HEALTH CARE DELIVERY, HOW 2751 01:44:00,829 --> 01:44:03,331 DO YOU KEEP TRACK OF THE FACT IT 2752 01:44:03,331 --> 01:44:03,631 WORKS? 2753 01:44:03,631 --> 01:44:04,532 DATASETS WILL CHANGE. 2754 01:44:04,532 --> 01:44:08,136 WHEN YOU GO LIVE YOUR DATASET 2755 01:44:08,136 --> 01:44:09,437 WILL CHANGE, YOU DON'T KNOW IF 2756 01:44:09,437 --> 01:44:12,407 IT'S WORKING THE WAY WITH THE 2757 01:44:12,407 --> 01:44:14,376 FIRST VALIDATION MODEL. 2758 01:44:14,376 --> 01:44:17,545 FARAZ, YOU IMPLEMENTED STUFF ON 2759 01:44:17,545 --> 01:44:18,680 HEART FAILURE SIDE. 2760 01:44:18,680 --> 01:44:19,614 DO YOU KEEP TRACK? 2761 01:44:19,614 --> 01:44:22,016 >> IT'S A GREAT QUESTION. 2762 01:44:22,016 --> 01:44:24,986 YEAH, WE DO. 2763 01:44:24,986 --> 01:44:28,790 WE HAVE THE COMMITTEE, A.I. 2764 01:44:28,790 --> 01:44:30,225 CATALYST COMMITTEE, 2765 01:44:30,225 --> 01:44:32,193 INTERDISCIPLINARY, WITH 2766 01:44:32,193 --> 01:44:33,728 CLINICIANS, ENGINEERS, 2767 01:44:33,728 --> 01:44:35,363 SCIENTISTS, HUMAN COMPUTER 2768 01:44:35,363 --> 01:44:37,999 EXPERTS, EVERYONE INVOLVED FROM 2769 01:44:37,999 --> 01:44:39,768 IDEA INCEPTION TO DEPLOYMENT, 2770 01:44:39,768 --> 01:44:41,169 POST DEPLOYMENT SURVEILLANCE. 2771 01:44:41,169 --> 01:44:44,239 SO AS WE GO THROUGH THE PROCESS 2772 01:44:44,239 --> 01:44:45,974 WE VALIDATE MODELS AS BEST WE 2773 01:44:45,974 --> 01:44:46,975 KNOW IN DIFFERENT POPULATIONS 2774 01:44:46,975 --> 01:44:47,842 OVER TIME. 2775 01:44:47,842 --> 01:44:49,511 ONCE DEPLOYED WE'RE WORKING ON 2776 01:44:49,511 --> 01:44:51,479 SETTING UP SYSTEMS WHICH WE 2777 01:44:51,479 --> 01:44:52,881 MODEL PERFORMANCE OVER TIME, SET 2778 01:44:52,881 --> 01:44:54,516 CHECK-INS, AND MAKE SURE IT'S 2779 01:44:54,516 --> 01:45:01,089 PERFORMING AS WE THINK IT WILL. 2780 01:45:01,089 --> 01:45:02,090 IDEALLY CAN RETAIN MODELS OVER 2781 01:45:02,090 --> 01:45:04,492 TIME TO IMPROVE QUALITY OF CARE. 2782 01:45:04,492 --> 01:45:06,027 THIS IS ALL VERY EARLY DAYS IN 2783 01:45:06,027 --> 01:45:09,297 THE WORK WE'RE IN, WE'RE STILL 2784 01:45:09,297 --> 01:45:10,231 LEARNING AS WE GO. 2785 01:45:10,231 --> 01:45:12,233 >> YES, JUST LOOKING AT SOME 2786 01:45:12,233 --> 01:45:12,801 QUESTIONS HERE. 2787 01:45:12,801 --> 01:45:14,669 ONE OF THOSE, HOW DO WE BUILD 2788 01:45:14,669 --> 01:45:16,538 TRUST IN MACHINE LEARNING 2789 01:45:16,538 --> 01:45:17,071 MODELS? 2790 01:45:17,071 --> 01:45:19,507 THAT'S LIKE A BIG, BIG QUESTION. 2791 01:45:19,507 --> 01:45:22,343 SO MAYBE IF I COULD TAKE OFF ONE 2792 01:45:22,343 --> 01:45:24,679 PIECE OF THAT AND GET YOUR 2793 01:45:24,679 --> 01:45:24,946 FEEDBACK. 2794 01:45:24,946 --> 01:45:27,582 AGAIN, LET'S SAY YOU HAVE A 2795 01:45:27,582 --> 01:45:29,250 MODEL, LET'S SAY HYPERTENSION, 2796 01:45:29,250 --> 01:45:32,086 SOME MODEL THAT USES A LOT OF 2797 01:45:32,086 --> 01:45:33,021 INFORMATION TO DIAGNOSE PRESENCE 2798 01:45:33,021 --> 01:45:33,955 OR ABSENCE. 2799 01:45:33,955 --> 01:45:36,891 THAT HAS TO GET REGULATORY 2800 01:45:36,891 --> 01:45:41,496 CLEARANCE OR PASS THE REGULATORY 2801 01:45:41,496 --> 01:45:41,830 THRESHOLD. 2802 01:45:41,830 --> 01:45:42,797 BUT IT'S SOLELY DEPENDENT ON THE 2803 01:45:42,797 --> 01:45:49,370 DATA ON WHICH YOU TRAIN THE 2804 01:45:49,370 --> 01:45:49,938 VALIDATOR, RIGHT? 2805 01:45:49,938 --> 01:45:51,573 SO IF YOU NEED TO DEVELOP TRUST 2806 01:45:51,573 --> 01:45:55,710 IN THAT KNOWING IT'S NOT TRAINED 2807 01:45:55,710 --> 01:45:56,711 ON THE FULL POPULATION, WHAT 2808 01:45:56,711 --> 01:45:58,213 WOULD YOU THINK OF THIS IDEA? 2809 01:45:58,213 --> 01:46:00,748 WHAT IF THERE WERE SOME 2810 01:46:00,748 --> 01:46:02,717 STANDARDIZED DATASET FOR OUTCOME 2811 01:46:02,717 --> 01:46:05,353 X, HYPERTENSION, LET'S SAY, AND 2812 01:46:05,353 --> 01:46:08,156 THAT ALL MODELS WERE TRAINED TO 2813 01:46:08,156 --> 01:46:09,724 GET WORK -- AND THIS IS DEFINED 2814 01:46:09,724 --> 01:46:10,725 BY PEOPLE WHO UNDERSTAND PEOPLE 2815 01:46:10,725 --> 01:46:12,560 LIKE DR. SPATZ WHO UNDERSTAND 2816 01:46:12,560 --> 01:46:14,195 THE COMMUNITIES AND NEEDS AND 2817 01:46:14,195 --> 01:46:15,196 PEOPLE, CONTEXT WHERE PEOPLE 2818 01:46:15,196 --> 01:46:16,731 NEED IT, THEY CAN SAY, OKAY, IF 2819 01:46:16,731 --> 01:46:20,001 YOU'RE GOING TO PUT THIS THING 2820 01:46:20,001 --> 01:46:21,970 ON THE MARKET, IT MUST WORK, SHE 2821 01:46:21,970 --> 01:46:23,738 KNOWS THAT POPULATION. 2822 01:46:23,738 --> 01:46:26,708 YOU HAD TO MEET THAT BAR. 2823 01:46:26,708 --> 01:46:29,644 WHAT DO YOU THINK OF SOMETHING 2824 01:46:29,644 --> 01:46:30,512 LIKE THAT? 2825 01:46:30,512 --> 01:46:34,916 STANDARDIZED SETS, YOU HAVE TO 2826 01:46:34,916 --> 01:46:35,517 PERFORM AGAINST? 2827 01:46:35,517 --> 01:46:39,854 >> I'D BE HAPPY TO TAKE THE 2828 01:46:39,854 --> 01:46:40,155 FIRST STAB. 2829 01:46:40,155 --> 01:46:42,690 SO, I THINK COLLEAGUES ARE DOING 2830 01:46:42,690 --> 01:46:45,226 EXCELLENT WORK WITH DIGITAL 2831 01:46:45,226 --> 01:46:47,061 CENTER NOW, AND ONE OF OUR 2832 01:46:47,061 --> 01:46:48,897 COLLEAGUES IS A CARDIOLOGIST 2833 01:46:48,897 --> 01:46:52,200 ACTUALLY, WE'RE IN THE PROCESS 2834 01:46:52,200 --> 01:46:54,502 OF IMPROVING MODELS NOW. 2835 01:46:54,502 --> 01:46:57,572 YOU SEE THEY PROPOSE WHAT YOU 2836 01:46:57,572 --> 01:46:57,839 PROPOSED. 2837 01:46:57,839 --> 01:46:59,741 BECAUSE THEY HAVE TO TAKE ONE 2838 01:46:59,741 --> 01:47:03,578 BENCH MARK FOR ALL STUDIES, ONE 2839 01:47:03,578 --> 01:47:04,979 FOR HYPERTENSION, USUALLY THESE 2840 01:47:04,979 --> 01:47:08,483 MODELS LOOK AT VERY SPECIFIC 2841 01:47:08,483 --> 01:47:08,750 OUTCOMES. 2842 01:47:08,750 --> 01:47:12,220 WE HAD TO GO TO DIFFERENT 2843 01:47:12,220 --> 01:47:14,088 HOSPITALS WITH DIFFERENT 2844 01:47:14,088 --> 01:47:15,290 DEMOGRAPHICS OF PATIENTS, AND 2845 01:47:15,290 --> 01:47:18,660 SHOW THAT THE WORKS ON ALL OF 2846 01:47:18,660 --> 01:47:21,095 THEM, RIGHT? 2847 01:47:21,095 --> 01:47:27,435 SO I THINK FDA ROLE IS CRUCIAL, 2848 01:47:27,435 --> 01:47:29,070 MAKING SURE MODELS HELP 2849 01:47:29,070 --> 01:47:31,606 PATIENTS, AND USUALLY NEED TO GO 2850 01:47:31,606 --> 01:47:35,443 ONE STEP FURTHER. 2851 01:47:35,443 --> 01:47:38,279 EXTERNAL VALIDATION IS THE 2852 01:47:38,279 --> 01:47:39,714 ABSOLUTE MUST, BUT HOW 2853 01:47:39,714 --> 01:47:44,185 CLINICIANS USING THE TOOL BEHAVE 2854 01:47:44,185 --> 01:47:45,386 IS ANOTHER VERY IMPORTANT TASK 2855 01:47:45,386 --> 01:47:50,858 BECAUSE MOST OF THESE MODELS ARE 2856 01:47:50,858 --> 01:47:52,193 GIVING THE CLINICIAN ONE 2857 01:47:52,193 --> 01:47:52,961 INSIGHT, RIGHT? 2858 01:47:52,961 --> 01:47:54,128 BUT CLINICIAN IS LOOKING AT THE 2859 01:47:54,128 --> 01:47:55,496 PATIENT, THERE'S A MILLION 2860 01:47:55,496 --> 01:47:56,664 THINGS THEY ARE CONSIDERING, 2861 01:47:56,664 --> 01:47:56,864 RIGHT? 2862 01:47:56,864 --> 01:47:59,634 WE NEED TO SEE IF THAT SPECIFIC 2863 01:47:59,634 --> 01:48:00,802 INSIGHT ACTUALLY IMPROVES THE 2864 01:48:00,802 --> 01:48:03,004 PATIENT CARE OVER THE LONG TERM. 2865 01:48:03,004 --> 01:48:05,640 THE MINIMUM IS AS YOU SUGGESTED 2866 01:48:05,640 --> 01:48:08,576 A BASELINE, A VERY 2867 01:48:08,576 --> 01:48:09,177 DEMOGRAPHIC-SPECIFIC ANALYSIS, 2868 01:48:09,177 --> 01:48:12,413 BUT I THINK WE HAVE TO HAVE A 2869 01:48:12,413 --> 01:48:15,350 HIGHER BAR AND HAVE PRACTICE 2870 01:48:15,350 --> 01:48:15,883 VALIDATION AT WORK. 2871 01:48:15,883 --> 01:48:18,553 >> THAT'S A REALLY EXCELLENT 2872 01:48:18,553 --> 01:48:20,188 POINT BECAUSE THERE'S UNKNOWN 2873 01:48:20,188 --> 01:48:21,022 EFFECTS ON JUST IMPLEMENTATION, 2874 01:48:21,022 --> 01:48:23,925 NOTHING TO DO WITH THE TECH, 2875 01:48:23,925 --> 01:48:25,226 SLOWLY ON IMPLEMENTATION SIDE, 2876 01:48:25,226 --> 01:48:26,861 UNINTENDED EFFECT YOU DIDN'T 2877 01:48:26,861 --> 01:48:32,233 THINK OF AND MAKE SURE THAT 2878 01:48:32,233 --> 01:48:33,735 WHATEVER YOU'RE IMPLEMENTING IS 2879 01:48:33,735 --> 01:48:36,237 STILL HAVING EFFECTIVENESS WITH 2880 01:48:36,237 --> 01:48:42,944 THOSE FACTORS INCLUDED. 2881 01:48:42,944 --> 01:48:44,145 ANOTHER GOOD QUESTION, WHAT 2882 01:48:44,145 --> 01:48:46,347 PRACTICAL ADVICE WOULD YOU GIVE 2883 01:48:46,347 --> 01:48:49,517 EARLY CAREER CLINICIAN AND 2884 01:48:49,517 --> 01:48:52,020 RESEARCHERS REACHING OUT TO A.I. 2885 01:48:52,020 --> 01:48:52,286 ENGINEERS? 2886 01:48:52,286 --> 01:48:54,555 >> IT'S A GREAT QUESTION. 2887 01:48:54,555 --> 01:48:56,958 I MEAN, WHEN I REACHED OUT TO 2888 01:48:56,958 --> 01:48:58,059 COLLABORATORS WHO WERE 2889 01:48:58,059 --> 01:48:59,794 ENGINEERS, REALLY FILLING THE 2890 01:48:59,794 --> 01:49:02,130 CLINICAL PROBLEM, EXPLAINING 2891 01:49:02,130 --> 01:49:05,600 THAT, GETS THEM EXCITED TO 2892 01:49:05,600 --> 01:49:06,601 PARTNER. 2893 01:49:06,601 --> 01:49:09,003 AND I THINK A LOT OF ENGINEERS 2894 01:49:09,003 --> 01:49:11,205 ARE EXCITED, HOW DO WE DEVELOP A 2895 01:49:11,205 --> 01:49:12,840 MODEL EMPLOYED IN PRACTICE AND 2896 01:49:12,840 --> 01:49:14,142 CHANGE CARE. 2897 01:49:14,142 --> 01:49:16,577 SELLING YOUR STRENGTHS AND THE 2898 01:49:16,577 --> 01:49:18,179 PROBLEM IS REALLY IMPORTANT. 2899 01:49:18,179 --> 01:49:20,181 BUILDING A BACKGROUND SO YOU 2900 01:49:20,181 --> 01:49:21,783 UNDERSTAND BASICS, A TON OF 2901 01:49:21,783 --> 01:49:22,583 SELF-LEARNING OPPORTUNITIES TO 2902 01:49:22,583 --> 01:49:24,552 BUILD UP A BASIC BACKGROUND IN 2903 01:49:24,552 --> 01:49:26,087 BIG DATA SCIENCE, THE SPACE, AND 2904 01:49:26,087 --> 01:49:27,855 SO I THINK LEARNING THE LANGUAGE 2905 01:49:27,855 --> 01:49:31,225 TOO IS REALLY IMPORTANT TO THOSE 2906 01:49:31,225 --> 01:49:31,592 COLLABORATIONS. 2907 01:49:31,592 --> 01:49:34,095 >> YEAH, I'LL DOUBLE ON THAT 2908 01:49:34,095 --> 01:49:34,295 ONE. 2909 01:49:34,295 --> 01:49:35,830 THAT SECOND ONE. 2910 01:49:35,830 --> 01:49:37,699 IF YOUR EARLY CAREER GETS INTO 2911 01:49:37,699 --> 01:49:40,201 THE WEEDS, ANYBODY CAN LEARN HOW 2912 01:49:40,201 --> 01:49:42,704 TO WRITE CODE THESE DAYS. 2913 01:49:42,704 --> 01:49:43,805 AND STATISTICS. 2914 01:49:43,805 --> 01:49:47,208 MOSTLY I TELL EARLY CAREER 2915 01:49:47,208 --> 01:49:48,276 PHYSICIANS, LEARN STATISTICS. 2916 01:49:48,276 --> 01:49:49,277 THAT'S REALLY IMPORTANT. 2917 01:49:49,277 --> 01:49:51,145 YEAH, HAVE YOU HAD GOOD 2918 01:49:51,145 --> 01:49:51,446 EXPERIENCE? 2919 01:49:51,446 --> 01:49:54,749 >> I MIGHT ECHO THAT SENTIMENT. 2920 01:49:54,749 --> 01:49:56,918 ON THE FLIP SIDE TOO AS YOU 2921 01:49:56,918 --> 01:49:58,352 START TO LEARN THESE THINGS I 2922 01:49:58,352 --> 01:50:00,555 THINK AS A RESULT YOU'LL THEN 2923 01:50:00,555 --> 01:50:02,523 QUICKLY BE ABLE TO TELL ON THE 2924 01:50:02,523 --> 01:50:05,126 FLIP SLIDE WHO ARE THE ENGINEERS 2925 01:50:05,126 --> 01:50:06,327 INTERESTED IN EMBEDDING WITHIN 2926 01:50:06,327 --> 01:50:09,397 MEDICINE AND LEARNING MORE, 2927 01:50:09,397 --> 01:50:09,630 RIGHT? 2928 01:50:09,630 --> 01:50:12,567 I CAN GO AND AT LEAST SPEAK TO 2929 01:50:12,567 --> 01:50:13,434 SOME EXTENT OF CARDIOVASCULAR 2930 01:50:13,434 --> 01:50:14,802 PROBLEMS AND CHALLENGES OF 2931 01:50:14,802 --> 01:50:18,039 COLLECTING DATA AND, YOU KNOW, 2932 01:50:18,039 --> 01:50:18,806 UNDERSTANDING THAT A 2933 01:50:18,806 --> 01:50:20,441 REINFORCEMENT LEARNING ALGORITHM 2934 01:50:20,441 --> 01:50:22,310 PLAYS A GAME AND FAILS A FEW 2935 01:50:22,310 --> 01:50:24,612 TIMES UNTIL IT LEARNS IS FINE 2936 01:50:24,612 --> 01:50:26,914 BUT YOU CAN'T INTENTIONALLY FAIL 2937 01:50:26,914 --> 01:50:29,751 50 TIMES WITH A PERSON. 2938 01:50:29,751 --> 01:50:33,488 YOU'LL START TO FIND MORE 2939 01:50:33,488 --> 01:50:34,055 ENGAGED COLLABORATORS THERE 2940 01:50:34,055 --> 01:50:35,123 EXCITED ABOUT TRYING TO SOLVE A 2941 01:50:35,123 --> 01:50:45,299 CLINICAL PROBLEM VERSE -- VERS 2942 01:50:45,299 --> 01:50:47,635 THE ONES WITH SOMETHING THEY CAN 2943 01:50:47,635 --> 01:50:49,437 RUNOFF LINE, THERE ARE DIFFERENT 2944 01:50:49,437 --> 01:50:51,105 LEVELS OF COLLABORATIONS BUT THE 2945 01:50:51,105 --> 01:50:52,940 MOST SUCCESSFUL WILL MAKE 2946 01:50:52,940 --> 01:50:54,041 GROUNDBREAKING SOLUTIONS, THAT 2947 01:50:54,041 --> 01:50:55,777 CAN GET BOTH SIDES INTO THE 2948 01:50:55,777 --> 01:50:57,111 NITTY-GRITTY SO THEY ARE WILLING 2949 01:50:57,111 --> 01:51:00,114 TO BE ENGAGED AT A FREQUENT 2950 01:51:00,114 --> 01:51:00,314 BASIS. 2951 01:51:00,314 --> 01:51:05,753 >> YEAH, IF WE BRING IT BACK TO 2952 01:51:05,753 --> 01:51:06,954 THE NIH AND NHLBI, THERE ARE 2953 01:51:06,954 --> 01:51:10,992 WAYS, MAYBE THERE ARE WAYS THAT 2954 01:51:10,992 --> 01:51:11,425 THE NATIONAL FUNDING 2955 01:51:11,425 --> 01:51:12,393 ORGANIZATIONS, YOU KNOW, CAN 2956 01:51:12,393 --> 01:51:13,194 SUPPORT THIS. 2957 01:51:13,194 --> 01:51:14,462 YOU HAVE TO REALLY GET OUT OF 2958 01:51:14,462 --> 01:51:17,698 YOUR COMFORT ZONE TO DO THIS 2959 01:51:17,698 --> 01:51:19,567 WORK AND OF COURSE THERE'S 2960 01:51:19,567 --> 01:51:20,201 WONDERFUL CAREER DEVELOPMENT 2961 01:51:20,201 --> 01:51:22,837 PROGRAMS AT THE NIH THAT CAN BE 2962 01:51:22,837 --> 01:51:24,605 GEARED TOWARDS THIS NEED WHICH I 2963 01:51:24,605 --> 01:51:27,675 THINK WE CLEARLY IDENTIFY HERE. 2964 01:51:27,675 --> 01:51:32,480 ALL RIGHT. 2965 01:51:32,480 --> 01:51:32,880 LET'S SEE. 2966 01:51:32,880 --> 01:51:35,082 I GUESS, DO YOU HAVE ANY 2967 01:51:35,082 --> 01:51:35,349 QUESTIONS? 2968 01:51:35,349 --> 01:51:38,686 WE HAVE A BREAK PLANNED HERE. 2969 01:51:38,686 --> 01:51:41,322 >> I DON'T KNOW IF YOU SAW -- 2970 01:51:41,322 --> 01:51:42,190 YOU MIGHT HAVE ADDRESSED MY 2971 01:51:42,190 --> 01:51:43,424 QUESTION IN THE CHAT TALKING 2972 01:51:43,424 --> 01:51:46,661 ABOUT EARLY YEAR. 2973 01:51:46,661 --> 01:51:53,734 >> LET ME GO BACK HERE. 2974 01:51:53,734 --> 01:51:55,336 >> I CAN REITERATE. 2975 01:51:55,336 --> 01:51:59,073 I SEE THE VALUE OF A.I., 2976 01:51:59,073 --> 01:51:59,740 CERTAINLY. 2977 01:51:59,740 --> 01:52:03,444 I'M THINKING FROM THE POINT OF 2978 01:52:03,444 --> 01:52:05,413 VIEW PREVENTIVE CARE, CLINICAL 2979 01:52:05,413 --> 01:52:08,916 CARE, WITH A YOUNG PHYSICIAN OR 2980 01:52:08,916 --> 01:52:10,251 MID-CAREER USING THESE, DO THEY 2981 01:52:10,251 --> 01:52:12,553 HAVE TO UNDERSTAND WHAT'S UNDER 2982 01:52:12,553 --> 01:52:15,256 THE HOOD IN ORDER TO IMPLEMENT? 2983 01:52:15,256 --> 01:52:17,425 I.E. UNDERSTAND ITS LIMITATIONS 2984 01:52:17,425 --> 01:52:19,660 AND STRENGTHS? 2985 01:52:19,660 --> 01:52:20,628 YOU'RE HANDING A TOOL TO 2986 01:52:20,628 --> 01:52:22,496 SOMEBODY, DO YOU SEE WHAT I'M 2987 01:52:22,496 --> 01:52:22,730 SAYING? 2988 01:52:22,730 --> 01:52:24,799 HOW MUCH DO THEY HAVE TO KNOW OR 2989 01:52:24,799 --> 01:52:28,836 SHOULD WE RELY JUST ON YOU ALL 2990 01:52:28,836 --> 01:52:31,339 WHO CROSS THE DIVIDE? 2991 01:52:31,339 --> 01:52:33,007 DID YOU UNDERSTAND WHAT I'M 2992 01:52:33,007 --> 01:52:34,609 SAYING? 2993 01:52:34,609 --> 01:52:35,743 THAT'S THE QUESTION, NOT A 2994 01:52:35,743 --> 01:52:36,110 COMMENT. 2995 01:52:36,110 --> 01:52:37,712 I DON'T KNOW WHAT THE ANSWER IS 2996 01:52:37,712 --> 01:52:40,214 BUT I THOUGHT IT WOULD POSE IT 2997 01:52:40,214 --> 01:52:41,182 TO YOU ALL. 2998 01:52:41,182 --> 01:52:44,051 >> I CAN START AND OTHERS CAN 2999 01:52:44,051 --> 01:52:44,719 JUMP IN. 3000 01:52:44,719 --> 01:52:46,687 IT DEPENDS ON USE CASE, SOME 3001 01:52:46,687 --> 01:52:49,090 CASES IN WHICH THEY DO NEED TO 3002 01:52:49,090 --> 01:52:49,891 HAVE SOME DEEPER UNDERSTANDING 3003 01:52:49,891 --> 01:52:52,693 WHAT'S UNDER THE HOOD. 3004 01:52:52,693 --> 01:52:54,662 OTHER USE CASES WHERE IF IT'S A 3005 01:52:54,662 --> 01:52:58,065 TOOL OR DEVICE TESTED IN A 3006 01:52:58,065 --> 01:52:59,267 RANDOMIZED CONTROLLED TRIAL AND 3007 01:52:59,267 --> 01:53:01,135 MEETS EVIDENCE BAR TO BE USED IN 3008 01:53:01,135 --> 01:53:01,869 PRACTICE THEY PROBABLY DON'T 3009 01:53:01,869 --> 01:53:02,937 NEED TO UNDERSTAND DETAILS OF 3010 01:53:02,937 --> 01:53:07,041 ALGORITHM BUT NEED TO UNDERSTAND 3011 01:53:07,041 --> 01:53:08,242 THE EVIDENCE THAT THE STUDY, 3012 01:53:08,242 --> 01:53:11,212 DETAILS OF THE STUDY THAT TEST 3013 01:53:11,212 --> 01:53:21,055 IT TO USE IT, HOW TO USE IT. 3014 01:53:21,055 --> 01:53:21,822 >> THE CURRENT GENERATION 3015 01:53:21,822 --> 01:53:23,991 WORKING ON THESE THINGS NEED TO 3016 01:53:23,991 --> 01:53:25,526 HAVE SOME EXPERIENCE, YOU KNOW, 3017 01:53:25,526 --> 01:53:29,096 SOME MERGED PROGRAM OF 3018 01:53:29,096 --> 01:53:31,332 ENGINEERING/MEDICINE TO HELP 3019 01:53:31,332 --> 01:53:32,767 DEVELOP, VALIDATE, DEVELOP TRUST 3020 01:53:32,767 --> 01:53:34,368 IN THE TECHNIQUES, UNTIL A POINT 3021 01:53:34,368 --> 01:53:36,037 IN WHICH THEY BECOME COMMON 3022 01:53:36,037 --> 01:53:38,873 ENOUGH THAT YOU CAN THEN 3023 01:53:38,873 --> 01:53:39,874 ABSTRACT DETAILS AND TRUST YOU 3024 01:53:39,874 --> 01:53:41,842 KNOW WHAT IT'S DOING AND WHY IT 3025 01:53:41,842 --> 01:53:43,311 PRODUCES WHAT IT PRODUCES 3026 01:53:43,311 --> 01:53:44,111 WITHOUT UNDERSTANDING WHAT IT'S 3027 01:53:44,111 --> 01:53:54,622 DOING UNDER THE HOOD. 3028 01:53:54,622 --> 01:53:55,156 >> I AGREE. 3029 01:53:55,156 --> 01:53:57,091 IF YOU WANT TO BE PART OF 3030 01:53:57,091 --> 01:53:59,260 BUILDING THE TOOL YOU GOT TO 3031 01:53:59,260 --> 01:54:00,895 UNDERSTAND A LOT MORE THAN IF 3032 01:54:00,895 --> 01:54:02,630 YOU'RE ON THE DELIVERY SIDE, 3033 01:54:02,630 --> 01:54:11,539 WHERE YOU HAVE TO UNDERSTAND THE 3034 01:54:11,539 --> 01:54:12,073 TYPICAL THINGS ABOUT 3035 01:54:12,073 --> 01:54:13,607 INTERVENTION, DOES THIS MATCH 3036 01:54:13,607 --> 01:54:14,709 THE POPULATION I'M TREATING, 3037 01:54:14,709 --> 01:54:16,544 WHAT'S THE TREATMENT EFFECT, DO 3038 01:54:16,544 --> 01:54:20,715 I HAVE TO THINK ABOUT PRE-TEST 3039 01:54:20,715 --> 01:54:22,350 PROBABILITY, THAT SORT OF THING. 3040 01:54:22,350 --> 01:54:23,484 IF YOU WANT TO BUILD TOOLS THEN 3041 01:54:23,484 --> 01:54:26,087 YOU HAVE TO GET INTO THE WEEDS I 3042 01:54:26,087 --> 01:54:28,155 THINK. 3043 01:54:28,155 --> 01:54:33,361 >> THANK YOU FOR ANSWERING MY 3044 01:54:33,361 --> 01:54:36,030 QUESTION. 3045 01:54:36,030 --> 01:54:39,333 >> DO YOU THINK WE SHOULD GO TO 3046 01:54:39,333 --> 01:54:39,533 BREAK? 3047 01:54:39,533 --> 01:54:43,904 >> YEAH, WHY DON'T WE TAKE A 3048 01:54:43,904 --> 01:54:46,474 BREAK HERE, BIO-BREAK, GRAB SOME 3049 01:54:46,474 --> 01:54:48,976 COFFEE, AND THEN AT 1:15 WE'LL 3050 01:54:48,976 --> 01:54:51,912 BE BACK FOR SESSION 2, BLOOD 3051 01:54:51,912 --> 01:54:52,480 PRESSURE MEASUREMENT, 3052 01:54:52,480 --> 01:54:54,081 HYPERTENSION RISK, BLOOD 3053 01:54:54,081 --> 01:54:54,849 PRESSURE CONTROL. 3054 01:54:54,849 --> 01:54:56,543 SO WE'LL TAKE A SHORT BREAK 3055 01:54:56,543 --> 01:54:58,512 WE'RE GOING TO KEEP MOVING 3056 01:54:58,512 --> 01:54:58,846 FORWARD HERE. 3057 01:54:58,846 --> 01:55:01,248 FIRST I WANT TO THANK THE 3058 01:55:01,248 --> 01:55:04,451 SPEAKERS FROM SESSION 1, REALLY 3059 01:55:04,451 --> 01:55:05,752 LAID SOME EXCELLENT GROUND WORK. 3060 01:55:05,752 --> 01:55:06,720 YOU KNOW, LAYING OUT THE STATE 3061 01:55:06,720 --> 01:55:10,023 OF THE FIELD FROM THE TECH AND 3062 01:55:10,023 --> 01:55:11,458 ENGINEERING SIDE TO MOVE FORWARD 3063 01:55:11,458 --> 01:55:12,326 ON THE NEXT SESSIONS. 3064 01:55:12,326 --> 01:55:15,295 THANK YOU TO ALL THREE OF YOU. 3065 01:55:15,295 --> 01:55:17,831 NOW TO SESSION 2, I'LL INTRODUCE 3066 01:55:17,831 --> 01:55:24,738 OUR MODERATOR, DR. KEITH 3067 01:55:24,738 --> 01:55:26,340 FERDINAND, ENDOWED CHAIR AT 3068 01:55:26,340 --> 01:55:29,209 PROFESSOR AT TULANE UNIVERSITY, 3069 01:55:29,209 --> 01:55:32,446 NATIONAL LEADER AND CHAMPION IN 3070 01:55:32,446 --> 01:55:32,913 PREVENTIVE CARDIOLOGY, 3071 01:55:32,913 --> 01:55:35,115 PARTICULARLY RACIAL AND ETHNIC 3072 01:55:35,115 --> 01:55:37,150 MINORITIES AND PUSHING US 3073 01:55:37,150 --> 01:55:38,819 FORWARD IN FOCUSING ON AND NOT 3074 01:55:38,819 --> 01:55:41,154 LOSE EVER SIGHT OF HEALTH EQUITY 3075 01:55:41,154 --> 01:55:42,589 THINGS WE NEED TO FOCUS ON. 3076 01:55:42,589 --> 01:55:44,524 IT'S MY PLEASURE TO INTRODUCE 3077 01:55:44,524 --> 01:55:46,159 KEITH FERDINAND AS THE MODERATOR 3078 01:55:46,159 --> 01:55:46,660 OF OUR NEXT SESSION. 3079 01:55:46,660 --> 01:55:49,663 >> THANK YOU FOR THE KIND 3080 01:55:49,663 --> 01:55:50,097 PRODUCTION. 3081 01:55:50,097 --> 01:55:54,601 SESSION 2 IS GOING TO LOOK AT 3082 01:55:54,601 --> 01:55:55,702 BLOOD PRESSURE MEASUREMENT, 3083 01:55:55,702 --> 01:55:56,670 HYPERTENSION RISK AND BLOOD 3084 01:55:56,670 --> 01:55:58,338 PRESSURE CONTROL. 3085 01:55:58,338 --> 01:56:00,073 WE HAVE EXCELLENT SPEAKERS, 3086 01:56:00,073 --> 01:56:03,243 DIVERSE IN TERMS OF GEOGRAPHY 3087 01:56:03,243 --> 01:56:05,679 AND INTEREST, STARTING WITH DR. 3088 01:56:05,679 --> 01:56:06,413 ABDULLAH, FROM COLUMBIA 3089 01:56:06,413 --> 01:56:09,483 UNIVERSITY IN NEW YORK, 3090 01:56:09,483 --> 01:56:11,018 DISCUSSING BLOOD PRESSURE 3091 01:56:11,018 --> 01:56:12,786 MEASUREMENT INSIDE AND OUTSIDE 3092 01:56:12,786 --> 01:56:15,956 OF THE OFFICE. 3093 01:56:15,956 --> 01:56:18,592 DR. ABDALLA, YOU MAY START. 3094 01:56:18,592 --> 01:56:28,969 >> THANK YOU SO MUCH. 3095 01:56:31,338 --> 01:56:33,240 I'M GOING TO DISCUSS DEVICES 3096 01:56:33,240 --> 01:56:40,480 USED FOR BLOOD PRESSURE 3097 01:56:40,480 --> 01:56:41,682 MEASUREMENT, GUIDELINE 3098 01:56:41,682 --> 01:56:43,317 APPROACHES, FOR FUTURE RESHAPED 3099 01:56:43,317 --> 01:56:44,751 BY CURRENT APPS IN LITERATURE. 3100 01:56:44,751 --> 01:56:45,552 BLOOD PRESSURE IS TYPICALLY 3101 01:56:45,552 --> 01:56:50,991 MEASURED IN THE OFFICE FROM THE 3102 01:56:50,991 --> 01:56:52,726 BRACHIAL ARTERY, THIS WAS DONE 3103 01:56:52,726 --> 01:57:00,267 USING MERCURY COLUMN DEVICE, NW 3104 01:57:00,267 --> 01:57:04,438 RECOMMENDING USE OF AUTOMATIC 3105 01:57:04,438 --> 01:57:05,772 DEVICE FOLLOWING A STANDARDIZED 3106 01:57:05,772 --> 01:57:10,043 PROCEED 3107 01:57:10,043 --> 01:57:13,113 PROTOCOL, SEATED FOR FIVE 3108 01:57:13,113 --> 01:57:15,649 MINUTES, NOT OFTEN DONE IN BUSY 3109 01:57:15,649 --> 01:57:16,183 OFFICE SETTINGS. 3110 01:57:16,183 --> 01:57:18,585 WE MEASURE IN OFFICE TO DIAGNOSE 3111 01:57:18,585 --> 01:57:28,462 WITH HYPERTENSION OR HIGH BLOOD 3112 01:57:28,462 --> 01:57:30,297 PRESSURE OR BLOOD PRESSURE 3113 01:57:30,297 --> 01:57:30,530 CONTROL. 3114 01:57:30,530 --> 01:57:34,901 BLOOD PRESSURE IN THE OFFICE HAS 3115 01:57:34,901 --> 01:57:38,538 MANY LIMITATIONS, FOR SOME IT IS 3116 01:57:38,538 --> 01:57:40,273 NOT REFLECTIVE OF THE OUTSIDE 3117 01:57:40,273 --> 01:57:40,574 ENVIRONMENT. 3118 01:57:40,574 --> 01:57:44,878 OUT OF OFFICE BLOOD PRESSURE CAN 3119 01:57:44,878 --> 01:57:46,079 PROVIDE MORE DATA POINTS, 3120 01:57:46,079 --> 01:57:47,047 COMPARED WITH THE SNAPSHOT 3121 01:57:47,047 --> 01:57:49,583 COMING INTO THE OFFICE WITH 3122 01:57:49,583 --> 01:57:49,950 CLINICIAN. 3123 01:57:49,950 --> 01:57:51,785 AND CAN TELL US REALLY HOW BLOOD 3124 01:57:51,785 --> 01:57:53,186 PRESSURE MAY VARY EITHER OVER 3125 01:57:53,186 --> 01:57:56,056 24-HOUR PERIOD OR SEVERAL DAYS 3126 01:57:56,056 --> 01:57:59,126 OR WEEKS. 3127 01:57:59,126 --> 01:58:00,961 MULTIPLE DATA HAS SHOWN IT MAY 3128 01:58:00,961 --> 01:58:03,196 BE ASSOCIATED WITH DISEASE 3129 01:58:03,196 --> 01:58:05,699 OUTCOMES COMPARED TO OFFICE 3130 01:58:05,699 --> 01:58:09,636 BLOOD PRESSURE, THE 2017 ACC/AHA 3131 01:58:09,636 --> 01:58:10,504 GUIDELINES AND 21 GUIDELINES 3132 01:58:10,504 --> 01:58:13,273 RECOMMEND OUT OF OFFICE BLOOD 3133 01:58:13,273 --> 01:58:20,047 PRESSURE FOR DIAGNOSTIC 3134 01:58:20,047 --> 01:58:20,380 CONFIRMATION. 3135 01:58:20,380 --> 01:58:25,218 THE 2017 SPECIFIC OUT OF OFFICE 3136 01:58:25,218 --> 01:58:26,053 FOR MEDS. 3137 01:58:26,053 --> 01:58:27,687 THERE ARE TWO WAYS BLOOD 3138 01:58:27,687 --> 01:58:29,022 PRESSURE IS TYPICALLY MEASURED 3139 01:58:29,022 --> 01:58:36,663 OUTSIDE THE OFFICE, USING 3140 01:58:36,663 --> 01:58:37,030 AUTOMATED. 3141 01:58:37,030 --> 01:58:40,300 ON THE LEFT SIDE WORN FOR 24 OR 3142 01:58:40,300 --> 01:58:43,236 48 HOURS, CAN MEASURE BLOOD 3143 01:58:43,236 --> 01:58:44,638 PRESSURE FREQUENTLY THROUGH THE 3144 01:58:44,638 --> 01:58:46,306 AWAKE OR DAYTIME PERIOD, OR 3145 01:58:46,306 --> 01:58:47,507 SLEEP NIGHTTIME PERIOD. 3146 01:58:47,507 --> 01:58:48,942 DOES NOT REQUIRE AN INDIVIDUAL 3147 01:58:48,942 --> 01:58:50,977 TO INITIATE BLOOD PRESSURE 3148 01:58:50,977 --> 01:58:51,378 READINGS. 3149 01:58:51,378 --> 01:58:54,414 THE OTHER IS HOME BLOOD PRESSURE 3150 01:58:54,414 --> 01:58:55,482 MONITORING, SELF-MEASURED BLOOD 3151 01:58:55,482 --> 01:58:55,782 PRESSURE. 3152 01:58:55,782 --> 01:58:57,217 WHICH DOES REQUIRE AN INDIVIDUAL 3153 01:58:57,217 --> 01:58:58,752 TO INITIATE BLOOD PRESSURE 3154 01:58:58,752 --> 01:59:00,954 READINGS, THE DEVICE IS USED 3155 01:59:00,954 --> 01:59:03,690 OVER SEVERAL DAYS OR WEEKS. 3156 01:59:03,690 --> 01:59:04,458 I'LL PROVIDE ADDITIONAL 3157 01:59:04,458 --> 01:59:05,659 INFORMATION ON EACH LATER. 3158 01:59:05,659 --> 01:59:09,529 FIRST I WANT TO TALK ABOUT THE 3159 01:59:09,529 --> 01:59:12,132 LIMITATIONS OF OFFICE BLOOD 3160 01:59:12,132 --> 01:59:12,499 PRESSURE. 3161 01:59:12,499 --> 01:59:13,967 IN PARTICULAR INCLUDING THE 3162 01:59:13,967 --> 01:59:16,503 INABILITY TO IDENTIFY CERTAIN 3163 01:59:16,503 --> 01:59:18,438 ABNORMAL BLOOD PRESSURE 3164 01:59:18,438 --> 01:59:18,738 PHENOTYPES. 3165 01:59:18,738 --> 01:59:19,873 TRADITIONAL DEFINITION OF 3166 01:59:19,873 --> 01:59:21,608 HYPERTENSION IS BASED ON OFFICE 3167 01:59:21,608 --> 01:59:23,944 BLOOD PRESSURE REPRESENTED HERE 3168 01:59:23,944 --> 01:59:25,445 ON THE LEFT SIDE. 3169 01:59:25,445 --> 01:59:27,114 WHEN YOU CROSS-CLASSIFY OFFICE 3170 01:59:27,114 --> 01:59:29,916 BLOOD PRESSURE WITH OUT OF 3171 01:59:29,916 --> 01:59:31,118 OFFICE, USING HOME BLOOD 3172 01:59:31,118 --> 01:59:33,887 PRESSURE MONITORING OR AWAKE OR 3173 01:59:33,887 --> 01:59:37,924 DAYTIME ABPM WE HAVE FOUR 3174 01:59:37,924 --> 01:59:38,225 PHENOTYPES. 3175 01:59:38,225 --> 01:59:40,327 TWO HIGHLIGHTED IN RED REPRESENT 3176 01:59:40,327 --> 01:59:42,863 A MISMATCH. 3177 01:59:42,863 --> 01:59:43,497 WHITE COAT HYPERTENSION, HIGH 3178 01:59:43,497 --> 01:59:44,498 OFFICE BLOOD PRESSURE BUT OUT OF 3179 01:59:44,498 --> 01:59:48,535 OFFICE IS NOT HIGHER THAN 3180 01:59:48,535 --> 01:59:49,636 NORMAL. 3181 01:59:49,636 --> 01:59:50,737 THE SECOND IS MASKED 3182 01:59:50,737 --> 01:59:53,140 HYPERTENSION, WHERE OFFICE BLOOD 3183 01:59:53,140 --> 01:59:56,510 PRESSURE IS NOT HIGH BUT OUT OF 3184 01:59:56,510 --> 01:59:57,611 OFFICE IS HIGH. 3185 01:59:57,611 --> 01:59:59,379 IT IS OFTEN MISSED IN THE OFFICE 3186 01:59:59,379 --> 02:00:00,147 BECAUSE OBVIOUSLY OFFICE BLOOD 3187 02:00:00,147 --> 02:00:01,781 PRESSURE IS NOT HIGH BY 3188 02:00:01,781 --> 02:00:04,184 DEFINITION BUT AN EXTREMELY 3189 02:00:04,184 --> 02:00:07,154 DANGEROUS PHENOTYPE ASSOCIATED 3190 02:00:07,154 --> 02:00:08,355 WITH CARDIOVASCULAR DISEASE 3191 02:00:08,355 --> 02:00:08,588 EVENTS. 3192 02:00:08,588 --> 02:00:10,957 COMPARED TO OFFICE BLOOD 3193 02:00:10,957 --> 02:00:15,996 PRESSURE, AMBULATORY MONITOR CAN 3194 02:00:15,996 --> 02:00:18,732 TAKE AUTOMATED READINGS EVERY 15 3195 02:00:18,732 --> 02:00:21,034 TO 30 MINUTES OVER A 24-HOUR 3196 02:00:21,034 --> 02:00:22,269 PERIOD. 3197 02:00:22,269 --> 02:00:24,971 ON THE RIGHT HIGHEST IN AWAKE OR 3198 02:00:24,971 --> 02:00:26,840 DAYTIME PERIOD, AND THAT DIP 3199 02:00:26,840 --> 02:00:29,242 DURING THE SLEEP PERIOD. 3200 02:00:29,242 --> 02:00:31,878 ADPM CAN IDENTIFY SEVERAL BLOOD 3201 02:00:31,878 --> 02:00:32,546 PRESSURE PHENOTYPES INCLUDING 3202 02:00:32,546 --> 02:00:34,614 ELEVATION IN BLOOD PRESSURE IN 3203 02:00:34,614 --> 02:00:37,918 SLEEP OR 24-HOUR PATTERN OF 3204 02:00:37,918 --> 02:00:39,653 BLOOD PRESSURE, INCLUDING 3205 02:00:39,653 --> 02:00:40,420 DIPPING. 3206 02:00:40,420 --> 02:00:43,023 I MENTIONED CAN DETECT WHITE 3207 02:00:43,023 --> 02:00:46,860 COAT AND MASKED, CAN BE USED TO 3208 02:00:46,860 --> 02:00:49,162 DIAGNOSE WITH POSTPRANDIAL, 3209 02:00:49,162 --> 02:00:52,866 POSTURAL OR DRUG INDUCED 3210 02:00:52,866 --> 02:00:53,166 HYPOTENSION. 3211 02:00:53,166 --> 02:00:54,501 AMBULATORY BLOOD PRESSURE HAS 3212 02:00:54,501 --> 02:00:56,136 STRONGER ASSOCIATION WITH 3213 02:00:56,136 --> 02:00:58,371 CARDIOVASCULAR DISEASE EVENTS 3214 02:00:58,371 --> 02:01:00,440 THAN OFFICE BLOOD PRESSURE. 3215 02:01:00,440 --> 02:01:03,043 THERE ARE SEVERAL LIMITATIONS. 3216 02:01:03,043 --> 02:01:04,477 SEVERAL STUDIES REPORTED POOR 3217 02:01:04,477 --> 02:01:09,616 PATIENT TOLERABILITY FROM THE 3218 02:01:09,616 --> 02:01:11,685 CUFF INFLATING SO FREQUENTLY, UP 3219 02:01:11,685 --> 02:01:13,687 TO HALF REPORTED SLEEP 3220 02:01:13,687 --> 02:01:14,654 DISRUPTION. 3221 02:01:14,654 --> 02:01:16,523 IT'S EXPENSIVE, COSTS MORE THAN 3222 02:01:16,523 --> 02:01:16,756 $2,000. 3223 02:01:16,756 --> 02:01:19,693 DEVICES HAVE TO BE PLACED AT 3224 02:01:19,693 --> 02:01:20,894 SPECIALIZED CENTERS WHERE DEVICE 3225 02:01:20,894 --> 02:01:23,630 MUST BE RETURNED, DATA 3226 02:01:23,630 --> 02:01:24,164 DOWNLOADED, PREPARED, 3227 02:01:24,164 --> 02:01:26,266 INTERPRETATION OF REPORTS DOES 3228 02:01:26,266 --> 02:01:27,567 REQUIRE EXPERTISE. 3229 02:01:27,567 --> 02:01:30,170 THE DEVICE ISN'T READILY 3230 02:01:30,170 --> 02:01:31,071 AVAILABLE. 3231 02:01:31,071 --> 02:01:31,938 OVERALL UTILIZATION OF ABPM IN 3232 02:01:31,938 --> 02:01:34,774 THE U.S. IS LOW DESPITE THE FACT 3233 02:01:34,774 --> 02:01:38,278 THAT CMS HAS BEEN REIMBURSING 3234 02:01:38,278 --> 02:01:42,115 ALBEIT AT LOWER RATES TO DETECT 3235 02:01:42,115 --> 02:01:44,384 WHITE COAT HYPERTENSION FOR 3236 02:01:44,384 --> 02:01:46,219 ALMOST TWO DECADES. 3237 02:01:46,219 --> 02:01:51,858 FROM 2007 TO 2010 ONLY 0.1% OF 3238 02:01:51,858 --> 02:01:53,927 MEDICARE PATIENTS, 3239 02:01:53,927 --> 02:01:57,430 BENEFICIARIES, ACTUALLY HAD ABPM 3240 02:01:57,430 --> 02:01:57,998 CLAIMS. 3241 02:01:57,998 --> 02:01:59,499 IN CONTRAST HOME OR 3242 02:01:59,499 --> 02:02:00,800 SELF-MEASURED IS MORE WIDELY 3243 02:02:00,800 --> 02:02:02,569 AVAILABLE, MAYBE A MORE 3244 02:02:02,569 --> 02:02:05,071 PRAGMATIC APPROACH IN CLINICAL 3245 02:02:05,071 --> 02:02:05,672 PRACTICE. 3246 02:02:05,672 --> 02:02:06,940 TO DO IT PROPERLY DOES REQUIRE 3247 02:02:06,940 --> 02:02:09,876 CERTAIN AMOUNT OF TRAINING OF 3248 02:02:09,876 --> 02:02:10,210 OUR PATIENTS. 3249 02:02:10,210 --> 02:02:11,177 BLOOD PRESSURE MEASUREMENT 3250 02:02:11,177 --> 02:02:13,947 SHOULD BE OBTAINED FOLLOWING 3251 02:02:13,947 --> 02:02:16,116 PROTOCOL SIMILAR TO WHAT SHOULD 3252 02:02:16,116 --> 02:02:19,185 BE PERFORMED IN THE OFFICE. 3253 02:02:19,185 --> 02:02:20,153 GUIDELINES SUGGEST INDIVIDUALS 3254 02:02:20,153 --> 02:02:22,155 PERFORM TWO READINGS IN THE 3255 02:02:22,155 --> 02:02:24,691 MORNING, TWO AT NIGHT, FOR SEVEN 3256 02:02:24,691 --> 02:02:25,025 DAYS. 3257 02:02:25,025 --> 02:02:26,760 THERE'S SOME DATA TO SHOW THAT 3258 02:02:26,760 --> 02:02:29,829 THREE DAYS OF READINGS ARE 3259 02:02:29,829 --> 02:02:30,497 ACCEPTABLE. 3260 02:02:30,497 --> 02:02:32,432 AND IN GENERAL PEOPLE THINK THIS 3261 02:02:32,432 --> 02:02:35,735 IS MUCH MORE FEASIBLE WHEN 3262 02:02:35,735 --> 02:02:36,503 COMPARED TO ABPM. 3263 02:02:36,503 --> 02:02:38,905 WHAT ARE THE LIMITATIONS OF HOME 3264 02:02:38,905 --> 02:02:41,975 BLOOD PRESSURE MONITORING? 3265 02:02:41,975 --> 02:02:44,377 UNLIKE ABPM MOST HOME BLOOD 3266 02:02:44,377 --> 02:02:46,112 PRESSURE DEVICES CAN'T MEASURE 3267 02:02:46,112 --> 02:02:47,113 BLOOD PRESSURE DURING SLEEP, 3268 02:02:47,113 --> 02:02:52,285 THOUGH THERE ARE NOCTURNAL 3269 02:02:52,285 --> 02:02:53,453 DEVICES, NOT WIDELY AVAILABLE, 3270 02:02:53,453 --> 02:02:56,489 OUR THE COUNTER DEVICES ARE NOT 3271 02:02:56,489 --> 02:02:58,591 VALIDATED, PATIENTS MAY PICK UP 3272 02:02:58,591 --> 02:03:00,060 SOMETHING THAT IS A DEVICE 3273 02:03:00,060 --> 02:03:03,797 THAT'S NOT CORRECT. 3274 02:03:03,797 --> 02:03:05,098 OFTEN THEY ONLY SUPPLY ONE CUFF 3275 02:03:05,098 --> 02:03:05,965 SIZE. 3276 02:03:05,965 --> 02:03:08,401 MANY ARE NOT USING THE CORRECT 3277 02:03:08,401 --> 02:03:11,037 CUFF SIZE. 3278 02:03:11,037 --> 02:03:12,872 BEST USUALLY WITH 3279 02:03:12,872 --> 02:03:13,273 CO-INTERVENTIONS. 3280 02:03:13,273 --> 02:03:21,247 AUTOMATIC RECORDING IS NOT 3281 02:03:21,247 --> 02:03:23,383 ALWAYS AVAILABLE, COPY OF A 3282 02:03:23,383 --> 02:03:24,017 PATIENT BRINGING IN BLOOD 3283 02:03:24,017 --> 02:03:27,554 PRESSURE RECORDINGS ON A PIECE 3284 02:03:27,554 --> 02:03:29,522 OF PAPER. 3285 02:03:29,522 --> 02:03:30,990 LONG-TERM ADHERENCE IS CHALLENGE 3286 02:03:30,990 --> 02:03:32,025 ASKING SOMEONE OVER DAYS OR 3287 02:03:32,025 --> 02:03:34,361 WEEKS OR MONTHS TO CONTINUE 3288 02:03:34,361 --> 02:03:35,895 CHECKING BLOOD PRESSURE TWICE IN 3289 02:03:35,895 --> 02:03:38,832 THE MORNING, TWICE AT NIGHT. 3290 02:03:38,832 --> 02:03:42,035 AGAIN, REIMBURSEMENT RATES ARE 3291 02:03:42,035 --> 02:03:42,202 LOW. 3292 02:03:42,202 --> 02:03:43,570 MAIN CHALLENGES IS BLOOD 3293 02:03:43,570 --> 02:03:44,938 PRESSURE THRESHOLDS, CHASE TO 3294 02:03:44,938 --> 02:03:46,172 UNDERSTAND WHAT MODALITY 3295 02:03:46,172 --> 02:03:47,173 PROVIDES THE BEST ESTIMATE OF 3296 02:03:47,173 --> 02:03:48,375 TRUE BLOOD PRESSURE. 3297 02:03:48,375 --> 02:03:50,243 TO QUOTE THE GUIDELINES PRO 3298 02:03:50,243 --> 02:03:51,978 SIGHS RELATIONSHIP BETWEEN 3299 02:03:51,978 --> 02:03:53,546 OFFICE READINGS, AMBULATORY AND 3300 02:03:53,546 --> 02:03:55,248 HOME READINGS IS UNSETTLED. 3301 02:03:55,248 --> 02:03:56,249 THERE'S GENERAL AGREEMENT THAT 3302 02:03:56,249 --> 02:03:57,884 OFFICE BLOOD PRESSURES ARE OFTEN 3303 02:03:57,884 --> 02:04:00,653 HIGHER THAN AMBULATORY AND HOME 3304 02:04:00,653 --> 02:04:01,955 BLOOD PRESSURES. 3305 02:04:01,955 --> 02:04:04,891 I HIGHLIGHT THE DIFFERENCES IN 3306 02:04:04,891 --> 02:04:07,727 BLOOD PRESSURE THRESHOLDS FOR 3307 02:04:07,727 --> 02:04:10,263 HOME BLOOD PRESSURE, DAYTIME, 3308 02:04:10,263 --> 02:04:12,332 SLEEP, 24 HOUR ABPM, AND OFFICE 3309 02:04:12,332 --> 02:04:15,301 BLOOD PRESSURE THRESHOLD OF 3310 02:04:15,301 --> 02:04:18,271 130/80 MILLIMETERS OF MERCURY, 3311 02:04:18,271 --> 02:04:22,075 AND 140/90 MILLIMETERS OF 3312 02:04:22,075 --> 02:04:22,642 MERCURY. 3313 02:04:22,642 --> 02:04:23,410 OFFICE THRESHOLD OF 130/80 DO 3314 02:04:23,410 --> 02:04:25,145 YOU HAVE THE SAME THRESHOLD FOR 3315 02:04:25,145 --> 02:04:27,380 HOME BLOOD PRESSURE AND DAYTIME 3316 02:04:27,380 --> 02:04:30,283 ABP M. 3317 02:04:30,283 --> 02:04:36,856 THIS IS NOT TRUE AT 140/90. 3318 02:04:36,856 --> 02:04:39,359 WHAT ARE THE BIGGEST UNANSWERED 3319 02:04:39,359 --> 02:04:42,629 QUESTIONS, WHICH DEVICE IS 3320 02:04:42,629 --> 02:04:43,062 SUPERIOR? 3321 02:04:43,062 --> 02:04:45,932 I MOST ASSOCIATE WITH EVENTS AND 3322 02:04:45,932 --> 02:04:46,332 MORTALITY. 3323 02:04:46,332 --> 02:04:47,133 WE CONDUCTED SYSTEMATIC REVIEW 3324 02:04:47,133 --> 02:04:49,903 OF MORE THAN A THOUSAND 3325 02:04:49,903 --> 02:04:51,871 ARTICLES, IDENTIFIED ONLY NINE 3326 02:04:51,871 --> 02:04:56,342 ARTICLES FROM SEVEN COHORTS 3327 02:04:56,342 --> 02:04:57,210 EXAMINING WHETHER BLOOD PRESSURE 3328 02:04:57,210 --> 02:04:58,545 HOME BLOOD PRESSURE MONITORING 3329 02:04:58,545 --> 02:05:04,017 IS MORE STRONGLY ASSOCIATED WITH 3330 02:05:04,017 --> 02:05:06,753 CARDIOVASCULAR EVENTS OR 3331 02:05:06,753 --> 02:05:07,353 MORTALITY. 3332 02:05:07,353 --> 02:05:08,288 WHEN AMBULATORY BLOOD PRESSURE 3333 02:05:08,288 --> 02:05:11,891 WAS ADJUSTED FOR HOME BLOOD 3334 02:05:11,891 --> 02:05:14,527 PRESSURE, SYSTOLIC BLOOD 3335 02:05:14,527 --> 02:05:17,530 PRESSURE ON ABPM WAS ASSOCIATED 3336 02:05:17,530 --> 02:05:19,699 IN TWO OF FOUR COHORTS, THREE OF 3337 02:05:19,699 --> 02:05:22,302 FOUR FOR DIE TOLIC. 3338 02:05:22,302 --> 02:05:24,337 WHEN HOME BLOOD PRESSURE WAS 3339 02:05:24,337 --> 02:05:26,606 ADJUSTED FOR AMBULATORY BLOOD 3340 02:05:26,606 --> 02:05:28,208 PRESSURE, SYSTOLIC BLOOD 3341 02:05:28,208 --> 02:05:32,378 PRESSURE ON HOME MONITORING IS 3342 02:05:32,378 --> 02:05:33,580 ASSOCIATED WITH OUTCOMES IN 3343 02:05:33,580 --> 02:05:34,981 ZERO, NO STUDIES REPORTING IT, 3344 02:05:34,981 --> 02:05:37,550 ONLY ONE OF TWO FOR DIASTOLIC 3345 02:05:37,550 --> 02:05:38,418 BLOOD PRESSURE. 3346 02:05:38,418 --> 02:05:42,121 WE STILL HAVE LACK OF DATA, AND 3347 02:05:42,121 --> 02:05:43,756 WE'LL DISCUSS THIS LATER, A 3348 02:05:43,756 --> 02:05:44,991 MAJOR BARRIER. 3349 02:05:44,991 --> 02:05:45,925 CLEARLY AN UNANSWERED QUESTION 3350 02:05:45,925 --> 02:05:47,760 GIVEN THE SMALL NUMBER OF 3351 02:05:47,760 --> 02:05:50,230 STUDIES IN THE LITERATURE. 3352 02:05:50,230 --> 02:05:58,805 NONETHELESS, DEPICTED ON THE 3353 02:05:58,805 --> 02:06:01,641 BOTTOM 2017 ACCAHA GUIDELINES, 3354 02:06:01,641 --> 02:06:03,943 UNTREATED USING DAYTIME ABPM IS 3355 02:06:03,943 --> 02:06:05,612 PREFERRED WITH HOME MONITORING 3356 02:06:05,612 --> 02:06:06,946 AS ALTERNATIVE. 3357 02:06:06,946 --> 02:06:10,617 FOR THOSE TREATED, I.E. ON 3358 02:06:10,617 --> 02:06:12,051 ANTI-HYPERTENSIVE MEDICATION FOR 3359 02:06:12,051 --> 02:06:13,019 EXAMPLE THE ALGORITHM SUGGESTS 3360 02:06:13,019 --> 02:06:16,089 USING HOME BLOOD PRESSURE 3361 02:06:16,089 --> 02:06:18,191 MONITORING, THE PREFERRED 3362 02:06:18,191 --> 02:06:19,726 APPROACH, SECONDARILY 3363 02:06:19,726 --> 02:06:21,694 ALTERNATIVE DAYTIME ABPM ONCE 3364 02:06:21,694 --> 02:06:25,198 HOME BLOOD PRESSURE MONITORING 3365 02:06:25,198 --> 02:06:26,065 IS DONE. 3366 02:06:26,065 --> 02:06:28,902 NOW, BESIDE LACK OF DATA ON 3367 02:06:28,902 --> 02:06:30,970 OUTCOMES, VALUES OBTAINED USING 3368 02:06:30,970 --> 02:06:31,638 HOME VERSUS AMBULATORY 3369 02:06:31,638 --> 02:06:38,878 MONITORING DO NOT ALWAYS AGREE. 3370 02:06:38,878 --> 02:06:40,947 WE EXAMINE ABPM ON MASKED 3371 02:06:40,947 --> 02:06:42,482 HYPERTENSION, THE DANGEROUS 3372 02:06:42,482 --> 02:06:44,651 PHENOTYPE, USING DATA FROM 3373 02:06:44,651 --> 02:06:46,085 IMPROVING DETECTION OF 3374 02:06:46,085 --> 02:06:50,123 HYPERTENSION COHORT. 3375 02:06:50,123 --> 02:06:51,558 THE IDL IS COMMUNITY-BASED STUDY 3376 02:06:51,558 --> 02:06:54,527 OF NEW YORK ADULTS WHO UNDERWENT 3377 02:06:54,527 --> 02:06:55,795 AMBULATORY AND HOME BLOOD 3378 02:06:55,795 --> 02:06:58,965 PRESSURE AND OFFICE BLOOD 3379 02:06:58,965 --> 02:07:00,533 PRESSURE MEASUREMENTS. 3380 02:07:00,533 --> 02:07:06,539 IN OUR SAMPLE, A LITTLE OVER 300 3381 02:07:06,539 --> 02:07:08,508 INDIVIDUALS, THE MAJORITY, 61%, 3382 02:07:08,508 --> 02:07:11,144 HAD MASKED HYPERTENSION ONLY 3383 02:07:11,144 --> 02:07:13,880 DETECTED BY ABPM. 3384 02:07:13,880 --> 02:07:17,050 30% HAD MASKED HYPERTENSION 3385 02:07:17,050 --> 02:07:19,452 DETECTED ON ABPM AND HOME 3386 02:07:19,452 --> 02:07:22,522 MONITORING, A SMALL MINORITY, 3387 02:07:22,522 --> 02:07:27,126 9%, MASKED HYPERTENSION DETECTED 3388 02:07:27,126 --> 02:07:28,494 ON HOME MONITORING BUT NOT 3389 02:07:28,494 --> 02:07:28,962 AMBULATORY. 3390 02:07:28,962 --> 02:07:31,064 IF YOU ONLY DO HOME, YOU 3391 02:07:31,064 --> 02:07:32,498 MISCLASSIFY MANY IF NOT THE 3392 02:07:32,498 --> 02:07:35,101 MAJORITY OF INDIVIDUALS WHO HAVE 3393 02:07:35,101 --> 02:07:36,202 DANGEROUS PHENOTYPE MASKED 3394 02:07:36,202 --> 02:07:45,511 HYPERTENSION AS YOU MIS60% ONLY 3395 02:07:45,511 --> 02:07:46,546 DETECTED ON ABPM. 3396 02:07:46,546 --> 02:07:48,414 IN THE LITERATURE ONE OF THE 3397 02:07:48,414 --> 02:07:50,316 GROUPS THAT'S MOST AT RISK ARE 3398 02:07:50,316 --> 02:07:51,017 BLACK ADULTS. 3399 02:07:51,017 --> 02:07:57,090 SO WE HAVE TO THINK ABOUT THIS 3400 02:07:57,090 --> 02:07:58,625 HEALTH INEQUITY PERSPECTIVE, 3401 02:07:58,625 --> 02:07:59,926 MISSING THIS DANGEROUS PHENOTYPE 3402 02:07:59,926 --> 02:08:03,763 USING HOME BLOOD PRESSURE 3403 02:08:03,763 --> 02:08:05,198 MONITORING ALONE. 3404 02:08:05,198 --> 02:08:07,800 NOW, INTERESTINGLY ENOUGH, HOME 3405 02:08:07,800 --> 02:08:08,368 BLOOD PRESSURE MONITORING, 3406 02:08:08,368 --> 02:08:10,637 PRELIMINARY DATA MAY BE MORE 3407 02:08:10,637 --> 02:08:12,405 RELIABLE THAN OFFICE BLOOD 3408 02:08:12,405 --> 02:08:15,241 PRESSURE AND ABPM, MORE STRONGLY 3409 02:08:15,241 --> 02:08:16,676 CORRELATED WITH ORGAN DAMAGE. 3410 02:08:16,676 --> 02:08:20,613 THIS IS DATA FROM THE IDH COHORT 3411 02:08:20,613 --> 02:08:22,148 COMPARING INDIVIDUALS ON OFFICE 3412 02:08:22,148 --> 02:08:23,549 BLOOD PRESSURE, HOME BP, 3413 02:08:23,549 --> 02:08:25,084 AMBULATORY BLOOD PRESSURE, WHEN 3414 02:08:25,084 --> 02:08:27,053 ALL WERE ASSESSED USING 3415 02:08:27,053 --> 02:08:29,255 GUIDELINE-RECOMMENDED 3416 02:08:29,255 --> 02:08:29,555 APPROACHES. 3417 02:08:29,555 --> 02:08:33,526 WE'VE COMPARED RELIABILITY OF 3418 02:08:33,526 --> 02:08:36,929 OFFICE IN THREE VISITS, THREE 3419 02:08:36,929 --> 02:08:38,965 READINGS, MEASURED BY ABPM EVERY 3420 02:08:38,965 --> 02:08:40,166 30 MINUTES, BLOOD PRESSURE 3421 02:08:40,166 --> 02:08:41,834 MEASURED BY HOME BLOOD PRESSURE 3422 02:08:41,834 --> 02:08:44,037 MONITORING USING TWO MORNING AND 3423 02:08:44,037 --> 02:08:45,471 TWO EVENING READINGS OVER A 3424 02:08:45,471 --> 02:08:47,340 WEEK. 3425 02:08:47,340 --> 02:08:50,710 WE LOOKED AT ASSOCIATIONS WITH 3426 02:08:50,710 --> 02:08:52,578 LESS VENTRICULAR MASS INDEX ON 3427 02:08:52,578 --> 02:08:53,680 2D ECHO. 3428 02:08:53,680 --> 02:08:55,648 THE COEFFICIENTS ARE REPRESENTED 3429 02:08:55,648 --> 02:08:57,383 ON THE FIRST TABLE. 3430 02:08:57,383 --> 02:08:58,551 FOR OFFICE BLOOD PRESSURE .9, 3431 02:08:58,551 --> 02:09:01,654 HIGHEST FOR HOME BLOOD PRESSURE 3432 02:09:01,654 --> 02:09:11,431 AT .94, AWAKE ON 24 HOUR. 3433 02:09:11,431 --> 02:09:15,134 THE MODEL BELOW WAS ADJUSTED, 3434 02:09:15,134 --> 02:09:18,638 THE ESTIMATED DIFFERENCE IN LEFT 3435 02:09:18,638 --> 02:09:20,673 VENTRICULAR MASS INDEX FOR 3436 02:09:20,673 --> 02:09:23,876 10-MILLIMETER HIGHER 3.2 GRAMS 3437 02:09:23,876 --> 02:09:27,380 FOR OFFICE BP, 4.04 HOME BLOOD 3438 02:09:27,380 --> 02:09:30,683 PRESSURE, AS WELL AS 3.71 GRAMS 3439 02:09:30,683 --> 02:09:33,720 PER METER SQUARED FOR 3440 02:09:33,720 --> 02:09:34,020 AMBULATORY. 3441 02:09:34,020 --> 02:09:36,522 FULLY ADJUSTED MODEL 3 INCLUDES 3442 02:09:36,522 --> 02:09:38,691 COVARIATES OF MODEL 2 AND ALL 3443 02:09:38,691 --> 02:09:41,828 THREE, ONLY HOME WAS ASSOCIATED 3444 02:09:41,828 --> 02:09:43,830 WITH HIGHER LEFT VENTRICULAR 3445 02:09:43,830 --> 02:09:45,031 MASS INDEX. 3446 02:09:45,031 --> 02:09:46,666 THIS WOULD SUGGEST WHEN BLOOD 3447 02:09:46,666 --> 02:09:57,176 PRESSURE IS ASSESSED, ABPM MAY 3448 02:09:57,543 --> 02:09:58,344 NOT BE IMMEDIATED, ESPECIALLY 3449 02:09:58,344 --> 02:10:01,447 WITH RESPECT TO DETECTION OF 3450 02:10:01,447 --> 02:10:05,818 ORGAN DAMAGE, MIGHT BE A 3451 02:10:05,818 --> 02:10:08,888 PARADIGM SHIFT. 3452 02:10:08,888 --> 02:10:10,289 IN SUMMARY PRESSING QUESTIONS, 3453 02:10:10,289 --> 02:10:12,125 STILL MUCH EXCITEMENT IN THE 3454 02:10:12,125 --> 02:10:13,526 FIELD, JUST PROVIDING A FEW 3455 02:10:13,526 --> 02:10:15,995 REFLECTIONS ON WHAT THE MOST 3456 02:10:15,995 --> 02:10:17,330 PROMISING AREAS ARE. 3457 02:10:17,330 --> 02:10:21,801 WE OBVIOUSLY KNOW WE'RE IN A 3458 02:10:21,801 --> 02:10:23,536 CONSUMER-DRIVEN MARKET, WE'VE 3459 02:10:23,536 --> 02:10:26,839 ALLUDED TO WRIST DEVICE, EMR 3460 02:10:26,839 --> 02:10:33,246 INTEGRATION, CUFFLESS WAS 3461 02:10:33,246 --> 02:10:34,380 ALLUDED TO ALREADY. 3462 02:10:34,380 --> 02:10:36,616 WHAT'S INTERESTING IS THE 3463 02:10:36,616 --> 02:10:38,017 CURRENT DEVICES DISTURB SLEEP. 3464 02:10:38,017 --> 02:10:39,886 WE DON'T HAVE A TRUE ESTIMATE OF 3465 02:10:39,886 --> 02:10:44,924 WHAT SLEEP BLOOD PRESSURE IS. 3466 02:10:44,924 --> 02:10:46,993 CUFFLESS MAY BE A WAY AROUND 3467 02:10:46,993 --> 02:10:47,593 THIS. 3468 02:10:47,593 --> 02:10:49,095 I WOULD CHALLENGE US TO SAY CAN 3469 02:10:49,095 --> 02:10:51,531 WE DISRUPT THE CONCEPT OF OFFICE 3470 02:10:51,531 --> 02:10:52,932 BLOOD PRESSURE, ONLY RELY ON OUT 3471 02:10:52,932 --> 02:10:54,066 OF OFFICE, MAYBE THAT'S THE 3472 02:10:54,066 --> 02:10:56,335 FUTURE IN PARTICULAR IN THE 3473 02:10:56,335 --> 02:10:57,303 PANDEMIC SHOWED MANY PEOPLE 3474 02:10:57,303 --> 02:11:00,273 COULDN'T COME TO THE CLINICIAN 3475 02:11:00,273 --> 02:11:00,773 OFFICE. 3476 02:11:00,773 --> 02:11:03,676 WHAT ARE THE GAPS? 3477 02:11:03,676 --> 02:11:05,077 I THINK MORE UNIFORM BLOOD 3478 02:11:05,077 --> 02:11:05,845 PRESSURE THRESHOLDS ACROSS 3479 02:11:05,845 --> 02:11:09,348 OFFICE AND OUT OF OFFICE 3480 02:11:09,348 --> 02:11:10,116 MEASUREMENTS AREN'T REALLY 3481 02:11:10,116 --> 02:11:13,719 UNDERSTOOD BY MANY IN TERMS OF 3482 02:11:13,719 --> 02:11:15,021 IMPLEMENTATION, CAN WE IMPROVE 3483 02:11:15,021 --> 02:11:22,562 UPON MEASUREMENT, THIS MIGHT BE 3484 02:11:22,562 --> 02:11:24,096 ANOTHER PARADIGM SHIFT, MAYBE WE 3485 02:11:24,096 --> 02:11:26,065 SHOULD DISRUPT AND IMPROVE THE 3486 02:11:26,065 --> 02:11:27,400 OFFICE MEASUREMENT, SOMETHING 3487 02:11:27,400 --> 02:11:29,035 CALLED UNATTENDED OFFICE BP 3488 02:11:29,035 --> 02:11:30,469 WHERE YOU TEACH PATIENTS TO 3489 02:11:30,469 --> 02:11:32,104 SELF-MEASURE BLOOD PRESSURE. 3490 02:11:32,104 --> 02:11:34,507 WE STILL DON'T KNOW OPTIMUM 3491 02:11:34,507 --> 02:11:36,709 METHODOLOGY AND FREQUENCY OF 3492 02:11:36,709 --> 02:11:38,644 HOME BLOOD PRESSURE MONITORING. 3493 02:11:38,644 --> 02:11:43,249 I'LL END WITH KEY CHALLENGES AND 3494 02:11:43,249 --> 02:11:43,850 BARRIERS. 3495 02:11:43,850 --> 02:11:45,885 I'VE DISCUSSED THE RELIABILITY 3496 02:11:45,885 --> 02:11:47,753 AND VALIDATION OF 3497 02:11:47,753 --> 02:11:48,955 NON-TRADITIONAL DEVICES IS HUGE. 3498 02:11:48,955 --> 02:11:50,756 THERE'S LACK OF DATA WITH OUT OF 3499 02:11:50,756 --> 02:11:53,192 OFFICE AND OFFICE BLOOD PRESSURE 3500 02:11:53,192 --> 02:11:56,262 CONDUCTED AT THE SAME TIME. 3501 02:11:56,262 --> 02:11:57,597 AND CANNOT HIGHLIGHT ENOUGH 3502 02:11:57,597 --> 02:11:58,898 THERE'S BARRIERS TO 3503 02:11:58,898 --> 02:12:01,868 IMPLEMENTATION AND ACCESS TO 3504 02:12:01,868 --> 02:12:04,036 CARE, IMPACT OF STRUCTURAL LEVEL 3505 02:12:04,036 --> 02:12:06,806 FACTORS, HEARKENING TO DR. 3506 02:12:06,806 --> 02:12:07,573 SPATZ'S KEYNOTE ADDRESS. 3507 02:12:07,573 --> 02:12:10,743 WE TALK ABOUT CURING OR BATTLING 3508 02:12:10,743 --> 02:12:13,379 HYPERTENSION BUT WE NEED TO 3509 02:12:13,379 --> 02:12:15,147 UNDERSTAND HOW DO WE EVEN GET 3510 02:12:15,147 --> 02:12:18,618 ACCESS TO CARE, TO OUR PATIENTS. 3511 02:12:18,618 --> 02:12:21,254 I'LL ANNOUNCE MY FUNDING SOURCES 3512 02:12:21,254 --> 02:12:21,687 AND SAY THANK YOU. 3513 02:12:21,687 --> 02:12:23,122 >> THANK YOU. 3514 02:12:23,122 --> 02:12:25,858 YOU COVERED A LOT OF GROUND. 3515 02:12:25,858 --> 02:12:27,059 IT'S IMPORTANT TO RECOGNIZE 3516 02:12:27,059 --> 02:12:29,028 HYPERTENSION IS THE MOST POTENT 3517 02:12:29,028 --> 02:12:31,497 AND PREVALENT CARDIOVASCULAR 3518 02:12:31,497 --> 02:12:33,766 RISK FACTORS, MEASUREMENT IS SO 3519 02:12:33,766 --> 02:12:34,066 HAPHAZARDLY. 3520 02:12:34,066 --> 02:12:35,968 WE'RE GOING TO HEAR ON 3521 02:12:35,968 --> 02:12:37,770 DETERMINING BLOOD PRESSURE USING 3522 02:12:37,770 --> 02:12:44,710 NOVEL TECHNOLOGIES VIA A.I. BY 3523 02:12:44,710 --> 02:12:49,181 DR. STERGIOU, UNIVERSITY OF 3524 02:12:49,181 --> 02:12:55,755 ATHENS IN GREECE. 3525 02:12:55,755 --> 02:12:57,523 WHILE WE'RE WAITING, I SHOULD 3526 02:12:57,523 --> 02:12:58,958 NOTE THERE ARE VALIDATED SOURCES 3527 02:12:58,958 --> 02:13:01,260 WHERE YOU CAN FIND MORE 3528 02:13:01,260 --> 02:13:02,328 INFORMATION ON MAKING SURE 3529 02:13:02,328 --> 02:13:04,430 PATIENT HAS BLOOD PRESSURE 3530 02:13:04,430 --> 02:13:10,303 DEVICE THAT ACTUALLY WORKS 3531 02:13:10,303 --> 02:13:11,537 CORRECTLY, VALIDATE BP, IN THE 3532 02:13:11,537 --> 02:13:12,838 CHAT, THOSE ARE IMPORTANT 3533 02:13:12,838 --> 02:13:19,845 BECAUSE MANY DEVICES JUST DON'T 3534 02:13:19,845 --> 02:13:21,147 WORK WELL. 3535 02:13:21,147 --> 02:13:21,480 ARE YOU HERE? 3536 02:13:21,480 --> 02:13:24,617 >> CAN YOU HEAR ME? 3537 02:13:24,617 --> 02:13:24,850 >> YES. 3538 02:13:24,850 --> 02:13:30,690 >> THANK YOU FOR ASKING ME TO BE 3539 02:13:30,690 --> 02:13:34,093 PREPARED FOR THIS TALK, WHICH 3540 02:13:34,093 --> 02:13:36,963 MEANS I HAVE LOOK AT NEW 3541 02:13:36,963 --> 02:13:39,665 INFORMATION IN MORE DETAIL. 3542 02:13:39,665 --> 02:13:40,566 THIS IS MY DECLARATION OF 3543 02:13:40,566 --> 02:13:42,068 POTENTIAL CONFLICT OF INTEREST. 3544 02:13:42,068 --> 02:13:44,470 NO RELATION TO THIS TALK. 3545 02:13:44,470 --> 02:13:47,673 I HAVE ALSO TO SAY THAT ALTHOUGH 3546 02:13:47,673 --> 02:13:55,681 I'M WORKING IN ATHENS, GREECE, I 3547 02:13:55,681 --> 02:13:57,550 COME FROM VENICE, LOOKING AT 3548 02:13:57,550 --> 02:13:59,518 WHAT PEOPLE MUST DO, AND WE'RE 3549 02:13:59,518 --> 02:14:03,990 INTERESTED IN WHAT THEY DO 3550 02:14:03,990 --> 02:14:06,826 BECAUSE THEY AFFECT US, AND WE 3551 02:14:06,826 --> 02:14:08,894 TRY TO TAKE ADVANTAGE FROM WHAT 3552 02:14:08,894 --> 02:14:11,430 THEY DO. 3553 02:14:11,430 --> 02:14:14,400 OF COURSE, WE'RE SKEPTICAL, AND 3554 02:14:14,400 --> 02:14:15,935 CAUTIOUS WITH WHAT THE ENGINEERS 3555 02:14:15,935 --> 02:14:16,235 DO. 3556 02:14:16,235 --> 02:14:18,637 AND WE WANT TO MAKE SURE THAT 3557 02:14:18,637 --> 02:14:24,677 WHAT THEY GIVE US IS A REAL 3558 02:14:24,677 --> 02:14:29,281 BENEFIT TO OUR PATIENTS. 3559 02:14:29,281 --> 02:14:29,915 CUFFLESS BLOOD PRESSURE 3560 02:14:29,915 --> 02:14:32,885 MEASUREMENT IS EXCITING TO 3561 02:14:32,885 --> 02:14:34,186 EVERYBODY, FROM EXPERTS TO 3562 02:14:34,186 --> 02:14:36,655 PRACTITIONERS AND TO PATIENTS, 3563 02:14:36,655 --> 02:14:37,256 TO PEOPLE. 3564 02:14:37,256 --> 02:14:41,961 IT IS A METHOD THAT CAN GIVE US 3565 02:14:41,961 --> 02:14:42,928 THE FULL PICTURE OF BLOOD 3566 02:14:42,928 --> 02:14:43,462 PRESSURE. 3567 02:14:43,462 --> 02:14:50,069 IF WE HAVE THAT, IF WE GET IT 3568 02:14:50,069 --> 02:14:52,905 RIGHT, OFFICE, HOME, AMBULATORY 3569 02:14:52,905 --> 02:14:54,974 DOESN'T EXIST. 3570 02:14:54,974 --> 02:14:57,309 WHITE COAT, MASKED DOESN'T 3571 02:14:57,309 --> 02:14:59,745 EXIST, BECAUSE WE HAVE THE FULL 3572 02:14:59,745 --> 02:15:00,713 PICTURE, ALL THE INFORMATION 3573 02:15:00,713 --> 02:15:11,257 ABOUT BLOOD PRESSURE PROFILE AND 3574 02:15:13,759 --> 02:15:14,994 BEHAVIOR OVER TIME. 3575 02:15:14,994 --> 02:15:18,798 IT'S SOMETHING IT WEAR ON THE 3576 02:15:18,798 --> 02:15:24,203 WRIST BUT COULD BE A RING, ON 3577 02:15:24,203 --> 02:15:24,970 YOUR GLASSES. 3578 02:15:24,970 --> 02:15:27,239 AND THIS IS SOMETHING YOU WEAR 3579 02:15:27,239 --> 02:15:28,674 ALL THE TIME. 3580 02:15:28,674 --> 02:15:33,045 BUT THIS IS ONE PICTURE OF 3581 02:15:33,045 --> 02:15:36,115 CUFFLESS MEASUREMENT POTENTIAL. 3582 02:15:36,115 --> 02:15:37,950 THERE'S ANOTHER EQUALLY 3583 02:15:37,950 --> 02:15:39,085 ATTRACTIVE AND QUITE DIFFERENT 3584 02:15:39,085 --> 02:15:43,923 POTENTIAL, AND IT IS THIS ONE. 3585 02:15:43,923 --> 02:15:47,426 IMAGINE IF ALL PEOPLE WHO OWN A 3586 02:15:47,426 --> 02:15:48,727 SMARTPHONE WOULD PUT THEIR 3587 02:15:48,727 --> 02:15:50,896 FINGER ON THE SMARTPHONE AND USE 3588 02:15:50,896 --> 02:15:57,036 ITS SENSORS TO GET A RELIABLE 3589 02:15:57,036 --> 02:15:59,105 BLOOD PRESSURE MEASUREMENT. 3590 02:15:59,105 --> 02:16:01,907 OR LEAVE THE CAMERA OF THE 3591 02:16:01,907 --> 02:16:04,910 SMARTPHONE TO LOOK AT THE FACE 3592 02:16:04,910 --> 02:16:08,047 AND TAKE A SIGNAL AND MAYBE IT 3593 02:16:08,047 --> 02:16:11,717 CAN GIVE YOU A GOOD VALUE OF 3594 02:16:11,717 --> 02:16:13,452 BLOOD PRESSURE. 3595 02:16:13,452 --> 02:16:15,855 SUCH HUGE POTENTIAL AND 3596 02:16:15,855 --> 02:16:25,931 INTEREST, AND VARIOUS SIGNALS, 3597 02:16:25,931 --> 02:16:28,868 PPG IS THE MOST POPULAR, REALLY 3598 02:16:28,868 --> 02:16:32,471 MANY DEVICES USING PPG AS BASIS 3599 02:16:32,471 --> 02:16:38,611 TRYING TO PROVIDE MEASUREMENTS 3600 02:16:38,611 --> 02:16:40,479 OF BLOOD PRESSURE. 3601 02:16:40,479 --> 02:16:43,749 YOU CAN SEE STEEP INCREASE IN 3602 02:16:43,749 --> 02:16:49,989 PUBLICATIONS RELATED TO PPG 3603 02:16:49,989 --> 02:16:50,222 SIGNALS. 3604 02:16:50,222 --> 02:16:54,160 I THINK IT'S IMPORTANT TO START 3605 02:16:54,160 --> 02:16:58,230 WITH THIS SLIDE ABOUT HOW IT 3606 02:16:58,230 --> 02:17:00,332 WORKS. 3607 02:17:00,332 --> 02:17:02,935 ONE THING PPG SIGNAL, A LOOK AT 3608 02:17:02,935 --> 02:17:09,742 THE WAVEFORM, SOMETIMES COMBINED 3609 02:17:09,742 --> 02:17:13,012 WITH ECG TO GIVE US PULSE 3610 02:17:13,012 --> 02:17:14,413 ARRIVAL TIME, THE TRAVEL, SPEED 3611 02:17:14,413 --> 02:17:18,584 FOR WHICH THE PULSE RATE TRAVELS 3612 02:17:18,584 --> 02:17:21,754 ACROSS THE ARTERIAL TREE. 3613 02:17:21,754 --> 02:17:24,056 AND ALSO THESE DEVICES GET SOME 3614 02:17:24,056 --> 02:17:26,725 KIND OF INFORMATION FOR THE 3615 02:17:26,725 --> 02:17:29,195 INDIVIDUAL USER, AND THIS IS 3616 02:17:29,195 --> 02:17:31,497 PERSONAL BIOMETRIC INFORMATION, 3617 02:17:31,497 --> 02:17:38,137 COULD SHALL THE AGE, GENDER, THE 3618 02:17:38,137 --> 02:17:40,372 SIZE, BODY SIZE, HEIGHT AND 3619 02:17:40,372 --> 02:17:46,712 WEIGHT, OR COULD BE CLASSIC 3620 02:17:46,712 --> 02:17:47,580 CUFFLESS MEASUREMENT. 3621 02:17:47,580 --> 02:17:49,114 WHEN YOU HAVE CUFFLESS 3622 02:17:49,114 --> 02:17:51,517 ESTIMATION BY A NOVEL DEVICE, 3623 02:17:51,517 --> 02:17:55,454 YOU GET TWO DIFFERENT KINDS OF 3624 02:17:55,454 --> 02:18:00,526 DATA WHICH SHOWED THE OUTPUT. 3625 02:18:00,526 --> 02:18:03,696 ONE IS HEMODYNAMIC COMPONENT, 3626 02:18:03,696 --> 02:18:05,564 MEASUREMENT, PPG ALONE OR PLUS 3627 02:18:05,564 --> 02:18:09,468 PTT, BUT ALSO YOU HAVE A 3628 02:18:09,468 --> 02:18:10,236 PREDICTIVE COMPONENT. 3629 02:18:10,236 --> 02:18:13,339 AND WE KNOW THAT YOU CAN PRETTY 3630 02:18:13,339 --> 02:18:15,407 WELL PREDICT THE BLOOD PRESSURE 3631 02:18:15,407 --> 02:18:19,011 OF A POPULATION BASED ON THE 3632 02:18:19,011 --> 02:18:23,983 AGE, SEX, WEIGHT, HEIGHT, SO ON. 3633 02:18:23,983 --> 02:18:26,518 SO, THE OUTPUT OF THE CUFFLESS 3634 02:18:26,518 --> 02:18:28,320 DEVICE IS COMBINATION OF THE 3635 02:18:28,320 --> 02:18:32,157 TWO, AND IT'S IMPORTANT TO KNOW 3636 02:18:32,157 --> 02:18:33,425 IN WHAT PROPORTION EACH 3637 02:18:33,425 --> 02:18:35,928 CONTRIBUTES TO BLOOD PRESSURE 3638 02:18:35,928 --> 02:18:37,496 VALUE WE SEE. 3639 02:18:37,496 --> 02:18:42,868 SO, THIS IS THE PULSE WAVE, THEY 3640 02:18:42,868 --> 02:18:46,472 KNOW THE PULSE RATE, HOW IT GOES 3641 02:18:46,472 --> 02:18:55,347 UP, RIGHT SIDE OF THE PULSE 3642 02:18:55,347 --> 02:19:01,453 RATE, ENGINEERS HAVE A LOOK, CUT 3643 02:19:01,453 --> 02:19:05,291 IT INTO PIECES, THEY LOOK AT 3644 02:19:05,291 --> 02:19:08,894 SMALL FEATURES AND ANALYZE AND 3645 02:19:08,894 --> 02:19:12,731 GIVE OUT FEATURES FROM THE PULSE 3646 02:19:12,731 --> 02:19:13,632 WAVE, AND HAVE OTHER FEATURES 3647 02:19:13,632 --> 02:19:19,738 FROM THE RISK OF THE PPG SIGNAL 3648 02:19:19,738 --> 02:19:22,574 AND FROM THE DEMOGRAPHIC 3649 02:19:22,574 --> 02:19:23,876 EDUCATION AND OTHER FEATURES, 3650 02:19:23,876 --> 02:19:27,513 THEY CAME UP WITH ALMOST 100 3651 02:19:27,513 --> 02:19:31,216 FEATURES FOR SINGLE MEASUREMENT 3652 02:19:31,216 --> 02:19:35,087 THAT CAN'T INFERENCE THE OUTPUT. 3653 02:19:35,087 --> 02:19:38,190 SO, WHEN YOU HAVE CUFFLESS, 3654 02:19:38,190 --> 02:19:39,792 INTERPLAY OF REFERENCE BLOOD 3655 02:19:39,792 --> 02:19:41,026 PRESSURE MEASUREMENT WITH CUFF 3656 02:19:41,026 --> 02:19:44,496 DEVICE, IF IT IS USED. 3657 02:19:44,496 --> 02:19:46,131 DEMOGRAPHIC INFORMATION ABOUT 3658 02:19:46,131 --> 02:19:49,902 THE USER IF THEY ARE USED, AND 3659 02:19:49,902 --> 02:19:50,969 MEASUREMENT. 3660 02:19:50,969 --> 02:19:56,775 HEMODYNAMIC COMPONENT WHICH IS 3661 02:19:56,775 --> 02:19:59,378 PPG, PLUS OR MINUS PAT, THIS IS 3662 02:19:59,378 --> 02:20:04,783 AN INTERPLAY OF THESE FACTORS. 3663 02:20:04,783 --> 02:20:07,953 AND WHAT HAPPENS IS THAT AS 3664 02:20:07,953 --> 02:20:08,854 CLINICIAN, THE INVESTIGATORS 3665 02:20:08,854 --> 02:20:10,255 LOOK AT THE ASSOCIATIONS OF 3666 02:20:10,255 --> 02:20:13,425 THESE FEATURES WITH A CUFF BLOOD 3667 02:20:13,425 --> 02:20:16,128 PRESSURE MEASUREMENT. 3668 02:20:16,128 --> 02:20:21,500 AND REGRESSIONS. 3669 02:20:21,500 --> 02:20:25,771 THEY PUT THEM IN THE MODEL AND 3670 02:20:25,771 --> 02:20:26,872 TRIED TO PREDICT SYSTOLIC BLOOD 3671 02:20:26,872 --> 02:20:27,506 PRESSURE. 3672 02:20:27,506 --> 02:20:31,677 BUT THERE ARE MORE COMPLEX 3673 02:20:31,677 --> 02:20:35,180 MODELS. 3674 02:20:35,180 --> 02:20:37,583 YOU MIGHT ASK THE MODEL TO 3675 02:20:37,583 --> 02:20:39,551 EXTRACT THE FEATURES SO YOU 3676 02:20:39,551 --> 02:20:42,521 DON'T KNOW WHICH FEATURES ARE 3677 02:20:42,521 --> 02:20:46,759 TAKEN INTO ACCOUNT. 3678 02:20:46,759 --> 02:20:53,565 SO THIS IS AUTOMATED SYSTEM, 3679 02:20:53,565 --> 02:20:56,168 SEVERAL MODELS FOR DEEP LEARNING 3680 02:20:56,168 --> 02:20:56,835 ALONE. 3681 02:20:56,835 --> 02:20:58,270 WHETHER HAVE YOU DEMOGRAPHIC 3682 02:20:58,270 --> 02:21:07,913 DATA, WHETHER YOU HAVE IMAGE OR 3683 02:21:07,913 --> 02:21:10,749 SENSOR, SO ON, ASK PEOPLE. 3684 02:21:10,749 --> 02:21:14,686 WE HAVE DIFFERENT DEVICES. 3685 02:21:14,686 --> 02:21:25,230 WE HAVE THE PULSE WAVE ANALYSIS, 3686 02:21:27,766 --> 02:21:29,668 FACIAL VIDEO, OTHERS 3687 02:21:29,668 --> 02:21:31,637 OSCILLOMETRIC, ULTRASOUND 3688 02:21:31,637 --> 02:21:33,272 TECHNIQUES FOR CUFFLESS, VOLUME 3689 02:21:33,272 --> 02:21:34,506 CONTROL TECHNIQUES. 3690 02:21:34,506 --> 02:21:38,644 APART FROM THAT SOME DEVICES 3691 02:21:38,644 --> 02:21:46,084 REQUIRE INDIVIDUAL USER 3692 02:21:46,084 --> 02:21:46,852 CALIBRATION OR INITIATION, THE 3693 02:21:46,852 --> 02:21:49,354 DEVICE NEEDS TO KNOW ABOUT THE 3694 02:21:49,354 --> 02:21:54,827 USER OR MAY NOT REQUIRE PERIODIC 3695 02:21:54,827 --> 02:21:55,127 CALIBRATION. 3696 02:21:55,127 --> 02:21:56,795 THE OTHER PROBLEM WE FACE IS 3697 02:21:56,795 --> 02:22:06,872 THAT SOME OF THESE DEVICES HAVE 3698 02:22:06,872 --> 02:22:09,374 SOME REGULATORY APPROVAL. 3699 02:22:09,374 --> 02:22:11,944 THIS DOES NOT MEAN THEY ARE 3700 02:22:11,944 --> 02:22:14,880 CLINICALLY USEFUL FOR US. 3701 02:22:14,880 --> 02:22:18,183 I'M GOING TO SHOW YOU VERY 3702 02:22:18,183 --> 02:22:28,727 RECENT DATA IN THE LAST YEAR AND 3703 02:22:29,728 --> 02:22:31,096 O-NEGATIVE, SMALL EXPERIMENT, 3704 02:22:31,096 --> 02:22:35,033 USING FINGER PPG AND PAT, USED 3705 02:22:35,033 --> 02:22:37,002 DIFFERENT TECHNIQUES TO CHANGE 3706 02:22:37,002 --> 02:22:39,171 BLOOD PRESSURE, AND THESE 3707 02:22:39,171 --> 02:22:41,807 TECHNOLOGIES COULD NOT TRACK 3708 02:22:41,807 --> 02:22:44,676 CHANGES IN BLOOD PRESSURE. 3709 02:22:44,676 --> 02:22:47,946 THIS IS SAMSUNG DEVICE. 3710 02:22:47,946 --> 02:22:51,683 SAMSUNG SMARTWATCH WHICH HAS 3711 02:22:51,683 --> 02:22:52,551 IMPLEMENTED CUFFLESS TECHNOLOGY, 3712 02:22:52,551 --> 02:22:55,254 PPG, STUDY HAS BEEN PUBLISHED 3713 02:22:55,254 --> 02:23:02,694 AND SHOWS THAT THIS DEVICE 3714 02:23:02,694 --> 02:23:04,563 CANNOT ESCAPE TOO FAR, CANNOT 3715 02:23:04,563 --> 02:23:07,499 FALL CHANGING BLOOD PRESSURE 3716 02:23:07,499 --> 02:23:11,670 DURING 24-HOUR PERIOD. 3717 02:23:11,670 --> 02:23:15,307 THIS IS ANOTHER DEVICE WHICH 3718 02:23:15,307 --> 02:23:18,277 ATTRACTED A LOT OF ATTENTION, 3719 02:23:18,277 --> 02:23:21,313 STUDY NOW IN PRESS, JOURNAL OF 3720 02:23:21,313 --> 02:23:24,416 HYPERTENSION, SHOWING CAN TRACK 3721 02:23:24,416 --> 02:23:27,786 ONLY ONE-THIRD OF THE BLOOD 3722 02:23:27,786 --> 02:23:29,321 PRESSURE DROP DURING SLEEP. 3723 02:23:29,321 --> 02:23:31,490 AND THIS IS ANOTHER DEVICE WHICH 3724 02:23:31,490 --> 02:23:34,226 ALSO SUFFERS FROM THE SAME 3725 02:23:34,226 --> 02:23:34,893 PROBLEM. 3726 02:23:34,893 --> 02:23:37,195 IT TRACKS LESS THAN 50% OF THE 3727 02:23:37,195 --> 02:23:40,933 DROP OF BLOOD PRESSURE DURING 3728 02:23:40,933 --> 02:23:41,133 SLEEP. 3729 02:23:41,133 --> 02:23:46,171 BUT I'D LIKE TO BRING YOUR 3730 02:23:46,171 --> 02:23:48,373 ATTENTION IN THIS PROJECT, BY 3731 02:23:48,373 --> 02:23:48,707 MICROSOFT. 3732 02:23:48,707 --> 02:23:51,343 YOU KNOW MICROSOFT RESEARCH IS 3733 02:23:51,343 --> 02:23:52,644 AN OPEN SOURCE COMPANY, WHICH 3734 02:23:52,644 --> 02:23:55,147 MEANS WE KNOW WHAT THEY DO. 3735 02:23:55,147 --> 02:23:56,582 AND WHEN THEY FINISH THEY GIVE 3736 02:23:56,582 --> 02:23:57,382 THE DATA. 3737 02:23:57,382 --> 02:23:59,685 THEY ARE PUBLICLY AVAILABLE. 3738 02:23:59,685 --> 02:24:03,388 IT'S A HUGE PROJECT. 3739 02:24:03,388 --> 02:24:04,990 PAPER SIGNED BY 23 3740 02:24:04,990 --> 02:24:06,558 INVESTIGATORS, MORE THAN 1,000 3741 02:24:06,558 --> 02:24:07,359 PARTICIPANTS, PROBABLY TOOK 3742 02:24:07,359 --> 02:24:10,295 SEVERAL YEARS TO BE COMPLETED. 3743 02:24:10,295 --> 02:24:12,064 IT INCLUDES NOT ONLY LOW BLOOD 3744 02:24:12,064 --> 02:24:13,465 PRESSURE PEOPLE BUT ALSO 3745 02:24:13,465 --> 02:24:15,400 HYPERTENSIVE, NOT ONLY YOUNG 3746 02:24:15,400 --> 02:24:25,944 PEOPLE BUT ALSO OLD AND HAD SOME 3747 02:24:26,578 --> 02:24:27,045 REFERENCE. 3748 02:24:27,045 --> 02:24:29,448 THEY TESTED FOUR TECHNOLOGIES 3749 02:24:29,448 --> 02:24:30,015 FOR CUFFLESS MEASUREMENT AND 3750 02:24:30,015 --> 02:24:32,951 THEY HAD THE ADVANTAGE TO BE 3751 02:24:32,951 --> 02:24:35,120 ABLE TO IMPROVE TECHNOLOGY 3752 02:24:35,120 --> 02:24:45,530 DURING THE EXPERIMENTS. 3753 02:24:47,633 --> 02:24:53,472 THEY INVESTIGATED FOUR WAVEFORM 3754 02:24:53,472 --> 02:24:54,239 MODELS. 3755 02:24:54,239 --> 02:24:58,443 FOR EACH TWO COMPONENTS, ONE IS 3756 02:24:58,443 --> 02:25:00,912 HEMODYNAMIC COMPONENT, 3757 02:25:00,912 --> 02:25:03,882 MEASUREMENT BASED ON PPG, ECG, 3758 02:25:03,882 --> 02:25:05,584 OR COMBINATION, HAD PREDICTIVE 3759 02:25:05,584 --> 02:25:09,988 COMPONENT WHICH IS BASED ON 3760 02:25:09,988 --> 02:25:12,758 CALIBRATION, TIME OF DAY, 3761 02:25:12,758 --> 02:25:13,225 ESTIMATION. 3762 02:25:13,225 --> 02:25:16,161 AND IN THIS STUDY THEY ALSO 3763 02:25:16,161 --> 02:25:17,295 REPORTED BASELINE MODEL WHICH 3764 02:25:17,295 --> 02:25:19,998 MEANS WHAT DO YOU GET IF YOU 3765 02:25:19,998 --> 02:25:21,566 SKIP THE HEMODYNAMIC COMPONENT 3766 02:25:21,566 --> 02:25:23,602 AND PREDICT THE BLOOD PRESSURE 3767 02:25:23,602 --> 02:25:28,206 BASED OF THE CUFF BLOOD PRESSURE 3768 02:25:28,206 --> 02:25:28,874 CALIBRATION. 3769 02:25:28,874 --> 02:25:30,709 THIS IS WHAT THEY GOT. 3770 02:25:30,709 --> 02:25:34,980 YOU SEE THE BEST OF THE FOUR 3771 02:25:34,980 --> 02:25:39,685 WAVEFORM PICTURES, AND THIS WILL 3772 02:25:39,685 --> 02:25:42,220 BE COMPARED, PREDICTION ALONE. 3773 02:25:42,220 --> 02:25:45,257 YOU CAN SEE MEASUREMENT IN GREEN 3774 02:25:45,257 --> 02:25:47,559 GAVE NO ADDITIONAL INFORMATION 3775 02:25:47,559 --> 02:25:50,829 ON THE MEASUREMENT APART FROM 3776 02:25:50,829 --> 02:25:54,666 THAT PREDICTED MODEL WHICH MEANS 3777 02:25:54,666 --> 02:25:55,834 HEMODYNAMIC COMPONENT, THE 3778 02:25:55,834 --> 02:26:01,473 MEASUREMENT DID NOT HELP THE 3779 02:26:01,473 --> 02:26:02,741 ACCURACY OF THE DEVICE. 3780 02:26:02,741 --> 02:26:05,844 THERE ARE POSITIVE STUDIES WHICH 3781 02:26:05,844 --> 02:26:08,346 I WON'T PRESENT, STATIC 3782 02:26:08,346 --> 02:26:11,216 VALIDATION IMMEDIATELY POST 3783 02:26:11,216 --> 02:26:13,819 CALIBRATION, USELESS EXPERIMENT, 3784 02:26:13,819 --> 02:26:16,254 ALL DEVICES PASS. 3785 02:26:16,254 --> 02:26:17,355 THEY PROVIDE CORRELATION, HAVE 3786 02:26:17,355 --> 02:26:27,866 SMALL SAMP SAMPLE SIZE, YOUNG 3787 02:26:28,800 --> 02:26:29,701 PARTICIPANTS, LOW BLOOD 3788 02:26:29,701 --> 02:26:30,035 PRESSURE. 3789 02:26:30,035 --> 02:26:33,338 I'D LIKE TO TALK ABOUT HOW TO 3790 02:26:33,338 --> 02:26:41,413 TEST THESE AND WE'VE BEEN HAPPY 3791 02:26:41,413 --> 02:26:43,181 IN 2018 TO AGREE ON UNIVERSAL 3792 02:26:43,181 --> 02:26:45,917 PROTOCOL TO BE USED GLOBALLY. 3793 02:26:45,917 --> 02:26:47,686 WELL, THESE STANDARDS WHICH HAVE 3794 02:26:47,686 --> 02:26:51,857 BEEN DEVELOPED FOR CUFF DEVICES 3795 02:26:51,857 --> 02:26:54,559 IS ALMOST ZERO INFORMATION FOR 3796 02:26:54,559 --> 02:26:56,862 MOST OF CUFFLESS DEVICES 3797 02:26:56,862 --> 02:26:59,598 REQUIRING CALIBRATION. 3798 02:26:59,598 --> 02:27:01,800 CUFF OR DEMOGRAPHICS. 3799 02:27:01,800 --> 02:27:06,037 THE IEEE HAS DEVELOPED A 3800 02:27:06,037 --> 02:27:07,506 STANDARD IN 2014, AMENDMENT 3801 02:27:07,506 --> 02:27:10,342 LATER ON, BUT NOT A COOKBOOK ON 3802 02:27:10,342 --> 02:27:17,215 LOU TO EXACTLY DO THIS WORK. 3803 02:27:17,215 --> 02:27:21,520 THE STUDY PROTOCOL WHICH IS ONLY 3804 02:27:21,520 --> 02:27:25,757 FOR CONTINUOUS CUFFLESS DEVICES. 3805 02:27:25,757 --> 02:27:28,293 SO, HOW THESE DEVICES SHOULD BE 3806 02:27:28,293 --> 02:27:28,593 TESTED? 3807 02:27:28,593 --> 02:27:32,430 NOT IN THE WAY WE TEST CUFF 3808 02:27:32,430 --> 02:27:32,664 DEVICES. 3809 02:27:32,664 --> 02:27:36,902 THIS TESTING HAS TO BE MUCH MORE 3810 02:27:36,902 --> 02:27:37,335 COMPLEX. 3811 02:27:37,335 --> 02:27:44,576 FIRST, WE NEED TO HAVE REFERENCE 3812 02:27:44,576 --> 02:27:48,647 MANUAL AUSCULTATORY MEDICINE, TO 3813 02:27:48,647 --> 02:27:53,351 USE IN CLINICAL HYPERTENSION. 3814 02:27:53,351 --> 02:27:56,388 VALIDATION, WE NEED POST 3815 02:27:56,388 --> 02:27:57,589 CALIBRATION ASSESSMENT, MINIMAL 3816 02:27:57,589 --> 02:27:58,924 INFORMATION, ONLY USEFUL 3817 02:27:58,924 --> 02:28:02,861 PARTICULARLY FOR DEVICES THAT DO 3818 02:28:02,861 --> 02:28:05,063 NOT NEED INITIALIZATION OR 3819 02:28:05,063 --> 02:28:05,363 CALIBRATION. 3820 02:28:05,363 --> 02:28:07,232 THE MOST IMPORTANT PART OF THE 3821 02:28:07,232 --> 02:28:09,634 TEST IS TO TEST THE ABILITY OF 3822 02:28:09,634 --> 02:28:10,268 THIS DEVICE TO TRACK BLOOD 3823 02:28:10,268 --> 02:28:11,303 PRESSURE CHANGES. 3824 02:28:11,303 --> 02:28:14,472 THIS IS THE MOST WEAK POINT OF 3825 02:28:14,472 --> 02:28:15,774 THE TECHNOLOGIES. 3826 02:28:15,774 --> 02:28:20,045 WE NEED TESTING FOR 3827 02:28:20,045 --> 02:28:21,546 POSITION/MOTION, AND WE NEED TO 3828 02:28:21,546 --> 02:28:23,648 CHECK STABILITY OVER TIME FOR 3829 02:28:23,648 --> 02:28:26,084 THOSE DEVICES WHICH REQUIRE 3830 02:28:26,084 --> 02:28:26,952 PERIODIC CALIBRATION. 3831 02:28:26,952 --> 02:28:30,755 THE PROBLEM IS WE HAVE DIFFERENT 3832 02:28:30,755 --> 02:28:32,190 TECHNOLOGIES, DIFFERENT DEVICES 3833 02:28:32,190 --> 02:28:34,226 AND INTENDED USES, AND WE HAVE 3834 02:28:34,226 --> 02:28:36,561 FOR EACH ONE TO SEE WHETHER IT'S 3835 02:28:36,561 --> 02:28:40,398 WEARABLE, OR NOT, IF IT'S CUFF 3836 02:28:40,398 --> 02:28:43,602 INITIATED OR NOT, IF DEMOGRAPHIC 3837 02:28:43,602 --> 02:28:48,173 OR NOT, AUTOMATED OR OCCASIONAL, 3838 02:28:48,173 --> 02:28:48,840 PROVIDES CONTINUOUS MEASUREMENT, 3839 02:28:48,840 --> 02:28:52,043 MEASURES ALWAYS AT HEART LEVEL 3840 02:28:52,043 --> 02:28:54,246 AND WHEN YOU ANSWER ALL THESE 3841 02:28:54,246 --> 02:28:55,847 QUESTIONS ABOUT THE SINGLE 3842 02:28:55,847 --> 02:28:59,484 DEVICE, THEN YOU'LL BE ABLE TO 3843 02:28:59,484 --> 02:29:05,190 TAILOR WHICH PROTOCOL AND WHICH 3844 02:29:05,190 --> 02:29:07,792 TEST EACH DEVICE REQUIRES. 3845 02:29:07,792 --> 02:29:10,962 SO, ANSWERING TO THE THREE 3846 02:29:10,962 --> 02:29:12,163 QUESTIONS I WAS ASKED TO ANSWER, 3847 02:29:12,163 --> 02:29:16,234 WHAT IS THE MOST PROMISING 3848 02:29:16,234 --> 02:29:19,838 SCIENTIFIC AREAS, IT SEEMS 3849 02:29:19,838 --> 02:29:23,441 SENSORS NEED TO BE DEVELOPED 3850 02:29:23,441 --> 02:29:26,745 FURTHER AND PROBABLY PPG ALONE 3851 02:29:26,745 --> 02:29:27,946 MOST ENGINEERS SAY CANNOT 3852 02:29:27,946 --> 02:29:33,652 MEASURE PRESSURE. 3853 02:29:33,652 --> 02:29:36,621 SO MULTI-SENSORS COMBINING WITH 3854 02:29:36,621 --> 02:29:40,358 OTHER SENSORS MIGHT IMPROVE THE 3855 02:29:40,358 --> 02:29:44,062 ESTIMATION OF BLOOD PRESSURE. 3856 02:29:44,062 --> 02:29:46,998 AND I LED THAT THERE ARE MORE 3857 02:29:46,998 --> 02:29:48,867 MODELS FOR MACHINE LEARNING AND 3858 02:29:48,867 --> 02:29:53,238 DEEP LEARNING THAT CAN BE 3859 02:29:53,238 --> 02:29:53,672 INVESTIGATED. 3860 02:29:53,672 --> 02:29:56,508 AND CERTAINLY THE LARGER THE 3861 02:29:56,508 --> 02:30:00,779 DATASET, THE BETTER THE LEARNING 3862 02:30:00,779 --> 02:30:02,213 OF THE MODEL. 3863 02:30:02,213 --> 02:30:04,382 GAPS IN KNOWLEDGE, HOW TO MOVE 3864 02:30:04,382 --> 02:30:05,717 FORWARD, NEED IMPROVE MODEL 3865 02:30:05,717 --> 02:30:08,119 TRAINING, DATA QUALITY AND 3866 02:30:08,119 --> 02:30:09,421 DIVERSITY, WE NEED DATABASES TO 3867 02:30:09,421 --> 02:30:11,523 INCLUDE PEOPLE WITH HIGH AND LOW 3868 02:30:11,523 --> 02:30:15,226 BLOOD PRESSURE, YOUNG AND OLD, 3869 02:30:15,226 --> 02:30:16,127 WITH DIFFERENT SKIN PIGMENTATION 3870 02:30:16,127 --> 02:30:22,467 AND ANYTHING ELSE THAT MIGHT 3871 02:30:22,467 --> 02:30:25,770 AFFECT DIFFERENT SENSORS, 3872 02:30:25,770 --> 02:30:27,839 AFFECTED BY DIFFERENT 3873 02:30:27,839 --> 02:30:28,139 PARAMETERS. 3874 02:30:28,139 --> 02:30:31,543 WE NEED MORE DATA PER SUBJECT, 3875 02:30:31,543 --> 02:30:33,311 BETTER HAVE MORE INFORMATION PER 3876 02:30:33,311 --> 02:30:33,645 SUBJECT. 3877 02:30:33,645 --> 02:30:38,116 AND WE NEED TO VALIDATE AND TEST 3878 02:30:38,116 --> 02:30:39,150 THESE ALGORITHMS. 3879 02:30:39,150 --> 02:30:43,154 AND THE KEY CHALLENGES AND 3880 02:30:43,154 --> 02:30:46,358 BARRIERS HINDERING PROGRESS, IT 3881 02:30:46,358 --> 02:30:48,093 SEEMS THAT MY UNDERSTANDING IS 3882 02:30:48,093 --> 02:30:52,931 WE'RE NOT TOO CLOSE TO HAVE 3883 02:30:52,931 --> 02:30:55,000 MEASUREMENT WITH SENSORS, 3884 02:30:55,000 --> 02:30:58,803 CUFFLESS, IN OUR PEOPLE. 3885 02:30:58,803 --> 02:31:00,672 A PROBLEM IS THE HETEROGENEITY 3886 02:31:00,672 --> 02:31:02,207 OF TECHNOLOGY AND DEVICES WHICH 3887 02:31:02,207 --> 02:31:03,742 AS I SAID NEED DIFFERENT 3888 02:31:03,742 --> 02:31:04,509 TESTING. 3889 02:31:04,509 --> 02:31:06,378 WE CAN'T COME OUT WITH A SINGLE 3890 02:31:06,378 --> 02:31:11,950 STANDARD FOR ALL OF THEM. 3891 02:31:11,950 --> 02:31:16,187 AND CERTAINLY WE HAVE TO GO FOR 3892 02:31:16,187 --> 02:31:17,422 MORE COMPLEX VALIDATION 3893 02:31:17,422 --> 02:31:19,190 PROCEDURES WITH THESE DEVICES. 3894 02:31:19,190 --> 02:31:22,894 WE CAN'T GET IT SO EASY AS WE 3895 02:31:22,894 --> 02:31:25,997 DID FOR THE CUFF DEVICES. 3896 02:31:25,997 --> 02:31:28,700 WE STILL DO NOT HAVE UNIVERSALLY 3897 02:31:28,700 --> 02:31:31,036 ACCEPTED PROCEDURES FOR THESE 3898 02:31:31,036 --> 02:31:31,336 DEVICES. 3899 02:31:31,336 --> 02:31:33,438 MY FINAL SLIDE IS A STATEMENT WE 3900 02:31:33,438 --> 02:31:40,712 PUBLISHED LAST YEAR. 3901 02:31:40,712 --> 02:31:43,415 NO QUESTION THEY HAVE 3902 02:31:43,415 --> 02:31:44,516 CONSIDERABLE POTENTIAL FOR 3903 02:31:44,516 --> 02:31:47,252 CHANGING WHATEVER WE DO FOR 3904 02:31:47,252 --> 02:31:49,320 DIAGNOSING AND MONITORING OF 3905 02:31:49,320 --> 02:31:49,654 HYPERTENSION. 3906 02:31:49,654 --> 02:31:53,158 IF WE GET IT RIGHT WE DON'T NEED 3907 02:31:53,158 --> 02:31:54,959 OFFICE, HOME, AMBULATORY. 3908 02:31:54,959 --> 02:31:57,796 BUT WE DO HAVE FUNDAMENTAL 3909 02:31:57,796 --> 02:32:02,367 QUESTIONS ABOUT THE ACCURACY, 3910 02:32:02,367 --> 02:32:04,569 PERFORMANCE, AND IMPLEMENTATION. 3911 02:32:04,569 --> 02:32:07,205 AND ALL THESE HAVE TO BE 3912 02:32:07,205 --> 02:32:08,506 CAREFULLY ADDRESSED BEFORE WE 3913 02:32:08,506 --> 02:32:11,676 CAN RECOMMEND THEM FOR CLINICAL 3914 02:32:11,676 --> 02:32:12,010 USE. 3915 02:32:12,010 --> 02:32:13,912 THANK YOU. 3916 02:32:13,912 --> 02:32:18,883 >> THANK YOU FOR SUCH A 3917 02:32:18,883 --> 02:32:19,751 FORWARD-THINKING PRESENTATION, 3918 02:32:19,751 --> 02:32:20,385 THE BEDROCK OF THE PROMISE OF 3919 02:32:20,385 --> 02:32:22,353 CONTROLLING BLOOD PRESSURE HAS 3920 02:32:22,353 --> 02:32:23,188 NOT BEEN FULFILLED AT THE 3921 02:32:23,188 --> 02:32:24,355 PRESENT TIME. 3922 02:32:24,355 --> 02:32:28,193 WE'LL HEAR FROM DR. PAUL WHELTON 3923 02:32:28,193 --> 02:32:30,061 FROM TULANE SCHOOL OF UNIVERSITY 3924 02:32:30,061 --> 02:32:35,200 SCHOOL OF MEDICINE AND TROPICAL 3925 02:32:35,200 --> 02:32:36,968 MEDICINE, WHERE I AM, UPDATE ON 3926 02:32:36,968 --> 02:32:38,837 TREATMENT AND CONTROL OF HIGH 3927 02:32:38,837 --> 02:32:39,270 BLOOD PRESSURE. 3928 02:32:39,270 --> 02:32:39,471 PAUL? 3929 02:32:39,471 --> 02:32:39,904 >> THANK YOU. 3930 02:32:39,904 --> 02:32:44,075 A PLEASURE TO BE WITH EVERYONE 3931 02:32:44,075 --> 02:32:45,376 TODAY. 3932 02:32:45,376 --> 02:32:46,911 I'M GOING TO TALK ABOUT 3933 02:32:46,911 --> 02:32:48,913 HYPERTENSION PREVALENCE AND 3934 02:32:48,913 --> 02:32:49,781 BLOOD PRESSURE CONTROL. 3935 02:32:49,781 --> 02:32:52,417 I DO NOT HAVE ANY CONFLICTS OF 3936 02:32:52,417 --> 02:32:54,919 INTEREST THAT I'M AWARE OF. 3937 02:32:54,919 --> 02:32:58,423 LET ME JUST START BY SAYING MOST 3938 02:32:58,423 --> 02:33:01,626 OF THE REPORTS ON PREVALENCE AND 3939 02:33:01,626 --> 02:33:02,594 CONTROL OF HYPERTENSION COME 3940 02:33:02,594 --> 02:33:05,563 FROM NHANES, AND THAT'S 3941 02:33:05,563 --> 02:33:06,498 PERFECTLY SENSIBLE AND 3942 02:33:06,498 --> 02:33:09,400 UNDERSTANDABLE BECAUSE IT IS OF 3943 02:33:09,400 --> 02:33:10,034 COURSE NATIONALLY REPRESENTATIVE 3944 02:33:10,034 --> 02:33:10,235 DATA. 3945 02:33:10,235 --> 02:33:11,903 THERE ARE A LOT OF DATA POINTS 3946 02:33:11,903 --> 02:33:14,772 BECAUSE THE SURVEY IS DONE ON A 3947 02:33:14,772 --> 02:33:15,773 BIENNIAL BASIS. 3948 02:33:15,773 --> 02:33:17,942 AND THE BLOOD PRESSURE 3949 02:33:17,942 --> 02:33:25,183 MEASUREMENT METHODS ARE 3950 02:33:25,183 --> 02:33:26,151 RELATIVELY STABLE. 3951 02:33:26,151 --> 02:33:29,120 SINCE 1999, BLOOD PRESSURES HAVE 3952 02:33:29,120 --> 02:33:32,824 BEEN MEASURED ONLY AT MOBILE 3953 02:33:32,824 --> 02:33:33,925 EXAMINE CENTER, STANDARDIZED 3954 02:33:33,925 --> 02:33:35,927 PROTOCOL, GREAT DEAL OF 3955 02:33:35,927 --> 02:33:38,196 ATTENTION TO QUALITY CONTROL. 3956 02:33:38,196 --> 02:33:39,531 TYPICALLY THREE SYSTOLIC AND 3957 02:33:39,531 --> 02:33:42,800 DIASTOLIC MEASURES, A FOURTH IF 3958 02:33:42,800 --> 02:33:43,234 NECESSARY. 3959 02:33:43,234 --> 02:33:45,236 AND NHANES RECOMMENDS AVERAGING 3960 02:33:45,236 --> 02:33:51,109 THE LAST TWO PRESSURES TO GET 3961 02:33:51,109 --> 02:33:53,178 AVERAGE ESTIMATE, ALTHOUGH MANY 3962 02:33:53,178 --> 02:33:54,746 INVESTIGATORS AVERAGE ALL THREE 3963 02:33:54,746 --> 02:33:57,248 BECAUSE WE KNOW THAT IN THAT 3964 02:33:57,248 --> 02:34:02,820 NHANES DATASET THAT ACTUALLY HAS 3965 02:34:02,820 --> 02:34:04,122 PERFECTLY ACCEPTABLE. 3966 02:34:04,122 --> 02:34:09,260 BETWEEN 2009 AND 2018, THE 3967 02:34:09,260 --> 02:34:15,733 MEASUREMENTS WERE MADE WITH 3968 02:34:15,733 --> 02:34:18,736 AUSCULTORY METHODS, SYSTOLIC K 3969 02:34:18,736 --> 02:34:25,944 1, DIASTOLIC K 5. 3970 02:34:25,944 --> 02:34:29,113 IN 2017 USING 907, OVERSEEN BY 3971 02:34:29,113 --> 02:34:31,983 HOUSE TECHNICIAN. 3972 02:34:31,983 --> 02:34:36,688 IN THAT FIRST BIENNIAL SURVEY, 3973 02:34:36,688 --> 02:34:43,361 2017-2018, NHANES UNDERTOOK 3974 02:34:43,361 --> 02:34:44,696 RANDOMIZED COMPARISON OF 3975 02:34:44,696 --> 02:34:55,206 OSCILLOMETRIC AND AUSCULTORY. 3976 02:34:56,307 --> 02:34:58,009 OSCILLOMETRIC WERE 6.15 3977 02:34:58,009 --> 02:35:02,180 MILLIMETERS LOWER ON AVERAGE, 3978 02:35:02,180 --> 02:35:06,985 DIASTOLICS 1.3 HIGHER ON AVERAGE 3979 02:35:06,985 --> 02:35:08,186 COMPARED TO OSCILLOMETRIC 3980 02:35:08,186 --> 02:35:08,653 MEASUREMENTS. 3981 02:35:08,653 --> 02:35:12,257 WORTH BEARING IN MIND NHANES 3982 02:35:12,257 --> 02:35:13,458 DEFINITIONS OF HYPERTENSION 3983 02:35:13,458 --> 02:35:14,659 DIFFER FROM GUIDELINE 3984 02:35:14,659 --> 02:35:15,560 RECOMMENDATIONS FOR HOW IT 3985 02:35:15,560 --> 02:35:18,263 SHOULD BE DONE. 3986 02:35:18,263 --> 02:35:23,835 GUIDELINES I THINK ALMOST ALL 3987 02:35:23,835 --> 02:35:26,137 GUIDELINES RECOMMEND THAT 3988 02:35:26,137 --> 02:35:27,739 PRESSURES BE OBTAINED AT 3989 02:35:27,739 --> 02:35:32,910 REPEATED VISITS, GOING BACK TO 3990 02:35:32,910 --> 02:35:41,019 EARLY DAYS, THE TURN OF THE 3991 02:35:41,019 --> 02:35:41,219 1900s. 3992 02:35:41,219 --> 02:35:43,187 GNC AND HCC/AHA HAVE THE SAME 3993 02:35:43,187 --> 02:35:48,660 REPRESENT ATION, TWO OR MORE 3994 02:35:48,660 --> 02:35:49,661 ACCURATE MEASUREMENTS AND 3995 02:35:49,661 --> 02:35:51,162 FURTHER RECOMMENDATION THAT HIGH 3996 02:35:51,162 --> 02:35:53,898 OFFICE OR CLINIC BP BE CONFIRMED 3997 02:35:53,898 --> 02:35:57,669 WITH AN OUT OF OFFICE BLOOD 3998 02:35:57,669 --> 02:35:58,303 PRESSURE. 3999 02:35:58,303 --> 02:36:00,938 SO NHANES ESTIMATES OF 4000 02:36:00,938 --> 02:36:03,875 HYPERTENSION PREVALENCE WILL 4001 02:36:03,875 --> 02:36:05,476 OVERESTIMATE GUIDELINE 4002 02:36:05,476 --> 02:36:05,910 DEFINITION, DEFINED 4003 02:36:05,910 --> 02:36:06,411 HYPERTENSION. 4004 02:36:06,411 --> 02:36:09,480 THERE ARE LOTS OF PUBLICATIONS, 4005 02:36:09,480 --> 02:36:10,715 PROBABLY MORE THAN HERE, MANY 4006 02:36:10,715 --> 02:36:12,016 FROM MY OWN DEPARTMENT. 4007 02:36:12,016 --> 02:36:18,690 I'M GOING TO SHOW DATA FROM TWO. 4008 02:36:18,690 --> 02:36:21,426 FROM THE DORANS PAPER AND PAUL 4009 02:36:21,426 --> 02:36:23,194 MUNTNER AND COLLEAGUES. 4010 02:36:23,194 --> 02:36:24,829 OVERALL PATTERNS IN ALMOST ALL 4011 02:36:24,829 --> 02:36:26,664 OF THESE PUBLICATIONS ARE QUITE 4012 02:36:26,664 --> 02:36:27,832 SIMILAR, ALTHOUGH THE ABSTRACT 4013 02:36:27,832 --> 02:36:31,269 VALUES DO DIFFER A LITTLE BIT. 4014 02:36:31,269 --> 02:36:34,439 I'M GOING TO SHOW THE DORANS 4015 02:36:34,439 --> 02:36:37,942 PUBLICATION BECAUSE I THINK IT 4016 02:36:37,942 --> 02:36:41,245 GIVES A NICE SORT OF VIEW OF 4017 02:36:41,245 --> 02:36:49,987 MANY DATA POINTS. 4018 02:36:49,987 --> 02:36:52,090 IT PRECEDES OSCILLOMETRIC. 4019 02:36:52,090 --> 02:36:58,463 THE MUNTNER IS MORE RECENT, FROM 4020 02:36:58,463 --> 02:36:59,630 2009 THROUGH 2020. 4021 02:36:59,630 --> 02:37:03,234 AND IT PROVIDES A LOT OF DATA. 4022 02:37:03,234 --> 02:37:09,273 THERE'S A LOT OF DETAILED 4023 02:37:09,273 --> 02:37:09,841 INFORMATION, THE SUPPLEMENT 4024 02:37:09,841 --> 02:37:11,109 PROVIDES ESTIMATES THAT ARE 4025 02:37:11,109 --> 02:37:14,846 MODIFIED, THAT'S IN THE MAIN 4026 02:37:14,846 --> 02:37:16,914 PAPER, ALSO UNMODIFIED, AND A 4027 02:37:16,914 --> 02:37:17,915 LOT MORE. 4028 02:37:17,915 --> 02:37:19,016 SO, IN THIS PRESENTATION I'M 4029 02:37:19,016 --> 02:37:20,418 GOING TO SHOW WHAT'S IN THE MAIN 4030 02:37:20,418 --> 02:37:24,789 PAPER, THAT IS THE MODIFIED 4031 02:37:24,789 --> 02:37:26,224 READINGS, FOR OSCILLOMETRIC THAT 4032 02:37:26,224 --> 02:37:31,696 CAN BE COMPARABLE OVER TIME TO 4033 02:37:31,696 --> 02:37:40,238 THE OSCILLOMETRIC MEASUREMENTS. 4034 02:37:40,238 --> 02:37:42,073 AND IN MUNTNER BASED ON 4035 02:37:42,073 --> 02:37:42,807 READINGS. 4036 02:37:42,807 --> 02:37:51,549 YOU'LL SEE UP HERE FROM 1999 4037 02:37:51,549 --> 02:37:54,118 THROUGH 2016, A FEW THINGS, EACH 4038 02:37:54,118 --> 02:37:55,887 BIENNIAL SURVEYS HAS A PRETTY 4039 02:37:55,887 --> 02:37:57,855 GOOD SAMPLE SIZE, EVEN WHEN 4040 02:37:57,855 --> 02:37:59,490 LOOKING AT THIS MAJOR SUBGROUPS, 4041 02:37:59,490 --> 02:38:01,893 YOU STILL HAVE A GOOD DEAL OF 4042 02:38:01,893 --> 02:38:02,160 PRECISION. 4043 02:38:02,160 --> 02:38:05,963 I WANT TO POINT OUT THAT USE OF 4044 02:38:05,963 --> 02:38:12,203 BLOOD PRESSURE MEDS IN GENERAL 4045 02:38:12,203 --> 02:38:13,070 POPULATION INCREASED 4046 02:38:13,070 --> 02:38:14,172 PROGRESSIVELY THROUGH 2008, 4047 02:38:14,172 --> 02:38:17,542 2009, SORT OF STABLE EVER SINCE. 4048 02:38:17,542 --> 02:38:22,914 I WANT TO POINT OUT EVEN IN THE 4049 02:38:22,914 --> 02:38:23,781 GENERAL POPULATION, NOT 4050 02:38:23,781 --> 02:38:24,882 SELECTING OUT PATIENTS GOING TO 4051 02:38:24,882 --> 02:38:30,455 CLINICS BUT IN THE GENERAL 4052 02:38:30,455 --> 02:38:34,859 POPULATION, RISK RATE EQUAL OR 4053 02:38:34,859 --> 02:38:36,828 GREATER THAN 10%, ACCHA HIGH 4054 02:38:36,828 --> 02:38:39,230 RISK, QUITE HIGH, 20% OF THE 4055 02:38:39,230 --> 02:38:39,764 POPULATION HAD THAT. 4056 02:38:39,764 --> 02:38:43,267 MUCH HIGHER WHEN YOU GO TO 4057 02:38:43,267 --> 02:38:46,871 CLINIC SETTINGS. 4058 02:38:46,871 --> 02:38:51,275 AND YOU'LL SEE FOUR DEPICTIONS 4059 02:38:51,275 --> 02:38:52,577 OF TRENDS, SYSTOLIC. 4060 02:38:52,577 --> 02:38:54,278 I WON'T GO THROUGH IN DETAIL BUT 4061 02:38:54,278 --> 02:38:57,181 YOU'LL SEE THE GENERAL PATTERN, 4062 02:38:57,181 --> 02:39:06,524 ALL OF THESE SUBGROUPS THAT 4063 02:39:06,524 --> 02:39:09,594 THERE'S A PROGRESSIVE DECLINE, 4064 02:39:09,594 --> 02:39:16,033 AND UPTICK, CERTAINLY NO 4065 02:39:16,033 --> 02:39:18,102 IMPROVEMENT AFTER THAT. 4066 02:39:18,102 --> 02:39:21,939 I'M GOING TO CATEGORICAL DATA. 4067 02:39:21,939 --> 02:39:23,641 IN THE MUNTNER ET AL. 4068 02:39:23,641 --> 02:39:27,545 PRESENTATION FOR MOST OF THE 4069 02:39:27,545 --> 02:39:29,280 TIME FRAME THE 140/90 DEFINITION 4070 02:39:29,280 --> 02:39:30,381 WOULD HAVE APPLIED IN CLINICAL 4071 02:39:30,381 --> 02:39:31,482 PRACTICE. 4072 02:39:31,482 --> 02:39:35,419 THAT'S WHAT WAS RECOMMENDED.. 4073 02:39:35,419 --> 02:39:39,123 THAT'S WHAT I'LL FOCUS ON, 4074 02:39:39,123 --> 02:39:39,724 SELF-REPORT OF TAKING 4075 02:39:39,724 --> 02:39:41,092 ANTI-HYPERTENSIVE MEDICATION. 4076 02:39:41,092 --> 02:39:42,059 HERE IS PREVALENCE. 4077 02:39:42,059 --> 02:39:47,331 YOU CAN SEE AT THE 140/90, A 4078 02:39:47,331 --> 02:39:49,100 LITTLE OVER 30%, MAYBE SLIGHT 4079 02:39:49,100 --> 02:39:51,969 TREND UPWARDS, IT'S NOT 4080 02:39:51,969 --> 02:39:52,937 STATISTICALLY SIGNIFICANT. 4081 02:39:52,937 --> 02:39:54,272 OBVIOUSLY IT'S AGE DEPENDENT. 4082 02:39:54,272 --> 02:39:57,341 YOU GET INTO THE UPPER AGE RANGE 4083 02:39:57,341 --> 02:40:01,712 OF 75+, YOU GET A VERY HIGH 4084 02:40:01,712 --> 02:40:02,246 PREVALENCE. 4085 02:40:02,246 --> 02:40:05,116 IF WE LOOK BY GENDER, RATE, 4086 02:40:05,116 --> 02:40:09,687 ETHNICITY, WHAT STANDS OUT IS 4087 02:40:09,687 --> 02:40:10,888 THAT NON-HISPANIC BLACKS, 4088 02:40:10,888 --> 02:40:12,990 PREVALENCE OF THAT HIGH CUT 4089 02:40:12,990 --> 02:40:13,958 POINT FOR DEFINITION OF 4090 02:40:13,958 --> 02:40:15,826 HYPERTENSION IS VERY, VERY HIGH. 4091 02:40:15,826 --> 02:40:19,230 MUCH HIGHER THAN ANY OF THE 4092 02:40:19,230 --> 02:40:21,632 OTHER RACE/ETHNICITY GROUPS IN 4093 02:40:21,632 --> 02:40:22,500 THE ITS. 4094 02:40:22,500 --> 02:40:24,168 I'M FOCUSING ON U.S. DATA 4095 02:40:24,168 --> 02:40:27,004 BECAUSE THIS IS AN NHANES 4096 02:40:27,004 --> 02:40:27,338 WORKSHOP. 4097 02:40:27,338 --> 02:40:31,175 I MEAN, AN NHLBI WORKSHOP. 4098 02:40:31,175 --> 02:40:33,744 LOOKING AT AWARENESS, YOU CAN 4099 02:40:33,744 --> 02:40:37,214 SEE OVERALL PATTERN ON THE LEFT 4100 02:40:37,214 --> 02:40:38,649 PANEL. 4101 02:40:38,649 --> 02:40:41,018 THERE'S A NOMINALLY SIGNIFICANT 4102 02:40:41,018 --> 02:40:41,452 DECLINE. 4103 02:40:41,452 --> 02:40:44,188 THAT'S TRUE FOR THE PATTERN -- 4104 02:40:44,188 --> 02:40:46,057 THE PATTERN TRUE FOR ALL AGE 4105 02:40:46,057 --> 02:40:50,761 GROUPS, MORE SIGNIFICANT FOR 4106 02:40:50,761 --> 02:40:53,164 OLDEST AGE GROUP, SEEING DECLINE 4107 02:40:53,164 --> 02:40:53,965 IN AWARENESS. 4108 02:40:53,965 --> 02:40:57,068 IF WE LOOK AT DRUG TREATMENT, 4109 02:40:57,068 --> 02:41:00,504 THOSE AWARE THAT THEY HAD 4110 02:41:00,504 --> 02:41:03,240 HYPERTENSION, IT'S QUITE HIGH, 4111 02:41:03,240 --> 02:41:05,643 OVERALL ABOUT A LITTLE OVER 90%. 4112 02:41:05,643 --> 02:41:08,079 OF COURSE ESPECIALLY HIGH IN THE 4113 02:41:08,079 --> 02:41:09,814 OLDER AGE GROUP. 4114 02:41:09,814 --> 02:41:14,185 IF WE LOOK MORE GENERALLY AT 4115 02:41:14,185 --> 02:41:15,920 DRUG TREATMENT BROADLY, NOT JUST 4116 02:41:15,920 --> 02:41:17,421 IN THOSE BEING TREATED BUT IN 4117 02:41:17,421 --> 02:41:21,192 THE GENERAL POPULATION AS A 4118 02:41:21,192 --> 02:41:23,494 WHOLE, IT'S LOWER. 4119 02:41:23,494 --> 02:41:26,664 AND YOU'LL SEE THERE'S 4120 02:41:26,664 --> 02:41:28,866 PROGRESSIVE TENDENCY FOR A 4121 02:41:28,866 --> 02:41:30,001 DECLINE. 4122 02:41:30,001 --> 02:41:39,910 YOU'LL SEE THAT FOR THE LAST 4123 02:41:39,910 --> 02:41:47,184 TIME PERIOD, WE'RE LOOKING AT -- 4124 02:41:47,184 --> 02:41:48,152 UPPER AGE RAGE, 50%. 4125 02:41:48,152 --> 02:41:50,354 THIS IS IN THOSE BEING TREATED. 4126 02:41:50,354 --> 02:41:53,524 THIS IS THE GENERAL. 4127 02:41:53,524 --> 02:41:56,460 AND PROGRESSIVE DECLINE, 4128 02:41:56,460 --> 02:41:57,662 SIGNIFICANT OVERALL, ESPECIALLY 4129 02:41:57,662 --> 02:41:59,530 SIGNIFICANT IN THE UPPER AGE 4130 02:41:59,530 --> 02:41:59,730 RANGE. 4131 02:41:59,730 --> 02:42:06,904 WHETHER THIS RELATES TO THE FACT 4132 02:42:06,904 --> 02:42:08,973 THAT ACCHA WE RECOMMEND 130/80, 4133 02:42:08,973 --> 02:42:13,477 LESS THAN 130, AND OLDER AGE 4134 02:42:13,477 --> 02:42:15,880 RANGE, A WAY TO COMPETING 4135 02:42:15,880 --> 02:42:18,949 GUIDELINE FROM ACP AND AAFP, 4136 02:42:18,949 --> 02:42:21,118 WHICH DURING THIS EARLY TIME 4137 02:42:21,118 --> 02:42:24,622 PERIOD IS DIFFERENT NOW, BUT 4138 02:42:24,622 --> 02:42:27,058 DURING THE SAME TIME PERIOD, 4139 02:42:27,058 --> 02:42:28,793 RECOMMENDED YOU COULD HAVE 4140 02:42:28,793 --> 02:42:33,397 SYSTOLIC AS HIGH AS 150 AND BE 4141 02:42:33,397 --> 02:42:36,467 COMFORTABLE UNLESS SOMEBODY HAD 4142 02:42:36,467 --> 02:42:37,768 VERY HIGH RISK. 4143 02:42:37,768 --> 02:42:39,170 THAT MAY HAVE HAVE SOMETHING TO 4144 02:42:39,170 --> 02:42:43,007 DO WITH IT, PERHAPS THE FACT 4145 02:42:43,007 --> 02:42:44,875 THAT HEDIS CONTINUES TO USE 4146 02:42:44,875 --> 02:42:46,110 140/90 MAY HAVE SOMETHING TO DO 4147 02:42:46,110 --> 02:42:46,944 WITH IT. 4148 02:42:46,944 --> 02:42:49,146 CAN'T BE SURE. 4149 02:42:49,146 --> 02:42:54,085 IF WE LOOK BY GENDER AND 4150 02:42:54,085 --> 02:42:54,652 RACE/ETHNICITY, NON-HISPANIC 4151 02:42:54,652 --> 02:42:57,488 BLACKS, WE NOT ONLY HAVE HIGHER 4152 02:42:57,488 --> 02:43:01,225 PREVALENCE, WE NOT ONLY HAVE 4153 02:43:01,225 --> 02:43:02,193 MORE OF ANY PARTICULAR LEVEL 4154 02:43:02,193 --> 02:43:07,665 COMPARED TO ANY OTHER GROUP, 4155 02:43:07,665 --> 02:43:09,400 ALSO HAVE LEAST EFFECTIVE 4156 02:43:09,400 --> 02:43:10,868 TREATMENT AND CONTROL THAN OTHER 4157 02:43:10,868 --> 02:43:14,138 GROUP, A DISMAL PICTURE. 4158 02:43:14,138 --> 02:43:15,840 I'LL LOOK AT 130/80, THIS WOULD 4159 02:43:15,840 --> 02:43:17,842 ONLY APPLY TO THE LAST OF THE 4160 02:43:17,842 --> 02:43:20,377 THREE PERIODS THAT I'M SHOWING 4161 02:43:20,377 --> 02:43:23,314 FROM THE MUNTNER PAPER. 4162 02:43:23,314 --> 02:43:25,282 HERE'S PREVALENCE, MUCH HIGHER 4163 02:43:25,282 --> 02:43:27,485 COMPARED TO 140/90, OBVIOUSLY. 4164 02:43:27,485 --> 02:43:31,388 ALMOST 50% OF THE POPULATION. 4165 02:43:31,388 --> 02:43:35,693 AND AGAIN VERY AGE DEPENDENT, 4166 02:43:35,693 --> 02:43:39,230 LIKEWISE SIMILAR TO 140/90, 4167 02:43:39,230 --> 02:43:40,097 STRIKINGLY DIFFERENT IN 4168 02:43:40,097 --> 02:43:41,799 NON-HISPANIC BLACKS, COMPARED TO 4169 02:43:41,799 --> 02:43:47,404 ALL THE OTHER RACE/ETHNICITY 4170 02:43:47,404 --> 02:43:48,005 GROUPS. 4171 02:43:48,005 --> 02:43:49,840 HERE'S AWARENESS. 4172 02:43:49,840 --> 02:43:52,343 AWARENESS IS CONSIDERABLY LOWER, 4173 02:43:52,343 --> 02:43:54,211 AND REALLY ONLY ABLE TO LOOK 4174 02:43:54,211 --> 02:43:56,714 REASONABLY AT THE LAST TIME 4175 02:43:56,714 --> 02:43:57,915 PERIOD TO SEE AWARENESS 4176 02:43:57,915 --> 02:44:00,217 IMPROVED, AND WHAT WE'RE SEEING 4177 02:44:00,217 --> 02:44:03,420 HERE IS, NO, AWARENESS DID NOT 4178 02:44:03,420 --> 02:44:04,622 IMPROVE DESPITE RECOMMENDATION 4179 02:44:04,622 --> 02:44:07,458 FROM ONE OF THE MAJOR GUIDELINES 4180 02:44:07,458 --> 02:44:11,729 WE SHOULD FOCUS ON 130/80, AND 4181 02:44:11,729 --> 02:44:14,265 PARTICULARLY SEEING DECLINE IN 4182 02:44:14,265 --> 02:44:16,767 OLDER AGE RANGES. 4183 02:44:16,767 --> 02:44:18,068 ANTI-HYPERTENSIVE DRUG TREATMENT 4184 02:44:18,068 --> 02:44:20,371 IN THOSE AWARE. 4185 02:44:20,371 --> 02:44:25,409 AGAIN, IT'S LESS SO THAN IN THE 4186 02:44:25,409 --> 02:44:25,743 140/90. 4187 02:44:25,743 --> 02:44:28,712 AND NO REAL SENSE THAT THERE'S 4188 02:44:28,712 --> 02:44:29,680 MUCH IMPROVEMENT IN DRUG 4189 02:44:29,680 --> 02:44:33,951 TREATMENT IN THE LAST TIME 4190 02:44:33,951 --> 02:44:34,185 PERIOD. 4191 02:44:34,185 --> 02:44:36,020 HERE IS CONTROL, IN THE GROUP 4192 02:44:36,020 --> 02:44:37,555 BEING TREATED. 4193 02:44:37,555 --> 02:44:40,658 AND NO EVIDENCE FOR IMPROVEMENT 4194 02:44:40,658 --> 02:44:43,127 IN CONTROL IN THE LAST TIME 4195 02:44:43,127 --> 02:44:43,494 PERIOD. 4196 02:44:43,494 --> 02:44:45,763 IF ANYTHING, IT'S DECLINING. 4197 02:44:45,763 --> 02:44:46,764 IT'S NOT STATISTICALLY 4198 02:44:46,764 --> 02:44:47,698 SIGNIFICANT BUT THE TREND 4199 02:44:47,698 --> 02:44:54,538 CERTAINLY IS IN THE WRONG 4200 02:44:54,538 --> 02:44:55,506 DIRECTION. 4201 02:44:55,506 --> 02:44:57,575 LOOKING AT CONTROL, AGAIN NO 4202 02:44:57,575 --> 02:44:59,243 EVIDENCE FOR IMPROVEMENT IN THAT 4203 02:44:59,243 --> 02:45:01,545 LAST TIME PERIOD. 4204 02:45:01,545 --> 02:45:02,613 SO, VERY DISTURBING PICTURE. 4205 02:45:02,613 --> 02:45:04,481 NOW, I WANT TO SHOW TWO OTHER 4206 02:45:04,481 --> 02:45:06,917 SLIDES AND THEN I'LL STOP. 4207 02:45:06,917 --> 02:45:12,389 I WANT TO SHOW A SLIDE OF 4208 02:45:12,389 --> 02:45:15,459 TEMPORAL TRENDS FROM SPRINT. 4209 02:45:15,459 --> 02:45:17,228 LEFT-HAND PANEL HAZARD RATIOS, 4210 02:45:17,228 --> 02:45:17,962 CARDIOVASCULAR MORTALITY. 4211 02:45:17,962 --> 02:45:25,069 AND AS YOU KNOW IN SPRINT, WE AS 4212 02:45:25,069 --> 02:45:26,170 INVESTIGATORS ENCOURAGE AND TALK 4213 02:45:26,170 --> 02:45:29,707 TO AND SO ON PRIMARY CARE 4214 02:45:29,707 --> 02:45:31,075 PHYSICIANS, STILL IN CHARGE OF 4215 02:45:31,075 --> 02:45:33,077 PATIENTS, BUT GAVE A LOT OF 4216 02:45:33,077 --> 02:45:33,444 ADVICE. 4217 02:45:33,444 --> 02:45:35,512 DURING THE TIME THE TRIAL IS 4218 02:45:35,512 --> 02:45:37,882 BEING DONE HAZARD RATIO WENT 4219 02:45:37,882 --> 02:45:40,618 DOWN PROGRESSIVELY, AND IN A 4220 02:45:40,618 --> 02:45:42,353 VERY NICE DIRECTION. 4221 02:45:42,353 --> 02:45:43,587 AND THEN TRIAL WAS STOPPED. 4222 02:45:43,587 --> 02:45:45,890 THERE'S A PERIOD AFTER THE TRIAL 4223 02:45:45,890 --> 02:45:47,625 WAS STOPPED WHERE WE STOPPED 4224 02:45:47,625 --> 02:45:49,026 GIVING ADVICE AND HANDED BACK 4225 02:45:49,026 --> 02:45:52,563 THE CARE OF THE PATIENTS TO 4226 02:45:52,563 --> 02:45:53,898 PRIMARY CARE PHYSICIANS. 4227 02:45:53,898 --> 02:45:55,532 THEY ALWAYS WERE IN CHARGE BUT 4228 02:45:55,532 --> 02:45:57,067 WE STOPPED GIVE ADVICE. 4229 02:45:57,067 --> 02:45:58,535 SORT OF A GENERAL HANDOVER 4230 02:45:58,535 --> 02:46:00,337 PERIOD, IT TAKES A WHILE TO DO 4231 02:46:00,337 --> 02:46:00,671 THAT. 4232 02:46:00,671 --> 02:46:02,439 THEN THERE'S A PERIOD AFTER 4233 02:46:02,439 --> 02:46:03,507 EVERYTHING IS COMPLETELY HANDED 4234 02:46:03,507 --> 02:46:05,476 BACK TO THE PRIMARY CARE 4235 02:46:05,476 --> 02:46:07,144 PHYSICIANS. 4236 02:46:07,144 --> 02:46:08,112 YOU SEE HAZARD RATIOS COMING 4237 02:46:08,112 --> 02:46:11,715 BACK UP TO WHERE IT STARTED, 4238 02:46:11,715 --> 02:46:12,149 MORE OR LESS. 4239 02:46:12,149 --> 02:46:14,985 WE CAN'T BE SURE TO UNDERSTAND 4240 02:46:14,985 --> 02:46:16,654 WHY THAT OCCURRED, BUT WE CAN 4241 02:46:16,654 --> 02:46:17,521 LOOK AT BLOOD PRESSURES. 4242 02:46:17,521 --> 02:46:20,257 IF YOU LOOK AT BLOOD PRESSURES, 4243 02:46:20,257 --> 02:46:25,162 DURING THE TRIAL, SHOWN HERE ON 4244 02:46:25,162 --> 02:46:26,797 THE TWO LINES, NICE SEPARATION. 4245 02:46:26,797 --> 02:46:30,234 WHEN WE LOOK AT ELECTRONIC 4246 02:46:30,234 --> 02:46:35,906 HEALTH RECORD PRESSURES, TAKEN 4247 02:46:35,906 --> 02:46:37,007 CONCURRENTLY FOR OFFICE VISITS, 4248 02:46:37,007 --> 02:46:38,742 NOT DONE AS WELL, OF COURSE, AS 4249 02:46:38,742 --> 02:46:40,978 YOU WOULD EXPECT. 4250 02:46:40,978 --> 02:46:44,181 THEY TEND TO OVERESTIMATE. 4251 02:46:44,181 --> 02:46:45,249 THERE WILL BE UNDERESTIMATION 4252 02:46:45,249 --> 02:46:47,751 BUT THEY TEND TO OVERESTIMATE SO 4253 02:46:47,751 --> 02:46:50,387 YOU GET HIGHER SYSTOLIC AND 4254 02:46:50,387 --> 02:46:52,022 DIASTOLICS WITH A NICE 4255 02:46:52,022 --> 02:46:53,223 SEPARATION NONETHELESS. 4256 02:46:53,223 --> 02:46:54,425 AS YOU FOLLOW OVER TIME WHAT 4257 02:46:54,425 --> 02:46:56,126 YOU'RE SEEING IS IN THE STANDARD 4258 02:46:56,126 --> 02:46:57,628 GROUP THERE'S NOT MUCH EVIDENCE 4259 02:46:57,628 --> 02:46:59,797 THAT THEY ARE GETTING MORE 4260 02:46:59,797 --> 02:47:03,200 INTENSIVE TREATMENT. 4261 02:47:03,200 --> 02:47:04,501 IN THE MORE INTENSIVELY TREATED 4262 02:47:04,501 --> 02:47:08,105 GROUP WHICH WE HOPE WOULD 4263 02:47:08,105 --> 02:47:09,673 CONTINUE TO HAVE FAIRLY 4264 02:47:09,673 --> 02:47:12,476 INTENSIVE TREATMENT, THEY ARE 4265 02:47:12,476 --> 02:47:13,377 PROGRESSIVELY GOING BACK UP AND 4266 02:47:13,377 --> 02:47:16,547 YOU'RE BACK TO BUSINESS AS USUAL 4267 02:47:16,547 --> 02:47:17,114 UP HERE. 4268 02:47:17,114 --> 02:47:18,849 SO, THIS IS DISTURBING. 4269 02:47:18,849 --> 02:47:20,918 IT'S NOT SURPRISING. 4270 02:47:20,918 --> 02:47:22,019 WE'VE SEEN THIS AFTER MANY 4271 02:47:22,019 --> 02:47:22,987 EFFICACY TRIALS. 4272 02:47:22,987 --> 02:47:26,857 WE DO THE EFFICACY TRIALS. 4273 02:47:26,857 --> 02:47:27,992 THEY DEMONSTRATE THE BENEFIT. 4274 02:47:27,992 --> 02:47:30,427 WHAT WE SEE IS IN PRACTICE THERE 4275 02:47:30,427 --> 02:47:33,097 ARE A LOT OF FACTORS THAT 4276 02:47:33,097 --> 02:47:33,864 INFLUENCE MANAGEMENT OF CARE, 4277 02:47:33,864 --> 02:47:38,168 AND WHAT WE'RE SEEING HERE IS 4278 02:47:38,168 --> 02:47:39,636 VERY POOR ADOPTION TO THE 4279 02:47:39,636 --> 02:47:44,908 FINDINGS OF THE SPRINT TRIAL. 4280 02:47:44,908 --> 02:47:47,511 NOW, ONE LAST DATA SLIDE HERE, 4281 02:47:47,511 --> 02:47:49,113 JUST TO SAY WE'RE DOING 4282 02:47:49,113 --> 02:47:49,480 TERRIBLY. 4283 02:47:49,480 --> 02:47:51,348 ON THE OTHER HAND, WE ABSOLUTELY 4284 02:47:51,348 --> 02:47:53,217 KNOW WHAT TO DO TO GET BLOOD 4285 02:47:53,217 --> 02:47:53,784 PRESSURES DOWN. 4286 02:47:53,784 --> 02:47:56,720 I WON'T GO INTO IT IN DETAIL BUT 4287 02:47:56,720 --> 02:47:59,223 THIS IS A GENERAL MODEL OF CARE 4288 02:47:59,223 --> 02:48:01,759 THAT HAS WORKED VERY WELL IN 4289 02:48:01,759 --> 02:48:03,293 HIGH-INCOME COUNTRIES, IT'S 4290 02:48:03,293 --> 02:48:06,897 WORKED VERY WELL IN LOW-INCOME 4291 02:48:06,897 --> 02:48:07,197 COUNTRIES. 4292 02:48:07,197 --> 02:48:07,865 STARTS WITH A COMMITMENT, 4293 02:48:07,865 --> 02:48:10,934 WHETHER IT'S AT THE PROVIDER 4294 02:48:10,934 --> 02:48:15,973 LEVEL, COUNTRY LEVEL, OR THE 4295 02:48:15,973 --> 02:48:17,508 INSTITUTION, OR HEALTH SYSTEM. 4296 02:48:17,508 --> 02:48:20,344 IT INVOLVES HAVING A BACKGROUND 4297 02:48:20,344 --> 02:48:23,614 OF HEALTH PROMOTION, SIMPLE 4298 02:48:23,614 --> 02:48:25,049 EVIDENCE-BASED PROTOCOLS FOR 4299 02:48:25,049 --> 02:48:27,584 COUNSELING PEOPLE FOR LIFESTYLE 4300 02:48:27,584 --> 02:48:29,553 IMPROVEMENT AND FOR 4301 02:48:29,553 --> 02:48:30,621 ANTI-HYPERTENSIVE DRUG 4302 02:48:30,621 --> 02:48:34,925 TREATMENT, RELIABLE ACCESS TO 4303 02:48:34,925 --> 02:48:38,729 MEDICATION IS VERY IMPORTANT. 4304 02:48:38,729 --> 02:48:39,396 COMMUNITY-BASED PATIENT-CENTERED 4305 02:48:39,396 --> 02:48:41,265 TEAM CARE, WITH ACCURATE BLOOD 4306 02:48:41,265 --> 02:48:43,300 PRESSURE MEASUREMENTS AND 4307 02:48:43,300 --> 02:48:44,301 INFORMATION TRACKING. 4308 02:48:44,301 --> 02:48:50,307 THIS IS THE MODEL USED IN W.H.O. 4309 02:48:50,307 --> 02:48:52,176 HEARTS PROGRAM, IN HYPERTENSION 4310 02:48:52,176 --> 02:48:53,610 LEAGUE, AND MOST RECENTLY THE 4311 02:48:53,610 --> 02:48:56,780 SORT OF MODEL USED FOR THE 4312 02:48:56,780 --> 02:48:59,616 COMMUNITY HEALTH CARE WORKER 4313 02:48:59,616 --> 02:49:02,453 TRIAL RURAL CHINA WHICH HAD 4314 02:49:02,453 --> 02:49:05,022 DRAMATIC DIFFERENCES IN SYSTOLIC 4315 02:49:05,022 --> 02:49:06,557 BLOOD PRESSURE BETWEEN THE 4316 02:49:06,557 --> 02:49:07,091 INTERVENTION VILLAGES AND 4317 02:49:07,091 --> 02:49:08,392 CONTROL VILLAGES. 4318 02:49:08,392 --> 02:49:09,927 IN FACT BIGGER DELTA IN BLOOD 4319 02:49:09,927 --> 02:49:13,097 PRESSURE THAN WE GOT IN SPRINT, 4320 02:49:13,097 --> 02:49:15,399 OVER 21 MILLIMETERS OF MERCURY 4321 02:49:15,399 --> 02:49:17,901 SYSTOLIC, AND YOU WOULD EXPECT 4322 02:49:17,901 --> 02:49:20,871 HUGE HEALTH BENEFITS BOTH 4323 02:49:20,871 --> 02:49:22,940 CARDIOVASCULAR AND ALL-CAUSE 4324 02:49:22,940 --> 02:49:23,474 MORTALITY. 4325 02:49:23,474 --> 02:49:27,111 IN SUMMARY MOST REPORTS OF 4326 02:49:27,111 --> 02:49:28,345 HYPERTENSION PREVALENCE AND 4327 02:49:28,345 --> 02:49:31,081 CONTROL ARE BASED ON NHANES, 4328 02:49:31,081 --> 02:49:35,319 MOST REPORTS FOR THE U.S. 4329 02:49:35,319 --> 02:49:37,855 THAT MAKES SENSE. 4330 02:49:37,855 --> 02:49:39,389 AND ADULTS WE'VE TENDED TO SEE 4331 02:49:39,389 --> 02:49:45,496 MEAN SYSTOLIC BLOOD PRESSURE 4332 02:49:45,496 --> 02:49:53,070 GOING DOWN TO 2018, 2010, SLIGHT 4333 02:49:53,070 --> 02:49:56,573 UPTICK, PREVALENCE 140/90, 4334 02:49:56,573 --> 02:50:02,379 STABLE AT 30%, AND DECLINES IN 4335 02:50:02,379 --> 02:50:03,347 AWARENESS, AND CERTAINLY DEFINES 4336 02:50:03,347 --> 02:50:04,882 AND CONTROL RATE. 4337 02:50:04,882 --> 02:50:09,786 IF WE LOOK AT 130/80, OBVIOUSLY 4338 02:50:09,786 --> 02:50:11,255 HIGHER PREVALENCE. 4339 02:50:11,255 --> 02:50:13,757 NO EVIDENCE IN MORE RECENT YEARS 4340 02:50:13,757 --> 02:50:15,492 THERE'S BEEN ANY IMPROVEMENT 4341 02:50:15,492 --> 02:50:20,531 COMPARED TO THE EARLIER PERIODS 4342 02:50:20,531 --> 02:50:22,499 AND ACHIEVING THE 130/80, IT WAS 4343 02:50:22,499 --> 02:50:23,600 MENTIONED EARLIER IN THE SESSION 4344 02:50:23,600 --> 02:50:28,405 LESS THAN A QUARTER OF THE U.S. 4345 02:50:28,405 --> 02:50:29,039 ADULT POPULATION WERE ACHIEVING 4346 02:50:29,039 --> 02:50:31,708 BLOOD PRESSURE GOAL OF LESS THAN 4347 02:50:31,708 --> 02:50:33,744 130/80, THAT'S OBVIOUSLY WORSE 4348 02:50:33,744 --> 02:50:35,112 IN SOME SUBSETS IN THE 4349 02:50:35,112 --> 02:50:35,679 COMMUNITY. 4350 02:50:35,679 --> 02:50:39,383 I THANK YOU FOR ALLOWING ME TO 4351 02:50:39,383 --> 02:50:40,150 PRESENT TODAY. 4352 02:50:40,150 --> 02:50:41,418 >> THANK YOU. 4353 02:50:41,418 --> 02:50:44,721 A LOT OF DATA, MUCH OF IT 4354 02:50:44,721 --> 02:50:45,022 SOBERING. 4355 02:50:45,022 --> 02:50:47,024 NEXT PRESENTATION TIES BACK INTO 4356 02:50:47,024 --> 02:50:52,162 THE CONCEPT OF HYPERTENSION AND 4357 02:50:52,162 --> 02:50:53,597 A.I. 4358 02:50:53,597 --> 02:50:55,799 DR. SONYA MAKHNI, USING A.I. TO 4359 02:50:55,799 --> 02:50:56,767 PRE-DIDN'T HYPERTENSION STATUS 4360 02:50:56,767 --> 02:50:59,069 AND BLOOD PRESSURE, COMES FROM 4361 02:50:59,069 --> 02:51:01,205 THE MAYO CLINIC ROCHESTER 4362 02:51:01,205 --> 02:51:01,471 MINNESOTA. 4363 02:51:01,471 --> 02:51:03,707 >> NICE TO MEET YOU ALL. 4364 02:51:03,707 --> 02:51:06,076 HOPEFULLY YOU CAN HEAR ME AND 4365 02:51:06,076 --> 02:51:12,950 SEE MY SLIDES OKAY. 4366 02:51:12,950 --> 02:51:13,417 >> YES. 4367 02:51:13,417 --> 02:51:16,053 >> I'M A CLINICAL INFORMATIST, 4368 02:51:16,053 --> 02:51:17,120 HOSPITALIST AT MAYO CLINIC, 4369 02:51:17,120 --> 02:51:27,664 MEDICAL DIRECTOR AT MAY O CLINIC 4370 02:51:28,265 --> 02:51:28,599 PLATFORM. 4371 02:51:28,599 --> 02:51:33,136 NO CONFLICTS OF INTEREST TO 4372 02:51:33,136 --> 02:51:33,370 REPORT. 4373 02:51:33,370 --> 02:51:37,407 NOT TO SPENT MUCH TIME ON THE 4374 02:51:37,407 --> 02:51:38,742 BACKGROUND, WE'VE HEARD 4375 02:51:38,742 --> 02:51:39,509 HYPERTENSION IS VERY COMMON, ONE 4376 02:51:39,509 --> 02:51:42,479 OF THE MOST IMPORTANT RISK 4377 02:51:42,479 --> 02:51:43,547 FACTORS FOR CARDIOVASCULAR 4378 02:51:43,547 --> 02:51:44,214 DISEASE. 4379 02:51:44,214 --> 02:51:47,284 INCREASES RISK OF MANY OTHER 4380 02:51:47,284 --> 02:51:47,584 CONDITIONS. 4381 02:51:47,584 --> 02:51:49,253 MANAGING THESE CONDITIONS IS NOT 4382 02:51:49,253 --> 02:51:52,556 ONLY CHALLENGING BUT COSTLY AS 4383 02:51:52,556 --> 02:51:52,756 WELL. 4384 02:51:52,756 --> 02:51:54,391 THERE'S AMPLE EVIDENCE TO 4385 02:51:54,391 --> 02:51:56,693 SUGGEST EARLY DETECTION OF 4386 02:51:56,693 --> 02:51:58,028 HYPERTENSION IN CONJUNCTION WITH 4387 02:51:58,028 --> 02:51:59,663 GOOD BLOOD PRESSURE CONTROL AND 4388 02:51:59,663 --> 02:52:02,065 CORRECTION OF LIFE HABITS CAN 4389 02:52:02,065 --> 02:52:03,700 FURTHER REDUCE PROGRESSION OF 4390 02:52:03,700 --> 02:52:08,071 THE DISEASE AND DEVELOPMENT OF 4391 02:52:08,071 --> 02:52:09,606 DOWNSTREAM CONSEQUENCES. 4392 02:52:09,606 --> 02:52:11,475 SO THIS UNDERSCORES THE 4393 02:52:11,475 --> 02:52:16,947 IMPORTANCE OF EARLY ACCURATE 4394 02:52:16,947 --> 02:52:17,481 DIAGNOSIS. 4395 02:52:17,481 --> 02:52:18,148 WE'VE HEARD MEASURING MEASURING 4396 02:52:18,148 --> 02:52:20,150 BLOOD PRESSURE IN AROUND OUT OF 4397 02:52:20,150 --> 02:52:22,452 THE OFFICE AND LIMITATIONS OF 4398 02:52:22,452 --> 02:52:23,754 CURRENT PRACTICES. 4399 02:52:23,754 --> 02:52:25,722 TO BRIEFLY RECAP OUR OUT OF 4400 02:52:25,722 --> 02:52:27,257 OFFICE MEASUREMENTS CAN BE 4401 02:52:27,257 --> 02:52:30,560 DIFFICULT TO OBTAIN DUE TO 4402 02:52:30,560 --> 02:52:36,333 AVAILABILITY OF EQUIPMENT, COST 4403 02:52:36,333 --> 02:52:38,769 AND LOGISTICAL ISSUES, AND IN 4404 02:52:38,769 --> 02:52:40,937 ABPM CAN BE DISRUPTIVE, IN THE 4405 02:52:40,937 --> 02:52:42,706 CASE OF HOME MEASUREMENT 4406 02:52:42,706 --> 02:52:44,474 ACCURATE BLOOD PRESSURE 4407 02:52:44,474 --> 02:52:53,417 MEASUREMENTS DEPENDS ON HAVING A 4408 02:52:53,417 --> 02:52:54,951 VALIDATED DEVICE AND CORRECT 4409 02:52:54,951 --> 02:52:55,485 USE. 4410 02:52:55,485 --> 02:52:59,556 THESE ARE OVER LIMITED 4411 02:52:59,556 --> 02:53:00,123 TIMEFRAMES. 4412 02:53:00,123 --> 02:53:02,959 IF HOME OPTIONS ARE NOT POSSIBLE 4413 02:53:02,959 --> 02:53:05,128 PATIENTS NEED TO DEMONSTRATE 4414 02:53:05,128 --> 02:53:06,029 CERTAIN NUMBER MUCH ELEVATED 4415 02:53:06,029 --> 02:53:08,432 MEASUREMENTS IN THE OFFICE AGAIN 4416 02:53:08,432 --> 02:53:11,168 OVER CERTAIN TIMES WHICH 4417 02:53:11,168 --> 02:53:13,236 REQUIRES MULTIPLE DOCTOR VISITS 4418 02:53:13,236 --> 02:53:16,406 AND AS WE HEARD THERE ARE MANY 4419 02:53:16,406 --> 02:53:17,307 FACTORS THAT MIGHT PREVENT 4420 02:53:17,307 --> 02:53:20,677 SOMEONE FROM BEING ABLE TO CARRY 4421 02:53:20,677 --> 02:53:22,212 THESE VISITS OUT. 4422 02:53:22,212 --> 02:53:25,382 AND IN GENERAL, OFFICE VISITS 4423 02:53:25,382 --> 02:53:28,652 HAVE ISSUES OF WHITE COAT 4424 02:53:28,652 --> 02:53:30,554 HYPERTENSION, MASKED 4425 02:53:30,554 --> 02:53:32,289 HYPERTENSION, GENERALLY NOT 4426 02:53:32,289 --> 02:53:33,590 REFLECTIVE OF VARIABILITY. 4427 02:53:33,590 --> 02:53:36,793 AND THEN EVEN IF YOU CAN GET 4428 02:53:36,793 --> 02:53:37,627 ACCURATE MEASUREMENTS, WORK 4429 02:53:37,627 --> 02:53:40,530 AROUND ALL THESE THINGS I 4430 02:53:40,530 --> 02:53:41,631 MENTIONED, OUR GUIDELINES ARE 4431 02:53:41,631 --> 02:53:42,165 ONE-SIZE-FITS-ALL. 4432 02:53:42,165 --> 02:53:44,034 WE DON'T HAVE A DEEP 4433 02:53:44,034 --> 02:53:46,002 UNDERSTANDING OF HOW SUBGROUPS 4434 02:53:46,002 --> 02:53:51,041 OF PATIENTS MAY DIFFER IN 4435 02:53:51,041 --> 02:53:52,909 OPTIMAL TARGETS, THERE ISN'T 4436 02:53:52,909 --> 02:53:54,544 MUCH PHENOACTIVIC 4437 02:53:54,544 --> 02:53:56,546 DIFFERENTIATION IN DIAGNOSING 4438 02:53:56,546 --> 02:53:58,048 WHEN WE TREAT IT. 4439 02:53:58,048 --> 02:54:00,984 CLEARLY THERE ARE SEVERAL 4440 02:54:00,984 --> 02:54:03,620 BARRIERS TO ATTAINING THOSE 4441 02:54:03,620 --> 02:54:04,721 RELIABLE MEASUREMENTS WHICH 4442 02:54:04,721 --> 02:54:08,658 COMPLICATES EARLY AND ACCURATE 4443 02:54:08,658 --> 02:54:10,227 DIAGNOSIS. 4444 02:54:10,227 --> 02:54:12,262 AND HETEROGENEITY OF PEOPLE MAY 4445 02:54:12,262 --> 02:54:15,665 GET POSSIBLE, IF NOT LIKELY 4446 02:54:15,665 --> 02:54:18,935 TARGETS ARE DIFFERENT ACROSS 4447 02:54:18,935 --> 02:54:22,005 SUBGROUPS, ONE-SIZE-FITS-ALL 4448 02:54:22,005 --> 02:54:23,006 APPROACH IS NOT ADEAL. 4449 02:54:23,006 --> 02:54:24,975 THERE'S A GREAT CASE FOR 4450 02:54:24,975 --> 02:54:26,276 LEVERAGING A.I. SOLUTIONS TO 4451 02:54:26,276 --> 02:54:28,578 HELP PREDICT HYPERTENSION IN 4452 02:54:28,578 --> 02:54:29,346 PATIENTS. 4453 02:54:29,346 --> 02:54:33,049 THE ABILITY TO ACCURATELY 4454 02:54:33,049 --> 02:54:34,584 PREDICT HYPERTENSION STATUS 4455 02:54:34,584 --> 02:54:37,421 WITHOUT INTERVENTION LIKE ABPM 4456 02:54:37,421 --> 02:54:39,523 ALLOW PCPs TO EFFECTIVELY AND 4457 02:54:39,523 --> 02:54:41,691 EFFICIENTLY DIAGNOSIS AND MANAGE 4458 02:54:41,691 --> 02:54:42,893 PATIENTS. 4459 02:54:42,893 --> 02:54:44,861 AS WELL AS MINIMIZING RISK OF 4460 02:54:44,861 --> 02:54:49,699 HARM FOR UNDERTREATMENT OR 4461 02:54:49,699 --> 02:54:50,033 OVERTREATMENT. 4462 02:54:50,033 --> 02:54:52,402 WE NEED TO BE ABLE TO UNDERSTAND 4463 02:54:52,402 --> 02:54:53,537 PATIENTS' CLINICAL STATES WHEN 4464 02:54:53,537 --> 02:54:55,806 NOT WITHIN OUR WALLS, WHICH IS 4465 02:54:55,806 --> 02:54:58,208 OVER 99% OF THEIR LIVED 4466 02:54:58,208 --> 02:54:58,542 EXPERIENCES. 4467 02:54:58,542 --> 02:55:01,411 AND WE NEED TO EXPAND OUR 4468 02:55:01,411 --> 02:55:05,115 EFFORTS, IF WE CAN SAFELY AND 4469 02:55:05,115 --> 02:55:06,082 APPROPRIATELY CREATE A.I. 4470 02:55:06,082 --> 02:55:10,353 SOLUTIONS TO HELP US WE CAN 4471 02:55:10,353 --> 02:55:11,455 POTENTIALLY EXPAND OUR REACH TO 4472 02:55:11,455 --> 02:55:12,722 THESE PATIENTS. 4473 02:55:12,722 --> 02:55:16,393 THERE'S TWO COMMON -- THIS IS A 4474 02:55:16,393 --> 02:55:17,694 SIMPLIFICATION, TWO COMMON 4475 02:55:17,694 --> 02:55:23,934 APPROACHES TO DETECTION USING 4476 02:55:23,934 --> 02:55:26,903 A.I. 4477 02:55:26,903 --> 02:55:31,508 IN CLASSIFICATION MODELS, 4478 02:55:31,508 --> 02:55:33,477 ALGORITHMS DETECT HYPERTENSION 4479 02:55:33,477 --> 02:55:35,979 AS A LABEL, TRAINED ON THE 4480 02:55:35,979 --> 02:55:38,381 TRAINED DATASET, BASED ON THAT 4481 02:55:38,381 --> 02:55:42,452 TRAINING CATEGORIZE DATA INTO 4482 02:55:42,452 --> 02:55:47,257 CLASSES. 4483 02:55:47,257 --> 02:55:49,125 THERE'S OFTEN EXTRACTED DATA 4484 02:55:49,125 --> 02:55:54,297 FROM EHRs, FOR EXAMPLE, AND 4485 02:55:54,297 --> 02:55:55,832 OUTCOME IS CATEGORICAL, LEVELS, 4486 02:55:55,832 --> 02:56:01,705 YES OR NO, OR PRE-HYPERTENSION, 4487 02:56:01,705 --> 02:56:03,607 NO HYPERTENSION. 4488 02:56:03,607 --> 02:56:04,641 REGRESSION MODELS GENERATE 4489 02:56:04,641 --> 02:56:06,877 CONTINUOUS VALUES, THAT WOULD BE 4490 02:56:06,877 --> 02:56:08,645 A NUMERIC MEASUREMENT WHICH WE 4491 02:56:08,645 --> 02:56:18,688 ALSO GOT TO HEAR ABOUT AS WELL. 4492 02:56:18,688 --> 02:56:20,924 AS WE'VE HEARD THERE ARE OTHER 4493 02:56:20,924 --> 02:56:23,960 SOURCES THAT CAN BE USED, THE 4494 02:56:23,960 --> 02:56:26,463 RAW SIGNALS THEMSELVES OR 4495 02:56:26,463 --> 02:56:27,797 EXTRACTED FEATURES. 4496 02:56:27,797 --> 02:56:30,867 ULTIMATELY THEY OUTPUT A NUMERIC 4497 02:56:30,867 --> 02:56:31,401 VALUE. 4498 02:56:31,401 --> 02:56:33,470 THERE ARE DIFFERENT BUT SIMILAR 4499 02:56:33,470 --> 02:56:36,339 WAYS TO EVALUATE PERFORMANCE OF 4500 02:56:36,339 --> 02:56:38,174 THESE MODELS DEPENDING ON TYPE 4501 02:56:38,174 --> 02:56:42,112 VIEWS AS WELL. 4502 02:56:42,112 --> 02:56:43,980 PUT ANOTHER WAY, CLASSIFICATION, 4503 02:56:43,980 --> 02:56:46,283 FUNCTION TO DIVIDE DATASET INTO 4504 02:56:46,283 --> 02:56:49,219 CLASS, MAPPING INPUT TO DISCRETE 4505 02:56:49,219 --> 02:56:51,321 OUTPUT Y, REGRESSION FINDS 4506 02:56:51,321 --> 02:56:53,823 CORRELATION BETWEEN DEPENDENT 4507 02:56:53,823 --> 02:56:58,328 AND INDEPENDENT VARIABLES, 4508 02:56:58,328 --> 02:56:59,829 MAPPING TO CONTINUOUS VARIABLE 4509 02:56:59,829 --> 02:57:00,597 OUTPUT Y. 4510 02:57:00,597 --> 02:57:03,900 THERE HAVE BEEN MANY ALGORITHMS 4511 02:57:03,900 --> 02:57:06,937 OF TYPES, AND I'LL SUMMARIZE AT 4512 02:57:06,937 --> 02:57:08,805 HIGH LEVEL WHAT THOSE LOOK LIKE. 4513 02:57:08,805 --> 02:57:11,675 KEEP IN MIND THIS IS JUST A 4514 02:57:11,675 --> 02:57:14,377 SUBSET OF WHAT IS IN 4515 02:57:14,377 --> 02:57:14,711 PUBLICATIONS. 4516 02:57:14,711 --> 02:57:18,214 YOU HAVE YOUR -- ON THE LEFT 4517 02:57:18,214 --> 02:57:19,149 MORE REGRESSION. 4518 02:57:19,149 --> 02:57:27,724 CLINICAL DATA ON THE RIGHT. 4519 02:57:27,724 --> 02:57:29,826 CLASSIFICATION MODEL USE 4520 02:57:29,826 --> 02:57:31,761 CLINICAL AND SOCIODEMOGRAPHIC 4521 02:57:31,761 --> 02:57:33,630 DATA INCORPORATING AGE, BMI, 4522 02:57:33,630 --> 02:57:35,398 GENDER, SYSTOLIC BLOOD PRESSURE, 4523 02:57:35,398 --> 02:57:38,468 HEART RATE. 4524 02:57:38,468 --> 02:57:39,903 LESS FREQUENTLY ACTUALLY 4525 02:57:39,903 --> 02:57:41,671 INCORPORATE OTHER VERY USEFUL 4526 02:57:41,671 --> 02:57:46,710 FACTORS SUCH AS RACE, LIFE 4527 02:57:46,710 --> 02:57:49,446 HABITS, GEOGRAPHY, YOU CAN 4528 02:57:49,446 --> 02:57:51,848 IMAGINE PAPERS THAT SHOW HOW 4529 02:57:51,848 --> 02:57:53,183 CRIME IMPACTS HYPERTENSION, 4530 02:57:53,183 --> 02:57:54,851 THAT'S NOT TYPICALLY 4531 02:57:54,851 --> 02:57:55,518 INCORPORATED IN STUDIES. 4532 02:57:55,518 --> 02:57:58,788 AND AGAIN LIKE I MENTIONED 4533 02:57:58,788 --> 02:58:00,824 OUTCOME IS A CLASSIFICATION. 4534 02:58:00,824 --> 02:58:04,995 HYPERTENSION YES OR NO. 4535 02:58:04,995 --> 02:58:05,428 STAGE. 4536 02:58:05,428 --> 02:58:07,297 ONE-YEAR RISK, PRESENCE OR 4537 02:58:07,297 --> 02:58:10,166 ABSENCE OF HYPERTENSION. 4538 02:58:10,166 --> 02:58:11,134 THERE ARE MORE POSSIBILITIES. 4539 02:58:11,134 --> 02:58:14,504 SO THIS IS A SMALL SAMPLE OF 4540 02:58:14,504 --> 02:58:15,405 MANY CLASSIFICATION MODELS. 4541 02:58:15,405 --> 02:58:19,109 I WANTED TO HIGHLIGHT A COUPLE 4542 02:58:19,109 --> 02:58:19,876 THINGS. 4543 02:58:19,876 --> 02:58:21,911 MORE RELEVANT TO THE PROCESS, 4544 02:58:21,911 --> 02:58:24,014 WHICH WILL SORT OF PAVE THE WAY 4545 02:58:24,014 --> 02:58:27,217 FOR LIMITATIONS I'LL TALK ABOUT 4546 02:58:27,217 --> 02:58:27,550 LATER. 4547 02:58:27,550 --> 02:58:29,185 FIRST THE DATASET COLUMN. 4548 02:58:29,185 --> 02:58:31,254 I'VE INCLUDED SAMPLE SIZE OF THE 4549 02:58:31,254 --> 02:58:33,423 DATASET, NOT TO BE CONFUSED AS 4550 02:58:33,423 --> 02:58:38,795 ACTUAL SIZE OF THE COHORTS USED. 4551 02:58:38,795 --> 02:58:39,896 CLEARLY SMALLER BUT TYPICALLY 4552 02:58:39,896 --> 02:58:41,431 DATASETS WOULD NOT ONLY BE 4553 02:58:41,431 --> 02:58:43,533 NARROWED DOWN BASED OFF 4554 02:58:43,533 --> 02:58:44,934 INCLUSION AND EXCLUSION CRITERIA 4555 02:58:44,934 --> 02:58:48,538 BUT ALSO DUE TO DATA QUALITY 4556 02:58:48,538 --> 02:58:49,005 ISSUES. 4557 02:58:49,005 --> 02:58:51,841 WHICH I'LL TOUCH ON LATER BUT 4558 02:58:51,841 --> 02:58:54,678 THE DATA IS IMPORTANT AND CAN 4559 02:58:54,678 --> 02:58:56,012 IMPACT OVERALL PERFORMANCE AND 4560 02:58:56,012 --> 02:58:57,847 GENERALIZABILITY OF THE MODEL. 4561 02:58:57,847 --> 02:59:00,684 IF THE RIGHT COHORT ISN'T USED 4562 02:59:00,684 --> 02:59:02,018 OR IF THERE ISN'T SUFFICIENT 4563 02:59:02,018 --> 02:59:06,056 DIVERSITY IN THE DATASET, OR IF 4564 02:59:06,056 --> 02:59:07,590 DATASET ITSELF HARBORS BIAS, 4565 02:59:07,590 --> 02:59:10,493 THAT WILL IMPACT THE MODEL, IN 4566 02:59:10,493 --> 02:59:15,598 OTHER CONTEXT, IT'S NOT THAT OWN 4567 02:59:15,598 --> 02:59:16,132 DATASET. 4568 02:59:16,132 --> 02:59:19,969 NEXT YOU CAN SEE THE USE OF THE 4569 02:59:19,969 --> 02:59:21,504 COMMON VARIABLES I MENTIONED, 4570 02:59:21,504 --> 02:59:23,139 YOUR MODEL TAKES DIFFERENT 4571 02:59:23,139 --> 02:59:24,407 VARIABLES INTO CONSIDERATION, 4572 02:59:24,407 --> 02:59:28,945 THIS CAN BE DUE TO FUNDAMENTAL 4573 02:59:28,945 --> 02:59:30,246 MODEL DESIGN, AVAILABILITY OF 4574 02:59:30,246 --> 02:59:31,848 DATA OR OTHER FEATURE SELECTION 4575 02:59:31,848 --> 02:59:34,651 METHODS THAT MAY LEAD TO THAT 4576 02:59:34,651 --> 02:59:38,121 PARTICULAR COMBINATION OF 4577 02:59:38,121 --> 02:59:38,655 PREDICTORS. 4578 02:59:38,655 --> 02:59:44,794 AGAIN, THERE'S MANY ML ALGORITHM 4579 02:59:44,794 --> 02:59:48,298 TIMES, A LOT COMPARE MODELS AND 4580 02:59:48,298 --> 02:59:49,933 USE THE BEST PERFORMING ONES. 4581 02:59:49,933 --> 02:59:59,676 THAT PERFORMANCE IS JUDGED USING 4582 02:59:59,676 --> 03:00:00,076 METRICS. 4583 03:00:00,076 --> 03:00:00,977 SENSITIVITY, SPECIFICITIES, 4584 03:00:00,977 --> 03:00:02,278 ACCURACY. 4585 03:00:02,278 --> 03:00:04,814 IT'S INTERESTING TO THINK ABOUT 4586 03:00:04,814 --> 03:00:06,349 METRICS IN MEANINGFUL CLINICAL 4587 03:00:06,349 --> 03:00:07,117 TERMS. 4588 03:00:07,117 --> 03:00:09,419 NOT ALL STUDIES CAN EXPLAIN FOR 4589 03:00:09,419 --> 03:00:10,854 EXAMPLE PREDICTION ACCURACY AS 4590 03:00:10,854 --> 03:00:16,326 PERFORMANCE METRIC IN THAT 4591 03:00:16,326 --> 03:00:16,893 MEANINGFUL CONTEXT. 4592 03:00:16,893 --> 03:00:20,029 IF WE'RE SAYING HYPERTENSION IS 4593 03:00:20,029 --> 03:00:22,232 UNDERDIAGNOSED AND USING A 4594 03:00:22,232 --> 03:00:23,867 DATASET THAT DOESN'T ACTUALLY 4595 03:00:23,867 --> 03:00:29,506 REFLECT THE TRUE PREVALENCE OF 4596 03:00:29,506 --> 03:00:33,076 HYPERTENSION, ACCURACY OF 99.5% 4597 03:00:33,076 --> 03:00:35,812 HELPFUL, PREDICTIVE? 4598 03:00:35,812 --> 03:00:38,214 ALSO IS THAT MAYBE AN OVERFIT 4599 03:00:38,214 --> 03:00:40,416 ALGORITHM, USING TOO MANY 4600 03:00:40,416 --> 03:00:41,484 FACTORS, BUT IT'S A COMPLEX 4601 03:00:41,484 --> 03:00:44,120 QUESTION BUT ALL OF THESE SORTS 4602 03:00:44,120 --> 03:00:47,791 OF ASPECTS OF ALGORITHM 4603 03:00:47,791 --> 03:00:48,625 DEVELOPMENT ARE IMPORTANT. 4604 03:00:48,625 --> 03:00:50,126 THIS TRANSITIONS TO THE NEXT 4605 03:00:50,126 --> 03:00:52,328 MODEL TYPE WE TALKED ABOUT, 4606 03:00:52,328 --> 03:00:54,631 REGRESSION PLOD ALSO THAT INTAKE 4607 03:00:54,631 --> 03:00:57,467 SIGNALS TO OUTPUT A NUMBER. 4608 03:00:57,467 --> 03:01:04,240 WE HAD THE OPPORTUNITY TO 4609 03:01:04,240 --> 03:01:07,443 DIVERSITY DEEPER. 4610 03:01:07,443 --> 03:01:16,186 THE ADVANTAGE IS THEY CAN SERVE 4611 03:01:16,186 --> 03:01:20,223 AS PROXY, BE CONTINUOUS, 4612 03:01:20,223 --> 03:01:24,727 NON-INVASIVE, WITH ECG AND PPG 4613 03:01:24,727 --> 03:01:26,162 BEING MOST COMMONLY USED 4614 03:01:26,162 --> 03:01:28,464 PREDICTORS, OTHER SIGNALS USED 4615 03:01:28,464 --> 03:01:28,898 AS WELL. 4616 03:01:28,898 --> 03:01:31,534 AGAIN, THERE ARE MANY MODELS 4617 03:01:31,534 --> 03:01:35,271 USING A COMBINATION OF SIGNAL 4618 03:01:35,271 --> 03:01:38,107 DATA, PERFORMANCE METRICS I HAVE 4619 03:01:38,107 --> 03:01:39,542 HERE MEAN ABSOLUTE ERROR CAN 4620 03:01:39,542 --> 03:01:39,843 VARY. 4621 03:01:39,843 --> 03:01:44,681 ERROR OF 11 IS MAYBE NOT HELPFUL 4622 03:01:44,681 --> 03:01:46,649 PRACTICALLY SPEAKING BUT 2 COULD 4623 03:01:46,649 --> 03:01:49,052 BE MORE USEFUL. 4624 03:01:49,052 --> 03:01:51,554 IT'S INTERESTING TO NOTE THAT 4625 03:01:51,554 --> 03:01:52,856 SOME OF THESE DATASETS 4626 03:01:52,856 --> 03:01:56,292 INCORPORATE MORE OF THE EHR TYPE 4627 03:01:56,292 --> 03:01:58,027 DATA, SOME LESS. 4628 03:01:58,027 --> 03:02:00,096 AND IDEALLY WE WOULD LOVE RICH 4629 03:02:00,096 --> 03:02:04,400 DATASETS THAT HAVE ALL DIFFERENT 4630 03:02:04,400 --> 03:02:06,769 TYPES OF DATA TYPES. 4631 03:02:06,769 --> 03:02:09,873 SIMILARLY THERE ARE HANDFULS OF 4632 03:02:09,873 --> 03:02:11,407 MOVED ALSO THAT ARE VERY 4633 03:02:11,407 --> 03:02:15,011 INTERESTING WHEN WE THINK OF 4634 03:02:15,011 --> 03:02:15,778 HYPERTENSION DETECTION AND 4635 03:02:15,778 --> 03:02:16,246 DIAGNOSIS. 4636 03:02:16,246 --> 03:02:18,615 THERE ARE MODELS THAT USE 4637 03:02:18,615 --> 03:02:21,684 UNSUPERVISED LEARNING TO PREDICT 4638 03:02:21,684 --> 03:02:22,552 DIFFERENT HYPERTENSION 4639 03:02:22,552 --> 03:02:23,086 PHENOTYPES. 4640 03:02:23,086 --> 03:02:26,289 OTHERS BETWEEN PRIMARY AND 4641 03:02:26,289 --> 03:02:27,824 SECONDARY HYPERTENSION, FURTHER 4642 03:02:27,824 --> 03:02:29,792 DISTINGUISH BETWEEN ETIOLOGY OF 4643 03:02:29,792 --> 03:02:30,660 ENDOCRINE HYPERTENSION, FOR 4644 03:02:30,660 --> 03:02:31,094 EXAMPLE. 4645 03:02:31,094 --> 03:02:33,830 THERE ARE ALGORITHMS THAT USE 4646 03:02:33,830 --> 03:02:36,900 OMIC DATA TO PREDICT 4647 03:02:36,900 --> 03:02:37,901 HYPERTENSION THROUGH VARIOUS 4648 03:02:37,901 --> 03:02:39,535 MODELS, LOOKING AT GENES 4649 03:02:39,535 --> 03:02:39,869 SPECIFICALLY. 4650 03:02:39,869 --> 03:02:42,372 AND OF COURSE THERE ARE MODELS 4651 03:02:42,372 --> 03:02:43,806 IN RESEARCH TO IDENTIFY VARIOUS 4652 03:02:43,806 --> 03:02:48,177 RISK FACTORS THAT WE MIGHT BE 4653 03:02:48,177 --> 03:02:48,611 MISSING. 4654 03:02:48,611 --> 03:02:50,046 AND THESE TOPICS I MENTION 4655 03:02:50,046 --> 03:02:51,881 REPRESENT SOME OF THE MORE 4656 03:02:51,881 --> 03:02:54,284 INTERESTING SCIENTIFIC AREAS OF 4657 03:02:54,284 --> 03:02:57,287 STUDY WITHIN HYPERTENSION. 4658 03:02:57,287 --> 03:03:00,657 IF WE CAN EFFECTIVELY INTEGRATE 4659 03:03:00,657 --> 03:03:02,859 MULTIOMIC DATA FROM DIFFERENT 4660 03:03:02,859 --> 03:03:06,329 SOURCES LIKE EHR, GENOME 4661 03:03:06,329 --> 03:03:08,665 DATABASES, IMAGING, 4662 03:03:08,665 --> 03:03:09,565 CARDIOVASCULAR IMAGING, WEARABLE 4663 03:03:09,565 --> 03:03:14,671 DEVICE, EVEN ENVIRONMENTAL AND 4664 03:03:14,671 --> 03:03:18,608 BEHAVIORAL DATA WE CAN LEVERAGE 4665 03:03:18,608 --> 03:03:20,376 TO ELUCIDATE EVEN DEEPER 4666 03:03:20,376 --> 03:03:20,677 INSIGHTS. 4667 03:03:20,677 --> 03:03:23,646 AND THOSE INCLUDE THINGS I 4668 03:03:23,646 --> 03:03:24,180 MENTIONED. 4669 03:03:24,180 --> 03:03:25,648 UNCOVERING NEW RISK FACTORS, 4670 03:03:25,648 --> 03:03:27,050 SHIFTING DIAGNOSIS AND TREATMENT 4671 03:03:27,050 --> 03:03:33,923 TO BE MORE PRECISE AND 4672 03:03:33,923 --> 03:03:34,824 PERSONALIZED ESPECIALLY, WITH 4673 03:03:34,824 --> 03:03:35,625 CUTOFFS FOR DIAGNOSIS. 4674 03:03:35,625 --> 03:03:38,661 WE CAN BETTER UNDERSTAND FACTORS 4675 03:03:38,661 --> 03:03:39,429 THAT CONTRIBUTE TO TREATMENT 4676 03:03:39,429 --> 03:03:41,331 SUCCESS AND THE HOPE IS THE 4677 03:03:41,331 --> 03:03:42,932 FUTURE INVESTIGATIONS WILL BE 4678 03:03:42,932 --> 03:03:46,336 ABLE TO EXPAND UPON AND VALIDATE 4679 03:03:46,336 --> 03:03:50,740 ABILITY OF A.I. TO DIAGNOSE 4680 03:03:50,740 --> 03:03:51,808 HYPERTENSION AND PREDICT BLOOD 4681 03:03:51,808 --> 03:03:52,075 PRESSURE. 4682 03:03:52,075 --> 03:03:55,178 THERE ARE MANY GAPS THAT NEED TO 4683 03:03:55,178 --> 03:03:57,680 BE FILLED, MANY ARE NOT JUST 4684 03:03:57,680 --> 03:03:59,549 SPECIFIC TO HYPERTENSION. 4685 03:03:59,549 --> 03:04:03,386 I TOOK THE BROAD APPROACH OF 4686 03:04:03,386 --> 03:04:04,921 WHAT IS HINDERING FROM 4687 03:04:04,921 --> 03:04:06,789 PERSPECTIVE THAT COULD BE 4688 03:04:06,789 --> 03:04:08,858 APPLIED TO OTHER DISEASES AND 4689 03:04:08,858 --> 03:04:09,258 CONTEXTS. 4690 03:04:09,258 --> 03:04:12,028 WE'VE BEEN ABLE TO TALK ABOUT 4691 03:04:12,028 --> 03:04:14,564 SOCIAL DETERMINANTS OF HEALTH, 4692 03:04:14,564 --> 03:04:16,966 NEEDS THAT THESE ARE EXPLORED IN 4693 03:04:16,966 --> 03:04:17,600 CONJUNCTION WITH CONTRIBUTING 4694 03:04:17,600 --> 03:04:18,067 FACTORS. 4695 03:04:18,067 --> 03:04:23,539 THERE'S A HUGE NEED FOR NEW 4696 03:04:23,539 --> 03:04:26,275 DATASETS THAT INCORPORATE SDOH 4697 03:04:26,275 --> 03:04:26,476 DATA. 4698 03:04:26,476 --> 03:04:29,112 IT'S VERY COMPLEX BUT IMPORTANT 4699 03:04:29,112 --> 03:04:32,949 TO ADDRESS SO WE CAN RECTIFY THE 4700 03:04:32,949 --> 03:04:34,150 PROBLEMS OF UNDERDIAGNOSIS IN 4701 03:04:34,150 --> 03:04:35,685 OUR DATA, FOR EXAMPLE. 4702 03:04:35,685 --> 03:04:41,691 THERE ARE ALSO DOZENS OF 4703 03:04:41,691 --> 03:04:43,326 STUDIES, FEW EXTERNALLY 4704 03:04:43,326 --> 03:04:44,761 VALIDATED THROUGH CLINICAL 4705 03:04:44,761 --> 03:04:45,962 PERSPECTIVE STUDIES EVEN AT 4706 03:04:45,962 --> 03:04:46,396 DIFFERENT SITES. 4707 03:04:46,396 --> 03:04:49,465 WE NEED TO UNDERSTAND HOW THESE 4708 03:04:49,465 --> 03:04:53,069 MODELS PERFORM IN THE REAL 4709 03:04:53,069 --> 03:04:53,636 WORLD. 4710 03:04:53,636 --> 03:04:55,838 AND MODELS DO NOT INCLUDE BIAS 4711 03:04:55,838 --> 03:04:56,472 ANALYSIS WHICH MAKES THEM 4712 03:04:56,472 --> 03:04:58,474 DIFFICULT TO UNDERSTAND IN THE 4713 03:04:58,474 --> 03:04:59,542 CONTEXT OF CERTAIN SUBGROUPS. 4714 03:04:59,542 --> 03:05:01,844 IF WE DON'T UNDERSTAND HOW 4715 03:05:01,844 --> 03:05:04,147 MODELS PERFORM WITHIN DIVERSITY 4716 03:05:04,147 --> 03:05:06,549 WENT GROUPS WE CAN POTENTIALLY 4717 03:05:06,549 --> 03:05:14,424 DELIVER WORSE CARE AND CAUSE 4718 03:05:14,424 --> 03:05:15,625 HARM. 4719 03:05:15,625 --> 03:05:17,160 ALSO CHALLENGES, TECHNICAL 4720 03:05:17,160 --> 03:05:19,929 LIMITATIONS IN THAT THESE 4721 03:05:19,929 --> 03:05:21,464 DATASETS ARE LIMITED. 4722 03:05:21,464 --> 03:05:24,534 REPRESENT A SINGULAR POPULATION, 4723 03:05:24,534 --> 03:05:25,635 UNCLEAR DATA QUALITY. 4724 03:05:25,635 --> 03:05:28,805 NOT MANY WAYS TO ADDRESS DATA 4725 03:05:28,805 --> 03:05:30,206 QUALITY CURRENTLY. 4726 03:05:30,206 --> 03:05:32,275 ALSO THESE ALGORITHMS ARE 4727 03:05:32,275 --> 03:05:33,743 TRAINED ON RETROSPECTIVE DATA 4728 03:05:33,743 --> 03:05:37,680 WHICH HAS ITS OWN ISSUES. 4729 03:05:37,680 --> 03:05:39,982 THEY ARE DIFFICULT TO REPRODUCE, 4730 03:05:39,982 --> 03:05:42,151 REQUIRES SHARING A LOT OF 4731 03:05:42,151 --> 03:05:44,353 INFORMATION WHICH IS DIFFICULT 4732 03:05:44,353 --> 03:05:49,058 TO DO AND THAT'S HOW FEDERATED 4733 03:05:49,058 --> 03:05:53,996 NETWORKS ARE INTERESTED. 4734 03:05:53,996 --> 03:05:56,599 FINALLY MANY ADOPTION 4735 03:05:56,599 --> 03:05:57,967 CHALLENGES, TRANSPARENT AND 4736 03:05:57,967 --> 03:05:58,634 EXPLAINABILITY MOST SIGNIFICANT, 4737 03:05:58,634 --> 03:05:59,802 A LOT OF INTERESTING WORK GOING 4738 03:05:59,802 --> 03:06:02,738 ON IN HOW WE CAN ADDRESS THESE 4739 03:06:02,738 --> 03:06:06,909 NEEDS BUT IT'S VERY COMPLEX. 4740 03:06:06,909 --> 03:06:08,778 THE MORE COMPLEX THE MODEL, THE 4741 03:06:08,778 --> 03:06:11,481 MORE DIFFICULT TO EXPLAIN. 4742 03:06:11,481 --> 03:06:17,220 AS A CLINICIAN, IT'S HARD. 4743 03:06:17,220 --> 03:06:20,756 AND WORKFLOW INTEGRATION ISSUES 4744 03:06:20,756 --> 03:06:23,893 WE'LL TALK ABOUT LATER. 4745 03:06:23,893 --> 03:06:25,328 MAYO CLINIC PLATFORM IS TRYING 4746 03:06:25,328 --> 03:06:26,529 TO ADDRESS CHALLENGES. 4747 03:06:26,529 --> 03:06:29,398 SOME DATA CHALLENGES THROUGH 4748 03:06:29,398 --> 03:06:31,234 DISTRIBUTIVE DATA NETWORK WHERE 4749 03:06:31,234 --> 03:06:35,271 WITH COMMON DATA MODEL AND 4750 03:06:35,271 --> 03:06:36,906 QUALITY CONTROL MECHANISMS, AND 4751 03:06:36,906 --> 03:06:39,108 SOLUTION DISCOVERY, OPENING UP 4752 03:06:39,108 --> 03:06:41,177 THESE DATA SOURCES BY 4753 03:06:41,177 --> 03:06:42,612 DE-IDENTIFYING, SO ALLOWING 4754 03:06:42,612 --> 03:06:46,582 OTHER PEOPLE TO TEST AND 4755 03:06:46,582 --> 03:06:46,949 INNOVATE. 4756 03:06:46,949 --> 03:06:48,417 VALIDATION IS SOMETHING WE'RE 4757 03:06:48,417 --> 03:06:51,821 TRYING TO TACKLE, NOT ONLY 4758 03:06:51,821 --> 03:06:53,789 MATHEMATICALLY BUT IN THE LENS 4759 03:06:53,789 --> 03:06:54,857 OF BIAS AND CLINICAL 4760 03:06:54,857 --> 03:06:55,458 INTERPRETATION. 4761 03:06:55,458 --> 03:07:02,865 SO WHAT DOES IT MEAN FOR CARE? 4762 03:07:02,865 --> 03:07:04,467 AND WORKFLOW AND DEPLOYMENT, HOW 4763 03:07:04,467 --> 03:07:05,735 DO WE GET THE RIGHT PREDICTION 4764 03:07:05,735 --> 03:07:07,570 AT THE RIGHT TIME AND KEEP 4765 03:07:07,570 --> 03:07:11,974 INVENTORY OF HOW THAT MODEL IS 4766 03:07:11,974 --> 03:07:12,275 PERFORMING. 4767 03:07:12,275 --> 03:07:14,043 SO, THAT'S ALL I HAVE. 4768 03:07:14,043 --> 03:07:15,411 THANK YOU SO MUCH FOR INVITING 4769 03:07:15,411 --> 03:07:16,546 ME TO SPEAK. 4770 03:07:16,546 --> 03:07:19,849 I LOOK FORWARD TO FURTHER 4771 03:07:19,849 --> 03:07:20,149 DISCUSSION. 4772 03:07:20,149 --> 03:07:25,288 >> THANK YOU VERY MUCH. 4773 03:07:25,288 --> 03:07:26,923 WE'RE RUNNING BEHIND BUT WE'LL 4774 03:07:26,923 --> 03:07:28,691 HAVE TIME FOR A FEW QUESTIONS. 4775 03:07:28,691 --> 03:07:30,226 THOSE WHO NEED A BREAK, FEEL 4776 03:07:30,226 --> 03:07:30,560 FREE. 4777 03:07:30,560 --> 03:07:32,595 WE'LL BE STARTING AGAIN IN 4778 03:07:32,595 --> 03:07:35,798 APPROXIMATELY 10 TO 15 MINUTES. 4779 03:07:35,798 --> 03:07:38,034 WE KNOW THAT WE HAVE TO 4780 03:07:38,034 --> 03:07:39,068 COMMUNICATE WITH PATIENTS TO 4781 03:07:39,068 --> 03:07:40,603 MAKE SURE THE BLOOD PRESSURES 4782 03:07:40,603 --> 03:07:43,739 THAT ARE DONE OUTSIDE THE OFFICE 4783 03:07:43,739 --> 03:07:44,273 ARE INCORPORATED. 4784 03:07:44,273 --> 03:07:46,142 HAVE YOU FOUND TRYING TO 4785 03:07:46,142 --> 03:07:49,545 INTEGRATE DIRECTLY INTO THE 4786 03:07:49,545 --> 03:07:50,846 HEALTH RECORD WORKS, THAT'S 4787 03:07:50,846 --> 03:07:52,248 SOMETHING THAT'S BEING DONE? 4788 03:07:52,248 --> 03:07:53,816 >> YEAH, IT DEPENDS ON THE 4789 03:07:53,816 --> 03:07:56,652 HEALTH CARE SYSTEM, RIGHT? 4790 03:07:56,652 --> 03:07:58,554 SO FOR SOME LARGE ACADEMIC 4791 03:07:58,554 --> 03:08:00,056 CENTERS, YES, THAT'S THE ABILITY 4792 03:08:00,056 --> 03:08:02,892 TO INTEGRATE THEM IN. 4793 03:08:02,892 --> 03:08:04,994 I THINK DATA WAS PRESENTED. 4794 03:08:04,994 --> 03:08:06,963 OTHER ACADEMIC CENTERS, IT'S NOT 4795 03:08:06,963 --> 03:08:11,100 POSSIBLE, BECAUSE OF THE IP 4796 03:08:11,100 --> 03:08:13,502 SECURITY CONCERNS OF PARTNERING 4797 03:08:13,502 --> 03:08:14,036 WITH PARTICULAR DEVICE 4798 03:08:14,036 --> 03:08:15,137 COMPANIES, ET CETERA. 4799 03:08:15,137 --> 03:08:19,475 IT'S BEEN A CHALLENGE, IN MY OWN 4800 03:08:19,475 --> 03:08:19,775 EXPERIENCE. 4801 03:08:19,775 --> 03:08:21,277 IN NEW YORK CITY IT'S BEEN 4802 03:08:21,277 --> 03:08:23,479 DIFFICULT TO GET THE FULL 4803 03:08:23,479 --> 03:08:26,215 INTEGRATION IN THE WAY ONE WOULD 4804 03:08:26,215 --> 03:08:28,351 WANT IT TO BE. 4805 03:08:28,351 --> 03:08:29,585 >> UNDERSTOOD. 4806 03:08:29,585 --> 03:08:32,121 YOU MENTIONED SOME OF THE 4807 03:08:32,121 --> 03:08:35,324 DEVICES HAVE BEEN STUDIED AND 4808 03:08:35,324 --> 03:08:36,192 APPROVED, NOT NECESSARILY VALID. 4809 03:08:36,192 --> 03:08:37,693 IS THERE ANYTHING ON THE MARKET 4810 03:08:37,693 --> 03:08:39,895 RIGHT NOW THAT'S BOTH APPROVED 4811 03:08:39,895 --> 03:08:47,003 AND VALID IN TERMS OF MEASURING 4812 03:08:47,003 --> 03:08:48,204 BLOOD PRESSURE? 4813 03:08:48,204 --> 03:08:52,808 AND WHILE YOU'RE -- ARE YOU 4814 03:08:52,808 --> 03:08:54,510 THERE, DR. STERGIOU? 4815 03:08:54,510 --> 03:08:56,112 >> THERE'S NO DEVICE THAT 4816 03:08:56,112 --> 03:08:56,979 FULFILLS THE REQUIREMENT FOR 4817 03:08:56,979 --> 03:08:58,114 CLINICAL USE. 4818 03:08:58,114 --> 03:08:59,849 THE MAIN PROBLEM IS THEIR 4819 03:08:59,849 --> 03:09:04,120 ABILITY TO TRACK CHANGES IN 4820 03:09:04,120 --> 03:09:05,988 BLOOD PRESSURE. 4821 03:09:05,988 --> 03:09:11,560 I HAVEN'T SEEN ANY DATA TOWARDS 4822 03:09:11,560 --> 03:09:13,195 TECHNOLOGY, BLOOD PRESSURE WITH 4823 03:09:13,195 --> 03:09:15,831 TREATMENT IS GOING TO TRACK 4824 03:09:15,831 --> 03:09:17,800 BLOOD PRESSURE CHANGE IN THESE 4825 03:09:17,800 --> 03:09:20,436 PATIENTS, IN WHOM THERE'S 4826 03:09:20,436 --> 03:09:21,637 NOTHING ELSE CHANGED ABOUT THE 4827 03:09:21,637 --> 03:09:23,072 BLOOD PRESSURE, AND THESE ARE 4828 03:09:23,072 --> 03:09:27,009 THE PROBLEMS WITH PREDICTING THE 4829 03:09:27,009 --> 03:09:28,978 BLOOD PRESSURE BECAUSE WE CHANGE 4830 03:09:28,978 --> 03:09:31,047 BLOOD PRESSURE WEEKEND NOTHING 4831 03:09:31,047 --> 03:09:32,248 ELSE. 4832 03:09:32,248 --> 03:09:37,386 I HAVEN'T SEEN DEVICES WHICH CAN 4833 03:09:37,386 --> 03:09:38,054 TRACK APPROPRIATELY NOCTURNALLY, 4834 03:09:38,054 --> 03:09:41,657 THIS IS WHAT WE DO IN CLINICAL 4835 03:09:41,657 --> 03:09:41,924 PRACTICE. 4836 03:09:41,924 --> 03:09:42,758 >> DR. WHELTON, WE'VE HAD 4837 03:09:42,758 --> 03:09:46,262 PERSONAL DISCUSSIONS IN THE 4838 03:09:46,262 --> 03:09:49,332 CHAT, MULTIPLE CONVERSATIONS, 4839 03:09:49,332 --> 03:09:50,733 WHY PERSISTENT POOR CONTROL IN 4840 03:09:50,733 --> 03:09:52,535 BLACK AMERICAN POPULATION, 4841 03:09:52,535 --> 03:09:54,937 DOESN'T SEEM TO BE GOING AWAY, 4842 03:09:54,937 --> 03:09:56,238 PERSISTENT FOR DECADES, WE DON'T 4843 03:09:56,238 --> 03:09:58,541 SEE IMPROVEMENT. 4844 03:09:58,541 --> 03:09:58,941 WHAT'S THE REASON? 4845 03:09:58,941 --> 03:10:01,711 >> YOU'RE MORE OF AN EXPERT THAN 4846 03:10:01,711 --> 03:10:03,579 ANYBODY ON THIS, CERTAINLY THAN 4847 03:10:03,579 --> 03:10:04,447 ME ON THIS CALL. 4848 03:10:04,447 --> 03:10:10,019 ON THE ONE HAND WE HAVE SEEN 4849 03:10:10,019 --> 03:10:15,024 SOME IMPROVEMENTS, YOU CAN TAKE 4850 03:10:15,024 --> 03:10:19,962 SOME CREDIT, WE SAW IMPROVEMENTS 4851 03:10:19,962 --> 03:10:22,064 IN AWARENESS, TREATMENT. 4852 03:10:22,064 --> 03:10:27,970 BUT STILL VERY, VERY POOR. 4853 03:10:27,970 --> 03:10:29,271 AWARENESS GOING DOWN. 4854 03:10:29,271 --> 03:10:31,240 TREATMENT POOR CONTROL, VERY 4855 03:10:31,240 --> 03:10:31,540 SUBSTANDARD. 4856 03:10:31,540 --> 03:10:34,410 PROBABLY HAS A LOT DO WITH THE 4857 03:10:34,410 --> 03:10:36,612 SOCIAL DETERMINANTS OF HEALTH. 4858 03:10:36,612 --> 03:10:37,913 IT REALLY UNDERLIES THE PROBLEM. 4859 03:10:37,913 --> 03:10:39,782 IT IS A VERY DIFFICULT AREA TO 4860 03:10:39,782 --> 03:10:42,284 TACKLE, AS YOU WELL KNOW. 4861 03:10:42,284 --> 03:10:45,020 I THINK THE SAD THING IS WE HAVE 4862 03:10:45,020 --> 03:10:48,524 MODELS THAT WE KNOW WORK. 4863 03:10:48,524 --> 03:10:49,392 THEY WORK IN NON-HISPANIC 4864 03:10:49,392 --> 03:10:51,360 BLACKS, JUST AS WELL AS IN 4865 03:10:51,360 --> 03:10:51,594 WHITES. 4866 03:10:51,594 --> 03:10:54,330 THEY WORK ALL OVER THE WORLD. 4867 03:10:54,330 --> 03:10:56,298 AND TRICK REALLY IS NOT ONLY TO 4868 03:10:56,298 --> 03:10:57,733 UNDERSTAND THAT MODEL BUT TO 4869 03:10:57,733 --> 03:10:59,668 IMPLEMENT IT. 4870 03:10:59,668 --> 03:11:01,437 THAT'S WHAT HAPPENS IN PRACTICE. 4871 03:11:01,437 --> 03:11:02,104 THERE'S NOT PROPER 4872 03:11:02,104 --> 03:11:04,373 IMPLEMENTATION OF WHAT WE KNOW 4873 03:11:04,373 --> 03:11:06,175 WORKS. 4874 03:11:06,175 --> 03:11:07,176 AND THAT'S THE FRUSTRATION OF 4875 03:11:07,176 --> 03:11:08,344 DOING ANY OF THE TRIALS. 4876 03:11:08,344 --> 03:11:12,047 YOU AND I GO BACK TO THE DAYS OF 4877 03:11:12,047 --> 03:11:13,916 BAHAD, WE'VE SEEN MANY EFFICACY 4878 03:11:13,916 --> 03:11:15,418 TRIALS, MOST RECENTLY SPRINT 4879 03:11:15,418 --> 03:11:17,420 THAT DEMONSTRATED WITHOUT 4880 03:11:17,420 --> 03:11:18,921 QUESTION THE BENEFIT OF A 4881 03:11:18,921 --> 03:11:22,124 TREATMENT, AND WE'VE SEEN THAT 4882 03:11:22,124 --> 03:11:23,959 LARGELY IGNORED IN CLINICAL 4883 03:11:23,959 --> 03:11:26,629 PRACTICE, VERY FRUSTRATING AND 4884 03:11:26,629 --> 03:11:29,365 WORSE OBVIOUSLY IN 4885 03:11:29,365 --> 03:11:31,901 HISPANIC/BLACK COMMUNITY THAN IN 4886 03:11:31,901 --> 03:11:34,970 OTHER RACE/ETHNICITY GROUPS IN 4887 03:11:34,970 --> 03:11:35,905 THE U.S. 4888 03:11:35,905 --> 03:11:38,007 >> THIS IS NOT JUST A NUMBER. 4889 03:11:38,007 --> 03:11:41,944 IT HAS A POWERFUL EFFECT ON 4890 03:11:41,944 --> 03:11:42,945 CARDIOVASCULAR OUTCOMES, MORE 4891 03:11:42,945 --> 03:11:44,380 STROKE, EARLIER HEART ATTACK, 4892 03:11:44,380 --> 03:11:45,681 MORE HEART FAILURE, MORE CHRONIC 4893 03:11:45,681 --> 03:11:46,115 KIDNEY DISEASE. 4894 03:11:46,115 --> 03:11:48,717 SO THIS IS NOT JUST LOOKING AT 4895 03:11:48,717 --> 03:11:50,152 THE PERCENTAGE OF POPULATION 4896 03:11:50,152 --> 03:11:54,323 THAT HAS CONTROL, IT TRANSLATES 4897 03:11:54,323 --> 03:11:59,995 INTO MORBIDITY AND MORTALITY. 4898 03:11:59,995 --> 03:12:05,234 DR. MAKHNI, VARIABILITY OF THE 4899 03:12:05,234 --> 03:12:06,902 HUMAN EXPERIENCE, HOW CAN YOU 4900 03:12:06,902 --> 03:12:09,405 PREDICT BASED ON CHANGES? 4901 03:12:09,405 --> 03:12:10,706 HUMANS CHANGE BEHAVIOR ALL THE 4902 03:12:10,706 --> 03:12:11,040 TIME. 4903 03:12:11,040 --> 03:12:12,141 WHATEVER DATA YOU'RE PUTTING IN, 4904 03:12:12,141 --> 03:12:13,676 TOMORROW MAY NOT BE VALID. 4905 03:12:13,676 --> 03:12:18,481 HOW DO YOU ADDRESS THAT? 4906 03:12:18,481 --> 03:12:19,281 >> COMPLEX QUESTION. 4907 03:12:19,281 --> 03:12:21,550 I THINK, YOU KNOW, WE MIGHT NOT 4908 03:12:21,550 --> 03:12:23,452 REALLY BE CLOSE TO FULLY BEING 4909 03:12:23,452 --> 03:12:24,987 ABLE TO ADDRESS THAT CONCERN. 4910 03:12:24,987 --> 03:12:27,823 BUT I THINK THERE ARE WAYS THAT 4911 03:12:27,823 --> 03:12:29,859 WE CAN BE MORE CREATIVE AND 4912 03:12:29,859 --> 03:12:32,261 CLEVER HOW WE INTEGRATE DATA 4913 03:12:32,261 --> 03:12:32,728 SOURCES. 4914 03:12:32,728 --> 03:12:35,030 SOME WORK GOING ON IN CHICAGO 4915 03:12:35,030 --> 03:12:37,766 THAT I WAS FORTUNATE TO BE 4916 03:12:37,766 --> 03:12:41,470 INVOLVED IN INVOLVED CONCEPT OF 4917 03:12:41,470 --> 03:12:43,439 SOCIO-DATA, DATA FROM OUR LIVED 4918 03:12:43,439 --> 03:12:44,740 ENVIRONMENT THAT, YOU KNOW, 4919 03:12:44,740 --> 03:12:47,610 INCLUDES NOT JUST CRIME BUT YOU 4920 03:12:47,610 --> 03:12:51,881 CAN GET DATASETS ON TRAFFIC AND 4921 03:12:51,881 --> 03:12:52,748 AIR POLLUTION. 4922 03:12:52,748 --> 03:12:55,918 AND THERE ARE SCENARIOS YOU CAN 4923 03:12:55,918 --> 03:12:59,321 IMAGINE HOW THAT SOCIAL AND 4924 03:12:59,321 --> 03:13:03,058 ENVIRONMENTAL DATA IN TANDEM 4925 03:13:03,058 --> 03:13:04,693 WITH CLINICAL AND OTHER SIGNAL 4926 03:13:04,693 --> 03:13:07,196 DATA POINTS WHERE MAYBE YOU CAN 4927 03:13:07,196 --> 03:13:08,430 CREATE A LONGITUDINAL 4928 03:13:08,430 --> 03:13:11,233 EXPERIENCE, AND KIND OF CREATE 4929 03:13:11,233 --> 03:13:13,869 PROXIES FOR CERTAIN ACTIVITIES, 4930 03:13:13,869 --> 03:13:17,940 SO MAYBE THERE'S A HIGHER BLOOD 4931 03:13:17,940 --> 03:13:19,575 PRESSURE LEVEL AT NIGHT WHEN A 4932 03:13:19,575 --> 03:13:21,010 CERTAIN PERSON GETS HOME FROM 4933 03:13:21,010 --> 03:13:25,948 WORK, IT'S A TOUGH AREA. 4934 03:13:25,948 --> 03:13:28,551 YOU CAN EXTRAPOLATE VARIOUS 4935 03:13:28,551 --> 03:13:30,753 INFERENCES ON THAT LIVED 4936 03:13:30,753 --> 03:13:31,053 EXPERIENCE. 4937 03:13:31,053 --> 03:13:32,821 >> A QUESTION IN THE CHAT, I'M 4938 03:13:32,821 --> 03:13:35,224 NOT SURE WHO MAY GIVE AN ANSWER. 4939 03:13:35,224 --> 03:13:39,962 ASKED ABOUT VALIDITY OF 4940 03:13:39,962 --> 03:13:42,164 ELECTRONIC EQUIPMENT USED BY 4941 03:13:42,164 --> 03:13:42,631 I-HEALTH. 4942 03:13:42,631 --> 03:13:44,366 DOES ANYONE KNOWN ABOUT I-HEALTH 4943 03:13:44,366 --> 03:13:47,736 AND THE EQUIPMENT? 4944 03:13:47,736 --> 03:13:49,939 NO ONE? 4945 03:13:49,939 --> 03:13:51,473 DR. ABDALLA, ONE THING WE DO IN 4946 03:13:51,473 --> 03:13:53,108 NEW ORLEANS, WE HAVE PILOT 4947 03:13:53,108 --> 03:13:56,045 STUDIES, NOT A BIG STUDY, 4948 03:13:56,045 --> 03:13:56,879 SELF-DEFINED AFRICAN AMERICANS 4949 03:13:56,879 --> 03:13:59,782 GAVE THEM VALID BLOOD PRESSURE 4950 03:13:59,782 --> 03:14:02,484 DEVICES AND NOT CALLING BUT 4951 03:14:02,484 --> 03:14:04,153 TEXTING, SOME MACHINES CAN 4952 03:14:04,153 --> 03:14:05,454 BLUETOOTH BLACK TO THE 4953 03:14:05,454 --> 03:14:06,989 TECHNICIAN, A MEDICAL STUDENT, I 4954 03:14:06,989 --> 03:14:09,959 DIDN'T DO A THING, SHOWED 4955 03:14:09,959 --> 03:14:10,926 INCREASE IN INHERENCE AND 4956 03:14:10,926 --> 03:14:12,261 CONTROL WITHOUT EVEN CALLING OR 4957 03:14:12,261 --> 03:14:13,228 TALKING TO THE PATIENT. 4958 03:14:13,228 --> 03:14:17,633 DO YOU THINK THAT'S GOING TO BE 4959 03:14:17,633 --> 03:14:20,135 A VALID WAY OF COMMUNICATIONS OF 4960 03:14:20,135 --> 03:14:20,402 PATIENTS? 4961 03:14:20,402 --> 03:14:22,204 >> MAYBE. 4962 03:14:22,204 --> 03:14:27,910 IT'S INTRIGUING DATA. 4963 03:14:27,910 --> 03:14:29,011 WE HAVEN'T DISCUSSED DIGITAL 4964 03:14:29,011 --> 03:14:29,244 DEVICE. 4965 03:14:29,244 --> 03:14:34,717 SOMEONE IN THE CHAT TALKED ABOT 4966 03:14:34,717 --> 03:14:34,917 THIS. 4967 03:14:34,917 --> 03:14:36,018 SOMETIMES THROWING TECHNOLOGY IS 4968 03:14:36,018 --> 03:14:38,287 PART OF THE SOLUTION BUT DOESN'T 4969 03:14:38,287 --> 03:14:40,723 GO BACK TO STRUCTURAL ISSUES. 4970 03:14:40,723 --> 03:14:42,124 ONLY A SMALL PROPORTION MAY BE 4971 03:14:42,124 --> 03:14:43,859 ABLE TO GET ACCESS OR BE 4972 03:14:43,859 --> 03:14:45,194 INVOLVED IN RESEARCH STUDIES BUT 4973 03:14:45,194 --> 03:14:47,496 REALLY THE QUESTION FOR ALL OF 4974 03:14:47,496 --> 03:14:49,565 US ON THIS CALL IS HOW DO WE 4975 03:14:49,565 --> 03:14:51,467 SCALE THIS AT LARGE, RIGHT? 4976 03:14:51,467 --> 03:14:54,536 NOT JUST IN, YOU KNOW, OUR U.S. 4977 03:14:54,536 --> 03:14:55,704 COMMUNITIES BUT ALSO GLOBALLY. 4978 03:14:55,704 --> 03:14:58,974 HYPERTENSION IS STILL THE 4979 03:14:58,974 --> 03:15:02,945 LEADING CAUSE OF MORTALITY 4980 03:15:02,945 --> 03:15:03,212 WORLDWIDE. 4981 03:15:03,212 --> 03:15:06,415 >> I HAVE A BIOWATCH ON NOW, I 4982 03:15:06,415 --> 03:15:07,583 USE IT FOR STEPS, HOW MANY STEMS 4983 03:15:07,583 --> 03:15:11,787 YOU TAKE -- HOW MANY STEPS YOU 4984 03:15:11,787 --> 03:15:13,656 TAKE A DAY. 4985 03:15:13,656 --> 03:15:15,524 YOU PUT COLD WATER ON THE 4986 03:15:15,524 --> 03:15:16,191 SELF-MONITORING BLOOD PRESSURE 4987 03:15:16,191 --> 03:15:17,826 BUT IS IT USEFUL, IS THERE ANY 4988 03:15:17,826 --> 03:15:23,832 DEVICE FOR BLOOD PRESSURE WE CAN 4989 03:15:23,832 --> 03:15:26,502 USE EVEN NOT VALIDATED 4990 03:15:26,502 --> 03:15:26,802 COMPLETELY? 4991 03:15:26,802 --> 03:15:29,838 >> I CANNOT FIND ANY POSITIVE 4992 03:15:29,838 --> 03:15:32,474 FEEDBACK FOR THE PRESENT TIME 4993 03:15:32,474 --> 03:15:34,343 ABOUT SOME PROMISES. 4994 03:15:34,343 --> 03:15:37,079 REALLY DEVICES CAN CHANGE 4995 03:15:37,079 --> 03:15:38,080 EVERYTHING. 4996 03:15:38,080 --> 03:15:39,181 REALLY, EVERYTHING. 4997 03:15:39,181 --> 03:15:41,250 AND CAN BE A GREAT IMPROVEMENT. 4998 03:15:41,250 --> 03:15:44,753 THAT'S WHY EVERYBODY LIKES THEM. 4999 03:15:44,753 --> 03:15:46,255 BUT IT DOESN'T SEEM THAT WHAT WE 5000 03:15:46,255 --> 03:15:50,325 HAVE FOR THE MOMENT CAN DO ANY 5001 03:15:50,325 --> 03:15:51,393 HELP. 5002 03:15:51,393 --> 03:15:54,797 THERE'S A DISCUSSION ABOUT THE 5003 03:15:54,797 --> 03:15:58,434 TRENDING DEVICES, THESE DEVICES 5004 03:15:58,434 --> 03:16:02,137 CANNOT MEASURE, IN THE WAY YOU 5005 03:16:02,137 --> 03:16:03,572 HAVE SET UP CLINICAL, I DON'T 5006 03:16:03,572 --> 03:16:09,812 SEE HOW THEY CAN BE USEFUL 5007 03:16:09,812 --> 03:16:10,145 UNFORTUNATELY. 5008 03:16:10,145 --> 03:16:12,548 MAYBE PREDICTION WHICH WE'RE NOT 5009 03:16:12,548 --> 03:16:15,617 FAMILIAR WITH THAT, WE WANT TO 5010 03:16:15,617 --> 03:16:18,554 MEASURE, NOT PREDICT, BUT MAYBE 5011 03:16:18,554 --> 03:16:22,524 PREDICTION IS MORE FEASIBLE FOR 5012 03:16:22,524 --> 03:16:24,927 SCREENING, BUT THE SENSORS BEING 5013 03:16:24,927 --> 03:16:29,198 ABSOLUTE MEASUREMENTS FOR US TO 5014 03:16:29,198 --> 03:16:30,733 USE FOR DECISION MAKING, IT 5015 03:16:30,733 --> 03:16:34,903 DOESN'T SEEM TO BE EASY, OR TOO 5016 03:16:34,903 --> 03:16:35,104 CLOSE. 5017 03:16:35,104 --> 03:16:36,071 >> THANK YOU. 5018 03:16:36,071 --> 03:16:38,807 I'M SMILING BECAUSE IN THE CHAT 5019 03:16:38,807 --> 03:16:40,676 I SPOKE ABOUT OUR VERY NICE 5020 03:16:40,676 --> 03:16:45,914 STUDY WHICH WE GAVE PATIENTS 5021 03:16:45,914 --> 03:16:47,683 DEVICES, SOMEBODY SAID TEXTING 5022 03:16:47,683 --> 03:16:49,651 IS NOT FOR EVERYBODY. 5023 03:16:49,651 --> 03:16:50,753 THERE ARE POSTPARTUM WOMEN THAT 5024 03:16:50,753 --> 03:16:54,123 GOT TIRED AND ASKED THEM TO 5025 03:16:54,123 --> 03:16:54,323 STOP. 5026 03:16:54,323 --> 03:16:55,557 THE HUMAN EXPERIENCE JUST 5027 03:16:55,557 --> 03:16:57,760 VARIES, DEPENDING ON THE 5028 03:16:57,760 --> 03:16:58,827 POPULATION, WHO YOU'RE STUDYING. 5029 03:16:58,827 --> 03:17:01,130 PAUL, YOU'LL HAVE THE LAST THREE 5030 03:17:01,130 --> 03:17:02,765 MINUTES, MAYBE TAKE TWO AND IF 5031 03:17:02,765 --> 03:17:03,999 ANYONE ELSE HAS SOMETHING ELSE 5032 03:17:03,999 --> 03:17:07,136 THEY CAN CHIP IN. 5033 03:17:07,136 --> 03:17:09,438 I'M STILL PERPLEXED, YOU HAVE 5034 03:17:09,438 --> 03:17:10,439 BLOOD PRESSURE CONTROL RATES 5035 03:17:10,439 --> 03:17:11,740 THAT IMPROVE THROUGHOUT THE 5036 03:17:11,740 --> 03:17:11,940 WORLD. 5037 03:17:11,940 --> 03:17:16,311 YOU SAID WORLDWIDE YOU MENTIONED 5038 03:17:16,311 --> 03:17:17,312 THE CHINA EXPERIENCE, 5039 03:17:17,312 --> 03:17:18,413 IMPROVEMENTS IN CONTROL. 5040 03:17:18,413 --> 03:17:19,515 WHY ARE WE NOT DOING IT IN THE 5041 03:17:19,515 --> 03:17:20,716 UNITED STATES? 5042 03:17:20,716 --> 03:17:22,618 I DON'T GET IT. 5043 03:17:22,618 --> 03:17:23,652 >> IT'S FRUSTRATING. 5044 03:17:23,652 --> 03:17:25,854 I WILL SAY ONE THING. 5045 03:17:25,854 --> 03:17:28,157 I DO A LOT OF GLOBAL HEALTH WORK 5046 03:17:28,157 --> 03:17:29,124 AROUND BLOOD PRESSURE. 5047 03:17:29,124 --> 03:17:33,629 AND ONE THING THAT YOU FIND IN 5048 03:17:33,629 --> 03:17:36,131 ALMOST EVERY REMOTE AREA, IT'S 5049 03:17:36,131 --> 03:17:38,567 NOT UNIVERSAL, BUT IT'S AN 5050 03:17:38,567 --> 03:17:42,037 iPHONE OR EQUIVALENT, YOU GO 5051 03:17:42,037 --> 03:17:46,141 INTO THE FLOATING VILLAGES IN 5052 03:17:46,141 --> 03:17:53,048 LAKE TITICAK A, THEY HAVE A SOLR 5053 03:17:53,048 --> 03:17:54,950 PANEL, TV, iPHONES, EVEN IN 5054 03:17:54,950 --> 03:17:55,884 SUB-SAHARAN AFRICA. 5055 03:17:55,884 --> 03:17:57,853 IN THE FUTURE IF THERE'S A WAY 5056 03:17:57,853 --> 03:17:59,822 TO REALLY GET iPHONES TO WORK, 5057 03:17:59,822 --> 03:18:03,091 I THINK THAT HAS MUCH BROADER 5058 03:18:03,091 --> 03:18:03,859 APPLICABILITY THAN WRIST WATCHES 5059 03:18:03,859 --> 03:18:06,595 WHICH PEOPLE AREN'T GOING TO BUY 5060 03:18:06,595 --> 03:18:09,998 BUT WILL BUY A MOBILE PHONE. 5061 03:18:09,998 --> 03:18:11,200 IT'S VERY FRUSTRATING. 5062 03:18:11,200 --> 03:18:13,502 THE QUESTION IS SO FRUSTRATING 5063 03:18:13,502 --> 03:18:15,437 BECAUSE WE KNOW WHAT WORKS. 5064 03:18:15,437 --> 03:18:18,307 WE HAVE THE EFFICACY STUDIES. 5065 03:18:18,307 --> 03:18:21,577 AND IT'S BEEN DARN DIFFICULT TO 5066 03:18:21,577 --> 03:18:21,910 IMPLEMENT. 5067 03:18:21,910 --> 03:18:23,779 WE KNOW WHEN IT'S DONE, IT'S NOT 5068 03:18:23,779 --> 03:18:24,546 THE MODEL. 5069 03:18:24,546 --> 03:18:25,747 THE MODEL WORKS. 5070 03:18:25,747 --> 03:18:30,552 WE KNOW WHEN IT'S DONE WITH A 5071 03:18:30,552 --> 03:18:33,722 HIGH LEVEL OF EXECUTION, IT 5072 03:18:33,722 --> 03:18:34,957 WORKS WONDERFULLY WELL. 5073 03:18:34,957 --> 03:18:37,659 THE CHINA STUDY WAS A GREAT 5074 03:18:37,659 --> 03:18:40,629 EXAMPLE, MORE THAN 21 5075 03:18:40,629 --> 03:18:42,297 MILLIMETERS OF MERCURY SYSTOLIC 5076 03:18:42,297 --> 03:18:43,498 DIFFERENCE, HUGE CARDIOVASCULAR 5077 03:18:43,498 --> 03:18:44,066 BENEFITS. 5078 03:18:44,066 --> 03:18:46,668 THE MOST RURAL OF RURAL AREAS. 5079 03:18:46,668 --> 03:18:49,705 AND WE'VE SEEN THE SAME THING IN 5080 03:18:49,705 --> 03:18:52,774 HIGH-INCOME COUNTRIES. 5081 03:18:52,774 --> 03:18:54,409 IT'S VERY FRUSTRATING TO SEE 5082 03:18:54,409 --> 03:18:57,679 THAT IT'S NOT HAPPENING, 5083 03:18:57,679 --> 03:19:00,883 FRUSTRATING TO SEE NO INTEREST 5084 03:19:00,883 --> 03:19:08,323 IN QUALITY OF MEASUREMENTS, 5085 03:19:08,323 --> 03:19:10,893 HEDIS WILL NOT TOUCH IT OR GET 5086 03:19:10,893 --> 03:19:14,463 OFF THE 140/90 GUIDELINE. 5087 03:19:14,463 --> 03:19:16,198 EVERYONE IS RECOMMENDING A LOWER 5088 03:19:16,198 --> 03:19:20,369 TARGET. 5089 03:19:20,369 --> 03:19:21,536 WE HAVE TO BE PERSISTENT. 5090 03:19:21,536 --> 03:19:23,705 >> THANK YOU TO THE PRESENTERS. 5091 03:19:23,705 --> 03:19:27,009 I'LL TURN IT BACK OVER TO DR. 5092 03:19:27,009 --> 03:19:27,242 SHIMBO. 5093 03:19:27,242 --> 03:19:28,677 >> THANK YOU. 5094 03:19:28,677 --> 03:19:29,311 WONDERFUL DISCUSSION. 5095 03:19:29,311 --> 03:19:31,546 WE HAVE RUN A LITTLE BIT BEHIND. 5096 03:19:31,546 --> 03:19:33,515 SO WE'RE GOING TO ASK PEOPLE TO 5097 03:19:33,515 --> 03:19:35,717 COME BACK, WE'LL TAKE A BREAK, 5098 03:19:35,717 --> 03:19:40,856 ASK PEOPLE TO COME BACK SHARP AT 5099 03:19:40,856 --> 03:19:42,925 2:45 EASTERN STANDARD TIME. 5100 03:19:42,925 --> 03:19:44,693 AT WHICH TIME WE'LL BEGIN 5101 03:19:44,693 --> 03:19:46,762 SESSION 3, THE FINAL SESSION 5102 03:19:46,762 --> 03:19:47,541 THIS AFTERNOON. 5103 03:19:47,541 --> 03:19:52,747 I THINK WE SHOULD GET 5104 03:19:52,747 --> 03:19:53,414 STARTED. 5105 03:19:53,414 --> 03:19:55,082 I'D LIKE TO OPEN SESSION 3, 5106 03:19:55,082 --> 03:19:59,186 MAKING A DENT IN THE PROBLEM. 5107 03:19:59,186 --> 03:20:01,856 WE STARTED WITH TECHNOLOGY AND 5108 03:20:01,856 --> 03:20:04,925 A.I. FOCUS, SESSION 2 SLANTED 5109 03:20:04,925 --> 03:20:06,594 TOWARD HYPERTENSION AND BLOOD 5110 03:20:06,594 --> 03:20:07,194 PRESSURE. 5111 03:20:07,194 --> 03:20:11,065 NOW WE ARE WELL EDUCATED ABOUT 5112 03:20:11,065 --> 03:20:12,066 A.I. AND HYPERTENSION, THE 5113 03:20:12,066 --> 03:20:12,933 PROBLEMS THERE. 5114 03:20:12,933 --> 03:20:16,103 THIS SESSION IS GOING TO FOCUS 5115 03:20:16,103 --> 03:20:19,273 ON A.I., INTERSECTION OF A.I. 5116 03:20:19,273 --> 03:20:19,673 AND HYPERTENSION. 5117 03:20:19,673 --> 03:20:24,211 I'D LIKE TO ASK OUR FIRST 5118 03:20:24,211 --> 03:20:34,688 SPEAKER, DR. JANE LEOPOLD TO 5119 03:20:35,022 --> 03:20:35,189 PRESENT. 5120 03:20:35,189 --> 03:20:36,791 ASSOCIATE PROFESSOR AT HARVARD 5121 03:20:36,791 --> 03:20:38,325 MEDICAL SCHOOL, DIRECTOR OF 5122 03:20:38,325 --> 03:20:40,861 CARDIOVASCULAR RESEARCH CORE OF 5123 03:20:40,861 --> 03:20:42,096 BRIGHAM AND WOMEN'S HOSPITAL. 5124 03:20:42,096 --> 03:20:42,396 WELCOME. 5125 03:20:42,396 --> 03:20:45,566 USING A.I. FOR PRIMARY 5126 03:20:45,566 --> 03:20:48,068 PREVENTION OF CV DISEASE WITH A 5127 03:20:48,068 --> 03:20:51,472 FOCUS ON HYPERTENSION, PRECISION 5128 03:20:51,472 --> 03:20:53,007 PUBLIC HEALTH. 5129 03:20:53,007 --> 03:20:53,507 THANK YOU AND WELCOME. 5130 03:20:53,507 --> 03:20:56,410 >> THANK YOU FOR THE KIND 5131 03:20:56,410 --> 03:20:58,179 INVITATION, TALKS SO FAR HAVE 5132 03:20:58,179 --> 03:20:59,914 BEEN FANTASTIC, I HOPE MY 5133 03:20:59,914 --> 03:21:01,882 DISCUSSION HERE ABOUT PRECISION 5134 03:21:01,882 --> 03:21:04,718 PUBLIC HEALTH WILL TIE IN WELL 5135 03:21:04,718 --> 03:21:07,488 WITH EVERYTHING. 5136 03:21:07,488 --> 03:21:08,556 THESE ARE MY DISCLOSURES. 5137 03:21:08,556 --> 03:21:14,662 AND SO IF WE'RE GOING TO TALK 5138 03:21:14,662 --> 03:21:15,896 ABOUTPRECISION MEDICINE WE HAVE 5139 03:21:15,896 --> 03:21:19,300 TO DEFINE IT. 5140 03:21:19,300 --> 03:21:20,935 IN OUR CURRENT TREATMENT SCHEME 5141 03:21:20,935 --> 03:21:22,870 MOST THERAPIES ARE DESIGNED FOR 5142 03:21:22,870 --> 03:21:25,206 THE AVERAGE PATIENT BASED ON 5143 03:21:25,206 --> 03:21:29,743 RESULTS FROM CLINICAL TRIALS. 5144 03:21:29,743 --> 03:21:31,979 HOWEVER, THIS ONE-SIZE-FITS-ALL 5145 03:21:31,979 --> 03:21:35,749 APPROACH MAY WORK FOR SOME, NOT 5146 03:21:35,749 --> 03:21:35,983 OTHERS. 5147 03:21:35,983 --> 03:21:41,088 IF YOU LOOK ATPRECISION MEDICINE 5148 03:21:41,088 --> 03:21:51,565 MED ASSIGN -- MEDICINE YOU 5149 03:21:52,233 --> 03:21:53,367 ACCOUNT FOR DIFFERENCES 5150 03:21:53,367 --> 03:21:54,235 REQUIRING DEEP PHENOTYPING. 5151 03:21:54,235 --> 03:21:55,436 WE WANT TO GET THE RIGHT 5152 03:21:55,436 --> 03:21:57,304 TREATMENT OR INTERVENTION TO THE 5153 03:21:57,304 --> 03:21:59,807 RIGHT PATIENT AT THE RIGHT TIME 5154 03:21:59,807 --> 03:22:00,975 FOR PRECISION PUBLIC HEALTH WE 5155 03:22:00,975 --> 03:22:03,444 WANT TO FOCUS ON THE HEALTHY 5156 03:22:03,444 --> 03:22:11,185 INDIVIDUALS AND THOSE AT RISK 5157 03:22:11,185 --> 03:22:11,952 FOR DISEASE. 5158 03:22:11,952 --> 03:22:14,154 THERE'S A CONTINUUM OF DISEASE, 5159 03:22:14,154 --> 03:22:16,790 INDIVIDUALS ARE EITHER IN IDEAL 5160 03:22:16,790 --> 03:22:18,325 HEALTH, DEVELOP RISK FACTORS FOR 5161 03:22:18,325 --> 03:22:22,496 A DISEASE OR ACTUALLY HAVE 5162 03:22:22,496 --> 03:22:23,797 ESTABLISHED DISEASE, AND THERE'S 5163 03:22:23,797 --> 03:22:25,099 VARYING GRADIENTS OF DISEASE 5164 03:22:25,099 --> 03:22:27,201 RISK OR SEVERITY WITHIN EACH OF 5165 03:22:27,201 --> 03:22:31,372 THE GROUPS, IT'S A SPECTRUM, BUT 5166 03:22:31,372 --> 03:22:33,440 THERE'S PLASTICITY IN THE 5167 03:22:33,440 --> 03:22:34,975 PHENOTYPES SO INDIVIDUALS CAN 5168 03:22:34,975 --> 03:22:36,610 TRANSITION BETWEEN GROUPS, AND 5169 03:22:36,610 --> 03:22:38,379 THIS CAN OCCUR EITHER OVER TIME 5170 03:22:38,379 --> 03:22:41,081 AND THIS WAS ALLUDED TO EARLIER, 5171 03:22:41,081 --> 03:22:45,519 OR IT CAN OCCUR IF WE CHANGE 5172 03:22:45,519 --> 03:22:47,488 DEFINITION OF WHAT CONSTITUTES 5173 03:22:47,488 --> 03:22:49,790 DISEASE AND HEALTH. 5174 03:22:49,790 --> 03:22:52,192 AS YOU CAN RECALL, THIS ACTUALLY 5175 03:22:52,192 --> 03:22:54,695 HAPPENED WHEN WE CHANGED THE 5176 03:22:54,695 --> 03:22:56,130 DEFINITION OF WHAT CONSTITUTES 5177 03:22:56,130 --> 03:22:58,332 HYPERTENSION, AND THE SAME THING 5178 03:22:58,332 --> 03:23:03,137 HAPPENED WHEN WE CHANGED 5179 03:23:03,137 --> 03:23:05,205 DEFINITION OF WHAT CONSTITUTES 5180 03:23:05,205 --> 03:23:07,207 HYPERCHOLESTEROL EMIA. 5181 03:23:07,207 --> 03:23:10,144 WE HAVE TO RECOGNIZE A LOT OF 5182 03:23:10,144 --> 03:23:12,246 HETEROGENEITY IN CARDIOVASCULAR 5183 03:23:12,246 --> 03:23:12,846 DISEASES. 5184 03:23:12,846 --> 03:23:15,616 SO HISTORICALLY WE USED TO THINK 5185 03:23:15,616 --> 03:23:17,718 THAT -- AND THIS IS QUITE A 5186 03:23:17,718 --> 03:23:20,354 WHILE AGO, THAT A DISEASE WAS 5187 03:23:20,354 --> 03:23:22,656 CAUSED BY A SINGLE GENE VARIANT 5188 03:23:22,656 --> 03:23:25,392 THAT MAY HAVE BEEN RESPONSIBLE 5189 03:23:25,392 --> 03:23:28,295 FOR MULTIPLE DIFFERENT TYPES OF 5190 03:23:28,295 --> 03:23:29,530 PHENOTYPES, AND THAT THIS IS 5191 03:23:29,530 --> 03:23:35,436 REALLY HOW WE ENDED UP WITH A 5192 03:23:35,436 --> 03:23:36,537 COMPLEX CARDIOVASCULAR 5193 03:23:36,537 --> 03:23:36,904 PATHOPHENOTYPE. 5194 03:23:36,904 --> 03:23:38,739 BUT THERE'S A LOT OF 5195 03:23:38,739 --> 03:23:39,740 HETEROGENEITY IN DISEASE. 5196 03:23:39,740 --> 03:23:42,910 IF YOU LOOK AT THESE 5197 03:23:42,910 --> 03:23:46,180 CARDIOVASCULAR PHENOTYPES, HERE 5198 03:23:46,180 --> 03:23:50,417 I HIGHLIGHTED ACUTE MYOCARDIAL 5199 03:23:50,417 --> 03:23:51,151 INFARCTION, CARDIOMYOPATHIES, 5200 03:23:51,151 --> 03:23:53,754 ALL OF THESE HAVE GENE VARIANTS 5201 03:23:53,754 --> 03:23:54,521 ASSOCIATED WITH THEM. 5202 03:23:54,521 --> 03:23:56,590 WE KNOW WHAT THE GENE VARIANTS 5203 03:23:56,590 --> 03:23:57,024 DO. 5204 03:23:57,024 --> 03:23:59,994 BUT IF YOU LOOK AT REALLY HOW 5205 03:23:59,994 --> 03:24:09,737 THEY EXPRESS THEMSELVES THEY CAN 5206 03:24:09,737 --> 03:24:11,038 HAVE DIFFERENT OUTWARD 5207 03:24:11,038 --> 03:24:13,674 PHENOTYPES, MORE COMPLICATED 5208 03:24:13,674 --> 03:24:16,010 THAN FOCUSING ON GENETICS ALONE. 5209 03:24:16,010 --> 03:24:17,845 WE TEND TO THINK OF THIS, 5210 03:24:17,845 --> 03:24:19,913 INCORPORATING THINGS THAT WE'VE 5211 03:24:19,913 --> 03:24:23,650 HEARD SEVERAL TIMES BEFORE 5212 03:24:23,650 --> 03:24:27,554 TODAY, THAT THERE'S BIOLOGICAL 5213 03:24:27,554 --> 03:24:30,090 RISK, THERE ARE POSSIBLE 5214 03:24:30,090 --> 03:24:33,494 ACQUIRED RISK FACTORS RELATED TO 5215 03:24:33,494 --> 03:24:35,262 OUR EXPOSURES, AND THERE'S 5216 03:24:35,262 --> 03:24:38,632 GENETIC VARIANTS THAT REALLY 5217 03:24:38,632 --> 03:24:45,806 COME TOGETHER TO CREATE 5218 03:24:45,806 --> 03:24:47,107 DIFFERENT ENDOPHENOTYPES, 5219 03:24:47,107 --> 03:24:49,410 INFORMING CARDIOVASCULAR 5220 03:24:49,410 --> 03:24:49,777 PATHOPHENOTYPE. 5221 03:24:49,777 --> 03:24:51,478 FOR ANYONE THAT DOESN'T BELIEVE 5222 03:24:51,478 --> 03:24:54,681 IN THE INTERACTION BETWEEN, SAY, 5223 03:24:54,681 --> 03:24:55,549 LIFESTYLE, EXPOSURES, GENETICS 5224 03:24:55,549 --> 03:24:57,651 AND HOW THEY MODIFY EACH OTHER, 5225 03:24:57,651 --> 03:25:02,122 THERE WAS A REALLY NICE ANALYSIS 5226 03:25:02,122 --> 03:25:04,358 DONE WHERE THEY POOLED TOGETHER 5227 03:25:04,358 --> 03:25:06,193 RESULTS FROM 50,000 PARTICIPANTS 5228 03:25:06,193 --> 03:25:09,997 FROM THREE STUDIES AND DEVELOPED 5229 03:25:09,997 --> 03:25:13,600 A POLYGENIC RISK SCORE FROM 50 5230 03:25:13,600 --> 03:25:15,302 SNPs ASSOCIATED WITH CORONARY 5231 03:25:15,302 --> 03:25:20,507 ARTERY DISEASE AND HAD DATA ON 5232 03:25:20,507 --> 03:25:24,978 LIFESTYLES, SO LOOKED AT TOBACCO 5233 03:25:24,978 --> 03:25:26,747 USE, WEIGHT, BMI, PATIENT DIET 5234 03:25:26,747 --> 03:25:28,282 AND PHYSICAL ACTIVITY, AND 5235 03:25:28,282 --> 03:25:30,350 CONSTRUCTED WHAT THEY CALLED A 5236 03:25:30,350 --> 03:25:34,088 LIFESTYLE SCORE. 5237 03:25:34,088 --> 03:25:35,189 EITHER FAVORABLE, INTERMEDIATE 5238 03:25:35,189 --> 03:25:35,656 OR UNFAVORABLE. 5239 03:25:35,656 --> 03:25:40,260 IN EACH OF THE WELL KNOWN 5240 03:25:40,260 --> 03:25:42,563 STUDIES, INDIVIDUALS WHO HAD 5241 03:25:42,563 --> 03:25:43,964 KNOWN GENETIC RISK ACTUALLY 5242 03:25:43,964 --> 03:25:47,401 COULD HAVE THAT GENETIC RISK 5243 03:25:47,401 --> 03:25:49,136 MODIFIED BY LIFESTYLE FACTORS. 5244 03:25:49,136 --> 03:25:50,871 SO, ALL OF THESE THINGS ARE 5245 03:25:50,871 --> 03:25:59,847 IMPORTANT AND THEY ALL COME INTO 5246 03:25:59,847 --> 03:26:00,147 PLAY. 5247 03:26:00,147 --> 03:26:02,483 IF YOU LOOK AT PRECISION 5248 03:26:02,483 --> 03:26:05,752 MEDICINE WE RECOGNIZE THAT AGAIN 5249 03:26:05,752 --> 03:26:07,287 PATIENTS WITH OUTWARD PHENOTYPES 5250 03:26:07,287 --> 03:26:08,689 SUCH AS HYPERTENSION WHO 5251 03:26:08,689 --> 03:26:11,358 APPEARED THE SAME ARE ACTUALLY A 5252 03:26:11,358 --> 03:26:13,327 MIXED GROUP OF INDIVIDUALS. 5253 03:26:13,327 --> 03:26:17,931 AND IF WE GO FORWARD AND WE DO 5254 03:26:17,931 --> 03:26:19,466 DEEP PHENOTYPING AND COLLECT A 5255 03:26:19,466 --> 03:26:23,303 LOT OF DATA, WE CAN THEN ANALYZE 5256 03:26:23,303 --> 03:26:25,472 IN MANY WAYS AND, AGAIN, THIS IS 5257 03:26:25,472 --> 03:26:27,241 JUST SHOWING A NETWORK ANALYSIS 5258 03:26:27,241 --> 03:26:30,644 BUT WE CAN USE THIS TO 5259 03:26:30,644 --> 03:26:33,814 SUBCATEGORIZE THE PATIENTS INTO 5260 03:26:33,814 --> 03:26:35,115 DIFFERENT CLUSTERS MORE ALIKE, 5261 03:26:35,115 --> 03:26:43,223 THIS MAY BE HELPFUL IN TERMS OF 5262 03:26:43,223 --> 03:26:45,425 IDENTIFYING BIOMARKERS FOR 5263 03:26:45,425 --> 03:26:47,494 MEDICATION DISTRIBUTION OR FOR 5264 03:26:47,494 --> 03:26:48,795 TAILORING DIFFERENT EXPOSURES 5265 03:26:48,795 --> 03:26:54,368 FOR THE PATIENTS. 5266 03:26:54,368 --> 03:26:56,470 THEY ALSO WILL HELP INFORM 5267 03:26:56,470 --> 03:26:57,471 ENROLLMENT IN CLINICAL STUDIES. 5268 03:26:57,471 --> 03:27:01,275 THE ISSUE THAT COMES UP WHEN YU 5269 03:27:01,275 --> 03:27:03,043 TALK ABOUT PRECISION PUBLIC 5270 03:27:03,043 --> 03:27:05,445 HEALTH DESPITE HAVING CLUSTERED 5271 03:27:05,445 --> 03:27:07,080 PHENOTYPES, WE REALLY WANT TO 5272 03:27:07,080 --> 03:27:10,184 KNOW WHAT CAN WE FIND OUT ABOUT 5273 03:27:10,184 --> 03:27:11,485 AN INDIVIDUAL PATIENT OR PERSON, 5274 03:27:11,485 --> 03:27:15,322 SO WHAT CAN WE FIND OUT ABOUT 5275 03:27:15,322 --> 03:27:16,456 THEIR INDIVIDUAL PHENOTYPE FROM 5276 03:27:16,456 --> 03:27:19,927 ALL OF THIS DATA TO HELP US DO 5277 03:27:19,927 --> 03:27:21,795 SOMETHING FOR THEM THAT WILL 5278 03:27:21,795 --> 03:27:25,199 PREVENT THEM FROM DEVELOPING 5279 03:27:25,199 --> 03:27:25,532 HYPERTENSION. 5280 03:27:25,532 --> 03:27:27,367 AND SO, YOU KNOW, ALONG WITH 5281 03:27:27,367 --> 03:27:28,468 DATA COLLECTION, AND ALL OF THE 5282 03:27:28,468 --> 03:27:32,272 WAYS THAT WE CAN GO FORWARD, AND 5283 03:27:32,272 --> 03:27:34,374 ANALYZE ALL THESE DATA, THERE'S 5284 03:27:34,374 --> 03:27:35,576 REALLY INTERESTING AND NEAT WAYS 5285 03:27:35,576 --> 03:27:36,877 TO PUT IT TOGETHER. 5286 03:27:36,877 --> 03:27:39,646 I KNOW THAT EARLIER WE TALKED A 5287 03:27:39,646 --> 03:27:41,715 LOT ABOUT DIFFERENT A.I. MODELS. 5288 03:27:41,715 --> 03:27:45,319 I ALSO PUT A PLUG IN HERE FOR 5289 03:27:45,319 --> 03:27:47,387 NETWORK MEDICINE WHICH USES SOME 5290 03:27:47,387 --> 03:27:54,194 SAME METHODOLOGY BUT LINKS 5291 03:27:54,194 --> 03:27:56,363 TOGETHER ALL OF THESE FACTORS. 5292 03:27:56,363 --> 03:28:01,969 THIS LOOKS LIKE REALLY AN IMAGE 5293 03:28:01,969 --> 03:28:03,370 OF HAIRBALLS THESE ARE 5294 03:28:03,370 --> 03:28:04,271 INDIVIDUAL PERSON-SPECIFIC 5295 03:28:04,271 --> 03:28:04,738 NETWORKS. 5296 03:28:04,738 --> 03:28:07,541 YOU CAN SEE HOW THEY LOOK 5297 03:28:07,541 --> 03:28:07,808 DIFFERENT. 5298 03:28:07,808 --> 03:28:10,944 THIS IS FROM 18 PATIENTS WHO ALL 5299 03:28:10,944 --> 03:28:14,214 HAVE THE SAME OUTWARD PHENOTYPE, 5300 03:28:14,214 --> 03:28:16,183 IN THIS CASE HYPERTROPHIC 5301 03:28:16,183 --> 03:28:16,550 CARDIOMYOPATHY. 5302 03:28:16,550 --> 03:28:18,051 NONE OF THEM HAD ANY OF THE 5303 03:28:18,051 --> 03:28:19,486 KNOWN MUTATIONS THAT WERE 5304 03:28:19,486 --> 03:28:20,354 ASSOCIATED WITH THE DISEASE. 5305 03:28:20,354 --> 03:28:23,290 AND IF YOU LOOK AT THE NETWORKS, 5306 03:28:23,290 --> 03:28:26,460 THEY ALL LOOK QUITE DIFFERENT. 5307 03:28:26,460 --> 03:28:27,661 SO, THERE'S VERY INTERESTING 5308 03:28:27,661 --> 03:28:32,165 WAYS TO FIND OUT THINGS ABOUT 5309 03:28:32,165 --> 03:28:32,599 INDIVIDUALS. 5310 03:28:32,599 --> 03:28:35,769 NOW, WE TALKED EARLIER ALSO 5311 03:28:35,769 --> 03:28:37,204 ABOUT DATA COLLECTION. 5312 03:28:37,204 --> 03:28:39,940 WHEN WE SEE OUR PATIENTS, WE 5313 03:28:39,940 --> 03:28:42,009 COLLECT A CERTAIN AMOUNT OF 5314 03:28:42,009 --> 03:28:44,745 DATA, AND THIS MAY BE COLLECTED 5315 03:28:44,745 --> 03:28:47,914 EITHER AT THE INITIAL 5316 03:28:47,914 --> 03:28:49,116 PRESENTATION OR OVER TIME, BUT 5317 03:28:49,116 --> 03:28:54,821 YOU CAN EITHER LOOK AT THIS 5318 03:28:54,821 --> 03:28:57,991 SAYING WE DO SEVEN OR EIGHT 5319 03:28:57,991 --> 03:28:59,660 TESTS, HISTORY AND PHYSICAL, 5320 03:28:59,660 --> 03:29:03,630 BLOOD WORKS, OR HAVE SEVEN OR 5321 03:29:03,630 --> 03:29:06,099 EIGHT TESTS, APPROXIMATELY 2,000 5322 03:29:06,099 --> 03:29:07,067 VARIABLES TO TRY TO UNDERSTAND 5323 03:29:07,067 --> 03:29:15,042 WHO IS AT RISK FOR DEVELOP 5324 03:29:15,042 --> 03:29:15,642 HYPERTENSION. 5325 03:29:15,642 --> 03:29:17,544 WE SEND ROUTINE LAB WORK, BUT 5326 03:29:17,544 --> 03:29:20,314 THE ROUTINE LAB WORK CAN 5327 03:29:20,314 --> 03:29:22,049 ACTUALLY, YOU KNOW, ALSO BE 5328 03:29:22,049 --> 03:29:23,817 INFORMATIVE, AND THIS CAN 5329 03:29:23,817 --> 03:29:26,553 ACTUALLY SERVE AS A LIQUID 5330 03:29:26,553 --> 03:29:27,020 BIOPSY. 5331 03:29:27,020 --> 03:29:28,622 SO, WHEN YOU CAN'T GET TISSUE, 5332 03:29:28,622 --> 03:29:29,856 WHEN YOU NEED TO PREDICT 5333 03:29:29,856 --> 03:29:31,925 SOMETHING THAT WILL HAPPEN IN 5334 03:29:31,925 --> 03:29:35,562 THE FUTURE, YOU CAN ACTUALLY USE 5335 03:29:35,562 --> 03:29:38,598 THESE SAMPLES FOR OMICS, WHICH 5336 03:29:38,598 --> 03:29:40,901 WAS AGAIN DISCUSSED EARLIER, AND 5337 03:29:40,901 --> 03:29:44,738 THESE TYPES OF STUDIES ARE 5338 03:29:44,738 --> 03:29:45,806 BECOMING MORE PREVALENT OWING TO 5339 03:29:45,806 --> 03:29:49,443 THE EASE AND ACCESSIBILITY OF 5340 03:29:49,443 --> 03:29:51,611 THE PLATFORMS, THE DECREASE IN 5341 03:29:51,611 --> 03:29:54,247 COST OVER TIME, INCREASE IN 5342 03:29:54,247 --> 03:29:55,982 SENSITIVITY, AND THE FACT THAT 5343 03:29:55,982 --> 03:30:00,487 THEY ARE BECOMING MORE 5344 03:30:00,487 --> 03:30:06,493 REPRODUCIBLE. 5345 03:30:06,493 --> 03:30:09,996 THERE'S AN IDEA HERE THAT 5346 03:30:09,996 --> 03:30:11,331 THERE'S A LOT OF DATA BUT WE 5347 03:30:11,331 --> 03:30:13,467 DON'T KNOW THE MINIMUM AMOUNT OF 5348 03:30:13,467 --> 03:30:16,370 DATA THAT WE NEED TO ACTUALLY 5349 03:30:16,370 --> 03:30:19,172 GET THE INFORMATION WE WANT. 5350 03:30:19,172 --> 03:30:21,842 AND THAT IS TO BE ABLE TO 5351 03:30:21,842 --> 03:30:25,746 PREDICT WHO WILL DEVELOP 5352 03:30:25,746 --> 03:30:26,847 INCIDENT HYPERTENSION, AND 5353 03:30:26,847 --> 03:30:27,447 SPECIFICALLY WHICH INDIVIDUALS 5354 03:30:27,447 --> 03:30:33,220 ARE AT RISK FOR IT. 5355 03:30:33,220 --> 03:30:34,855 SO WHILE WE'RE TALKING ABOUT 5356 03:30:34,855 --> 03:30:38,258 USING A.I. TO, YOU KNOW, EITHER 5357 03:30:38,258 --> 03:30:39,593 PREDICT WHO WILL DEVELOP 5358 03:30:39,593 --> 03:30:41,361 DISEASE, WHO HAS DISEASE, ET 5359 03:30:41,361 --> 03:30:43,296 CETERA, WE ALSO NEED TO 5360 03:30:43,296 --> 03:30:44,931 RECOGNIZE THAT OUR PATIENTS ARE 5361 03:30:44,931 --> 03:30:46,566 ACTUALLY AT HOME DOING EXACTLY 5362 03:30:46,566 --> 03:30:48,769 THE SAME THING, BUT IN A 5363 03:30:48,769 --> 03:30:49,736 DIFFERENT WAY. 5364 03:30:49,736 --> 03:30:51,805 AND THIS WAS AN INTERESTING 5365 03:30:51,805 --> 03:30:55,976 STUDY THAT WAS DONE IN DECEMBER 5366 03:30:55,976 --> 03:30:59,713 OF LAST YEAR, WHERE A NUMBER OF 5367 03:30:59,713 --> 03:31:05,051 INVESTIGATORS PUT TOGETHER A 5368 03:31:05,051 --> 03:31:07,354 25-QUESTION ASSESSMENT, LOOKING 5369 03:31:07,354 --> 03:31:08,255 AT TYPICAL QUESTIONS PATIENTS 5370 03:31:08,255 --> 03:31:13,727 COULD ENTER AT -- ONLINE TO GET 5371 03:31:13,727 --> 03:31:14,327 INFORMATION ABOUT PREVENTING 5372 03:31:14,327 --> 03:31:15,796 CARDIOVASCULAR DISEASE. 5373 03:31:15,796 --> 03:31:19,733 THEY ASKED THESE QUESTIONS OF A 5374 03:31:19,733 --> 03:31:22,369 CHATBOT, THREE DIFFERENT TIMES, 5375 03:31:22,369 --> 03:31:24,371 AND HAD CARDIOLOGISTS SCORE THE 5376 03:31:24,371 --> 03:31:24,671 ANSWERS. 5377 03:31:24,671 --> 03:31:27,741 AND SO WHAT THEY FOUND WHEN THEY 5378 03:31:27,741 --> 03:31:31,812 DID THIS IS 85% OF THE TIME THE 5379 03:31:31,812 --> 03:31:32,779 RESPONSES WERE APPROPRIATE, BUT 5380 03:31:32,779 --> 03:31:34,481 THAT MEANS 15% OF TIME OUR 5381 03:31:34,481 --> 03:31:35,649 PATIENTS WEREN'T GETTING THE 5382 03:31:35,649 --> 03:31:36,383 RIGHT INFORMATION. 5383 03:31:36,383 --> 03:31:42,856 OR AT LEAST WHAT WE THOUGHT WAS 5384 03:31:42,856 --> 03:31:43,824 NOT THE RIGHT INFORMATION. 5385 03:31:43,824 --> 03:31:45,592 WE NEED TO REMEMBER THAT WE'RE 5386 03:31:45,592 --> 03:31:51,064 NOT THE ONLY ONES USING THESE 5387 03:31:51,064 --> 03:31:54,000 TOOLS TO UNDERSTAND HOW TO 5388 03:31:54,000 --> 03:31:58,939 PREVENT DISEASE OR GET 5389 03:31:58,939 --> 03:31:59,606 INFORMATION ABOUT IT. 5390 03:31:59,606 --> 03:32:03,109 NOW, WHEN TALKING ABOUT USING 5391 03:32:03,109 --> 03:32:05,278 A.I. TO PREDICT INCIDENT 5392 03:32:05,278 --> 03:32:07,914 HYPERTENSION, PRECISION PUBLIC 5393 03:32:07,914 --> 03:32:09,015 HEALTH APPROACH TO HYPERTENSION, 5394 03:32:09,015 --> 03:32:11,351 THIS IS A VERY INTERESTING AREA 5395 03:32:11,351 --> 03:32:13,487 BECAUSE THERE HASN'T BEEN A LOT 5396 03:32:13,487 --> 03:32:15,722 OF WORK DONE HERE. 5397 03:32:15,722 --> 03:32:19,125 AND THIS IS A TERRITORY WIDE 5398 03:32:19,125 --> 03:32:21,761 OPEN FOR FURTHER INVESTIGATION. 5399 03:32:21,761 --> 03:32:25,866 SO AMONG, YOU KNOW, ONE OF THE 5400 03:32:25,866 --> 03:32:28,802 FEW STUDIES RELATED TO THIS AREA 5401 03:32:28,802 --> 03:32:32,005 WAS A STUDY THAT WAS DONE IN 5402 03:32:32,005 --> 03:32:35,075 JAPAN, WHERE ALL EMPLOYERS 5403 03:32:35,075 --> 03:32:36,943 ACTUALLY HAVE TO GIVE FREE 5404 03:32:36,943 --> 03:32:42,182 ANNUAL PHYSICALS TO ALL OF THE 5405 03:32:42,182 --> 03:32:42,449 EMPLOYEES. 5406 03:32:42,449 --> 03:32:44,484 THESE INVESTIGATORS TOOK 20,000 5407 03:32:44,484 --> 03:32:47,521 PATIENTS, AND THEY LOOKED AT 5408 03:32:47,521 --> 03:32:53,093 BLOOD PRESSURE LEVELS AT THE 5409 03:32:53,093 --> 03:32:55,328 INITIAL EXAM, AND THEN THEY 5410 03:32:55,328 --> 03:32:57,831 LOOKED TWO YEARS OUT. 5411 03:32:57,831 --> 03:32:59,699 AND SO THEY CREATED A MODEL TO 5412 03:32:59,699 --> 03:33:03,270 FIGURE OUT WHO WAS GOING TO 5413 03:33:03,270 --> 03:33:05,705 DEVELOP INCIDENT HYPERTENSION. 5414 03:33:05,705 --> 03:33:07,040 SO, IN THEIR DERIVATION COHORT 5415 03:33:07,040 --> 03:33:09,743 THEY HAD A VERY NICE AREA UNDER 5416 03:33:09,743 --> 03:33:11,611 THE CURVE. 5417 03:33:11,611 --> 03:33:13,480 IN THE VALIDATION COHORT, NOT 5418 03:33:13,480 --> 03:33:14,681 QUITE AS HIGH. 5419 03:33:14,681 --> 03:33:18,385 BUT WHEN THEY WENT TO LOOK AT 5420 03:33:18,385 --> 03:33:19,920 PREDICTORS OF WHAT -- FROM ALL 5421 03:33:19,920 --> 03:33:21,888 THE DATA THEY ENTERED, WHAT WERE 5422 03:33:21,888 --> 03:33:24,424 THEIR TOP PREDICTORS OF BLOOD 5423 03:33:24,424 --> 03:33:26,326 PRESSURE, IT TURNED OUT THAT 5424 03:33:26,326 --> 03:33:30,230 SYSTOLIC BLOOD PRESSURE WHEN 5425 03:33:30,230 --> 03:33:32,866 THEY WERE MAKING MEASUREMENTS 5426 03:33:32,866 --> 03:33:34,167 FOR AORTIC STIFFNESS, A YEAR 5427 03:33:34,167 --> 03:33:40,774 BEFORE, WAS REALLY THE BEST 5428 03:33:40,774 --> 03:33:41,174 PREDICTOR. 5429 03:33:41,174 --> 03:33:42,509 KEEP THAT IN MIND AS WE TALK 5430 03:33:42,509 --> 03:33:45,011 ABOUT OTHER STUDIES. 5431 03:33:45,011 --> 03:33:46,780 ANOTHER ONE LOOKED AT ELECTRONIC 5432 03:33:46,780 --> 03:33:48,081 HEALTH REPORT DATABASE FROM THE 5433 03:33:48,081 --> 03:33:49,416 STATE OF MAINE. 5434 03:33:49,416 --> 03:33:50,951 AND THIS WAS INTERESTING BECAUSE 5435 03:33:50,951 --> 03:33:55,989 THEY HAD ACCESS TO ABOUT 900,000 5436 03:33:55,989 --> 03:33:58,058 CASES WITH DATA. 5437 03:33:58,058 --> 03:34:02,228 THEY USED THIS TO DEVELOP A 5438 03:34:02,228 --> 03:34:04,297 MODEL THAT INCLUDED OVER 1500 5439 03:34:04,297 --> 03:34:06,933 VARIABLES, AND AMONG THESE 5440 03:34:06,933 --> 03:34:07,801 VARIABLES HAD SOCIOECONOMIC 5441 03:34:07,801 --> 03:34:09,769 INDICATORS, WHICH I THOUGHT WAS 5442 03:34:09,769 --> 03:34:10,804 INTERESTING. 5443 03:34:10,804 --> 03:34:14,007 AND THEN THEY CREATED A 5444 03:34:14,007 --> 03:34:14,774 PROSPECTIVE COHORT OF 5445 03:34:14,774 --> 03:34:16,209 INDIVIDUALS AND THEY FOLLOWED 5446 03:34:16,209 --> 03:34:18,078 THEM TO CLASSIFY THEM AS BEING 5447 03:34:18,078 --> 03:34:22,248 AT VERY LOW RISK FOR DEVELOPING 5448 03:34:22,248 --> 03:34:24,284 HYPERTENSION WITHIN A YEAR UP TO 5449 03:34:24,284 --> 03:34:26,753 BEING VERY HIGH RISK FOR 5450 03:34:26,753 --> 03:34:27,721 DEVELOPING HYPERTENSION. 5451 03:34:27,721 --> 03:34:29,589 SO WHEN THEY TESTED THEIR MODEL 5452 03:34:29,589 --> 03:34:32,759 THEY FOUND OUT FOR THE VERY LOW 5453 03:34:32,759 --> 03:34:34,928 RISK PATIENTS, ONLY ABOUT 1 5454 03:34:34,928 --> 03:34:36,696 PERCENT OF THOSE INDIVIDUALS 5455 03:34:36,696 --> 03:34:40,433 WERE MISCLASSIFIED AND DID GO ON 5456 03:34:40,433 --> 03:34:41,601 TO DEVELOP HYPERTENSION, AND 5457 03:34:41,601 --> 03:34:43,737 AMONG INDIVIDUALS IN THE VERY 5458 03:34:43,737 --> 03:34:46,673 HIGH RISK GROUP ABOUT 50% OF 5459 03:34:46,673 --> 03:34:47,574 THOSE INDIVIDUALS DID DEVELOP 5460 03:34:47,574 --> 03:34:52,078 HYPERTENSION WITHIN A YEAR. 5461 03:34:52,078 --> 03:34:56,282 SO THE MODEL TO -- 5462 03:34:56,282 --> 03:35:05,392 [ NO AUDIO ] 5463 03:35:05,392 --> 03:35:06,059 TO PREDICT INCIDENT HYPERTENSION 5464 03:35:06,059 --> 03:35:07,927 IN THE LOW RISK GROUP AND HIGH 5465 03:35:07,927 --> 03:35:10,764 RISK GROUP, IF YOU LOOK AT THE 5466 03:35:10,764 --> 03:35:12,999 VERY LOW RISK GROUP, WHEN THEY 5467 03:35:12,999 --> 03:35:16,269 LOOKED AT INDIVIDUALS AND 5468 03:35:16,269 --> 03:35:18,104 STRATIFIED THEM BY PREEXISTING 5469 03:35:18,104 --> 03:35:21,941 CONDITIONS, SO WHAT THEY CALL 5470 03:35:21,941 --> 03:35:23,576 PRE-HYPERTENSION, DIABETES, EVEN 5471 03:35:23,576 --> 03:35:26,880 MENTAL ILLNESS, ABOUT 85% OF 5472 03:35:26,880 --> 03:35:29,049 INDIVIDUALS DID NOT DEVELOP 5473 03:35:29,049 --> 03:35:30,483 HYPERTENSION WITHIN THE COURSE 5474 03:35:30,483 --> 03:35:31,618 OF THE NEXT YEAR. 5475 03:35:31,618 --> 03:35:34,621 WHEN YOU LOOK AT THOSE IN THE 5476 03:35:34,621 --> 03:35:38,124 VERY HIGH RISK CATEGORY, WITH 5477 03:35:38,124 --> 03:35:43,063 ALL OF THESE OTHER CONDITIONS, 5478 03:35:43,063 --> 03:35:44,397 ABOUT 55% OF THEM DEVELOPED 5479 03:35:44,397 --> 03:35:48,535 HYPERTENSION WITHIN A YEAR. 5480 03:35:48,535 --> 03:35:50,537 SO REALLY HAVING ONE COMORBID 5481 03:35:50,537 --> 03:35:52,672 CONDITION IN THE HIGH RISK 5482 03:35:52,672 --> 03:35:54,140 CATEGORY WAS IMPORTANT. 5483 03:35:54,140 --> 03:35:55,975 WHEN THEY ACTUALLY DIVIDED THIS 5484 03:35:55,975 --> 03:35:58,278 UP INTO INDIVIDUALS WHO HAD AT 5485 03:35:58,278 --> 03:36:00,146 LEAST ONE CHRONIC DISEASE SHOWN 5486 03:36:00,146 --> 03:36:02,415 ON THE RIGHT VERSUS NONE AND 5487 03:36:02,415 --> 03:36:04,284 STRATIFIED BY MALE VERSUS 5488 03:36:04,284 --> 03:36:07,353 FEMALE, AGE, ET CETERA, YOU CAN 5489 03:36:07,353 --> 03:36:11,658 SEE THAT AMONG PATIENTS WHO HAD 5490 03:36:11,658 --> 03:36:12,726 NO CHRONIC DISEASES, YOU KNOW, 5491 03:36:12,726 --> 03:36:14,394 THEY TENDED TO DO FAIRLY WELL 5492 03:36:14,394 --> 03:36:16,229 OVER THE COURSE OF THE YEAR. 5493 03:36:16,229 --> 03:36:20,300 REALLY WITH THE EXCEPTION OF 5494 03:36:20,300 --> 03:36:21,601 INDIVIDUALS WHO HAD DEPRESSION, 5495 03:36:21,601 --> 03:36:23,169 OR ADVANCING AGE. 5496 03:36:23,169 --> 03:36:26,239 SO, WE ALREADY KNOW AGE FACTORS 5497 03:36:26,239 --> 03:36:26,539 IN. 5498 03:36:26,539 --> 03:36:28,541 BUT THE FACT THE DEPRESSION 5499 03:36:28,541 --> 03:36:30,810 DOUBLES YOUR RISK OF DEVELOPING 5500 03:36:30,810 --> 03:36:32,779 HYPERTENSION WAS INTERESTING. 5501 03:36:32,779 --> 03:36:37,584 AMONG PATIENTS WHO HAD AT LEAST 5502 03:36:37,584 --> 03:36:39,586 ONE CHRONIC -- ONE DIAGNOSIS OF 5503 03:36:39,586 --> 03:36:41,254 CHRONIC DISEASE THEIR RISK OF 5504 03:36:41,254 --> 03:36:42,756 DEVELOPING HYPERTENSION OVER THE 5505 03:36:42,756 --> 03:36:46,159 COURSE OF THE YEAR REGARDLESS OF 5506 03:36:46,159 --> 03:36:54,267 THE MALE/FEMALE AND AGE LEVEL 5507 03:36:54,267 --> 03:36:57,303 WAS STILL PRETTY HIGH. 5508 03:36:57,303 --> 03:36:58,938 WE CANNOT FORGET ABOUT THE 5509 03:36:58,938 --> 03:37:00,907 SOCIAL DETERMINANTS OF HEALTH 5510 03:37:00,907 --> 03:37:03,109 BECAUSE USING THE SPEARMAN RANK 5511 03:37:03,109 --> 03:37:06,746 CORRELATION, THEY WERE ALSO ABLE 5512 03:37:06,746 --> 03:37:11,851 TO SHOW EDUCATION, INSURANCE 5513 03:37:11,851 --> 03:37:14,287 COVERAGE, SALARY, AND 5514 03:37:14,287 --> 03:37:15,488 AVAILABILITY OF LOCAL MARKETS 5515 03:37:15,488 --> 03:37:19,859 AND STORES AND GREEN SPACES FOR 5516 03:37:19,859 --> 03:37:23,129 EXERCISE ALL WERE IMPORTANT FOR 5517 03:37:23,129 --> 03:37:27,500 DETERMINING THE RISK TO INCIDENT 5518 03:37:27,500 --> 03:37:27,834 HYPERTENSION. 5519 03:37:27,834 --> 03:37:29,269 AND FINALLY, ANOTHER GROUP 5520 03:37:29,269 --> 03:37:31,905 ACTUALLY ASKED THE QUESTION THAT 5521 03:37:31,905 --> 03:37:33,239 I POSED EARLIER, WHICH IS WHAT 5522 03:37:33,239 --> 03:37:35,642 CAN YOU FIND OUT WHEN YOU HAVE 5523 03:37:35,642 --> 03:37:38,278 JUST A MINIMAL AMOUNT OF 5524 03:37:38,278 --> 03:37:39,679 INFORMATION THAT YOU'RE PUTTING 5525 03:37:39,679 --> 03:37:40,980 INTO YOUR MODEL? 5526 03:37:40,980 --> 03:37:43,850 AND SO IN THIS STUDY THEY TOOK A 5527 03:37:43,850 --> 03:37:47,120 NUMBER OF INDIVIDUALS, THIS WAS 5528 03:37:47,120 --> 03:37:49,522 DONE IN BEIJING, AND, YOU KNOW, 5529 03:37:49,522 --> 03:37:51,291 ASKED JUST QUESTIONS ABOUT THE 5530 03:37:51,291 --> 03:37:55,862 CLINICAL VARIABLES ON THE LEFT. 5531 03:37:55,862 --> 03:38:05,738 SO TYPICAL AGE, BMI, WAIST 5532 03:38:05,738 --> 03:38:06,840 CIRCUMFERENCE, FAMILY HISTORY, 5533 03:38:06,840 --> 03:38:08,041 HOW MUCH STRESS YOU'RE UNDER. 5534 03:38:08,041 --> 03:38:12,078 WHEN YOU LOOK AT THE PREDICTION 5535 03:38:12,078 --> 03:38:15,915 OF INCIDENT HYPERTENSION THEY 5536 03:38:15,915 --> 03:38:19,018 RAN THIS THROUGH FOUR MODELS AND 5537 03:38:19,018 --> 03:38:20,119 GOT DIFFERENT PERFORMANCE 5538 03:38:20,119 --> 03:38:21,754 RESULTS FOR EACH ONE WHICH I 5539 03:38:21,754 --> 03:38:22,622 THOUGHT WAS, AGAIN, ALSO 5540 03:38:22,622 --> 03:38:25,091 INTERESTING AND SPEAKS TO THE 5541 03:38:25,091 --> 03:38:29,295 FACT THAT WE NEED TO REALLY PAY 5542 03:38:29,295 --> 03:38:30,063 ATTENTION TO METHODOLOGY. 5543 03:38:30,063 --> 03:38:32,498 BUT THEY ALSO WERE ABLE TO SHOW 5544 03:38:32,498 --> 03:38:35,869 IN THIS STUDY THAT WHEN YOU 5545 03:38:35,869 --> 03:38:38,071 LOOKED AT THE FEATURE IMPORTANCE 5546 03:38:38,071 --> 03:38:41,040 FOR RANKING VARIABLES BMI CAME 5547 03:38:41,040 --> 03:38:43,543 OUT HIGHER THAN AGE, YOU KNOW, 5548 03:38:43,543 --> 03:38:44,544 FAMILY HISTORY, WAIST 5549 03:38:44,544 --> 03:38:47,614 CIRCUMFERENCE AND OTHER THINGS 5550 03:38:47,614 --> 03:38:50,350 WE KNOW ARE RELATED TO RISK FOR 5551 03:38:50,350 --> 03:38:53,419 INCIDENT HYPERTENSION. 5552 03:38:53,419 --> 03:38:56,356 SO NOW WE'VE GOT, YOU KNOW, 5553 03:38:56,356 --> 03:38:57,657 SEVERAL STUDIES THAT TELL US 5554 03:38:57,657 --> 03:38:59,425 SOMETHING A LITTLE BIT DIFFERENT 5555 03:38:59,425 --> 03:39:01,160 WITH EACH STUDY. 5556 03:39:01,160 --> 03:39:04,230 SO, THIS ALSO SPEAKS TO THE IDEA 5557 03:39:04,230 --> 03:39:05,865 OF REPRODUCIBILITY, WHAT WENT 5558 03:39:05,865 --> 03:39:08,301 INTO THE MODEL, HOW GOOD WERE 5559 03:39:08,301 --> 03:39:15,408 THE MODELS, AND WHAT CAN WE 5560 03:39:15,408 --> 03:39:17,810 LEARN FROM THEM. 5561 03:39:17,810 --> 03:39:21,748 WE HAVE REALLY PROMISING SCIENCE 5562 03:39:21,748 --> 03:39:24,284 IN THIS AREA, AND THIS CONCEPT 5563 03:39:24,284 --> 03:39:26,586 OF MAKING PROGRESS IN DEEP 5564 03:39:26,586 --> 03:39:28,021 PHENOTYPING AND FINDING WAYS TO 5565 03:39:28,021 --> 03:39:31,291 INCLUDES ALL OF THESE DATA, 5566 03:39:31,291 --> 03:39:34,594 INCLUDING NETWORK MEDICINE FOR 5567 03:39:34,594 --> 03:39:35,695 ANALYSIS, IS REALLY PROGRESSING. 5568 03:39:35,695 --> 03:39:38,331 THE FACT THAT PEOPLE ARE 5569 03:39:38,331 --> 03:39:39,966 FOCUSING ON INCIDENT DISEASE AND 5570 03:39:39,966 --> 03:39:42,168 DISEASE INCEPTION AS OPPOSED TO 5571 03:39:42,168 --> 03:39:44,137 JUST TREATING ESTABLISHED 5572 03:39:44,137 --> 03:39:48,174 DISEASE IS ALSO INCREDIBLY 5573 03:39:48,174 --> 03:39:48,441 IMPORTANT. 5574 03:39:48,441 --> 03:39:50,143 THEN MANY OF MY OTHER COMMENTS 5575 03:39:50,143 --> 03:39:52,545 HERE, WHAT DO WE NEED TO MOVE 5576 03:39:52,545 --> 03:39:54,881 THE FIELD FORWARD AND WHAT'S 5577 03:39:54,881 --> 03:39:57,684 HINDERING US ARE COMMON THEMES 5578 03:39:57,684 --> 03:39:59,652 THAT PEOPLE HAVE SPOKEN ABOUT 5579 03:39:59,652 --> 03:40:00,553 BEFORE. 5580 03:40:00,553 --> 03:40:02,722 I WOULD JUST ADD HERE THAT ONE 5581 03:40:02,722 --> 03:40:06,492 OF THE THINGS WE NEED TO FIGURE 5582 03:40:06,492 --> 03:40:11,397 OUT IS WHEN -- WHAT IS REALLY 5583 03:40:11,397 --> 03:40:12,932 THE SO-CALLED GO/NO-GO TIME 5584 03:40:12,932 --> 03:40:19,172 POINT FOR DISEASE INCEPTION 5585 03:40:19,172 --> 03:40:20,807 PROCESS WHERE WE CAN'T INTERVENE 5586 03:40:20,807 --> 03:40:23,876 AND CAN WE INTEGRATE ALL THESE 5587 03:40:23,876 --> 03:40:25,411 THINGS TOGETHER, PRECISION 5588 03:40:25,411 --> 03:40:27,714 PUBLIC HEALTH, NETWORK MEDICINE, 5589 03:40:27,714 --> 03:40:29,682 A.I. FOR RISK PREDICTION, AND 5590 03:40:29,682 --> 03:40:34,053 THEN KEY CHALLENGES AND BARRIERS 5591 03:40:34,053 --> 03:40:38,324 REALLY COME DOWN TO WIDESPREAD 5592 03:40:38,324 --> 03:40:41,394 ACCEPTANCE, STANDARDIZING DATA 5593 03:40:41,394 --> 03:40:42,428 COLLECTION, CURATION, SECURITY, 5594 03:40:42,428 --> 03:40:44,764 PRIVACY, AND DEVELOPING THE 5595 03:40:44,764 --> 03:40:47,533 SOLID PARTNERSHIPS BETWEEN THE 5596 03:40:47,533 --> 03:40:49,268 STAKEHOLDERS AND REALLY GETTING 5597 03:40:49,268 --> 03:40:51,471 BACK TO PUBLIC ACCEPTANCE, 5598 03:40:51,471 --> 03:40:52,905 ACCEPTANCE FROM, YOU KNOW, THE 5599 03:40:52,905 --> 03:40:55,575 PATIENTS THAT WE WOULD LIKE TO 5600 03:40:55,575 --> 03:40:58,378 BE WORKING WITH, TO HELP IRON 5601 03:40:58,378 --> 03:40:59,912 THIS OUT AND BRING PRECISION 5602 03:40:59,912 --> 03:41:02,949 PUBLIC HEALTH TO THE FOREFRONT. 5603 03:41:02,949 --> 03:41:06,319 SO THANK YOU VERY MUCH. 5604 03:41:06,319 --> 03:41:11,391 >> THANK YOU, DR. LEOPOLD. 5605 03:41:11,391 --> 03:41:13,826 I HAVE SOME QUESTIONS FOR THE 5606 03:41:13,826 --> 03:41:15,795 DISCUSSION PERIOD. 5607 03:41:15,795 --> 03:41:19,499 NEXT SPEAKER IS DR. BULL, 5608 03:41:19,499 --> 03:41:21,467 MASTER'S IN PUBLIC HEALTH, 5609 03:41:21,467 --> 03:41:22,869 TULANE UNIVERSITY SCHOOL OF 5610 03:41:22,869 --> 03:41:27,673 PUBLIC HEALTH AND ENTREPRENEUR 5611 03:41:27,673 --> 03:41:28,908 -- TROPICAL 5612 03:41:28,908 --> 03:41:34,347 MEDICINE, Ph.D. IN SOCIOLOGY. 5613 03:41:34,347 --> 03:41:36,549 I FORGOT TO UNMUTE MYSELF. 5614 03:41:36,549 --> 03:41:38,851 I'LL START OVER. 5615 03:41:38,851 --> 03:41:41,354 I'D LIKE TO INTRODUCE DR. BULL, 5616 03:41:41,354 --> 03:41:45,858 WHO RECEIVED MASTER'S IN PUBLIC 5617 03:41:45,858 --> 03:41:48,995 HEALTH, TULANE UNIVERSITY, 5618 03:41:48,995 --> 03:41:49,662 Ph.D. IN SOCIOLOGY FROM 5619 03:41:49,662 --> 03:41:51,531 GEORGIA STATE UNIVERSITY. 5620 03:41:51,531 --> 03:41:53,633 SHE IS A FOUNDING FACULTY MEMBER 5621 03:41:53,633 --> 03:41:56,903 IN THE COLORADO SCHOOL OF PUBLIC 5622 03:41:56,903 --> 03:41:59,305 HEALTH, 2006. 5623 03:41:59,305 --> 03:42:00,073 CURRENTLY HOLDS POSITION OF 5624 03:42:00,073 --> 03:42:03,276 PROFESSOR OF COMMUNITY AND 5625 03:42:03,276 --> 03:42:04,010 BEHAVIORAL HEALTH. 5626 03:42:04,010 --> 03:42:04,243 WELCOME. 5627 03:42:04,243 --> 03:42:11,117 YOU'RE GOING TO TALK ABOUT 5628 03:42:11,117 --> 03:42:11,717 A.I.-ENABLED HEALTHBOTS. 5629 03:42:11,717 --> 03:42:14,954 >> CAN YOU HEAR ME AND SEE MY 5630 03:42:14,954 --> 03:42:15,188 SLIDES? 5631 03:42:15,188 --> 03:42:16,489 >> I CAN HEAR YOU. 5632 03:42:16,489 --> 03:42:19,092 I SEE YOUR SLIDES AT THE MOMENT. 5633 03:42:19,092 --> 03:42:19,592 >> GREAT. 5634 03:42:19,592 --> 03:42:30,103 >> IT'S IN PRESENTER MODE FYI. 5635 03:42:33,072 --> 03:42:35,541 >> OKAY. 5636 03:42:35,541 --> 03:42:37,643 >> THERE'S AN ICON, BOTTOM 5637 03:42:37,643 --> 03:42:37,844 RIGHT. 5638 03:42:37,844 --> 03:42:39,645 >> HOW'S THAT? 5639 03:42:39,645 --> 03:42:40,780 STILL PRESENTER? 5640 03:42:40,780 --> 03:42:45,351 I'M GOING TO TRY DOING A PDF. 5641 03:42:45,351 --> 03:42:45,651 HOW'S THAT? 5642 03:42:45,651 --> 03:42:48,888 >> LOOKS GOOD TO ME. 5643 03:42:48,888 --> 03:42:50,623 >> I THINK SOMETHING PUT THEM 5644 03:42:50,623 --> 03:42:52,692 UP, AND MIGHT ADVANCE THEM FOR 5645 03:42:52,692 --> 03:42:52,859 ME. 5646 03:42:52,859 --> 03:42:53,392 IS THAT CORRECT? 5647 03:42:53,392 --> 03:42:54,127 >> THAT'S CORRECT. 5648 03:42:54,127 --> 03:42:55,962 WE'LL SHARE THE SLIDES FOR YOU. 5649 03:42:55,962 --> 03:43:00,433 JUST TELL US NEXT SLIDE PLEASE. 5650 03:43:00,433 --> 03:43:02,201 >> GREAT, THANK YOU. 5651 03:43:02,201 --> 03:43:05,371 IT'S LOVELY TO BE HERE TO TALK 5652 03:43:05,371 --> 03:43:07,240 ABOUT HEALTHBOTS TO SUPPORT 5653 03:43:07,240 --> 03:43:08,875 PATIENT SELF-MANAGEMENT. 5654 03:43:08,875 --> 03:43:11,277 DR. LEOPOLD SET ME UP NICELY FOR 5655 03:43:11,277 --> 03:43:12,712 THIS TALK. 5656 03:43:12,712 --> 03:43:18,718 BEFORE I GO ON, I WANTED TO MAKE 5657 03:43:18,718 --> 03:43:19,752 ACKNOWLEDGMENTS. 5658 03:43:19,752 --> 03:43:23,322 SOME WORK IS FUNDED BY AN NHLBI 5659 03:43:23,322 --> 03:43:25,424 STUDY, THE NUDGE STUDY, ALL THE 5660 03:43:25,424 --> 03:43:28,961 FOLKS LISTED ON THIS SLIDE ARE 5661 03:43:28,961 --> 03:43:30,029 COLLABORATORS ON THAT STUDY. 5662 03:43:30,029 --> 03:43:31,664 SOME WORK I'M TALKING ABOUT IS 5663 03:43:31,664 --> 03:43:39,338 FUNDED BY THE COLORADO 5664 03:43:39,338 --> 03:43:49,849 DEPARTMENT OF PUBLIC HEALTH. 5665 03:44:01,961 --> 03:44:03,229 TODAY TALKING ABOUT LEVERAGING 5666 03:44:03,229 --> 03:44:05,164 TO MANAGE CHRONIC CARDIOVASCULAR 5667 03:44:05,164 --> 03:44:06,432 CONDITIONS, ALSO CHALLENGES THAT 5668 03:44:06,432 --> 03:44:08,701 WE FACE IN THE NEAR TERM FOR 5669 03:44:08,701 --> 03:44:13,306 LEVERAGING A.I. TO SUPPORT 5670 03:44:13,306 --> 03:44:13,973 PATIENTS. 5671 03:44:13,973 --> 03:44:15,675 FINALLY ENDING WITH OPTIMIZING 5672 03:44:15,675 --> 03:44:18,444 OPPORTUNITIES FOR OUR 5673 03:44:18,444 --> 03:44:19,212 A.I.-ENABLED CHAT BOTS. 5674 03:44:19,212 --> 03:44:20,413 NEXT SLIDE PLEASE. 5675 03:44:20,413 --> 03:44:22,582 I WON'T SPEND A LOT OF TIME. 5676 03:44:22,582 --> 03:44:24,450 EVERYONE KNOWS THIS CONTEXT BUT 5677 03:44:24,450 --> 03:44:26,552 I WANT TO UNDERSCORE THREE 5678 03:44:26,552 --> 03:44:26,886 POINTS. 5679 03:44:26,886 --> 03:44:30,489 WE'VE HEARD A LOT TODAY ABOUT 5680 03:44:30,489 --> 03:44:33,326 THE PROBLEM OF CARDIOVASCULAR 5681 03:44:33,326 --> 03:44:34,060 ILLNESS. 5682 03:44:34,060 --> 03:44:35,494 WE'VE HEARD ABOUT DISPARITIES 5683 03:44:35,494 --> 03:44:37,196 AND THE NEED TO PAY GREATER 5684 03:44:37,196 --> 03:44:38,497 ATTENTION TO THOSE. 5685 03:44:38,497 --> 03:44:40,132 WE'VE ALSO HEARD ABOUT THE 5686 03:44:40,132 --> 03:44:42,101 OPPORTUNITIES THAT WE HAVE FOR 5687 03:44:42,101 --> 03:44:49,242 PATIENTS TO ENGAGE IN 5688 03:44:49,242 --> 03:44:49,976 SELF-MANAGEMENT, STRONGLY 5689 03:44:49,976 --> 03:44:52,511 EVIDENCE-BASED, AND EFFECTIVE. 5690 03:44:52,511 --> 03:44:55,781 WHAT IS THE OPPORTUNITY? 5691 03:44:55,781 --> 03:44:58,284 WE HAD DISCUSSION ON EARLIER 5692 03:44:58,284 --> 03:45:00,820 PANEL ABOUT THINGS LIKE ACCESS. 5693 03:45:00,820 --> 03:45:03,089 SO I WILL SHARE THAT, YOU KNOW, 5694 03:45:03,089 --> 03:45:04,423 EVERYONE KNOWS THE AVAILABILITY 5695 03:45:04,423 --> 03:45:06,692 OF MOBILE PHONES AND POPULARITY 5696 03:45:06,692 --> 03:45:11,530 OF TEXT MESSAGING IS BECOMING 5697 03:45:11,530 --> 03:45:14,467 ALMOST UNIVERSAL. 5698 03:45:14,467 --> 03:45:16,335 DESPITE LIMITATIONS IN PEOPLE'S 5699 03:45:16,335 --> 03:45:17,436 ENTHUSIASM FOR TEXT MESSAGING, 5700 03:45:17,436 --> 03:45:19,171 WE'VE BEEN ABLE TO SEE THAT IT'S 5701 03:45:19,171 --> 03:45:20,506 A VERY EFFECTIVE WAY TO REACH 5702 03:45:20,506 --> 03:45:22,808 OUT TO PEOPLE AND MEETS THEM 5703 03:45:22,808 --> 03:45:23,342 WHERE THEY ARE. 5704 03:45:23,342 --> 03:45:25,645 THEY ARE USED TO USING THESE 5705 03:45:25,645 --> 03:45:25,978 SYSTEMS. 5706 03:45:25,978 --> 03:45:27,813 MORE PATIENTS HAVE ACCESS TO THE 5707 03:45:27,813 --> 03:45:28,681 INTERNET AND USE PATIENT 5708 03:45:28,681 --> 03:45:29,148 PORTALS. 5709 03:45:29,148 --> 03:45:31,651 THIS IS AN AREA WHERE I DO 5710 03:45:31,651 --> 03:45:32,852 RECOGNIZE THERE'S STILL 5711 03:45:32,852 --> 03:45:35,955 REMAINING A DECENT LEVEL OF 5712 03:45:35,955 --> 03:45:40,960 DIGITAL DIVIDE, ALTHOUGH THAT IS 5713 03:45:40,960 --> 03:45:46,332 SHRINKING, EVEN IN LOWER AND 5714 03:45:46,332 --> 03:45:47,366 MIDDLE INCOME SETTINGS PEOPLE 5715 03:45:47,366 --> 03:45:48,668 USE PHONES TO ACCESS 5716 03:45:48,668 --> 03:45:50,936 COMMUNICATION THROUGH THE 5717 03:45:50,936 --> 03:45:51,203 INTERNET. 5718 03:45:51,203 --> 03:45:55,308 AND THIRD, PEOPLE ARE WELCOMING 5719 03:45:55,308 --> 03:46:00,479 FOR FAMILIAR, SEEING THEM WHEN 5720 03:46:00,479 --> 03:46:09,522 THEY DO SHOPPING ONLINE, SEEING 5721 03:46:09,522 --> 03:46:15,494 THEM IN PROVIDER PORTALS. 5722 03:46:15,494 --> 03:46:18,764 THIS IS AN EXAMPLE OF A TEXT 5723 03:46:18,764 --> 03:46:21,167 MESSAGE THAT'S GENERIC, THAT CAN 5724 03:46:21,167 --> 03:46:22,601 BE SENT OUT. 5725 03:46:22,601 --> 03:46:27,506 AND THROUGH A TELEPHONE, AND WE 5726 03:46:27,506 --> 03:46:30,376 HAVE GOOD EVIDENCE FROM RESEARCH 5727 03:46:30,376 --> 03:46:33,846 THAT THIS APPROACH DOES WORK TO 5728 03:46:33,846 --> 03:46:36,048 IMPROVE MEDICATION ADHERENCE, OR 5729 03:46:36,048 --> 03:46:37,583 PATIENT CONSISTENCY KEEPING 5730 03:46:37,583 --> 03:46:39,652 APPOINTMENTS, FOR EXAMPLE. 5731 03:46:39,652 --> 03:46:41,087 NEXT SLIDE PLEASE. 5732 03:46:41,087 --> 03:46:43,122 SO, OUR OWN WORK IN THE NUDGE 5733 03:46:43,122 --> 03:46:45,791 STUDY LOOKED AT WHETHER OR NOT 5734 03:46:45,791 --> 03:46:48,327 WE COULD OPTIMIZE MESSAGES AND 5735 03:46:48,327 --> 03:46:50,062 MAKE THEM MORE BIDIRECTIONAL AND 5736 03:46:50,062 --> 03:46:50,329 ENGAGING. 5737 03:46:50,329 --> 03:46:53,666 SO THIS IS AN EXAMPLE OF A FIRST 5738 03:46:53,666 --> 03:46:56,068 GENERATION BOT, NOT AN 5739 03:46:56,068 --> 03:46:58,170 A.I.-ENABLED BOT, BUT FROM OUR 5740 03:46:58,170 --> 03:46:59,472 PRELIMINARY ANALYSES OF THE 5741 03:46:59,472 --> 03:47:04,143 NUDGE DATA WE SEE THIS APPROACH, 5742 03:47:04,143 --> 03:47:07,713 THE INTERACTIVE FEATURE, AS WELL 5743 03:47:07,713 --> 03:47:08,381 AS OPTIMIZED MESSAGE CONTENT 5744 03:47:08,381 --> 03:47:10,783 I'LL TALK ABOUT IN A MOMENT, 5745 03:47:10,783 --> 03:47:14,387 THOSE TWO APPROACHES ARE 5746 03:47:14,387 --> 03:47:17,490 SIGNIFICANTLY SUPERIOR TO THE 5747 03:47:17,490 --> 03:47:19,325 GENERIC MESSAGING FOR INCREASING 5748 03:47:19,325 --> 03:47:22,528 ADHERENCE TO MEDICATION REFILL 5749 03:47:22,528 --> 03:47:23,429 FOR CARDIOVASCULAR MEDICATIONS. 5750 03:47:23,429 --> 03:47:25,664 AND SO THEREFORE WE CAN SEE 5751 03:47:25,664 --> 03:47:30,503 HIGHER PROPORTION OF DAYS 5752 03:47:30,503 --> 03:47:32,705 COVERED, FOR MEDICATIONS, AND 5753 03:47:32,705 --> 03:47:35,307 IMPROVED PATIENT SELF-MANAGEMENT 5754 03:47:35,307 --> 03:47:35,574 BEHAVIORS. 5755 03:47:35,574 --> 03:47:36,842 NEXT SLIDE PLEASE. 5756 03:47:36,842 --> 03:47:39,779 NOW WE HAVE THE OPPORTUNITY TO 5757 03:47:39,779 --> 03:47:41,647 LEVERAGE NATURAL LANGUAGE 5758 03:47:41,647 --> 03:47:43,849 PROCESSING AS WELL AS MACHINE 5759 03:47:43,849 --> 03:47:46,786 LEARNING FOR MORE ENGAINING AND 5760 03:47:46,786 --> 03:47:50,089 DYNAMIC EXPERIENCE, SO PEOPLE 5761 03:47:50,089 --> 03:47:52,158 AREN'T FORCED INTO 5762 03:47:52,158 --> 03:47:53,125 FIRST-GENERATION TYPE BOTS. 5763 03:47:53,125 --> 03:47:55,227 THIS IS AN EXAMPLE OF HOW THAT 5764 03:47:55,227 --> 03:47:58,164 MIGHT WORK. 5765 03:47:58,164 --> 03:47:59,265 IT USES SYSTEM DIALOGUE 5766 03:47:59,265 --> 03:48:00,266 CLASSIFICATION, SOMETHING WE'RE 5767 03:48:00,266 --> 03:48:02,768 USING RIGHT NOW. 5768 03:48:02,768 --> 03:48:04,837 AND THE PERSON CAN EITHER 5769 03:48:04,837 --> 03:48:08,107 RESPOND TO A PUSH NOTIFICATION 5770 03:48:08,107 --> 03:48:10,409 THAT THEY GET, OR THEY CAN 5771 03:48:10,409 --> 03:48:11,744 INITIATE A CONVERSATION. 5772 03:48:11,744 --> 03:48:13,479 AND WHAT HAPPENS FIRST IS THEY 5773 03:48:13,479 --> 03:48:16,949 GET TO USE THEIR OWN WORDS AND 5774 03:48:16,949 --> 03:48:19,318 THEIR OWN -- AND TALK ABOUT 5775 03:48:19,318 --> 03:48:20,953 THEIR OWN PREFERRED TOPIC. 5776 03:48:20,953 --> 03:48:23,889 THE SYSTEM CAN USE NATURAL 5777 03:48:23,889 --> 03:48:25,391 LANGUAGE PROCESSES TO CLASSIFY 5778 03:48:25,391 --> 03:48:26,959 AND PUT BACK A RESPONSE THAT 5779 03:48:26,959 --> 03:48:28,961 MATCHES THE INTENT OF THEIR 5780 03:48:28,961 --> 03:48:29,428 QUESTION. 5781 03:48:29,428 --> 03:48:31,697 THE MACHINE LEARNING COMES ABOUT 5782 03:48:31,697 --> 03:48:35,301 WHEN THAT CLASSIFICATION DOESN'T 5783 03:48:35,301 --> 03:48:36,936 HAPPEN CONSISTENTLY, WE CAN 5784 03:48:36,936 --> 03:48:38,370 RECLASSIFY SO THE NEXT TIME 5785 03:48:38,370 --> 03:48:40,639 SOMEBODY ASKS A QUESTION IN THAT 5786 03:48:40,639 --> 03:48:43,075 VEIN IT CAN BE RECLASSIFIED SO 5787 03:48:43,075 --> 03:48:45,678 THAT IT IS CONTINUALLY UPDATED 5788 03:48:45,678 --> 03:48:49,281 WITH MORE USERS. 5789 03:48:49,281 --> 03:48:49,682 NEXT SLIDE PLEASE. 5790 03:48:49,682 --> 03:48:52,685 SO, THIS IS FROM A STUDY THAT 5791 03:48:52,685 --> 03:48:55,521 CAME OUT LAST YEAR, AROUND THIS 5792 03:48:55,521 --> 03:48:59,458 TIME, LOOKING AT A REVIEW OF 5793 03:48:59,458 --> 03:49:02,294 CONVERSATIONAL AGENTS, CHAT 5794 03:49:02,294 --> 03:49:03,963 BOTS, IN PERSON-CENTERED CARE. 5795 03:49:03,963 --> 03:49:06,699 IN GENERAL FOUND THAT VERY FEW 5796 03:49:06,699 --> 03:49:08,100 OF THESE ARE TRULY OPTIMIZED 5797 03:49:08,100 --> 03:49:10,302 WITH THE FEATURES THAT WE KNOW 5798 03:49:10,302 --> 03:49:17,877 CAN WORK. 5799 03:49:17,877 --> 03:49:19,278 NEXT SLIDE PLEASE. 5800 03:49:19,278 --> 03:49:23,549 THEY LOOKED AT 78 DIFFERENT 5801 03:49:23,549 --> 03:49:26,285 CHATBOTS, PRIMARY CARE AND 5802 03:49:26,285 --> 03:49:28,020 MENTAL HEALTH. 5803 03:49:28,020 --> 03:49:30,556 FEWER THAN 10% HAD THEORETICAL 5804 03:49:30,556 --> 03:49:31,023 FRAMEWORK. 5805 03:49:31,023 --> 03:49:33,392 WE USED THESE TO IMPROVE EFFECT 5806 03:49:33,392 --> 03:49:35,227 SIZE AND HAVE GREATER PRECISION 5807 03:49:35,227 --> 03:49:37,663 IN TARGETING HEALTH BEHAVIORS 5808 03:49:37,663 --> 03:49:39,532 AND OUTCOMES. 5809 03:49:39,532 --> 03:49:42,334 ONLY 12% WERE HIPAA COMPLIANT, 5810 03:49:42,334 --> 03:49:43,569 LIKELY A NON-STARTER FOR 5811 03:49:43,569 --> 03:49:45,638 PROVIDERS AND PROVIDER CARE 5812 03:49:45,638 --> 03:49:45,971 SYSTEMS. 5813 03:49:45,971 --> 03:49:50,576 AND ONLY A FEW ARE TRULY USING 5814 03:49:50,576 --> 03:49:53,212 MACHINE LANGUAGE AND -- MACHINE 5815 03:49:53,212 --> 03:49:56,649 LEARNING AND NATURAL LANGUAGE 5816 03:49:56,649 --> 03:49:57,249 PROS EGGS. 5817 03:49:57,249 --> 03:50:00,019 I'LL TALK ABOUT GAPS WE HAVE IN 5818 03:50:00,019 --> 03:50:02,087 OUR KNOWLEDGE FOR A.I. HEALTH 5819 03:50:02,087 --> 03:50:03,923 BOTS, THREE I WANT TO FOCUS ON. 5820 03:50:03,923 --> 03:50:11,297 THE FIRST IS RELATED TO OUR 5821 03:50:11,297 --> 03:50:18,037 TECHNOLOGY, INFRASTRUCTURE AND 5822 03:50:18,037 --> 03:50:18,270 SYSTEM. 5823 03:50:18,270 --> 03:50:21,106 ONE ISSUE THEY WOULD LIKE TO SEE 5824 03:50:21,106 --> 03:50:22,107 SOME INTEGRATION WITH THEIR 5825 03:50:22,107 --> 03:50:24,977 SYSTEMS TO HELP WITH WORKFLOW. 5826 03:50:24,977 --> 03:50:28,681 WE NEED TO HAVE PROVIDER AND 5827 03:50:28,681 --> 03:50:29,615 PATIENT-FACING SYSTEMS. 5828 03:50:29,615 --> 03:50:33,485 AND THEN THE THIRD WE'VE TALKED 5829 03:50:33,485 --> 03:50:40,159 ABOUT SEVERAL TIMES TODAY, 5830 03:50:40,159 --> 03:50:40,793 INTEROPERABILITY, FHIR-ENABLED 5831 03:50:40,793 --> 03:50:42,261 TO LINK TO OTHER CHAT BOTS 5832 03:50:42,261 --> 03:50:45,064 SYSTEMS ARE WORKING WITH. 5833 03:50:45,064 --> 03:50:46,265 NEXT SLIDE PLEASE. 5834 03:50:46,265 --> 03:50:48,801 SO IN OUR OWN SYSTEM WHAT WE'RE 5835 03:50:48,801 --> 03:50:51,070 SEEING, WHAT WE'RE USING RIGHT 5836 03:50:51,070 --> 03:50:52,304 NOW, ADDRESSES ALL OF THESE. 5837 03:50:52,304 --> 03:50:55,808 ON THE LEFT WHAT YOU SEE THERE 5838 03:50:55,808 --> 03:50:57,476 IS THE USER COULD INITIATE A 5839 03:50:57,476 --> 03:51:03,515 QUESTION, WE'RE USING THE 5840 03:51:03,515 --> 03:51:04,583 MACHINE LANGUAGE PROCESSING TO 5841 03:51:04,583 --> 03:51:05,918 GET A RESPONSE. 5842 03:51:05,918 --> 03:51:08,220 ALL OF THOSE COMMUNICATIONS ARE 5843 03:51:08,220 --> 03:51:09,755 DOCUMENTED IN A LOG. 5844 03:51:09,755 --> 03:51:11,824 HERE IS WHERE HIPAA COMPLIANCE 5845 03:51:11,824 --> 03:51:15,194 COMES IF. 5846 03:51:15,194 --> 03:51:17,296 IF WE'RE COLLABORATING WITH A 5847 03:51:17,296 --> 03:51:18,263 HEALTH CARE DELIVERY SYSTEM, FOR 5848 03:51:18,263 --> 03:51:19,932 EXAMPLE, AND IT'S GOING THROUGH 5849 03:51:19,932 --> 03:51:22,034 A TEXT MESSAGE ON THE PHONE, 5850 03:51:22,034 --> 03:51:25,304 WHICH MIGHT BE PREFERRED FOR THE 5851 03:51:25,304 --> 03:51:27,673 PATIENT, THAT TELEPHONE NUMBER 5852 03:51:27,673 --> 03:51:29,875 IS PHI, PROTECTED HEALTH 5853 03:51:29,875 --> 03:51:30,409 INFORMATION. 5854 03:51:30,409 --> 03:51:31,844 SO THAT NEEDS TO EITHER BE -- 5855 03:51:31,844 --> 03:51:34,246 MAKE SURE THE LOG IS STORED 5856 03:51:34,246 --> 03:51:37,249 BEHIND A FIRE WALL, AND THE 5857 03:51:37,249 --> 03:51:46,725 TELEPHONE NUMBERS CAN GET 5858 03:51:46,725 --> 03:51:48,694 ENCRYPTED OR THERE COULD BE DATA 5859 03:51:48,694 --> 03:51:50,596 USE AGREEMENTS, BUT THERE'S WAYS 5860 03:51:50,596 --> 03:51:51,430 TO ADDRESS HIPAA COMPLIANCE. 5861 03:51:51,430 --> 03:51:53,332 YOU HAVE TO PAY CLOSE ATTENTION 5862 03:51:53,332 --> 03:51:54,066 TO THEM. 5863 03:51:54,066 --> 03:51:57,036 THE SECOND ISSUE OF PATIENT AND 5864 03:51:57,036 --> 03:51:58,003 PROVIDER-FACING CONTENT, SO WHEN 5865 03:51:58,003 --> 03:51:59,438 WE WORK WITH PROVIDERS THEY TELL 5866 03:51:59,438 --> 03:52:01,073 US AGAIN AND AGAIN THEY DO NOT 5867 03:52:01,073 --> 03:52:04,476 WANT TO BE THE PERSON WHO LOOKS 5868 03:52:04,476 --> 03:52:07,212 THROUGH THE LOG AND SEES EVERY 5869 03:52:07,212 --> 03:52:08,514 SINGLE EXCHANGE WITH THE 5870 03:52:08,514 --> 03:52:08,847 CHATBOT. 5871 03:52:08,847 --> 03:52:10,382 THAT'S WAY TOO MUCH FOR THEM. 5872 03:52:10,382 --> 03:52:12,117 THEY WANT THESE THINGS TO HELP 5873 03:52:12,117 --> 03:52:14,453 THEM WITH WORKFLOW, NOT IMPEDE 5874 03:52:14,453 --> 03:52:15,220 THEIR WORKFLOW. 5875 03:52:15,220 --> 03:52:16,622 SO, THERE'S TWO WAYS THAT WE'RE 5876 03:52:16,622 --> 03:52:19,024 WORKING ON THAT. 5877 03:52:19,024 --> 03:52:21,093 THE FIRST IS TO IDENTIFY WHAT 5878 03:52:21,093 --> 03:52:22,861 ARE KEY PIECES OF INFORMATION 5879 03:52:22,861 --> 03:52:25,064 THAT PROVIDERS DO WANT, AND 5880 03:52:25,064 --> 03:52:26,598 GENERATE AN ALGORITHM TO PUSH 5881 03:52:26,598 --> 03:52:28,901 OUT THAT INFORMATION WHEN IT 5882 03:52:28,901 --> 03:52:29,601 BECOMES APPARENT. 5883 03:52:29,601 --> 03:52:31,870 SUCH AS WHEN WE KNOW THAT A 5884 03:52:31,870 --> 03:52:33,806 PATIENT HAS NOT FILLED OR IS 5885 03:52:33,806 --> 03:52:37,643 INDICATING THAT THEY DON'T PLAN 5886 03:52:37,643 --> 03:52:37,876 TO. 5887 03:52:37,876 --> 03:52:41,146 OR THEY HAVE GONE TO AN URGENT 5888 03:52:41,146 --> 03:52:42,014 CARE FACILITY. 5889 03:52:42,014 --> 03:52:44,550 ON THE OTHER THING ON THE TOP 5890 03:52:44,550 --> 03:52:46,385 RIGHT IS GENERATION OF 5891 03:52:46,385 --> 03:52:47,386 DASHBOARDS THAT ARE REALTIME 5892 03:52:47,386 --> 03:52:48,654 THAT PROVIDERS CAN TAKE A LOOK 5893 03:52:48,654 --> 03:52:50,823 AT TO SEE HOW MANY PEOPLE ARE 5894 03:52:50,823 --> 03:52:52,758 USING THE SYSTEM, WHAT ARE THE 5895 03:52:52,758 --> 03:52:53,826 PRIMARY QUESTIONS THAT PEOPLE 5896 03:52:53,826 --> 03:52:55,160 HAVE, WHAT ARE THE TIMES OF DAY 5897 03:52:55,160 --> 03:52:58,564 AND DAYS OF THE WEEK, WHEN THE 5898 03:52:58,564 --> 03:53:00,733 SYSTEM USES HIGHEST VOLUME. 5899 03:53:00,733 --> 03:53:04,570 THE THIRD ISSUE FOR 5900 03:53:04,570 --> 03:53:06,538 INFRASTRUCTURE IS RELATED TO 5901 03:53:06,538 --> 03:53:06,939 INTEROPERABILITY. 5902 03:53:06,939 --> 03:53:08,207 LOTS OF IDEAS CAME THROUGH THE 5903 03:53:08,207 --> 03:53:10,843 TALKS TODAY. 5904 03:53:10,843 --> 03:53:12,711 IF SOMEBODY IS WEARING A 5905 03:53:12,711 --> 03:53:13,779 WEARABLE DEVICE AND INFORMATION 5906 03:53:13,779 --> 03:53:17,516 SUGGESTS THAT THEY NEED TO BE 5907 03:53:17,516 --> 03:53:18,717 GIVEN AN ALERT, THAT COULD BE 5908 03:53:18,717 --> 03:53:20,486 PUSHED TO THEM THROUGH A CHATBOT 5909 03:53:20,486 --> 03:53:21,987 AND THEY COULD ENGAGE WITH THE 5910 03:53:21,987 --> 03:53:24,289 SYSTEM TO GET THEIR QUESTIONS 5911 03:53:24,289 --> 03:53:24,556 ANSWERED. 5912 03:53:24,556 --> 03:53:28,994 THIS IS ALSO AN EXAMPLE OF 5913 03:53:28,994 --> 03:53:29,661 INTEROPERABILITY WITH 5914 03:53:29,661 --> 03:53:30,095 SCHEDULING. 5915 03:53:30,095 --> 03:53:33,065 THEY WOULDN'T HAVE TO LEAVE THE 5916 03:53:33,065 --> 03:53:35,334 CHATBOT IF THE SYSTEM COULD 5917 03:53:35,334 --> 03:53:43,876 IDENTIFY IMMEDIATELY PLACES THY 5918 03:53:43,876 --> 03:53:45,511 COULD GET AN APPOINTMENT OR 5919 03:53:45,511 --> 03:53:45,944 MEDICATION. 5920 03:53:45,944 --> 03:53:50,682 THE OTHER IS RELATED TO CONTENT. 5921 03:53:50,682 --> 03:53:52,985 WE'VE HEARD ABOUT SYSTEMS WHERE 5922 03:53:52,985 --> 03:53:54,286 YOU COULD HAVE COMMUNICATION, 5923 03:53:54,286 --> 03:53:58,123 NOT JUST WITH THE A.I. BUT ALSO 5924 03:53:58,123 --> 03:54:00,192 WITH TEXT MESSAGING PROGRAMS OR 5925 03:54:00,192 --> 03:54:04,129 OTHER HEALTH BEHAVIOR TYPES OF 5926 03:54:04,129 --> 03:54:05,764 INITIATIVES WE'VE LEARNED FROM 5927 03:54:05,764 --> 03:54:08,233 OUR OWN RESEARCH AND RESEARCH 5928 03:54:08,233 --> 03:54:09,501 ACROSS MANY COLLEAGUES IN THE 5929 03:54:09,501 --> 03:54:13,906 FIELD THAT WHEN YOU HAVE 5930 03:54:13,906 --> 03:54:14,873 OPTIMIZED AND THEORY BASED 5931 03:54:14,873 --> 03:54:16,642 MESSAGING THAT USES HEALTH 5932 03:54:16,642 --> 03:54:18,510 COMMUNICATION AND BEHAVIOR 5933 03:54:18,510 --> 03:54:20,145 CHANGE THEORY WE CAN DO BETTER 5934 03:54:20,145 --> 03:54:22,347 AND CAN IMPACT NOT JUST HEALTH 5935 03:54:22,347 --> 03:54:24,850 BEHAVIOR BUT HEALTH OUTCOMES. 5936 03:54:24,850 --> 03:54:27,886 SO CHANGES IN THINGS LIKE 5937 03:54:27,886 --> 03:54:29,121 COMPLIANCE WITH CHILDHOOD 5938 03:54:29,121 --> 03:54:31,190 VACCINES OR HIV TESTING, FOR 5939 03:54:31,190 --> 03:54:31,423 EXAMPLE. 5940 03:54:31,423 --> 03:54:34,927 WE NEED TO MAKE SURE THAT 5941 03:54:34,927 --> 03:54:36,161 MESSAGES ARE CULTURALLY RELEVANT 5942 03:54:36,161 --> 03:54:39,097 AND TAILORED, AND THEY FOCUS ON 5943 03:54:39,097 --> 03:54:39,731 DISPARITIES. 5944 03:54:39,731 --> 03:54:42,167 I'M GOING TO COME BACK TO THAT. 5945 03:54:42,167 --> 03:54:45,003 PLEASE GO TO THE NEXT SLIDE AND 5946 03:54:45,003 --> 03:54:47,506 I'LL SET THE STAGE FOR THAT. 5947 03:54:47,506 --> 03:54:51,043 WE'VE HEARD NOT JUST TODAY BUT 5948 03:54:51,043 --> 03:55:01,220 AM AP LOT -- A LOT ABOUT CHAT 5949 03:55:01,220 --> 03:55:01,553 GPT. 5950 03:55:01,553 --> 03:55:05,824 A GROUP DID THIS LAST MONTH, 5951 03:55:05,824 --> 03:55:07,993 LOOKED AT CHAT GPT RESPONSES 5952 03:55:07,993 --> 03:55:10,062 AROUND CARDIOVASCULAR DISEASE 5953 03:55:10,062 --> 03:55:12,464 PREVENTION RECOMMENDATIONS. 5954 03:55:12,464 --> 03:55:14,766 THEY FOUND THAT THE SYSTEM DOES 5955 03:55:14,766 --> 03:55:17,402 HAVE PROMISE, IT LACKS PRECISION 5956 03:55:17,402 --> 03:55:19,671 AND CORRECTNESS IN 16% OF 5957 03:55:19,671 --> 03:55:21,106 RESPONSES WHICH COULD BE 5958 03:55:21,106 --> 03:55:21,540 PROBLEMATIC. 5959 03:55:21,540 --> 03:55:24,509 I THINK THAT MIGHT BE A 5960 03:55:24,509 --> 03:55:25,143 NON-STARTER FOR MANY. 5961 03:55:25,143 --> 03:55:28,547 AND THEY ALSO HAVE LIMITED 5962 03:55:28,547 --> 03:55:30,883 READABILITY AND NO CONSIDERATION 5963 03:55:30,883 --> 03:55:31,950 OF DIVERSITY. 5964 03:55:31,950 --> 03:55:32,951 NEXT SLIDE PLEASE. 5965 03:55:32,951 --> 03:55:36,455 I'M GOING TO COME BACK TO THAT 5966 03:55:36,455 --> 03:55:37,990 ISSUE OF CULTURAL 5967 03:55:37,990 --> 03:55:39,291 APPROPRIATENESS AND DISPARITIES. 5968 03:55:39,291 --> 03:55:40,726 WE'VE HEARD LOTS TODAY ABOUT 5969 03:55:40,726 --> 03:55:42,261 SOCIAL DETERMINANTS OF HEALTH. 5970 03:55:42,261 --> 03:55:44,563 HERE'S WAYS THAT WE'RE TRYING TO 5971 03:55:44,563 --> 03:55:46,431 ADDRESS THAT IN A WAY TO MAKE 5972 03:55:46,431 --> 03:55:48,367 SURE THAT MESSAGES CAN RESONATE 5973 03:55:48,367 --> 03:55:50,135 AND PEOPLE WILL STAY ENGAGED 5974 03:55:50,135 --> 03:55:51,236 WITH SYSTEMS. 5975 03:55:51,236 --> 03:55:52,504 SO WE'VE GOT EXAMPLES HERE OF 5976 03:55:52,504 --> 03:55:55,173 WHAT WE'RE TRYING TO DO WHICH IS 5977 03:55:55,173 --> 03:55:58,677 TO PUSH OUT MESSAGES AND ASSESS 5978 03:55:58,677 --> 03:55:59,211 WHAT ARE SPECIFIC SOCIAL 5979 03:55:59,211 --> 03:56:01,213 DETERMINANTS OF HEALTH THAT 5980 03:56:01,213 --> 03:56:03,582 PEOPLE ARE STRUGGLING WITH SAY 5981 03:56:03,582 --> 03:56:06,318 IN AREAS OF HOUSING OR FOOD OR 5982 03:56:06,318 --> 03:56:06,952 TRANSPORTATION. 5983 03:56:06,952 --> 03:56:08,086 AND THIS TOP LEFT MESSAGE 5984 03:56:08,086 --> 03:56:16,295 SUGGESTS THAT THE USER MAY HAVE 5985 03:56:16,295 --> 03:56:19,131 DIFFICULTY WITH FOOD, PROMPTING 5986 03:56:19,131 --> 03:56:20,766 REFERRAL TO FOOD BANK OR 5987 03:56:20,766 --> 03:56:22,200 RESOURCES FOR LOW COST FOOD. 5988 03:56:22,200 --> 03:56:24,603 WE SEE AN EXAMPLE WHERE THE 5989 03:56:24,603 --> 03:56:25,604 PATIENT MIGHT EXPLAIN THAT 5990 03:56:25,604 --> 03:56:28,340 MEDICATION COST IS AN ISSUE. 5991 03:56:28,340 --> 03:56:30,309 AND WE CAN GIVE THEM REFERRALS 5992 03:56:30,309 --> 03:56:33,145 TO GET LOWER COST MEDICATIONS. 5993 03:56:33,145 --> 03:56:36,882 AND THEN FINALLY ANOTHER EXAMPLE 5994 03:56:36,882 --> 03:56:38,417 OF INTEROPERABILITY, WE CAN LINK 5995 03:56:38,417 --> 03:56:39,618 PATIENTS TO SCHEDULE AN 5996 03:56:39,618 --> 03:56:40,919 APPOINTMENT TO TALK TO A 5997 03:56:40,919 --> 03:56:43,989 PROVIDER OR HAVE A TELEHEALTH 5998 03:56:43,989 --> 03:56:44,423 VISIT. 5999 03:56:44,423 --> 03:56:45,624 OR PHONE CALL THAT ALLOWS THEM 6000 03:56:45,624 --> 03:56:48,160 IN THIS CASE TO TALK TO A 6001 03:56:48,160 --> 03:56:48,493 PHARMACIST. 6002 03:56:48,493 --> 03:56:51,563 SO THAT THEY CAN IMMEDIATELY GET 6003 03:56:51,563 --> 03:56:53,098 SUPPORT FOR WHAT THE THINGS THAT 6004 03:56:53,098 --> 03:56:55,834 THEY NEED. 6005 03:56:55,834 --> 03:56:58,003 NEXT SLIDE PLEASE. 6006 03:56:58,003 --> 03:57:00,572 THIRD AREA OF GAP IN KNOWLEDGE 6007 03:57:00,572 --> 03:57:04,476 IS RELATED TO TEAM SCIENCE, ALSO 6008 03:57:04,476 --> 03:57:05,744 CAME UP TODAY. 6009 03:57:05,744 --> 03:57:08,413 NEED FOR INTEGRATED TEAMS, NOT 6010 03:57:08,413 --> 03:57:11,149 JUST COMPUTER SCIENTISTS AND 6011 03:57:11,149 --> 03:57:12,884 CLINICIAN EXPERTS BUT ALSO 6012 03:57:12,884 --> 03:57:15,087 SOCIAL SCIENTISTS FOR CONTENT 6013 03:57:15,087 --> 03:57:18,156 DESIGN AND THEN THINK MORE 6014 03:57:18,156 --> 03:57:20,425 BROADLY ABOUT HEALTH ECONOMISTS, 6015 03:57:20,425 --> 03:57:24,696 WHO CAN TALK ABOUT COSTS, AND 6016 03:57:24,696 --> 03:57:27,966 COLLECTIVELY THESE GROUPS SHOULD 6017 03:57:27,966 --> 03:57:32,037 BE WORKING ON QUESTIONS THAT ARE 6018 03:57:32,037 --> 03:57:40,045 EXPLORING SCALABILITY AS WELL AS 6019 03:57:40,045 --> 03:57:41,146 IMPLEMENTATION AND ON HEALTH 6020 03:57:41,146 --> 03:57:43,248 OUTCOMES AT THE POPULATION 6021 03:57:43,248 --> 03:57:43,648 LEVEL. 6022 03:57:43,648 --> 03:57:45,717 NEXT SLIDE PLEASE. 6023 03:57:45,717 --> 03:57:48,253 IN CONCLUSION I'M GOING TO 6024 03:57:48,253 --> 03:57:50,355 SUGGEST PROMISING AREAS FOR 6025 03:57:50,355 --> 03:57:52,090 ADVANCEMENT WOULD BE TO DEVELOP 6026 03:57:52,090 --> 03:57:55,727 A.I. HEALTH BOTS THAT HAVE THESE 6027 03:57:55,727 --> 03:58:00,232 SIX FEATURES UTILIZE NATURAL 6028 03:58:00,232 --> 03:58:04,236 LANGUAGE PROCESSING, WIDELY 6029 03:58:04,236 --> 03:58:07,639 ACCESSIBLE ACROSS DIFFERENT 6030 03:58:07,639 --> 03:58:08,073 PLATFORMS. 6031 03:58:08,073 --> 03:58:10,275 THEY NEED TO BE HIPAA COMPLIANT. 6032 03:58:10,275 --> 03:58:14,413 IT'S NOT A BIG HURDLE. 6033 03:58:14,413 --> 03:58:16,948 THEY SHOULD OFFER LINKAGE TO 6034 03:58:16,948 --> 03:58:17,916 CARE AND INTEROPERABILITY WITH 6035 03:58:17,916 --> 03:58:19,818 OTHER TYPES OF SYSTEMS THAT 6036 03:58:19,818 --> 03:58:23,055 WE'VE TALKED ABOUT TODAY. 6037 03:58:23,055 --> 03:58:24,489 THEY SHOULD OFFER PERSUASIVE 6038 03:58:24,489 --> 03:58:26,024 COMMUNICATIONS AND WE CAN 6039 03:58:26,024 --> 03:58:26,992 CONTROL COMMUNICATION WITH THE 6040 03:58:26,992 --> 03:58:29,394 CONTENT THAT WE KNOW WILL BE 6041 03:58:29,394 --> 03:58:31,530 EFFECTIVE IN IMPACTING HEALTH 6042 03:58:31,530 --> 03:58:35,300 BEHAVIOR AND HEALTH OUTCOMES. 6043 03:58:35,300 --> 03:58:36,735 FINALLY THEY SHOULD BE 6044 03:58:36,735 --> 03:58:37,069 ADAPTABLE. 6045 03:58:37,069 --> 03:58:39,805 IF YOU WOULD BE INTERESTED IN 6046 03:58:39,805 --> 03:58:40,672 COLLABORATING ON DEVELOPING OR 6047 03:58:40,672 --> 03:58:42,007 EVALUATING THOSE I WOULD LOVE TO 6048 03:58:42,007 --> 03:58:42,641 HEAR FROM YOU. 6049 03:58:42,641 --> 03:58:45,243 THANKS VERY MUCH FOR YOUR TIME. 6050 03:58:45,243 --> 03:58:48,680 >> THANK YOU VERY MUCH, DR. 6051 03:58:48,680 --> 03:58:49,114 BULL. 6052 03:58:49,114 --> 03:58:49,881 APPRECIATE IT. 6053 03:58:49,881 --> 03:58:51,616 I'VE BEEN MONITORING THE CHAT. 6054 03:58:51,616 --> 03:58:55,020 THERE'S A LOT OF GOOD DISCUSSION 6055 03:58:55,020 --> 03:58:57,956 FOR THE DISCUSSION PANEL. 6056 03:58:57,956 --> 03:59:02,227 I'D LIKE TO INTRODUCE DR. KHERA 6057 03:59:02,227 --> 03:59:04,429 FROM YALE UNIVERSITY, LEADS THE 6058 03:59:04,429 --> 03:59:06,398 CARDIOVASCULAR DATA SCIENCE LAB. 6059 03:59:06,398 --> 03:59:07,499 ALSO CLINICAL DIRECTOR FOR 6060 03:59:07,499 --> 03:59:09,801 CENTER FOR HEALTH INFORMATICS 6061 03:59:09,801 --> 03:59:12,337 AND ANALYTICS AT YALE CENTER FOR 6062 03:59:12,337 --> 03:59:13,305 OUTCOMES RESEARCH AND 6063 03:59:13,305 --> 03:59:14,406 EVALUATION. 6064 03:59:14,406 --> 03:59:17,342 HE WILL TALK ABOUT A.I. TOP 6065 03:59:17,342 --> 03:59:18,543 INDIVIDUALIZE TREATMENT RESPONSE 6066 03:59:18,543 --> 03:59:19,311 IN HYPERTENSION. 6067 03:59:19,311 --> 03:59:19,544 WELCOME. 6068 03:59:19,544 --> 03:59:27,686 >> I'M GOING TO SHARE MY OWN 6069 03:59:27,686 --> 03:59:27,919 SLIDES. 6070 03:59:27,919 --> 03:59:30,288 >> NO PROBLEM. 6071 03:59:30,288 --> 03:59:31,223 >> THANK YOU. 6072 03:59:31,223 --> 03:59:31,456 >> OKAY. 6073 03:59:31,456 --> 03:59:32,757 >> PERFECT. 6074 03:59:32,757 --> 03:59:33,458 THANKS SO MUCH. 6075 03:59:33,458 --> 03:59:35,861 CAN YOU SEE MY SLIDES? 6076 03:59:35,861 --> 03:59:38,130 >> YES, I CAN SEE THEM, VERY 6077 03:59:38,130 --> 03:59:38,330 CLEAR. 6078 03:59:38,330 --> 03:59:39,731 >> PERFECT. 6079 03:59:39,731 --> 03:59:40,765 THANKS SO MUCH. 6080 03:59:40,765 --> 03:59:44,169 THANKS FOR HAVING ME HERE. 6081 03:59:44,169 --> 03:59:45,937 THANKS FOR THE KIND 6082 03:59:45,937 --> 03:59:46,638 INTRODUCTION. 6083 03:59:46,638 --> 03:59:48,540 EXCELLENT MORNING OF TALKS. 6084 03:59:48,540 --> 03:59:50,075 I'M PRIVILEGED TO PRESENT SMALL 6085 03:59:50,075 --> 03:59:51,977 COMPONENT OF WHAT WE CAN OFFER 6086 03:59:51,977 --> 03:59:56,214 THROUGH A.I. IN THE TREATMENT 6087 03:59:56,214 --> 03:59:57,182 RESPONSE OPTIMIZATION 6088 03:59:57,182 --> 03:59:57,782 HYPERTENSION. 6089 03:59:57,782 --> 04:00:00,385 THE TALK IS ABOUT 6090 04:00:00,385 --> 04:00:00,986 INDIVIDUALIZING TREATMENT 6091 04:00:00,986 --> 04:00:03,054 RESPONSE IN HYPERTENSION. 6092 04:00:03,054 --> 04:00:04,456 I HAVE SOME DISCLOSURES. 6093 04:00:04,456 --> 04:00:06,291 KEY IS NOTE IS ANY ALGORITHM I 6094 04:00:06,291 --> 04:00:09,494 DISCUSS IN THIS PRESENTATION IS 6095 04:00:09,494 --> 04:00:12,297 ONLY RESEARCH USE, NOT FOR 6096 04:00:12,297 --> 04:00:13,532 CLINICAL USE YET. 6097 04:00:13,532 --> 04:00:16,034 FOCUS MAY BE ABOUT HYPERTENSION 6098 04:00:16,034 --> 04:00:16,701 BUT LARGELY ABOUT PRECISION 6099 04:00:16,701 --> 04:00:17,569 HEALTH CARE. 6100 04:00:17,569 --> 04:00:19,337 THAT MEANS FOR A GIVEN 6101 04:00:19,337 --> 04:00:22,941 INDIVIDUAL HOW DO WE PROVIDE 6102 04:00:22,941 --> 04:00:23,575 MANAGEMENT THAT IMPROVES THEIR 6103 04:00:23,575 --> 04:00:27,412 HEALTH AND BASE THE DECISION ON 6104 04:00:27,412 --> 04:00:28,313 THEIR UNIQUE FEATURES. 6105 04:00:28,313 --> 04:00:31,149 GIVEN A LARGE NUMBER OF BIAS AND 6106 04:00:31,149 --> 04:00:34,452 CONFOUNDING IN REAL WORLD DATA 6107 04:00:34,452 --> 04:00:36,421 FINDING SIGNATURES OF RESPONSE 6108 04:00:36,421 --> 04:00:43,195 AND SOLUTIONS IS CHALLENGING. 6109 04:00:43,195 --> 04:00:45,597 RANDOMIZED TRIALS REPRESENT 6110 04:00:45,597 --> 04:00:48,433 LARGE STUDIES, THAT TAKE AWAY 6111 04:00:48,433 --> 04:00:49,334 CHALLENGES, SPECIFICALLY AROUND 6112 04:00:49,334 --> 04:00:51,603 BIAS AND CONFOUNDING BY 6113 04:00:51,603 --> 04:00:53,371 INDICATION. 6114 04:00:53,371 --> 04:00:57,509 THE WAY TO LEVERAGE DATA ARE 6115 04:00:57,509 --> 04:00:57,742 LIMITED. 6116 04:00:57,742 --> 04:01:04,649 FOR EVERY DISEASE, ESPECIALLY 6117 04:01:04,649 --> 04:01:07,586 HYPERTENSION A PROPORTION GET 6118 04:01:07,586 --> 04:01:09,521 ENROLLED, AND THE FINDING, 6119 04:01:09,521 --> 04:01:11,656 POSITIVE OR NEGATIVE, NEEDS TO 6120 04:01:11,656 --> 04:01:13,825 APPLY UNIFORMLY TO ALL, TAKING 6121 04:01:13,825 --> 04:01:15,594 AWAY DIFFERENCES. 6122 04:01:15,594 --> 04:01:22,567 HOWEVER THIS APPROACH IS 6123 04:01:22,567 --> 04:01:22,834 IMPRECISE. 6124 04:01:22,834 --> 04:01:24,669 MORE SPECIFICALLY, RCTs FOCUS 6125 04:01:24,669 --> 04:01:25,904 ON AVERAGE DIFFERENCE BETWEEN 6126 04:01:25,904 --> 04:01:28,707 TWO GROUPS IN THE INTERVENTION 6127 04:01:28,707 --> 04:01:30,675 AND CONTROL ARMS, AND THIS FORM 6128 04:01:30,675 --> 04:01:32,544 OF INTERPRETATION IS BEDROCK OF 6129 04:01:32,544 --> 04:01:38,683 SCIENCE BUT HAS LIMITATIONS. 6130 04:01:38,683 --> 04:01:40,218 WE HAVE TO DISCARD INFORMATION 6131 04:01:40,218 --> 04:01:42,754 FROM LARGE HUMAN EXPERIMENT WITH 6132 04:01:42,754 --> 04:01:45,023 LARGE RESOURCES INVESTED, DATA 6133 04:01:45,023 --> 04:01:45,790 ARE DISRECORDED. 6134 04:01:45,790 --> 04:01:46,992 WHAT REALLY HAPPENS IN A 6135 04:01:46,992 --> 04:01:48,426 CLINICAL TRIAL, SOME INDIVIDUALS 6136 04:01:48,426 --> 04:01:49,961 MAY BENEFIT FROM THERAPY, OTHERS 6137 04:01:49,961 --> 04:01:52,264 MAY NOT. 6138 04:01:52,264 --> 04:01:53,565 AND BY CHANCE MANY WILL 6139 04:01:53,565 --> 04:01:56,501 EXPERIENCE AN ADVANTAGE IN EACH 6140 04:01:56,501 --> 04:01:58,270 STUDY ARM, MANY HAVE TRIED TO 6141 04:01:58,270 --> 04:02:00,772 ADDRESS THIS IN DIFFERENT WAYS. 6142 04:02:00,772 --> 04:02:05,277 THE MOST COMMON AGE-OLD APPROACH 6143 04:02:05,277 --> 04:02:10,849 IS SUBGROUP COMPARISONS. 6144 04:02:10,849 --> 04:02:15,153 INDIVIDUAL SUBGROUPS CONTINUE TO 6145 04:02:15,153 --> 04:02:17,222 BE CLINICALLY HETEROGENEOUS 6146 04:02:17,222 --> 04:02:18,657 AMONG THEMSELVES, THEORETICAL 6147 04:02:18,657 --> 04:02:21,059 UNTIL A PUSH TO SHARE DATA LED 6148 04:02:21,059 --> 04:02:24,195 BY NHLBI. 6149 04:02:24,195 --> 04:02:25,330 MAJOR ADVANCES FROM CLINICAL 6150 04:02:25,330 --> 04:02:35,807 TRIALS HAVE BEEN PROMPTED BY 6151 04:02:37,208 --> 04:02:39,778 DATA SHARING A BioLINCC, 218 6152 04:02:39,778 --> 04:02:41,713 SUBMISSIONS, VARIOUS ASPECTS OF 6153 04:02:41,713 --> 04:02:42,947 INTERPRETING CLINICAL TRIAL DATA 6154 04:02:42,947 --> 04:02:45,450 AND INFERENCE BASED ON 6155 04:02:45,450 --> 04:02:47,652 PARTICIPANT LEVEL DATA. 6156 04:02:47,652 --> 04:02:49,954 MANY STUDIES SUBMITTED DURING 6157 04:02:49,954 --> 04:02:52,057 THE CHALLENGE SPECIFICALLY 6158 04:02:52,057 --> 04:02:52,924 FOCUSED ON HETEROGENEITY 6159 04:02:52,924 --> 04:02:54,659 ESTIMATES INCLUDING BY OUR 6160 04:02:54,659 --> 04:02:58,096 GROUP, MANY FOUND COMMON 6161 04:02:58,096 --> 04:03:01,599 PREDICTORS OF TREATMENT EFFECTS. 6162 04:03:01,599 --> 04:03:04,969 USING SPRINT DATA CONTINUES TO 6163 04:03:04,969 --> 04:03:07,172 BE OF INTEREST WITH PUBLICATIONS 6164 04:03:07,172 --> 04:03:10,542 WITH VARIOUS NOVEL AND EMERGING 6165 04:03:10,542 --> 04:03:11,309 STRATEGIES. 6166 04:03:11,309 --> 04:03:13,511 WHAT IS THE DIFFERENCE BETWEEN 6167 04:03:13,511 --> 04:03:14,479 APPROACHES TO INDIVIDUALIZING 6168 04:03:14,479 --> 04:03:18,550 TREATMENT EFFECT ESTIMATES? 6169 04:03:18,550 --> 04:03:21,052 IT CAN BE CLASSIFIED A 6170 04:03:21,052 --> 04:03:22,253 PROGNOSTIC VERSUS PREDICTIVE. 6171 04:03:22,253 --> 04:03:28,560 STUDIES I MENTIONED HAVE LARGELY 6172 04:03:28,560 --> 04:03:30,795 FOCUSED A PROGNOSTIC. 6173 04:03:30,795 --> 04:03:32,430 CENTRAL ASSUMPTION IS LARGEST 6174 04:03:32,430 --> 04:03:34,499 DRIVER OF EFFECT DIFFERENCES 6175 04:03:34,499 --> 04:03:36,034 BETWEEN INDIVIDUALS IS BASELINE 6176 04:03:36,034 --> 04:03:41,239 ABSOLUTE RISK FOR EFFICACY OR 6177 04:03:41,239 --> 04:03:42,374 SAFETY OUTCOME. 6178 04:03:42,374 --> 04:03:43,942 THERE ARE DIFFERENCES IN 6179 04:03:43,942 --> 04:03:46,544 ABSOLUTE RISK REDUCTION ACROSS 6180 04:03:46,544 --> 04:03:46,978 INDIVIDUALS. 6181 04:03:46,978 --> 04:03:48,847 THE ASSUMPTION THAT INDIVIDUALS 6182 04:03:48,847 --> 04:03:49,848 WITH GIVEN CHARACTERISTICS HAVE 6183 04:03:49,848 --> 04:03:52,250 THE SAME RISK REDUCTION MAY NOT 6184 04:03:52,250 --> 04:03:54,252 BE COMPLETE AND COMPREHENSIVE. 6185 04:03:54,252 --> 04:03:56,354 SEVERAL HIGH RISK INDIVIDUALS WE 6186 04:03:56,354 --> 04:04:02,961 HAVE NON-MODIFIABLE RISK BASED 6187 04:04:02,961 --> 04:04:03,828 ON UNIQUE CHARACTERISTICS, 6188 04:04:03,828 --> 04:04:05,029 PRESENTED IN THE SCHEMATIC ON 6189 04:04:05,029 --> 04:04:07,465 THE RIGHT LEADING TO VARIABLE 6190 04:04:07,465 --> 04:04:08,767 ABSOLUTE RISK REDUCTION FOR 6191 04:04:08,767 --> 04:04:16,107 HIGHER BASE THAN ABSOLUTE RISK. 6192 04:04:16,107 --> 04:04:20,044 THE VALUE CAN BE BUILT TO 6193 04:04:20,044 --> 04:04:21,146 IDENTIFY RISK FACTORS 6194 04:04:21,146 --> 04:04:23,214 INDEPENDENT OF STUDY ARM USING 6195 04:04:23,214 --> 04:04:27,719 THAT APPROACH TO DEFINE HIGH 6196 04:04:27,719 --> 04:04:28,920 POPULATIONS. 6197 04:04:28,920 --> 04:04:29,788 ADDITIONAL LAYER IS ADDED, 6198 04:04:29,788 --> 04:04:32,624 INTERVENTION AND CONTROL ARMS 6199 04:04:32,624 --> 04:04:37,328 ARE BUILT, DIFFERENCE IS 6200 04:04:37,328 --> 04:04:38,430 QUANTIFIED, ASSESSING EVEN 6201 04:04:38,430 --> 04:04:39,731 INTERACTION EFFECTING ON 6202 04:04:39,731 --> 04:04:41,199 RELATIVE RISK SCALE BUT 6203 04:04:41,199 --> 04:04:43,468 OPPORTUNISTIC, WHAT COMES OUT OF 6204 04:04:43,468 --> 04:04:47,372 DATA AND ANALYSIS, BUT NOT 6205 04:04:47,372 --> 04:04:47,705 MODELS. 6206 04:04:47,705 --> 04:04:50,141 PREDICTIVE MODELS ARE EFFECT 6207 04:04:50,141 --> 04:04:52,644 MODELING APPROACH EXAMINE 6208 04:04:52,644 --> 04:04:53,745 WHETHER A PARTICIPANT RECEIVING 6209 04:04:53,745 --> 04:04:57,715 INTERVENTION HAD A GREATER 6210 04:04:57,715 --> 04:05:03,154 REDUCTION IN THEIR ADVERSE EVENT 6211 04:05:03,154 --> 04:05:05,256 PROFILE THAN RECEIVING STANDARD. 6212 04:05:05,256 --> 04:05:07,759 WHAT WE MODEL IS EFFECT ESTIMATE 6213 04:05:07,759 --> 04:05:09,294 OR EFFECT SIZE. 6214 04:05:09,294 --> 04:05:12,997 IF WE COULD DEFINE THIS BASED ON 6215 04:05:12,997 --> 04:05:14,532 PATIENT CHARACTERISTICS, WE HAVE 6216 04:05:14,532 --> 04:05:15,400 POTENTIAL OF GENERALIZING 6217 04:05:15,400 --> 04:05:17,502 OBSERVATION TO PEOPLE NOT 6218 04:05:17,502 --> 04:05:17,769 ENROLLED? 6219 04:05:17,769 --> 04:05:18,002 TRIALS. 6220 04:05:18,002 --> 04:05:20,572 I WANT TO USE THE EXAMPLE OF THE 6221 04:05:20,572 --> 04:05:22,740 RECENT STUDY TO DEFINE APPROACH 6222 04:05:22,740 --> 04:05:26,144 OF PERSONALIZING BENEFIT AND 6223 04:05:26,144 --> 04:05:29,981 RISK OF TREATMENT STRATEGIES IN 6224 04:05:29,981 --> 04:05:30,715 HYPERTENSION. 6225 04:05:30,715 --> 04:05:32,383 WE'VE DONE A FEW. 6226 04:05:32,383 --> 04:05:35,353 HERE ADDRESSING BLOOD PRESSURE 6227 04:05:35,353 --> 04:05:37,522 TREATMENT USING SPRINT AND 6228 04:05:37,522 --> 04:05:39,390 ACCORD DATA. 6229 04:05:39,390 --> 04:05:44,896 I'LL LEAVE THE QR CODE UP FOR 6230 04:05:44,896 --> 04:05:46,197 ONE SECOND. 6231 04:05:46,197 --> 04:05:46,865 PERFECT. 6232 04:05:46,865 --> 04:05:48,500 ON THE LEFT INCLUDES PATIENTS 6233 04:05:48,500 --> 04:05:50,702 WITHOUT DIABETES OR PRIOR 6234 04:05:50,702 --> 04:05:53,571 STROKE, LARGE REDUCTION IN MAJOR 6235 04:05:53,571 --> 04:05:54,639 ADVERSE CARDIOVASCULAR EVENTS, 6236 04:05:54,639 --> 04:05:55,673 INTENSIVE VERSUS STANDARD BLOOD 6237 04:05:55,673 --> 04:06:05,517 PRESSURE LOWERING, SYSTOLIC OF 6238 04:06:05,517 --> 04:06:07,352 120 OR 140. 6239 04:06:07,352 --> 04:06:10,121 THE ACCORD TRIAL WITH DIABETES 6240 04:06:10,121 --> 04:06:12,290 OR SAME INTERVENTION, ON THE 6241 04:06:12,290 --> 04:06:12,724 RIGHT. 6242 04:06:12,724 --> 04:06:14,592 WE CAN ATTRIBUTE TRIAL 6243 04:06:14,592 --> 04:06:18,530 DIFFERENCES, TRIALS WERE JUST 6244 04:06:18,530 --> 04:06:19,731 DIFFERENT. 6245 04:06:19,731 --> 04:06:21,366 DOES SPRINT SUGGEST PROFILES 6246 04:06:21,366 --> 04:06:24,302 WHICH CAN IDENTIFY THOSE IN 6247 04:06:24,302 --> 04:06:27,272 ACCORD THAT BENEFIT FROM BLOOD 6248 04:06:27,272 --> 04:06:29,107 PRESSURE LOWERING SUCH THERE'S 6249 04:06:29,107 --> 04:06:33,511 INDIVIDUALIZED PROFILE TO 6250 04:06:33,511 --> 04:06:35,480 INTENSIVE BLOOD PRESSURE 6251 04:06:35,480 --> 04:06:35,980 LOWERING. 6252 04:06:35,980 --> 04:06:41,052 WHO DO WE STUDY HETEROGENEITY? 6253 04:06:41,052 --> 04:06:43,454 UNLIKE CASE CONTROL STUDIES 6254 04:06:43,454 --> 04:06:45,323 PEOPLE RESEMBLE EACH OTHER, A 6255 04:06:45,323 --> 04:06:49,294 DISTRIBUTION OF FEATURES, SO, 6256 04:06:49,294 --> 04:06:54,132 FOR EXAMPLE, A WOMAN WITH CKD, 6257 04:06:54,132 --> 04:06:57,502 140/95, A MAN WITH CKD, SIMILAR 6258 04:06:57,502 --> 04:06:58,303 CREATININE, LOWER BLOOD 6259 04:06:58,303 --> 04:07:01,172 PRESSURE, THIRD PERSON A WOMAN 6260 04:07:01,172 --> 04:07:02,340 WITHOUT CKD, LOWER CREATININE, 6261 04:07:02,340 --> 04:07:04,642 SIMILAR BLOOD PRESSURE, AND SO 6262 04:07:04,642 --> 04:07:10,982 FORTH ON ALL COMBINATIONS OF 6263 04:07:10,982 --> 04:07:11,416 FEATURES. 6264 04:07:11,416 --> 04:07:14,953 WHILE I SHOW THIS IN TWO 6265 04:07:14,953 --> 04:07:17,555 DIMENSION, IT CAN BE DONE IN ANY 6266 04:07:17,555 --> 04:07:17,889 DIMENSION. 6267 04:07:17,889 --> 04:07:19,424 A PATIENT WITH ALL 6268 04:07:19,424 --> 04:07:20,625 CHARACTERISTICS HAS MULTIPLE 6269 04:07:20,625 --> 04:07:22,493 SHARED FEATURES WITH SOME 6270 04:07:22,493 --> 04:07:24,696 PEOPLE, CLOSED IN THE 6271 04:07:24,696 --> 04:07:25,997 MULTI-DIMENSIONAL PLANE, AND 6272 04:07:25,997 --> 04:07:30,902 FARTER FROM OTHERS WITH FEWER 6273 04:07:30,902 --> 04:07:31,569 SHARED CHARACTERISTICS. 6274 04:07:31,569 --> 04:07:32,570 THIS HAS BEEN CHALLENGING FOR A 6275 04:07:32,570 --> 04:07:33,104 LONG TIME. 6276 04:07:33,104 --> 04:07:35,740 IF YOU TAKE THIS TRIAL AND MAKE 6277 04:07:35,740 --> 04:07:39,544 A PROJECTION IN ALL PHENOTYPIC 6278 04:07:39,544 --> 04:07:40,445 CHARACTERISTICS, FOCUS ON THE 6279 04:07:40,445 --> 04:07:43,381 LOCATION OF A SINGLE PERSONAL IN 6280 04:07:43,381 --> 04:07:45,249 THE PHENOTYPIC SPACE THEY WILL 6281 04:07:45,249 --> 04:07:47,452 BE SURROUNDED BY OTHER 6282 04:07:47,452 --> 04:07:49,621 INDIVIDUALS LIKE THEM, HALF 6283 04:07:49,621 --> 04:07:51,089 WOULD HAVE RECEIVED THE 6284 04:07:51,089 --> 04:07:53,591 INTERVENTION, THE OTHER HALF 6285 04:07:53,591 --> 04:07:54,225 CONTROL. 6286 04:07:54,225 --> 04:07:55,693 GIVEN FACT RANDOMIZED TRIAL, 6287 04:07:55,693 --> 04:07:59,263 RANDOM ALLOCATION OF EFFECT. 6288 04:07:59,263 --> 04:08:00,565 FARTHER YOU GO, LESSER LOOKS 6289 04:08:00,565 --> 04:08:02,667 LIKE INDEX PERSON. 6290 04:08:02,667 --> 04:08:09,107 THIS CAN BE USED TO INFER 6291 04:08:09,107 --> 04:08:09,874 TREATMENT VERSUS CONTROL BY HOW 6292 04:08:09,874 --> 04:08:12,844 FAR THE TRIAL IS FROM THE INDEX 6293 04:08:12,844 --> 04:08:13,378 PATIENT. 6294 04:08:13,378 --> 04:08:14,812 AND WHETHER THEY RECEIVE 6295 04:08:14,812 --> 04:08:17,548 INTERVENTION OR CONTROL, YOU CAN 6296 04:08:17,548 --> 04:08:19,317 CONDUCT EQUIVALENT FOR THAT 6297 04:08:19,317 --> 04:08:21,719 INDEX PERSON. 6298 04:08:21,719 --> 04:08:23,688 AND WEIGH THEM BY DISTANCE AND 6299 04:08:23,688 --> 04:08:26,524 REPEAT THIS FOR EVERY PERSON IN 6300 04:08:26,524 --> 04:08:29,727 THE TRIAL WHO MAY HAVE A 6301 04:08:29,727 --> 04:08:32,864 DIFFERENT ESTIMATE AND REPEATED 6302 04:08:32,864 --> 04:08:34,632 THROUGHOUT -- FOR THE ENTIRE 6303 04:08:34,632 --> 04:08:36,601 ACTIVATION WHICH ALLOWS AN 6304 04:08:36,601 --> 04:08:37,802 INDIVIDUALIZED HAZARD ESTIMATE 6305 04:08:37,802 --> 04:08:40,772 FOR EACH PERSON'S UNIQUE 6306 04:08:40,772 --> 04:08:41,105 NEIGHBORHOOD. 6307 04:08:41,105 --> 04:08:50,715 THIS IS WHAT WE DID IN SPRINT, 6308 04:08:50,715 --> 04:08:52,150 TOOK ALL PRE-RANDOMIZATION 6309 04:08:52,150 --> 04:08:54,786 FEATURES, AND INCLUDED ALL 6310 04:08:54,786 --> 04:08:56,554 CONTINUOUS CATEGORICAL FEATURES, 6311 04:08:56,554 --> 04:09:01,025 LABS, ANYTHING IN TABLE 1. 6312 04:09:01,025 --> 04:09:02,560 ASSESSED SIMILARITY, USING A 6313 04:09:02,560 --> 04:09:05,830 METRIC FROM 0 TO 1, DISTANCE IS 6314 04:09:05,830 --> 04:09:07,498 0 BETWEEN TWO INDIVIDUALS, 6315 04:09:07,498 --> 04:09:08,900 MATCHED ON CHARACTERISTICS 6316 04:09:08,900 --> 04:09:09,167 PERFECTLY. 6317 04:09:09,167 --> 04:09:14,038 1 REPRESENTS MATCHING ON NONE OF 6318 04:09:14,038 --> 04:09:16,808 THE CHARACTERISTICS, DIGITALIZED 6319 04:09:16,808 --> 04:09:22,280 USING UMAP FOR INTERPRETATION. 6320 04:09:22,280 --> 04:09:25,783 UMAP'S 2D REPRESENTATION HAS 6321 04:09:25,783 --> 04:09:28,419 PROJECTION AND COMPLEX 6322 04:09:28,419 --> 04:09:30,388 ASSOCIATIONS, CONSTRUCTING A 6323 04:09:30,388 --> 04:09:32,890 MODEL THAT FINDS EFFECTS LIKE I 6324 04:09:32,890 --> 04:09:34,892 SHOWED AND OPERATIONALIZE FOR 6325 04:09:34,892 --> 04:09:36,394 ALL SPRINT TRIAL PARTICIPANTS. 6326 04:09:36,394 --> 04:09:39,997 THE OUTPUT OF THAT IS THIS 6327 04:09:39,997 --> 04:09:42,533 OUTCOME MAP. 6328 04:09:42,533 --> 04:09:44,702 EACH DOT IS A PERSON. 6329 04:09:44,702 --> 04:09:46,237 COLOR AND DEPTH INDICATES LOG 6330 04:09:46,237 --> 04:09:49,307 HAZARD RATIO FOR THE PRIMARY 6331 04:09:49,307 --> 04:09:50,274 OUTCOME OF SPRINT. 6332 04:09:50,274 --> 04:09:53,444 ON THE RIGHT NET CLINICAL 6333 04:09:53,444 --> 04:09:56,848 BENEFIT, PRIMARY OUTCOME OR ANY 6334 04:09:56,848 --> 04:09:58,483 ADVERSE EVENT. 6335 04:09:58,483 --> 04:10:01,219 AS YOU CAN SEE, MOST PATIENTS 6336 04:10:01,219 --> 04:10:02,653 BENEFITED FROM THE PRIMARY 6337 04:10:02,653 --> 04:10:03,621 OUTCOME IN SPRINT. 6338 04:10:03,621 --> 04:10:07,258 BUT DEGREE OF BENEFIT VARIES. 6339 04:10:07,258 --> 04:10:08,893 WHILE THIS PROCESS WAS 6340 04:10:08,893 --> 04:10:09,627 COMPUTATIONAL INTENSIVE WE 6341 04:10:09,627 --> 04:10:15,700 FURTHER BUILT LAYER ON TOP, 6342 04:10:15,700 --> 04:10:17,001 IDENTIFYING MINIMUM PATIENT 6343 04:10:17,001 --> 04:10:18,636 FEATURES PRESENT ACROSS MULTIPLE 6344 04:10:18,636 --> 04:10:21,405 NEIGHBORHOODS AND CONSISTENTLY 6345 04:10:21,405 --> 04:10:22,907 ASSOCIATED WITH BENEFIT FOR 6346 04:10:22,907 --> 04:10:25,109 MAJOR CARDIOVASCULAR EVENT FROM 6347 04:10:25,109 --> 04:10:25,676 INTENSIVE BLOOD PRESSURE 6348 04:10:25,676 --> 04:10:29,046 LOWERING, AND SO WE COULD BUILD 6349 04:10:29,046 --> 04:10:30,348 PREDICTIVE MODEL FOR 6350 04:10:30,348 --> 04:10:31,249 INDIVIDUALIZED EFFECT ESTIMATE 6351 04:10:31,249 --> 04:10:35,520 FOR MAJOR CARDIOVASCULAR EVENTS. 6352 04:10:35,520 --> 04:10:38,022 THIS MODEL WITH EIGHT TOP 6353 04:10:38,022 --> 04:10:39,023 FEATURES, COMBINATION SUFFICIENT 6354 04:10:39,023 --> 04:10:42,827 TO IDENTIFY MAJORITY OF 6355 04:10:42,827 --> 04:10:43,528 RESPONSE. 6356 04:10:43,528 --> 04:10:45,329 BASED ON SHAP VALUES, THE 6357 04:10:45,329 --> 04:10:49,167 FEATURES ARE MARKED HERE, 6358 04:10:49,167 --> 04:10:50,701 SIMILAR TO OTHER TRIAL STUDIES. 6359 04:10:50,701 --> 04:10:57,375 THESE WERE THEN USED TO MAKE A 6360 04:10:57,375 --> 04:10:58,709 CALCULATOR, ONLINE CALCULATOR 6361 04:10:58,709 --> 04:11:01,879 THAT CAN PREDICT HAZARD RATIOS 6362 04:11:01,879 --> 04:11:04,715 AND FOR THE CALCULATOR, FEATURES 6363 04:11:04,715 --> 04:11:06,484 WERE BROKEN DOWN, COMPLEX 6364 04:11:06,484 --> 04:11:08,319 FEATURES COMBINATIONS OF OTHER 6365 04:11:08,319 --> 04:11:09,754 FEATURES, WE TAKE NINE INPUTS 6366 04:11:09,754 --> 04:11:11,289 AND GIVE YOU THE PREDICTED 6367 04:11:11,289 --> 04:11:16,994 EFFECT ESTIMATE FOR A PERSON. 6368 04:11:16,994 --> 04:11:19,730 CAN YOU ACCESS THIS ON THE WEB 6369 04:11:19,730 --> 04:11:20,598 PAGE. 6370 04:11:20,598 --> 04:11:22,800 WE HAVE THIS MODEL, AND THIS 6371 04:11:22,800 --> 04:11:25,069 TOOL, CAN HOST IT, IT CAN BE 6372 04:11:25,069 --> 04:11:29,040 EMBEDDED IN EHR, BUT WHAT IF 6373 04:11:29,040 --> 04:11:30,608 WE'RE FINDING SOMETHING SPURIOUS 6374 04:11:30,608 --> 04:11:31,209 IN SPRINT? 6375 04:11:31,209 --> 04:11:35,279 WE SAID IF THERE WAS A PROFILE 6376 04:11:35,279 --> 04:11:36,914 WE EXPECTED IT TO FOLD OVER TO 6377 04:11:36,914 --> 04:11:42,820 ACCORD, IT'S HARD TO BELIEVE 6378 04:11:42,820 --> 04:11:46,090 PATIENTS WITH DIABETES WITH 6379 04:11:46,090 --> 04:11:48,626 FUNDAMENTALLY DIFFERENCE. 6380 04:11:48,626 --> 04:11:50,261 USING ACCORD, ADVERSE 6381 04:11:50,261 --> 04:11:51,262 CARDIOVASCULAR EVENTS STILL, 6382 04:11:51,262 --> 04:11:53,631 CALCULATING EFFECT ESTIMATE FOR 6383 04:11:53,631 --> 04:11:55,633 BENEFIT, USING OUR TOOL, IN THE 6384 04:11:55,633 --> 04:11:56,500 SPRINT TRIAL APPLIED TWO 6385 04:11:56,500 --> 04:11:58,669 PATIENTS IN THE ACCORD TRIAL, 6386 04:11:58,669 --> 04:12:01,639 FOUND A SIGNIFICANT QUANTITATIVE 6387 04:12:01,639 --> 04:12:03,507 INTERACTION SUCH THAT 6388 04:12:03,507 --> 04:12:04,942 INDIVIDUALSIZED PROFILE BASED ON 6389 04:12:04,942 --> 04:12:06,844 SPRINT IDENTIFIED PATIENTS WHO 6390 04:12:06,844 --> 04:12:08,212 BENEFITED FROM INTENSIVE BLOOD 6391 04:12:08,212 --> 04:12:10,615 PRESSURE LOWERING IN ACCORD WITH 6392 04:12:10,615 --> 04:12:12,250 A 30% RELATIVE RISK REDUCTION IN 6393 04:12:12,250 --> 04:12:14,018 THOSE WITH HIGH EFFECT ESTIMATE, 6394 04:12:14,018 --> 04:12:19,657 DEFINED AS LOW MEDIAN RISK, BUT 6395 04:12:19,657 --> 04:12:21,792 IN THE PLOT ON THE RIGHT. 6396 04:12:21,792 --> 04:12:23,427 WE'RE ASSESSING WHAT SURROGATES 6397 04:12:23,427 --> 04:12:24,962 WE CAN USE TO DEFINE. 6398 04:12:24,962 --> 04:12:27,565 WE DON'T HAVE TO CONDUCT 6399 04:12:27,565 --> 04:12:30,234 FIVE-YEAR STUDY TO EVALUATE OUR 6400 04:12:30,234 --> 04:12:30,601 TOOL. 6401 04:12:30,601 --> 04:12:34,839 AS I MENTIONED, WE HAVE SEVERAL 6402 04:12:34,839 --> 04:12:37,008 APPLICATIONS AND VARIATIONS, IN, 6403 04:12:37,008 --> 04:12:39,977 DIAGNOSTICS, DIABETES 6404 04:12:39,977 --> 04:12:41,612 MANAGEMENT, SO FORTH, THAT BUILD 6405 04:12:41,612 --> 04:12:43,915 ON HOW APPROACH EVOLVED OVER 6406 04:12:43,915 --> 04:12:46,984 TIME, ALL AVAILABLE AS RESEARCH 6407 04:12:46,984 --> 04:12:51,689 TOOLS. 6408 04:12:51,689 --> 04:12:55,293 KEY TAKEWAYS, CLINICAL DATA 6409 04:12:55,293 --> 04:13:00,431 SHARING IS INSTRUMENTAL. 6410 04:13:00,431 --> 04:13:07,338 APPLICATIONS OF mL/AI CAN 6411 04:13:07,338 --> 04:13:08,639 OPERATIONAL MODELS. 6412 04:13:08,639 --> 04:13:10,041 THERE ARE CHALLENGES. 6413 04:13:10,041 --> 04:13:15,546 WHAT IS THE GOLD STANDARD? 6414 04:13:15,546 --> 04:13:16,981 THERE IS NONE. 6415 04:13:16,981 --> 04:13:19,250 WE'RE BUILDING COMPLEX TREATMENT 6416 04:13:19,250 --> 04:13:23,888 EFFECTS, RIGOROUS EVALUATION OF 6417 04:13:23,888 --> 04:13:25,856 EXISTING MODELS TO ASSESS 6418 04:13:25,856 --> 04:13:27,491 DETECTION OF THESE 6419 04:13:27,491 --> 04:13:30,027 INDIVIDUALIZED EFFECTS. 6420 04:13:30,027 --> 04:13:31,195 HOW DO TRIALS WORK? 6421 04:13:31,195 --> 04:13:32,196 REPRESENTATION IN TRIALS HAS 6422 04:13:32,196 --> 04:13:36,667 BEEN AN ISSUE FOR A LONG TIME. 6423 04:13:36,667 --> 04:13:37,702 AS I MENTIONED, VALIDATION 6424 04:13:37,702 --> 04:13:40,171 REQUIRES US TO DO PRAGMATIC 6425 04:13:40,171 --> 04:13:46,677 DESIGNS AND BUILD NETWORKS TO 6426 04:13:46,677 --> 04:13:47,611 ASSESS SUFFICIENTLY. 6427 04:13:47,611 --> 04:13:48,245 THANK YOU. 6428 04:13:48,245 --> 04:13:50,147 ALL THANKS TO MY AMAZING LAB 6429 04:13:50,147 --> 04:13:55,386 MEMBERS FOR THE WORK I 6430 04:13:55,386 --> 04:13:57,021 PRESENTED, ESPECIALLY THE 6431 04:13:57,021 --> 04:13:58,422 CARDIOLOGY FELLOW AT YALE, FIRST 6432 04:13:58,422 --> 04:13:59,523 AUTHOR ON THE WORK IN THE 6433 04:13:59,523 --> 04:14:01,459 CLINICAL TRIALS I PRESENTED 6434 04:14:01,459 --> 04:14:01,659 TODAY. 6435 04:14:01,659 --> 04:14:01,959 THANK YOU. 6436 04:14:01,959 --> 04:14:03,461 >> THANK YOU. 6437 04:14:03,461 --> 04:14:04,795 APPRECIATE IT. 6438 04:14:04,795 --> 04:14:07,431 LAST SPEAKER IS DR. CHANG, 6439 04:14:07,431 --> 04:14:08,432 ASSOCIATE PROFESSOR IN 6440 04:14:08,432 --> 04:14:10,401 DEPARTMENT OF POPULATION SCIENCE 6441 04:14:10,401 --> 04:14:14,538 CO-DIRECTOR CENTER FOR KIDNEY 6442 04:14:14,538 --> 04:14:18,709 HEALTH RESEARCH, NEPHROLOGIST AT 6443 04:14:18,709 --> 04:14:19,377 GEISINGER. 6444 04:14:19,377 --> 04:14:21,545 IF WE COULD ADD 15 MINUTES TO 6445 04:14:21,545 --> 04:14:24,615 NOW, EXPECTING THAT YOUR TALK 6446 04:14:24,615 --> 04:14:26,584 ABOUT END AT 3:54, AND THE 6447 04:14:26,584 --> 04:14:30,087 SESSION ENDS AT 4:00. 6448 04:14:30,087 --> 04:14:35,226 I'M GOING TO EXTEND THIS AND LET 6449 04:14:35,226 --> 04:14:36,227 THE AUDIENCE KNOW THAT WE'RE 6450 04:14:36,227 --> 04:14:37,161 GOING TO GO THAT LONG. 6451 04:14:37,161 --> 04:14:40,498 IF YOU HAVE TO LEAVE AT 4:00 6452 04:14:40,498 --> 04:14:42,566 THAT'S PERFECTLY FINE. 6453 04:14:42,566 --> 04:14:43,768 DR. CHANG, YOU MAY PROCEED. 6454 04:14:43,768 --> 04:14:46,537 >> THANK YOU SO MUCH. 6455 04:14:46,537 --> 04:14:52,777 THANKS TO THE NHLBI AND AMAZING 6456 04:14:52,777 --> 04:14:58,315 PRESENTERS WITH TALKS TODAY. 6457 04:14:58,315 --> 04:14:59,750 MY DISCLOSURES. 6458 04:14:59,750 --> 04:15:01,919 SO, I ABSORBED A LOT OF GREAT 6459 04:15:01,919 --> 04:15:03,254 INFORMATION FROM EVERYTHING THAT 6460 04:15:03,254 --> 04:15:05,756 PEOPLE HAVE SAID BEFORE ME. 6461 04:15:05,756 --> 04:15:07,091 AND THE COMMENTS. 6462 04:15:07,091 --> 04:15:13,431 AND SO I'M PRESENTING THIS FROM 6463 04:15:13,431 --> 04:15:16,067 VIEW OF CLINICIAN-SCIENTIST, AND 6464 04:15:16,067 --> 04:15:18,469 TRYING TO UNDERSTAND ALSO HOW 6465 04:15:18,469 --> 04:15:21,505 WOULD YOU ACTUALLY USE THESE 6466 04:15:21,505 --> 04:15:24,175 TOOLS IN CLINICAL PRACTICE. 6467 04:15:24,175 --> 04:15:25,676 WE'RE OFTEN WORKING ON QUALITY 6468 04:15:25,676 --> 04:15:27,111 IMPROVEMENT WITH OUR POPULATION 6469 04:15:27,111 --> 04:15:32,249 HEALTH GROUP, AND A LARGE HEALTH 6470 04:15:32,249 --> 04:15:33,818 SYSTEM, AND WE'RE OFTEN SENSING 6471 04:15:33,818 --> 04:15:35,419 INFORMATION ABOUT A.I. TOOLS AND 6472 04:15:35,419 --> 04:15:37,521 PEOPLE WANTING TO ADOPT 6473 04:15:37,521 --> 04:15:38,322 DIFFERENT THINGS. 6474 04:15:38,322 --> 04:15:40,357 I'M GOING TO DESCRIBE EXISTING 6475 04:15:40,357 --> 04:15:45,529 LITERATURE ON USE OF A.I. AND 6476 04:15:45,529 --> 04:15:46,597 PREDICTING HYPERTENSIVE OR 6477 04:15:46,597 --> 04:15:48,032 SEQUELAE, CHRONIC KIDNEY DISEASE 6478 04:15:48,032 --> 04:15:49,467 AS EXAMPLE CONDITION, DESCRIBE 6479 04:15:49,467 --> 04:15:50,868 UNMET NEEDS AND POTENTIAL FOR 6480 04:15:50,868 --> 04:15:53,737 A.I. TO IMPROVE EARLY DIAGNOSIS 6481 04:15:53,737 --> 04:15:54,271 AND MANAGEMENT. 6482 04:15:54,271 --> 04:15:56,407 AND DESCRIBE KEY CHALLENGES AND 6483 04:15:56,407 --> 04:16:06,517 BARRIERS USING A.I. IN THIS 6484 04:16:06,517 --> 04:16:06,750 CONTEXT. 6485 04:16:06,750 --> 04:16:09,787 WE'VE HEARD WILL BLOOD PRESSURE 6486 04:16:09,787 --> 04:16:16,694 AND -- ABOUT BLOOD PRESSURE AND 6487 04:16:16,694 --> 04:16:19,563 END ORGAN DAMAGE, HOW CAN WE 6488 04:16:19,563 --> 04:16:20,965 PREDICT BETTER, FIT PREDICTION 6489 04:16:20,965 --> 04:16:22,600 MODEL INTO EXISTING CLINICAL 6490 04:16:22,600 --> 04:16:24,802 WORKFLOW, WHICH IS OFTEN VERY 6491 04:16:24,802 --> 04:16:27,204 CHALLENGING. 6492 04:16:27,204 --> 04:16:29,006 AND DO WE HAVE EVIDENCE THAT USE 6493 04:16:29,006 --> 04:16:34,411 OF A.I. PREDICTION MODELS CAN 6494 04:16:34,411 --> 04:16:35,546 HELP OUTCOMES. 6495 04:16:35,546 --> 04:16:38,082 THIS IS WAYS THAT IT COULD BE 6496 04:16:38,082 --> 04:16:39,583 USED, POPULATION OR HEALTH 6497 04:16:39,583 --> 04:16:42,019 SYSTEM LEVEL WHERE YOU CAN 6498 04:16:42,019 --> 04:16:43,154 IDENTIFY HYPERTENSIVE PATIENTS 6499 04:16:43,154 --> 04:16:44,755 AT PARTICULARLY HIGH RISK FOR 6500 04:16:44,755 --> 04:16:46,056 END ORGAN DAMAGE, AND MAYBE 6501 04:16:46,056 --> 04:16:48,959 THERE'S SOME NEED FOR SCREENING 6502 04:16:48,959 --> 04:16:49,894 OF HYPERTENSION-RELATED 6503 04:16:49,894 --> 04:16:50,561 CONDITIONS. 6504 04:16:50,561 --> 04:16:56,133 YOU CAN ALSO POTENTIALLY USE 6505 04:16:56,133 --> 04:16:59,637 RISK THRESHOLDS, AS PEOPLE 6506 04:16:59,637 --> 04:17:05,109 MENTIONED, THERE'S CLINICIAN 6507 04:17:05,109 --> 04:17:05,676 INERTIA. 6508 04:17:05,676 --> 04:17:09,947 AT THE INDIVIDUAL LEVEL, CAN WE 6509 04:17:09,947 --> 04:17:11,482 INCORPORATE, CLINICIANS IN 6510 04:17:11,482 --> 04:17:12,449 SHARED DECISION MAKING WITH 6511 04:17:12,449 --> 04:17:13,551 PATIENTS SO THEY UNDERSTAND 6512 04:17:13,551 --> 04:17:17,388 RISKS AND THAT MAY ACTUALLY HELP 6513 04:17:17,388 --> 04:17:22,193 DRIVE DECISION MAKING AND 6514 04:17:22,193 --> 04:17:25,462 ADDRESS CLINICAL INERTIA. 6515 04:17:25,462 --> 04:17:28,632 HEART FAILURE, I'M TOUCHING 6516 04:17:28,632 --> 04:17:29,200 BRIEFLY. 6517 04:17:29,200 --> 04:17:32,603 APOLOGIES TO THOSE THAT STUDY 6518 04:17:32,603 --> 04:17:32,903 EXTENSIVELY. 6519 04:17:32,903 --> 04:17:37,541 1 TO 2%, 4% ABOVE 65 TO 70 YEARS 6520 04:17:37,541 --> 04:17:39,376 OF AGE, ARE MORTALITY IS HIGH. 6521 04:17:39,376 --> 04:17:46,050 IN TERMS OF A.I. LITERATURE, 6522 04:17:46,050 --> 04:17:48,519 REVIEWS SHOWING THAT ARE IN 6523 04:17:48,519 --> 04:17:49,820 VARIOUS STUDIES THERE IS A LOT 6524 04:17:49,820 --> 04:17:53,557 OF POTENTIAL BIAS IN VALIDATION 6525 04:17:53,557 --> 04:17:55,426 PROCEDURES, LACK OF ADDRESSING 6526 04:17:55,426 --> 04:17:56,927 CALIBRATION WAS COMMON IN A LOT 6527 04:17:56,927 --> 04:17:58,596 OF PUBLISHED PAPERS. 6528 04:17:58,596 --> 04:18:01,865 AND NO EVIDENCE OF SUPERIORITY 6529 04:18:01,865 --> 04:18:05,135 OVER LOGISTIC REGRESSION FOR 6530 04:18:05,135 --> 04:18:06,036 PREDICTING HEART FAILURE 6531 04:18:06,036 --> 04:18:07,538 REHOSPITALIZATION, MAYBE SOME 6532 04:18:07,538 --> 04:18:08,305 IMPROVEMENT FOR PREDICTING 6533 04:18:08,305 --> 04:18:09,006 MORTALITY WAS SHOWN. 6534 04:18:09,006 --> 04:18:10,941 AND OF COURSE THERE'S TONS OF 6535 04:18:10,941 --> 04:18:13,911 HETEROGENEITY BETWEEN THE 6536 04:18:13,911 --> 04:18:17,314 STUDIES AND POPULATION. 6537 04:18:17,314 --> 04:18:19,483 THINKING ABOUT OTHER 6538 04:18:19,483 --> 04:18:20,985 COMPLICATIONS, MILD COGNITIVE 6539 04:18:20,985 --> 04:18:22,319 IMPAIRMENT AND DEMENTIA AFFECTS 6540 04:18:22,319 --> 04:18:24,555 LOTS OF PEOPLE IN OUR SOCIETY 6541 04:18:24,555 --> 04:18:30,761 GETTING ORDINARY, UP TO 1/3 OF 6542 04:18:30,761 --> 04:18:31,428 OLDER ADULTS. 6543 04:18:31,428 --> 04:18:34,164 INTENSIVE BLOOD PRESSURE CONTROL 6544 04:18:34,164 --> 04:18:36,100 MAY PREVENT COGNITIVE IMPAIRMENT 6545 04:18:36,100 --> 04:18:36,867 FROM SPRINT MIND. 6546 04:18:36,867 --> 04:18:42,139 AND THERE HAVE BEEN VARIOUS RISK 6547 04:18:42,139 --> 04:18:43,340 PREDICTIONS DEVELOPED USING 6548 04:18:43,340 --> 04:18:45,075 VARIOUS CLINICAL FACTORS AND A 6549 04:18:45,075 --> 04:18:48,245 LOT HAVE BEEN VALIDATED IN OTHER 6550 04:18:48,245 --> 04:18:48,812 COHORTS. 6551 04:18:48,812 --> 04:18:49,880 THERE'S OTHER SOURCES OF DATA 6552 04:18:49,880 --> 04:18:51,515 THAT ARE USUALLY IN SMALLER 6553 04:18:51,515 --> 04:18:53,717 STUDIES LOOKING AT BRAIN 6554 04:18:53,717 --> 04:18:54,485 IMAGING, GENETICS, INFORMATION 6555 04:18:54,485 --> 04:19:00,824 ON TOP OF RISK SCORES, VOICE 6556 04:19:00,824 --> 04:19:04,328 DATA, COGNITIVE FUNCTION TESTS, 6557 04:19:04,328 --> 04:19:08,399 BIOSAMPLES, A LOT OF RESEARCH 6558 04:19:08,399 --> 04:19:10,234 AND POTENTIAL WITH ANIMAL MODELS 6559 04:19:10,234 --> 04:19:13,504 THAT CAN IDENTIFY FACTORS THAT 6560 04:19:13,504 --> 04:19:19,109 ARE NOT EASY FOR HUMANS TO SEE 6561 04:19:19,109 --> 04:19:19,543 EASILY. 6562 04:19:19,543 --> 04:19:22,946 I'M POINTING OUT ONE PARTICULAR 6563 04:19:22,946 --> 04:19:24,682 STUDY, U.K. BIOBANK, RESEARCHERS 6564 04:19:24,682 --> 04:19:29,720 HAD USED DATA FROM THIS TO LOOK 6565 04:19:29,720 --> 04:19:34,458 AT 366 CANDIDATE VARIABLES TO 6566 04:19:34,458 --> 04:19:35,192 PREDICT DEMENTIA. 6567 04:19:35,192 --> 04:19:37,695 U.K. BIOBANK THEY HAVE REGULAR 6568 04:19:37,695 --> 04:19:41,298 CLINICAL PREDICTORS, ALSO 6569 04:19:41,298 --> 04:19:44,134 ADDITIONAL TESTS, THEY HAVE 6570 04:19:44,134 --> 04:19:46,370 APOE4, A GENETIC RISK FACTOR, A 6571 04:19:46,370 --> 04:19:52,476 GAME WHERE THEY HAVE TO MATCH 6572 04:19:52,476 --> 04:19:57,281 PAIRS OF CARDS, OTHER THINGS. 6573 04:19:57,281 --> 04:20:02,986 THEY HAD A MUCH BETTER AUC THAN 6574 04:20:02,986 --> 04:20:06,357 CLINICAL RISK SCORES, AND GOOD 6575 04:20:06,357 --> 04:20:07,057 CALIBRATION. 6576 04:20:07,057 --> 04:20:11,929 THIS WILL NEED EXTERNAL 6577 04:20:11,929 --> 04:20:12,363 VALIDATION. 6578 04:20:12,363 --> 04:20:15,899 IN TERMS OF CHRONIC KIDNEY 6579 04:20:15,899 --> 04:20:18,736 DISEASE, THIS AFFECTS 1 IN 7 6580 04:20:18,736 --> 04:20:20,170 U.S. ADULTS, COMMON WITH 6581 04:20:20,170 --> 04:20:22,439 HYPERTENSION, MOST COMMON RISK 6582 04:20:22,439 --> 04:20:28,145 FACTORS DIABETES, HYPERTENSION, 6583 04:20:28,145 --> 04:20:31,248 YOU CAN CONSIDER CONSIDER CKD 6584 04:20:31,248 --> 04:20:33,751 AND IT'S IMPORTANT TO POINT OUT 6585 04:20:33,751 --> 04:20:37,121 PATIENTS HAVE NO IDEA THEY HAVE 6586 04:20:37,121 --> 04:20:38,122 CHRONIC KIDNEY DISEASE. 6587 04:20:38,122 --> 04:20:41,625 THIS IS THE SCHEMA THAT WE USE 6588 04:20:41,625 --> 04:20:52,035 TO CLASSIFY KIDNEY DISEASE BY 6589 04:20:52,035 --> 04:20:52,736 ESTIMATED GLOMULAR FILTRATION 6590 04:20:52,736 --> 04:20:54,338 RATE, OR A URINE TEST FOR 6591 04:20:54,338 --> 04:20:55,739 PATIENTS AT RISK, YOU CAN USE 6592 04:20:55,739 --> 04:20:59,476 THAT TO PREDICT RISK IN BOTH OF 6593 04:20:59,476 --> 04:21:01,545 THOSE THINGS ON TOP OF EACH 6594 04:21:01,545 --> 04:21:02,980 OTHER CAN DRIVE DECISION MAKING 6595 04:21:02,980 --> 04:21:08,919 IN TERMS OF HOW AGGRESSIVE YOU 6596 04:21:08,919 --> 04:21:12,890 TREAT AND REFERRAL PATTERNS. 6597 04:21:12,890 --> 04:21:15,592 THIS HAS BEEN INTEGRATED INTO A 6598 04:21:15,592 --> 04:21:20,931 RISK EQUATION SCORE, WORK DONE 6599 04:21:20,931 --> 04:21:25,669 WITH MANY COHORTS AROUND THE 6600 04:21:25,669 --> 04:21:26,003 WORLD. 6601 04:21:26,003 --> 04:21:31,442 SOURCE DATA FROM CANADA. 6602 04:21:31,442 --> 04:21:35,612 THEY HAD EXCELLENT 6603 04:21:35,612 --> 04:21:38,248 DISCRIMINATION AUC 0.9 6604 04:21:38,248 --> 04:21:39,249 PREDICTING KIDNEY FAILURE, 6605 04:21:39,249 --> 04:21:41,418 CALIBRATION CAN BE AN ISSUE 6606 04:21:41,418 --> 04:21:43,187 SOMETIMES, ESPECIALLY FOR THE 6607 04:21:43,187 --> 04:21:45,088 NON-NORTH AMERICAN COHORTS 6608 04:21:45,088 --> 04:21:47,024 INCLUDED IN THE STUDY. 6609 04:21:47,024 --> 04:21:50,093 SO THIS IS A STANDARD -- SOME 6610 04:21:50,093 --> 04:21:51,962 HAS FLOWED INTO ELECTRONIC 6611 04:21:51,962 --> 04:21:52,930 HEALTH RECORDS. 6612 04:21:52,930 --> 04:21:55,332 IT'S NOT UNIVERSAL QUITE YET BUT 6613 04:21:55,332 --> 04:21:56,433 THIS REALLY IS PROBABLY ONE OF 6614 04:21:56,433 --> 04:22:02,139 THE MAIN THINGS WE WILL BE USING 6615 04:22:02,139 --> 04:22:03,240 TO DRIVE DECISION MAKING, WE'D 6616 04:22:03,240 --> 04:22:06,877 LIKE TO KEEP ROLLING OUT. 6617 04:22:06,877 --> 04:22:12,349 ONE OF THE PROBLEMS, YOU NEED 6618 04:22:12,349 --> 04:22:15,619 ALBUMIN CREATININE RATIO TO HELP 6619 04:22:15,619 --> 04:22:16,353 RISK STRATIFY KIDNEY DISEASE, 6620 04:22:16,353 --> 04:22:20,023 AND YOU CAN SEE AMONG PATIENTS 6621 04:22:20,023 --> 04:22:21,758 WITH DIABETES OR HYPERTENSION AT 6622 04:22:21,758 --> 04:22:28,899 RISK, VERY FEW END UP GETTING 6623 04:22:28,899 --> 04:22:30,968 ALBUMINEREA SCREENING, 5% FOR 6624 04:22:30,968 --> 04:22:32,836 HYPERTENSION, THAT RESULTS IN 6625 04:22:32,836 --> 04:22:34,571 UNDERDIAGNOSIS OF CHRONIC KIDNEY 6626 04:22:34,571 --> 04:22:36,206 DISEASE AND PROBABLY CONTRIBUTES 6627 04:22:36,206 --> 04:22:38,809 TO AWARENESS PROBLEM. 6628 04:22:38,809 --> 04:22:40,377 AND ALSO THERE'S A LOT OF 6629 04:22:40,377 --> 04:22:42,479 REASONS WE'RE NOT OPTIMIZING USE 6630 04:22:42,479 --> 04:22:43,881 OF MEDICATIONS AND GETTING BLOOD 6631 04:22:43,881 --> 04:22:45,749 PRESSURE UNDER CONTROL BUT 6632 04:22:45,749 --> 04:22:50,020 THAT'S DEFINITELY CONTRIBUTING 6633 04:22:50,020 --> 04:22:51,989 TO THAT. 6634 04:22:51,989 --> 04:22:54,291 IMAGINE AN A.I. RISK SCORE 6635 04:22:54,291 --> 04:22:56,159 THAT'S ABLE TO STRATIFY 6636 04:22:56,159 --> 04:22:57,027 HYPERTENSION PATIENTS INTO 6637 04:22:57,027 --> 04:23:01,832 HIGHER OR LOWER BUCKETS OF CKD 6638 04:23:01,832 --> 04:23:06,637 RISK, YOU CAN IMPLEMENT 6639 04:23:06,637 --> 04:23:09,072 POPULATION LEVEL STRATEGY TO 6640 04:23:09,072 --> 04:23:10,707 IMPROVE ALBUMINEREA SCREENING 6641 04:23:10,707 --> 04:23:12,776 THROUGH NUDGES, IMPROVE 6642 04:23:12,776 --> 04:23:15,612 ADHERENCE, AMONG THOSE WHO HAVE 6643 04:23:15,612 --> 04:23:18,248 KIDNEY DISEASE OR COULD QUALIFY 6644 04:23:18,248 --> 04:23:20,450 FOR TREATMENT, THAT MAY INFORM 6645 04:23:20,450 --> 04:23:22,619 CLINICAL DECISION MAKING AND 6646 04:23:22,619 --> 04:23:26,123 IMPROVE THE USE OF CARDIO RENAL 6647 04:23:26,123 --> 04:23:27,891 RISK REDUCING TREATMENTS. 6648 04:23:27,891 --> 04:23:29,626 SO I THINK THERE'S BEEN QUITE A 6649 04:23:29,626 --> 04:23:35,332 FEW STUDIES ON USE OF A.I. CKD. 6650 04:23:35,332 --> 04:23:37,200 I HAVE A COUPLE. 6651 04:23:37,200 --> 04:23:38,702 BOTTOM LINE, THERE'S A LOT OF 6652 04:23:38,702 --> 04:23:41,338 STUDIES, SOME HAVE EXTERNAL 6653 04:23:41,338 --> 04:23:43,874 VALIDATION, SOME DON'T. 6654 04:23:43,874 --> 04:23:47,578 DIFFERENT OUTCOMES. 6655 04:23:47,578 --> 04:23:49,212 SOME USE OTHER BIOMARKERS NOT 6656 04:23:49,212 --> 04:23:51,181 REGULARLY COLLECTED IN CLINICAL 6657 04:23:51,181 --> 04:23:53,817 PRACTICE, AND OF COURSE WILL 6658 04:23:53,817 --> 04:23:55,218 IMPROVE THE RISK PREDICTION. 6659 04:23:55,218 --> 04:23:58,288 THESE ARE TWO STUDIES THAT I'M 6660 04:23:58,288 --> 04:24:01,458 GOING FOCUS ON MORE HERE, SO 6661 04:24:01,458 --> 04:24:04,861 THIS FIRST ONE WAS A NICE STUDY 6662 04:24:04,861 --> 04:24:08,365 DONE USING ADMINISTRATIVE DATA 6663 04:24:08,365 --> 04:24:10,200 FROM CANADA, MANITOBA, SO THEY 6664 04:24:10,200 --> 04:24:14,037 HAD 77,000 IN THE COHORTS, 6665 04:24:14,037 --> 04:24:16,673 VALIDATED RESULTS IN EXTERNAL 6666 04:24:16,673 --> 04:24:18,008 ALBERTA, CANADA, COHORT. 6667 04:24:18,008 --> 04:24:20,777 AND THIS ONE REQUIRED THEM TO 6668 04:24:20,777 --> 04:24:21,745 HAVE EGFR GREATER THAN 10. 6669 04:24:21,745 --> 04:24:26,350 AND THEY HAD TO HAVE THE RATIO, 6670 04:24:26,350 --> 04:24:28,085 THAT URINE TEST, AVAILABLE. 6671 04:24:28,085 --> 04:24:29,686 THEY LOOKED AT OTHER COMMONLY 6672 04:24:29,686 --> 04:24:31,588 MEASURED LABS THAT COME UP IN 6673 04:24:31,588 --> 04:24:32,789 CLINICAL PRACTICE. 6674 04:24:32,789 --> 04:24:35,492 AND THEN THE OUTCOME WAS 40% 6675 04:24:35,492 --> 04:24:39,863 DECLINE IN EGFR, KIDNEY FAILURE, 6676 04:24:39,863 --> 04:24:44,468 AN ACCEPTED OUTCOME FOR KIDNEY 6677 04:24:44,468 --> 04:24:44,901 PROBLEMS. 6678 04:24:44,901 --> 04:24:51,942 AND THEY USED RANDOM FORCE. 6679 04:24:51,942 --> 04:24:54,478 AND SO OVERALL NOT SURPRISING 6680 04:24:54,478 --> 04:24:59,683 THEY WERE ABLE TO PREDICT KIDNEY 6681 04:24:59,683 --> 04:25:00,917 FAILURE AND EGFR DECLINE, ABLE 6682 04:25:00,917 --> 04:25:03,186 TO COMPARE IT TO SORT OF THE 6683 04:25:03,186 --> 04:25:04,321 PREEXISTING MODEL THAT I 6684 04:25:04,321 --> 04:25:07,357 MENTIONED SO HEAT MAP MODEL 6685 04:25:07,357 --> 04:25:10,027 BASED OFF EGFR AND ACR CATEGORY, 6686 04:25:10,027 --> 04:25:12,095 AND SHOW THERE'S SIGNIFICANT 6687 04:25:12,095 --> 04:25:14,498 IMPROVEMENT IN THE AUC COMPARED 6688 04:25:14,498 --> 04:25:19,002 TO THAT, AND THROW IN OTHER 6689 04:25:19,002 --> 04:25:20,504 CLINICAL FACTORS LIKE DIABETES, 6690 04:25:20,504 --> 04:25:21,938 HYPERTENSION, STROKE, ET CETERA, 6691 04:25:21,938 --> 04:25:23,907 WE'RE ABLE TO PREDICT BETTER. 6692 04:25:23,907 --> 04:25:26,643 YOU CAN SEE SOME OF THE FACTORS 6693 04:25:26,643 --> 04:25:33,483 THAT WERE IMPORTANT BEYOND ACR 6694 04:25:33,483 --> 04:25:34,851 AND EGFR, UREA, HEMATOCRIT AND 6695 04:25:34,851 --> 04:25:35,652 GLUCOSE. 6696 04:25:35,652 --> 04:25:38,388 THAT WAS A NICE STUDY. 6697 04:25:38,388 --> 04:25:39,923 THEY HAVE PRETTY GOOD 6698 04:25:39,923 --> 04:25:43,627 CALIBRATION THAT THEY SHOW HERE. 6699 04:25:43,627 --> 04:25:44,728 THERE'S EXTERNAL VALIDATION, 6700 04:25:44,728 --> 04:25:51,301 COMMONLY MEASURED LAB DATA USING 6701 04:25:51,301 --> 04:25:52,469 REAL EHR DATA, APPLICABLE. 6702 04:25:52,469 --> 04:25:54,237 YOU REQUIRE PATIENTS TO HAVE ACR 6703 04:25:54,237 --> 04:26:01,244 DATA AND A LOT ARE NOT TESTED 6704 04:26:01,244 --> 04:26:02,446 APPROPRIATELY. 6705 04:26:02,446 --> 04:26:09,319 SO, THIS IS ANOTHER STUDY, THE 6706 04:26:09,319 --> 04:26:19,863 EUROPEAN DATABASE, ALSO INCLUDES 6707 04:26:27,270 --> 04:26:28,171 OTHER COUNTRIES. 6708 04:26:28,171 --> 04:26:29,272 TRY TO PREDICT IF THEY ARE GOING 6709 04:26:29,272 --> 04:26:33,210 TO END UP WITH END STAGE KIDNEY 6710 04:26:33,210 --> 04:26:33,744 DISEASE. 6711 04:26:33,744 --> 04:26:36,379 WHAT THEY FOUND WAS THAT THE 6712 04:26:36,379 --> 04:26:40,317 KFRE, COMPARED TO THE KIDNEY 6713 04:26:40,317 --> 04:26:43,286 FAILURE RISK EQUATION, PREDICTED 6714 04:26:43,286 --> 04:26:45,789 SIMILAR AUC AS ALGORITHM. 6715 04:26:45,789 --> 04:26:46,990 AND HOWEVER THE OTHER 6716 04:26:46,990 --> 04:26:49,292 INTERESTING THING IS THAT YOU 6717 04:26:49,292 --> 04:26:51,928 DON'T REQUIRE THE ACR TO USE THE 6718 04:26:51,928 --> 04:26:52,896 ALGORITHM THAT THEY DEVELOPED, 6719 04:26:52,896 --> 04:26:54,998 THEY ARE ABLE TO GENERATE 6720 04:26:54,998 --> 04:26:59,402 PREDICTION ON ALL THE PATIENTS, 6721 04:26:59,402 --> 04:27:00,337 WHEREAS THE ALBUMINEREA WAS 6722 04:27:00,337 --> 04:27:03,840 AVAILABLE BE ON 30% OF SIX 6723 04:27:03,840 --> 04:27:06,042 MONTH, 16% OF 24-MONTH COHORT, 6724 04:27:06,042 --> 04:27:11,181 IF YOU'RE SEEING A PATIENT IN 6725 04:27:11,181 --> 04:27:13,784 CLINIC THIS MIGHT BE ABLE TO 6726 04:27:13,784 --> 04:27:14,384 GENERATE SOMETHING CLINICALLY 6727 04:27:14,384 --> 04:27:19,923 USEFUL, THIS IS FROM THE PAPER 6728 04:27:19,923 --> 04:27:22,092 OF RISK REPORT, SHOWING THE RISK 6729 04:27:22,092 --> 04:27:26,797 PROFILE OVER TIME, WHICH FACTORS 6730 04:27:26,797 --> 04:27:29,766 ARE PROTECTIVE VERSUS NOT A RISK 6731 04:27:29,766 --> 04:27:33,270 FACTOR, AND THEN THE OVERALL 6732 04:27:33,270 --> 04:27:35,205 RISK, AND WHAT MISSING 6733 04:27:35,205 --> 04:27:36,640 INFORMATION IS NOT THERE THAT 6734 04:27:36,640 --> 04:27:40,811 COULD BE INFORMATIVE AS WELL. 6735 04:27:40,811 --> 04:27:43,647 THIS IS A SIMULATION THAT THEY 6736 04:27:43,647 --> 04:27:46,383 DID WHERE THEY TOOK SEVERAL 6737 04:27:46,383 --> 04:27:50,320 NEPHROLOGISTS AND HAD THEM 6738 04:27:50,320 --> 04:27:53,290 EVALUATE CASES, ACTUAL CASES, 6739 04:27:53,290 --> 04:27:54,191 AND PROVIDE CLASSIFICATION 6740 04:27:54,191 --> 04:27:56,226 WHETHER PATIENTS WERE HIGH RISK 6741 04:27:56,226 --> 04:27:57,227 OR NOT. 6742 04:27:57,227 --> 04:27:59,296 AND THEN COMPARED TO WHAT IF 6743 04:27:59,296 --> 04:28:02,799 THEY USED THEIR ALGORITHMS AND 6744 04:28:02,799 --> 04:28:05,869 COMPARED TO THE CLINICIAN, YOU 6745 04:28:05,869 --> 04:28:08,839 CAN SEE ON THE PART B SECTION 6746 04:28:08,839 --> 04:28:13,410 HERE THAT THEY ARE ABLE TO HAVE 6747 04:28:13,410 --> 04:28:14,311 A GREATER IMPACT ON A 6748 04:28:14,311 --> 04:28:15,345 HYPOTHETICAL SITUATION WHERE YOU 6749 04:28:15,345 --> 04:28:17,147 TAKE THOSE PATIENTS THAT ARE 6750 04:28:17,147 --> 04:28:18,348 HIGH RISK AND GIVE THEM 6751 04:28:18,348 --> 04:28:20,951 SOMETHING TO REDUCE RISK OF 6752 04:28:20,951 --> 04:28:24,421 KIDNEY FAILURE COMPARED TO THE 6753 04:28:24,421 --> 04:28:24,955 EXPERT OPINION. 6754 04:28:24,955 --> 04:28:27,224 SO, THIS WOULD BE A GOOD 6755 04:28:27,224 --> 04:28:28,658 APPROACH WHERE YOU COULD TRY TO 6756 04:28:28,658 --> 04:28:30,760 IDENTIFY THOSE AT HIGHEST RISK 6757 04:28:30,760 --> 04:28:32,295 AND THEN HEALTH CARE IS A 6758 04:28:32,295 --> 04:28:35,365 LIMITED RESOURCE, SO YOU DRIVE 6759 04:28:35,365 --> 04:28:39,502 IT TOWARDS THE HIGHEST RISK 6760 04:28:39,502 --> 04:28:40,370 PATIENTS. 6761 04:28:40,370 --> 04:28:42,472 THAT'S ONE OF THE SCIENTIFIC 6762 04:28:42,472 --> 04:28:44,774 AREAS TRYING TO IMPLEMENT A 6763 04:28:44,774 --> 04:28:50,013 TOOL, WHETHER CKD OR HEART 6764 04:28:50,013 --> 04:28:52,215 FAILURE, OR DEMENTIA, TRY TO 6765 04:28:52,215 --> 04:28:54,818 IMPACT SHARED DECISION MAKING 6766 04:28:54,818 --> 04:28:56,686 AND IMPROVE CLINICAL CARE, MAYBE 6767 04:28:56,686 --> 04:28:58,788 USE IT TO DETECT EARLY 6768 04:28:58,788 --> 04:29:01,191 MODIFIABLE DISEASE AT THE 6769 04:29:01,191 --> 04:29:02,959 POPULATION LEVEL, AND THEN ALSO 6770 04:29:02,959 --> 04:29:04,361 WHAT HAPPENS WHEN YOU 6771 04:29:04,361 --> 04:29:10,834 INCORPORATE ALL THESE OTHER DATA 6772 04:29:10,834 --> 04:29:12,903 SOURCES, WEARABLES, EKG, 6773 04:29:12,903 --> 04:29:15,071 BIOMARKERS AS WELL. 6774 04:29:15,071 --> 04:29:17,374 OTHER GAPS IN KNOWLEDGE, DO WE 6775 04:29:17,374 --> 04:29:19,342 KNOW THAT OUR PATIENTS AND 6776 04:29:19,342 --> 04:29:21,077 PROVIDERS ARE GOING TO ACCEPT 6777 04:29:21,077 --> 04:29:26,349 THE A.I.-BASED ALGORITHMS? 6778 04:29:26,349 --> 04:29:28,318 CAN WE ACTUALLY SHOW, WE NEED TO 6779 04:29:28,318 --> 04:29:30,287 SHOW YOU CAN GET IMPROVEMENT, 6780 04:29:30,287 --> 04:29:33,690 SOME COMMENTS IN THE CHAT, 6781 04:29:33,690 --> 04:29:34,424 MAKING THINGS MORE COMPLICATED 6782 04:29:34,424 --> 04:29:37,494 MAY NOT BE IN THE BEST INTEREST, 6783 04:29:37,494 --> 04:29:40,330 IF THE SIMPLE ANSWER IS HARD 6784 04:29:40,330 --> 04:29:41,031 ENOUGH ITSELF. 6785 04:29:41,031 --> 04:29:43,967 WE NEED TO GENERATE EVIDENCE TO 6786 04:29:43,967 --> 04:29:45,402 SHOW ALL THIS. 6787 04:29:45,402 --> 04:29:49,005 SOME OTHER KEY CHALLENGES AND 6788 04:29:49,005 --> 04:29:50,774 BARRIERS, INTEROPERABILITY, DATA 6789 04:29:50,774 --> 04:29:53,176 SHARING AS MENTIONED BEFORE, AND 6790 04:29:53,176 --> 04:29:54,678 PRIVACY ISSUES AROUND THAT. 6791 04:29:54,678 --> 04:29:56,246 LACK OF VALIDATION OF THE 6792 04:29:56,246 --> 04:29:58,114 COHORTS, AND SOME OF THAT 6793 04:29:58,114 --> 04:30:00,417 PROBABLY IS RELATED TO 6794 04:30:00,417 --> 04:30:01,451 DIFFICULTIES OF SHARING DATA AND 6795 04:30:01,451 --> 04:30:04,154 THERE'S A LOT OF TALK ABOUT 6796 04:30:04,154 --> 04:30:05,021 FEDERATED MODELS. 6797 04:30:05,021 --> 04:30:07,424 EXPLAINABILITY OF A.I. IS VERY 6798 04:30:07,424 --> 04:30:09,392 IMPORTANT IN UNDERSTANDING, YOU 6799 04:30:09,392 --> 04:30:11,695 KNOW, THE DIFFERENT SUPERVISOR 6800 04:30:11,695 --> 04:30:13,897 VERSUS UNSUPERVISED LEARNING, 6801 04:30:13,897 --> 04:30:17,067 AND THEN OF COURSE ON THE 6802 04:30:17,067 --> 04:30:17,834 MANUFACTURERS, REGULATORY 6803 04:30:17,834 --> 04:30:18,802 CONSTRAINTS, LACK OF 6804 04:30:18,802 --> 04:30:21,004 REIMBURSEMENT FOR A.I. AND SOME 6805 04:30:21,004 --> 04:30:23,406 OF THE BIGGER CHALLENGES THAT 6806 04:30:23,406 --> 04:30:26,142 HAVE BEEN DISCUSSED SO FAR ON 6807 04:30:26,142 --> 04:30:31,181 THE UNIQUE PROPERTIES OF THESE 6808 04:30:31,181 --> 04:30:33,483 AND HOW FDA IS ADAPTING TO 6809 04:30:33,483 --> 04:30:34,684 FIGURE OUT THESE PROBLEMS. 6810 04:30:34,684 --> 04:30:38,221 THANK YOU VERY MUCH FOR YOUR 6811 04:30:38,221 --> 04:30:40,156 ATTENTION AND STAYING LATER. 6812 04:30:40,156 --> 04:30:44,894 THIS IS JUST A PHOTOGRAPH OF 6813 04:30:44,894 --> 04:30:46,963 ABIGAIL GEISINGER WHO FOUNDED 6814 04:30:46,963 --> 04:30:48,698 OUR HOSPITAL SYSTEM AT THE AGE 6815 04:30:48,698 --> 04:30:53,203 OF 85 IN 1915, AND I THINK IT'S 6816 04:30:53,203 --> 04:30:55,305 SOMETHING WE LIKE TO REFLECT, 6817 04:30:55,305 --> 04:30:56,606 IMAGINE WHAT SHE WOULD THINK 6818 04:30:56,606 --> 04:30:59,109 ABOUT WHAT'S GONE ON FROM THIS 6819 04:30:59,109 --> 04:31:00,543 HUMBLE HEALTH SYSTEM SHE BUILT 6820 04:31:00,543 --> 04:31:03,046 TO NOW WE'RE TALKING ABOUT 6821 04:31:03,046 --> 04:31:04,481 INCORPORATING A.I. INTO CLINICAL 6822 04:31:04,481 --> 04:31:05,448 DECISION MAKING AND CARE. 6823 04:31:05,448 --> 04:31:09,085 SO THANK YOU VERY MUCH FOR YOUR 6824 04:31:09,085 --> 04:31:09,352 ATTENTION. 6825 04:31:09,352 --> 04:31:12,222 >> THANK YOU, DR. CHANG. 6826 04:31:12,222 --> 04:31:13,223 I THINK WE'LL QUICKLY TRANSITION 6827 04:31:13,223 --> 04:31:14,858 INTO DISCUSSION PERIOD. 6828 04:31:14,858 --> 04:31:17,827 WE'RE GOING TO GO A LITTLE BIT 6829 04:31:17,827 --> 04:31:18,628 BEYOND 4:00. 6830 04:31:18,628 --> 04:31:20,130 I HAVE A QUESTION. 6831 04:31:20,130 --> 04:31:22,399 I'VE BEEN MONITORING THE CHAT. 6832 04:31:22,399 --> 04:31:24,267 I TWO MAIN QUESTIONS FOR OUR 6833 04:31:24,267 --> 04:31:28,304 GROUP OF SPEAKERS FOR THIS 6834 04:31:28,304 --> 04:31:28,538 SESSION. 6835 04:31:28,538 --> 04:31:31,808 SO, AS I WAS LISTENING TO YOUR 6836 04:31:31,808 --> 04:31:33,143 TALKS, MONITORING THE CHAT, I 6837 04:31:33,143 --> 04:31:35,645 THINK THERE'S A PRESSURE POINT 6838 04:31:35,645 --> 04:31:37,981 BETWEEN WHAT I CALL THE LAW OF 6839 04:31:37,981 --> 04:31:40,383 AVERAGES, WHICH ARE THE THINGS 6840 04:31:40,383 --> 04:31:42,552 THAT WE ASSESS IN CLINICAL 6841 04:31:42,552 --> 04:31:45,388 TRIALS. 6842 04:31:45,388 --> 04:31:45,588 RIGHT? 6843 04:31:45,588 --> 04:31:46,823 ONE GROUP RANDOMIZED, AND THEN 6844 04:31:46,823 --> 04:31:49,793 THE CONTROL, AND ON AVERAGE THE 6845 04:31:49,793 --> 04:31:50,860 GROUP DOES BETTER WITH REGARDS 6846 04:31:50,860 --> 04:31:52,295 TO BLOOD PRESSURE REDUCTION AND 6847 04:31:52,295 --> 04:31:55,899 CARDIOVASCULAR EVENTS THAN THE 6848 04:31:55,899 --> 04:31:56,332 CONTROL. 6849 04:31:56,332 --> 04:31:58,201 OF COURSE, IN CLINICAL CARE WE 6850 04:31:58,201 --> 04:32:00,603 FOCUS ON THE INDIVIDUAL. 6851 04:32:00,603 --> 04:32:04,974 I NOTICE THIS KIND OF BALANCE 6852 04:32:04,974 --> 04:32:06,643 BETWEEN USING EHR ALERTS, 6853 04:32:06,643 --> 04:32:09,245 PERHAPS DRIVEN BY A.I. BOTS, 6854 04:32:09,245 --> 04:32:10,880 CHAT BOTS, WHO WERE IDENTIFYING 6855 04:32:10,880 --> 04:32:15,385 PEOPLE THAT SHOULD BE SCREENED 6856 04:32:15,385 --> 04:32:17,821 FOR HYPERTENSION, OR HAVE THEIR 6857 04:32:17,821 --> 04:32:18,288 HYPERTENSION TREATMENT 6858 04:32:18,288 --> 04:32:20,657 INTENSIFIED BECAUSE THEY ARE 6859 04:32:20,657 --> 04:32:22,292 POORLY CONTROLLED, AND SO IT'S 6860 04:32:22,292 --> 04:32:25,261 ALMOST LIKE A DECISION SUPPORT. 6861 04:32:25,261 --> 04:32:27,664 AND THAT MODEL EVERYONE GETS THE 6862 04:32:27,664 --> 04:32:30,300 SAME SORT OF STEPPED 6863 04:32:30,300 --> 04:32:30,733 INTERVENTION. 6864 04:32:30,733 --> 04:32:32,902 HEY, YOU'RE NOT WELL CONTROLLED. 6865 04:32:32,902 --> 04:32:35,872 YOU SHOULD DO DIET AND EXERCISE, 6866 04:32:35,872 --> 04:32:39,576 AFTER THREE MONTHS YOU SHOULD 6867 04:32:39,576 --> 04:32:40,376 MOVE TO MEDICATION, THAT'S 6868 04:32:40,376 --> 04:32:44,747 SOMETHING I SAW IN THE CHAT, ONE 6869 04:32:44,747 --> 04:32:45,115 SIZE FITS ALL. 6870 04:32:45,115 --> 04:32:48,251 THEN ON THE OTHER HAND I KNOW 6871 04:32:48,251 --> 04:32:49,486 FROM THE TRIALS HUGE 6872 04:32:49,486 --> 04:32:50,887 HETEROGENEITY IN HOW PEOPLE 6873 04:32:50,887 --> 04:32:51,121 RESPOND. 6874 04:32:51,121 --> 04:32:53,623 SO, FOR EXAMPLE, SHOULD WE BE 6875 04:32:53,623 --> 04:32:57,760 USING A.I. RISK SCORE TO 6876 04:32:57,760 --> 04:32:59,429 DETERMINE WHO SHOULD BENEFIT 6877 04:32:59,429 --> 04:33:00,997 FROM DIET, EXERCISE, VERSUS A 6878 04:33:00,997 --> 04:33:04,134 LIFE COACH, WHO HAVE YOU GET A 6879 04:33:04,134 --> 04:33:05,568 CALCIUM CHANNEL BLOCKER VERSUS 6880 04:33:05,568 --> 04:33:07,103 ACE INHIBITOR, ONE PERSON MAY 6881 04:33:07,103 --> 04:33:07,971 BENEFIT OVER ANOTHER. 6882 04:33:07,971 --> 04:33:09,939 SO I WANTED TO ASK THIS GROUP, I 6883 04:33:09,939 --> 04:33:14,110 KNOW YOU'RE ALL IN THE A.I. 6884 04:33:14,110 --> 04:33:14,344 FIELD. 6885 04:33:14,344 --> 04:33:16,579 WHAT DO YOU THINK ABOUT THAT 6886 04:33:16,579 --> 04:33:18,815 SORT OF BALANCE BETWEEN 6887 04:33:18,815 --> 04:33:21,584 TREATMENT FOR ALL VERSUS 6888 04:33:21,584 --> 04:33:25,755 TREATMENT FOR AN INDIVIDUAL? 6889 04:33:25,755 --> 04:33:28,725 CAN THAT BE PERSONALIZED? 6890 04:33:28,725 --> 04:33:29,726 ANYONE CAN ANSWER. 6891 04:33:29,726 --> 04:33:31,995 >> I SEE MYSELF ON THE RIGHT. 6892 04:33:31,995 --> 04:33:34,063 I'M NEXT TO YOU. 6893 04:33:34,063 --> 04:33:34,430 >> GO FOR IT. 6894 04:33:34,430 --> 04:33:39,235 >> I THINK THIS IS OF COURSE 6895 04:33:39,235 --> 04:33:40,236 AGE-OLD TENSION BETWEEN PUBLIC 6896 04:33:40,236 --> 04:33:42,539 HEALTH AND PRECISION MEDICINE. 6897 04:33:42,539 --> 04:33:44,507 AND SOME OF THE GOALS OF THE 6898 04:33:44,507 --> 04:33:47,544 MEETING TODAY, I HOPE, WERE 6899 04:33:47,544 --> 04:33:48,444 ASPIRATIONAL RATHER THAN 6900 04:33:48,444 --> 04:33:48,778 FOUNDATIONAL. 6901 04:33:48,778 --> 04:33:49,045 >> RIGHT. 6902 04:33:49,045 --> 04:33:52,382 >> WHAT IS HAPPENING IN REALITY. 6903 04:33:52,382 --> 04:33:55,018 SO FOR MANY PATIENTS THESE 6904 04:33:55,018 --> 04:33:55,952 INDIVIDUALIZED STRATEGIES ARE 6905 04:33:55,952 --> 04:33:57,086 PROBABLY NOT SUITABLE FOR 6906 04:33:57,086 --> 04:33:58,621 MAJORITY OF OUR SOCIETY RIGHT 6907 04:33:58,621 --> 04:33:59,255 NOW. 6908 04:33:59,255 --> 04:34:01,357 AND I FEEL LIKE THE HOPE, I MEAN 6909 04:34:01,357 --> 04:34:04,327 THE GOAL OVERALL IS METHODS, AS 6910 04:34:04,327 --> 04:34:05,528 METHODS EMERGE, YOU'RE SEEING 6911 04:34:05,528 --> 04:34:07,630 THIS PATIENT, WHO YOU HAVE 6912 04:34:07,630 --> 04:34:08,932 ACHIEVED THAT STATE WHERE 6913 04:34:08,932 --> 04:34:10,466 PATIENTS ARE ALL SCREENED, 6914 04:34:10,466 --> 04:34:12,001 DIAGNOSED, THEY GET TREATED, 6915 04:34:12,001 --> 04:34:15,939 COME TO YOUR PRACTICE, ARE THERE 6916 04:34:15,939 --> 04:34:19,008 WAYS YOU CAN OPTIMIZE NET 6917 04:34:19,008 --> 04:34:21,411 CLINICAL BENEFIT, THAT'S WHEN 6918 04:34:21,411 --> 04:34:22,879 ALL STRATEGIES ARE UNDEFINED 6919 04:34:22,879 --> 04:34:27,417 RISK OR COMMUNICATING AND SO 6920 04:34:27,417 --> 04:34:27,617 FORTH. 6921 04:34:27,617 --> 04:34:28,017 >> GOOD COMMENT. 6922 04:34:28,017 --> 04:34:30,253 DO YOU HAVE ANYTHING TO ADD? 6923 04:34:30,253 --> 04:34:31,187 >> SURE. 6924 04:34:31,187 --> 04:34:33,356 I MEAN, I WOULD JUST ADD THAT 6925 04:34:33,356 --> 04:34:35,792 THE ANSWER IS WE HAVE A LOT OF 6926 04:34:35,792 --> 04:34:37,227 GREAT TOOLS THAT NEED TO BE 6927 04:34:37,227 --> 04:34:38,528 DEVELOPED, BUT WE ACTUALLY DON'T 6928 04:34:38,528 --> 04:34:42,031 KNOW THE ANSWER TO THE QUESTION. 6929 04:34:42,031 --> 04:34:44,000 BECAUSE WE NEED TO ACTUALLY 6930 04:34:44,000 --> 04:34:48,137 EVALUATE THIS IN A ROBUST WAY, 6931 04:34:48,137 --> 04:34:49,138 AND FIND OUT. 6932 04:34:49,138 --> 04:34:50,673 AND IT GOES TO A COMMENT THAT 6933 04:34:50,673 --> 04:34:52,075 WAS IN THE CHAT BEFORE. 6934 04:34:52,075 --> 04:34:57,013 DO WE NEED THE CADILLAC OR VW 6935 04:34:57,013 --> 04:34:57,780 BEETLE? 6936 04:34:57,780 --> 04:34:58,615 WE DON'T KNOW. 6937 04:34:58,615 --> 04:35:01,384 >> I WOULD ADD ONE THING, THAT, 6938 04:35:01,384 --> 04:35:04,787 YOU KNOW, IT COULD BE A SHARED 6939 04:35:04,787 --> 04:35:06,623 DECISION MAKING PART OF THE 6940 04:35:06,623 --> 04:35:07,257 PROCESS. 6941 04:35:07,257 --> 04:35:11,861 IT CAN BE BOTH, AND, WHERE YOU 6942 04:35:11,861 --> 04:35:13,730 MIGHT WANT TO SAY YOUR 6943 04:35:13,730 --> 04:35:14,831 PRESCRIPTION IS MORE PHYSICAL 6944 04:35:14,831 --> 04:35:16,599 ACTIVITY BUT THAT PERSON MAY NOT 6945 04:35:16,599 --> 04:35:17,834 HAVE ANY DESIRE OR INCLINATION 6946 04:35:17,834 --> 04:35:20,637 TO DO THAT ARE. 6947 04:35:20,637 --> 04:35:22,505 SO IT WOULD BE BETTER TO START 6948 04:35:22,505 --> 04:35:24,040 CAN SOMETHING THEY CAN BE 6949 04:35:24,040 --> 04:35:24,674 SUCCESSFUL BEFORE MOVING ON. 6950 04:35:24,674 --> 04:35:27,543 IT HAS TO BE A PARTNERSHIP WHERE 6951 04:35:27,543 --> 04:35:30,046 THE PERSON HAS AGENCY AND OF IN 6952 04:35:30,046 --> 04:35:33,316 DECIDING WHAT THEY CAN TAKE ON 6953 04:35:33,316 --> 04:35:33,750 AS WELL. 6954 04:35:33,750 --> 04:35:35,385 >> THAT MAKES SENSE. 6955 04:35:35,385 --> 04:35:36,386 THANK YOU. 6956 04:35:36,386 --> 04:35:37,387 DR. CHANG, ANYTHING TO ADD? 6957 04:35:37,387 --> 04:35:40,757 I WANT TO MAKE SURE EVERYONE IS 6958 04:35:40,757 --> 04:35:40,957 HEARD. 6959 04:35:40,957 --> 04:35:43,593 >> YEAH, I THINK IT'S -- MAYBE 6960 04:35:43,593 --> 04:35:45,862 IT'S NOT EITHER/OR, FROM AN 6961 04:35:45,862 --> 04:35:47,664 NHLBI FUNDING PERSPECTIVE, OF 6962 04:35:47,664 --> 04:35:49,299 COURSE, THE MONEY IS, YOU KNOW, 6963 04:35:49,299 --> 04:35:52,035 FUNDING HAS TO BE ALLOCATED A 6964 04:35:52,035 --> 04:35:52,368 CERTAIN WAY. 6965 04:35:52,368 --> 04:35:55,004 YEAH, I THINK YOU HAVE TO 6966 04:35:55,004 --> 04:35:56,973 ADDRESS BOTH SIMULTANEOUSLY, YOU 6967 04:35:56,973 --> 04:35:59,509 GOT TO THINK BEYOND, WITH THE 6968 04:35:59,509 --> 04:36:01,811 PATIENTS WE HAVE A PATIENT 6969 04:36:01,811 --> 04:36:03,346 ADVISORY GROUP MEETING, AND I 6970 04:36:03,346 --> 04:36:05,081 DISCUSSED SOME OF THE A.I. 6971 04:36:05,081 --> 04:36:07,083 CONCEPTS WITH THEM, JUST TO GET 6972 04:36:07,083 --> 04:36:09,152 ANY KIND OF SENSE. 6973 04:36:09,152 --> 04:36:11,754 AND I MEAN IT SEEMS FROM A SMALL 6974 04:36:11,754 --> 04:36:13,956 SAMPLE, PATIENTS WANT TO KNOW 6975 04:36:13,956 --> 04:36:16,025 MORE INFORMATION, SO IF THERE IS 6976 04:36:16,025 --> 04:36:17,627 A WAY TO EFFECTIVELY PERSONALIZE 6977 04:36:17,627 --> 04:36:19,962 CARE WITH SOME OF THESE TOOLS, 6978 04:36:19,962 --> 04:36:21,364 THE PATIENTS DO WANT TO KNOW, 6979 04:36:21,364 --> 04:36:24,233 WHETHER IT WORKS OR NOT, THAT'S 6980 04:36:24,233 --> 04:36:24,867 THE NEXT STEP. 6981 04:36:24,867 --> 04:36:29,038 >> THAT'S A GREAT POINT. 6982 04:36:29,038 --> 04:36:29,839 GREAT POINT. 6983 04:36:29,839 --> 04:36:31,774 HERE IS MY SECOND QUESTION. 6984 04:36:31,774 --> 04:36:35,611 I'M LISTENING TO YOUR TALKS. 6985 04:36:35,611 --> 04:36:39,449 DR. LEOPOLD, YOUR TALK MADE ME 6986 04:36:39,449 --> 04:36:39,649 THINK. 6987 04:36:39,649 --> 04:36:41,317 FOR SECONDARY PREVENTION, A LOT 6988 04:36:41,317 --> 04:36:43,820 OF EVIDENCE WITH REGARDS TO 6989 04:36:43,820 --> 04:36:45,788 HYPERTENSION MANAGEMENT, YOU'VE 6990 04:36:45,788 --> 04:36:47,090 BEEN DIAGNOSED ALREADY, REALLY 6991 04:36:47,090 --> 04:36:51,594 SEEMS LIKE IT'S CENTERED IN THE 6992 04:36:51,594 --> 04:36:52,628 EHR. 6993 04:36:52,628 --> 04:37:00,136 AND OBVIOUSLY SOMEPLACE LIKE DR. 6994 04:37:00,136 --> 04:37:02,205 CHANG, GEISINGER HAS A HUGE 6995 04:37:02,205 --> 04:37:03,406 DATABASE, VERY EFFECTIVE. 6996 04:37:03,406 --> 04:37:06,142 BUT FOR PREVENTION HOW DO YOU 6997 04:37:06,142 --> 04:37:08,678 DEAL WITH THE 40-YEAR-OLD MALE, 6998 04:37:08,678 --> 04:37:10,646 MAKING IT, WHO HAS NEVER SEEN A 6999 04:37:10,646 --> 04:37:13,149 DOCTOR, NO TOUCH POINT, THEY ARE 7000 04:37:13,149 --> 04:37:15,017 NOT IN A STUDY. 7001 04:37:15,017 --> 04:37:17,286 IS A.I. OFF LIMITS TO THAT 7002 04:37:17,286 --> 04:37:17,653 PERSON? 7003 04:37:17,653 --> 04:37:20,556 WHERE I'M GOING WITH THIS, NOT 7004 04:37:20,556 --> 04:37:26,496 TO PUT YOU ON THE SPOT, WE KNOW 7005 04:37:26,496 --> 04:37:27,730 THAT SOME SOCIAL MEDIA 7006 04:37:27,730 --> 04:37:30,900 TECHNOLOGY COMPANIES ARE USING 7007 04:37:30,900 --> 04:37:32,001 ONLINE BEHAVIOR TO PREDICT WHAT 7008 04:37:32,001 --> 04:37:34,070 PEOPLE ARE GOING TO PURCHASE OR 7009 04:37:34,070 --> 04:37:36,239 EVEN WHAT MEDICAL CONDITION THEY 7010 04:37:36,239 --> 04:37:37,006 HAVE. 7011 04:37:37,006 --> 04:37:37,206 RIGHT? 7012 04:37:37,206 --> 04:37:41,077 SO, I WANTED TO ASK YOU, DR. 7013 04:37:41,077 --> 04:37:42,912 LEOPOLD, WHEN IT COMES TO 7014 04:37:42,912 --> 04:37:45,014 PRECISION HEALTH, I KNOW THERE'S 7015 04:37:45,014 --> 04:37:48,050 AN ASPIRATIONAL LIST OF DATA 7016 04:37:48,050 --> 04:37:49,252 INPUTS, CURRENTLY IN MY MIND 7017 04:37:49,252 --> 04:37:52,789 THOSE DON'T EXIST FOR PEOPLE WHO 7018 04:37:52,789 --> 04:37:54,524 ARE NOT ACCESSING RESEARCH STUDY 7019 04:37:54,524 --> 04:37:57,493 OR CLINICAL CARE, OR MAYBE I'M 7020 04:37:57,493 --> 04:37:57,693 WRONG. 7021 04:37:57,693 --> 04:37:59,796 >> NO, YOU'RE ABSOLUTELY RIGHT. 7022 04:37:59,796 --> 04:38:03,633 I MEAN, THIS IS WHERE THIS WHOLE 7023 04:38:03,633 --> 04:38:05,368 CONCEPT OF YOUR ENVIRONMENT, 7024 04:38:05,368 --> 04:38:06,636 YOUR EXPOSURES HAS TO BE 7025 04:38:06,636 --> 04:38:09,305 REALLY -- YOU HAVE TO START 7026 04:38:09,305 --> 04:38:10,740 THINKING OUTSIDE THE USUAL 7027 04:38:10,740 --> 04:38:12,241 MEASURES FOR THIS. 7028 04:38:12,241 --> 04:38:15,244 SO, YOU KNOW, IS IT SOMETHING 7029 04:38:15,244 --> 04:38:17,180 WHERE USING A.I. YOU FIND OUT 7030 04:38:17,180 --> 04:38:21,250 THAT THERE'S JUST A LINK 7031 04:38:21,250 --> 04:38:22,151 BETWEEN, SAY, PURCHASES OF 7032 04:38:22,151 --> 04:38:23,553 TYLENOL BECAUSE YOU HAVE A 7033 04:38:23,553 --> 04:38:27,290 HEADACHE AND THE HEADACHE IS 7034 04:38:27,290 --> 04:38:28,591 REALLY ATTRIBUTABLE TO 7035 04:38:28,591 --> 04:38:30,126 HYPERTENSION, OR CAN YOU -- YOU 7036 04:38:30,126 --> 04:38:32,495 KNOW, IS THERE DATA WE CAN 7037 04:38:32,495 --> 04:38:34,730 COLLECT ELSEWHERE, OUTSITE OF 7038 04:38:34,730 --> 04:38:36,833 THE EHR THAT POINTS US TOWARDS 7039 04:38:36,833 --> 04:38:38,768 SOMEONE WHO IS EITHER AT RISK OR 7040 04:38:38,768 --> 04:38:43,706 WHO IS ABLE TO -- WHO IS GOING 7041 04:38:43,706 --> 04:38:45,107 TO DEVELOP DISEASE? 7042 04:38:45,107 --> 04:38:47,844 AND, AGAIN, WE HAVE TO INTERACT 7043 04:38:47,844 --> 04:38:55,952 WITH, SAY, PEOPLE WHO UNDERSTAND 7044 04:38:55,952 --> 04:38:57,487 HUMAN BEHAVIOR, AND WHAT SHOULD 7045 04:38:57,487 --> 04:38:59,355 BE COLLECTED, WHICH ONES SHOULD 7046 04:38:59,355 --> 04:39:00,957 WE COLLECT. 7047 04:39:00,957 --> 04:39:02,625 >> THAT MAKES SENSE. 7048 04:39:02,625 --> 04:39:05,928 ANYONE ELSE HAVE ANY FEEDBACK 7049 04:39:05,928 --> 04:39:06,696 ABOUT MY QUESTION? 7050 04:39:06,696 --> 04:39:11,367 NOT MEANT TO PICK ON DR. 7051 04:39:11,367 --> 04:39:14,670 LEOPOLD. 7052 04:39:14,670 --> 04:39:15,571 ANYTHING ELSE? 7053 04:39:15,571 --> 04:39:16,606 >> I AGREE COMPLETELY. 7054 04:39:16,606 --> 04:39:18,941 THE ONLY CONCERN WOULD BE 7055 04:39:18,941 --> 04:39:19,809 PRIVACY, AND HOW APPROPRIATE IT 7056 04:39:19,809 --> 04:39:22,778 IS TO IDENTIFY THIS FEATURE, AND 7057 04:39:22,778 --> 04:39:24,180 FLAG SOMEONE, ESPECIALLY WITH 7058 04:39:24,180 --> 04:39:27,250 MISTRUST OF THE HEALTH SYSTEM OF 7059 04:39:27,250 --> 04:39:33,389 SOCIAL MEDIA ORGANIZATIONS. 7060 04:39:33,389 --> 04:39:35,358 >> THAT MAKES SENSE. 7061 04:39:35,358 --> 04:39:40,162 >> WE HAVEN'T EXPLOITED SOCIAL 7062 04:39:40,162 --> 04:39:40,596 NETWORKS. 7063 04:39:40,596 --> 04:39:42,465 THE PATIENT MIGHT HAVE PEOPLE IN 7064 04:39:42,465 --> 04:39:43,900 THEIR PERSONAL NETWORKS THEY 7065 04:39:43,900 --> 04:39:44,767 COULD INFLUENCE. 7066 04:39:44,767 --> 04:39:49,305 SO YOU MIGHT NOT BE TALKING 7067 04:39:49,305 --> 04:39:49,505 ABOUT 7068 04:39:49,505 --> 04:39:49,906 [AUDIO DISTORTION] 7069 04:39:49,906 --> 04:39:53,409 BUT YOU COULD REACH OUT TO HAVE 7070 04:39:53,409 --> 04:39:55,177 THEM INFLUENCE OTHER PEOPLE. 7071 04:39:55,177 --> 04:39:59,215 >> MAKES SENSE. 7072 04:39:59,215 --> 04:39:59,515 OKAY. 7073 04:39:59,515 --> 04:40:02,585 IF ANYONE HAS OTHER COMMENTS? 7074 04:40:02,585 --> 04:40:03,686 ONE MORE QUESTION. 7075 04:40:03,686 --> 04:40:05,755 THIS GOES BACK TO A QUESTION 7076 04:40:05,755 --> 04:40:08,958 ASKED IN AN EARLIER SESSION BUT 7077 04:40:08,958 --> 04:40:10,359 IT WAS LEFT UNANSWERED. 7078 04:40:10,359 --> 04:40:16,399 I'M NOT A DATA SCIENTIST, I'M A 7079 04:40:16,399 --> 04:40:17,133 REGULAR HYPERTENSION RESEARCHER. 7080 04:40:17,133 --> 04:40:24,340 THIS IS A MASSIVE AMOUNT MUCH 7081 04:40:24,340 --> 04:40:29,745 DATA, DATA INPUTS. 7082 04:40:29,745 --> 04:40:33,015 WE TALKED ABOUT GENETICS, 7083 04:40:33,015 --> 04:40:34,216 EPIGENETIC, INSIDE AND OUTSIDE 7084 04:40:34,216 --> 04:40:35,651 THE OFFICE BLOOD PRESSURE, 7085 04:40:35,651 --> 04:40:36,953 PREDICTOR, SO FORTH. 7086 04:40:36,953 --> 04:40:40,122 IT SEEMS OVERWHELMING. 7087 04:40:40,122 --> 04:40:43,526 WITH ALL THAT DATA, THAT WE HAVE 7088 04:40:43,526 --> 04:40:46,829 TO GO THROUGH, HOW DO WE 7089 04:40:46,829 --> 04:40:47,096 INTEGRATE? 7090 04:40:47,096 --> 04:40:49,365 WE DON'T HAVE A SYSTEM SET UP TO 7091 04:40:49,365 --> 04:40:50,433 INTEGRATE IT RIGHT NOW. 7092 04:40:50,433 --> 04:40:55,805 BUT IF YOU HAD ALL THE MONEY IN 7093 04:40:55,805 --> 04:40:58,207 THE WORLD FROM NIH, HOW WOULD 7094 04:40:58,207 --> 04:40:58,975 YOU IMPLEMENT SOMETHING? 7095 04:40:58,975 --> 04:41:01,611 WHAT DOES THE IDEA LOOK LIKE? 7096 04:41:01,611 --> 04:41:03,346 I'M THINKING 20 OR 30 YEARS IN 7097 04:41:03,346 --> 04:41:04,447 THE FUTURE. 7098 04:41:04,447 --> 04:41:06,282 JUST TRYING TO THINK PIE IN THE 7099 04:41:06,282 --> 04:41:06,482 SKY. 7100 04:41:06,482 --> 04:41:11,687 DO HAVE YOU ANY COMMENTS ABOUT 7101 04:41:11,687 --> 04:41:11,887 THAT? 7102 04:41:11,887 --> 04:41:15,257 >> I THINK SOME STUFF, SPOT ON 7103 04:41:15,257 --> 04:41:17,426 ABOUT RELATION OF EHR. 7104 04:41:17,426 --> 04:41:22,999 IF A CHATBOT DOES EXIST FOR 7105 04:41:22,999 --> 04:41:24,200 PATIENT INTERACTION, MEASUREMENT 7106 04:41:24,200 --> 04:41:28,704 CAN BE DONE FOR AMBULATORY BLOOD 7107 04:41:28,704 --> 04:41:30,439 PRESSURE MEASUREMENT AND 7108 04:41:30,439 --> 04:41:31,207 SYNTHESIZES, NOT JUST 7109 04:41:31,207 --> 04:41:32,208 AGGREGATES, CAN BE USEFUL. 7110 04:41:32,208 --> 04:41:39,115 IT JUST MEANS IT HAS TO BE 7111 04:41:39,115 --> 04:41:39,749 INDEPENDENTLY VALIDATED. 7112 04:41:39,749 --> 04:41:46,355 >> WE ALSO NEED STANDARDS. 7113 04:41:46,355 --> 04:41:46,722 STANDARDIZATION. 7114 04:41:46,722 --> 04:41:47,089 >> MAKES SENSE. 7115 04:41:47,089 --> 04:41:50,960 I DON'T KNOW HOW YOU WORK WITH 7116 04:41:50,960 --> 04:41:51,627 EHR DATA. 7117 04:41:51,627 --> 04:41:57,900 I'M NOT A DATA SCIENTIST. 7118 04:41:57,900 --> 04:42:00,636 DR. SPATZ MENTIONED SEEMS LIKE A 7119 04:42:00,636 --> 04:42:07,410 BIG EFFORT IS TO CLEAN IT FIRST. 7120 04:42:07,410 --> 04:42:15,818 ONE FINAL QUESTION FROM DR. FINE 7121 04:42:15,818 --> 04:42:16,118 FROM NHLBI. 7122 04:42:16,118 --> 04:42:18,354 DR. LEOPOLD INDICATES WHETHER 7123 04:42:18,354 --> 04:42:21,190 IMPROVEMENT CARES WOULD BE 7124 04:42:21,190 --> 04:42:23,793 HELPFUL FOR EVENTS YEARS IN THE 7125 04:42:23,793 --> 04:42:26,896 FUTURE, REQUIRING LARGE SAMPLES, 7126 04:42:26,896 --> 04:42:28,097 RANDOMIZATION OR EQUIVALENT AND 7127 04:42:28,097 --> 04:42:29,565 LONG PERIODS OF OBSERVATION. 7128 04:42:29,565 --> 04:42:31,667 WHAT ARE SOLUTIONS TO THE COST 7129 04:42:31,667 --> 04:42:32,802 OF ROBUST VALIDATION, WHAT ARE 7130 04:42:32,802 --> 04:42:38,474 NEXT STEPS? 7131 04:42:38,474 --> 04:42:39,141 HOW DO WE VALIDATE? 7132 04:42:39,141 --> 04:42:41,210 WE'RE NOT DOING A HUGE 7133 04:42:41,210 --> 04:42:43,345 RANDOMIZED TRIAL, I GUESS. 7134 04:42:43,345 --> 04:42:49,685 MAYBE, I DON'T KNOW. 7135 04:42:49,685 --> 04:42:50,252 >> NO. 7136 04:42:50,252 --> 04:42:54,190 BUT I THINK WE REALLY DO NEED AN 7137 04:42:54,190 --> 04:42:58,894 ENORMOUS SAMPLE SIZE, AND REALLY 7138 04:42:58,894 --> 04:43:00,763 TO FIGURE OUT THE DURATION OF 7139 04:43:00,763 --> 04:43:02,264 TIME THAT'S CONSIDERED 7140 04:43:02,264 --> 04:43:04,600 ACCEPTABLE AND WHAT DATA TO 7141 04:43:04,600 --> 04:43:05,501 COLLECT. 7142 04:43:05,501 --> 04:43:08,070 AND I THINK CLUES ARE GOING TO 7143 04:43:08,070 --> 04:43:09,972 COME FROM THESE VERY LARGE 7144 04:43:09,972 --> 04:43:13,242 LONGITUDINAL STUDIES, WHAT COMES 7145 04:43:13,242 --> 04:43:14,677 TO MIND IS FRAMINGHAM WHICH HAS 7146 04:43:14,677 --> 04:43:18,280 COLLECTED DATA OVER A VERY LONG 7147 04:43:18,280 --> 04:43:18,481 TIME. 7148 04:43:18,481 --> 04:43:22,852 AND, YOU KNOW, A LOT OF THESE 7149 04:43:22,852 --> 04:43:24,420 OTHER OBSERVATIONAL STUDIES THAT 7150 04:43:24,420 --> 04:43:27,456 ARE -- THAT HAVE DONE 7151 04:43:27,456 --> 04:43:28,958 OUTSTANDING JOBS PHENOTYPING 7152 04:43:28,958 --> 04:43:30,559 PATIENTS, I THINK THERE'S CLUES 7153 04:43:30,559 --> 04:43:33,596 WE HAVEN'T CONSIDERED YET. 7154 04:43:33,596 --> 04:43:35,464 7155 04:43:35,464 --> 04:43:35,965 >> THANK YOU. 7156 04:43:35,965 --> 04:43:41,036 >> FIRST AND FOREMOST I'M A 7157 04:43:41,036 --> 04:43:41,370 CARDIOLOGIST. 7158 04:43:41,370 --> 04:43:42,872 BUT I KNOW ABOUT THE TECH WORLD. 7159 04:43:42,872 --> 04:43:45,508 THIS IS WHERE THIS ACADEMIC 7160 04:43:45,508 --> 04:43:48,043 INDUSTRY COLLABORATION COULD 7161 04:43:48,043 --> 04:43:50,980 REALLY HELP, WHAT IS TECH GOOD 7162 04:43:50,980 --> 04:43:51,547 AT? 7163 04:43:51,547 --> 04:43:53,415 SCALE THINGS AND DRIVING DOWN 7164 04:43:53,415 --> 04:43:53,616 COST. 7165 04:43:53,616 --> 04:43:55,251 IS THERE INCENTIVE TO DO STUDIES 7166 04:43:55,251 --> 04:43:58,888 IN A MORE SCALABLE LOWER COST 7167 04:43:58,888 --> 04:44:08,888 WAY?